{"numRecords":"1091","DataElementQueryResults":[{"publicId":"2182403","version":"1","preferredName":"Physician Reading Imaging Study Name","preferredDefinition":"Name of the physician(s) or person(s) reading an imaging study.","longName":"MD_READ_IMAGSTUDY_NM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D703117C-880A-00CA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-01","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeNote":"2/8/13 jc Removed caBIG ACRIN CSI references;  added ACRIN Context CS/CSI.  Changed context to ACRIN.   7/14/08- Updated to support curation of ACRIN GYN CDEs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2598117","version":"1","preferredName":"Image Exam Not Performed 20 Character Text","preferredDefinition":"Text describing reason why imaging exam was not cpmpleted.","longName":"IMG_EXM_NOT_PERF_TXT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"29DDD11D-A3F2-67D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-02-19","modifiedBy":"CHILLIJ","dateModified":"2012-11-04","changeNote":"11/4/12 - moved from caBIG-ACRIN CSIs to ACRIN Context Imaging Modality-MRI CSI.  10/12/10 CDE released as part of content cleanup activities.  1/16/09 Added to CSI for ACRIN Renal DCE-MRI.  7/24/08 - updated with ACRIN DE definition as manually-curated.  7/14/08- Updated to support curation of ACRIN GYN CDEs.  3/12/08 - updated with revised DEC.  4/8/07-Added CSI for ACRIN Lung & Breast DCE-MRI use; 2/19/07 - Created to support ACRIN Breast CDE development task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2615423","version":"1","preferredName":"Image Positive Finding Previous Exam Number Code","preferredDefinition":"A numeric code indicating if the current observation confirming the presence of a disease/condition occurred prior to the current evaluation on a previous image study. [Manually-curated]","longName":"2615165v1.0:2615166v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C9568F9-E9BE-5E9A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-26","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-03-26","modifiedBy":"CHILLIJ","dateModified":"2012-11-06","changeNote":"11/6/12 jc Released, change to ACRIN context; associate with Image Finding CSI; remove from caBIG ACRIN CSI. 3/26/07 - Created to support ACRIN Breast CDE development task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2615477","version":"1","preferredName":"Image Positive Lesion Vertical Measurement","preferredDefinition":"The upright measurement of a positive observation in an imaging study.","longName":"2614653v1.0:2615204v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C979B79-89E6-4597-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-26","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-03-26","modifiedBy":"ZHANGWE","dateModified":"2013-10-10","changeNote":"10/8/13 released for reuse by BOLD. jc 11/6/12 jc Add to ACRIN Old Content CSI; remove from caBIG ACRIN CSI  3/26/07 - Created to support ACRIN Breast CDE development task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738602","version":"1","preferredName":"MRI Gadolinium Manual Injection Rate Value","preferredDefinition":"If gadolinium was manually injected, provide the Injection rate.","longName":"MRI_GD_MAN_INJCT_RT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49DAB8D6-C873-39E7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-04-01","modifiedBy":"CHILLIJ","dateModified":"2012-11-04","changeNote":"11/4/12 jc  Add to ACRIN Context Imaging Modality-MRI CSI; remove from caBIG ACRIN CSIs.  1/20/09 Added to CSI for ACRIN Renal DCE-MRI.  1/13/09 Released to support C3D Adopter reuse request.  3/31/08 - created to support ACRIN Breast DCE-MRI data elements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2738604","version":"1","preferredName":"MRI Gadolinium Type Code","preferredDefinition":"A numeric code to identify the Gadolinium-based agent used for MR imaging.","longName":"MRI_GD_TP_CD","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49DAE7B4-213F-431E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-04-01","modifiedBy":"CHILLIJ","dateModified":"2013-11-12","changeNote":"11/12/13 released as part of draft content review; related other specify CDE 2746417 already released. jc  1/24/13 Edit to definition. 11/16/12 jc moved from caBIG to ACRIN context; Add to ACRIN-Imaging Modality-MRI CSI; remove references to caBIG ACRIN CSIs.  3/31/08 - created to support ACRIN Breast DCE-MRI data elements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2746546","version":"1","preferredName":"MRI Gadolinium Not Complete Other Specify","preferredDefinition":"Other reason DCE-MRI portion with Gadolinium was not completed.","longName":"MRI_Gd_NOT_COMP_OTH","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C48F92E-7F20-4EEE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-30","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-02","modifiedBy":"CHILLIJ","dateModified":"2012-11-04","changeNote":"11/4/12 jc  Add to ACRIN Context Imaging Modality-MRI CSI; remove from caBIG ACRIN CSIs.  1/16/09 Added to CSI for ACRIN Renal DCE-MRI.  1/6/08 - released for use in a C3D study; still needs final review an approval from ACRIN.  4/30/08 - created for ACRIN Breast DCE/MRI 6676-M3 & 6676-M4.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2747195","version":"1","preferredName":"Magnet Manufacturer Type","preferredDefinition":"A response for the manufacturer/vendor of equipment used for the image acquisition.","longName":"2746398v1.0:2746394v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C931591-254D-373B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-06","modifiedBy":"TAYLORT","dateModified":"2015-07-06","changeNote":"7/6/15 CE in use; released as part of the 3Q2015 draft content review /tt_2/21/14 edit to definition. tt 12/10/12 edit to definition 12/4/12 jc removed manually-curate from definition.  11/4/12 - moved from caBIG-ACRIN CSIs to ACRIN Context Imaging Modality-MRI CSI; remove from caBIG ACRIN CSIs. 1/6/08   Added CSI for Renal DCE-MRI study (ACRIN 6676; ECOG 2804)  5/1/08 - created for ACRIN DCE-MRI study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2747198","version":"1","preferredName":"Magnet Manufacturer Other Specify Text","preferredDefinition":"Magnet manufacturer other than specified within provided list.","longName":"MAGNET_MANU_OTH_SPEC","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C931591-2582-373B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-06","modifiedBy":"TAYLORT","dateModified":"2015-07-07","changeNote":"7/7/15 change to VD/ACRIN and released as part of the 3Q2015 draft content review /t_12/4/12 jc removed manually-curated from definition.  11/16/12 jc  moved from caBIG to ACRIN Context-Imaging Modality-MRI CSI; remove caBIG ACRIN CSIs.  5/1/08 - created for ACRIN DCE-MRI study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2750995","version":"1","preferredName":"MRI Magnetic Field Strength Tesla Float","preferredDefinition":"The MRI magnet field strength measured in tesla (T).","longName":"2666743v1.0:2750577v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DB6125A-402F-03C2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-20","modifiedBy":"JKNABLE","dateModified":"2023-10-18","changeNote":"TL released 2/23/22.; 11/4/12 jc  Add to ACRIN Context Imaging Modality-MRI CSI; remove from caBIG ACRIN CSIs.  1/20/09 Added to CSI for ACRIN Renal DCE-MRI.  5/20/08 - created for ACRIN DCE-MRI data element","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2751241","version":"1","preferredName":"MRI Receive Coil Name 20 Character Text","preferredDefinition":"Coil of the RF receiver;\"picks up\" the NMR signal.","longName":"2749658v1.0:2666627v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DBF1AC5-8C7F-4443-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-21","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-21","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 1/6/08   Added CSI for Renal DCE-MRI study (ACRIN 6676; ECOG 2804)  5/20/08 - created for ACRIN DCE-MRI data element","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2751544","version":"1","preferredName":"Tumor Post Gadolinium Delayed Image Enhancement Category","preferredDefinition":"A response for questions to capture tumor enhancement on delayed imaging after the administration of Gadolinium.","longName":"2750870v1.0:2750560v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DD6FFD5-5B9C-3DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-22","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-05-22","modifiedBy":"TAYLORT","dateModified":"2015-07-09","changeNote":"7/9/15 released as part of the 3Q2015 draft content review/TT_11/4/12 - moved from caBIG-ACRIN CSIs to ACRIN Context Imaging Modality-MRI CSI; remove from caBIG ACRIN CSIs. 1/21/09 Added to CSI for ACRIN Renal DCE-MRI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2768313","version":"1","preferredName":"Radiologist Subsequent Reading Event Date","preferredDefinition":"Date images were re-read per protocol requirements by a Radiologist.  [Manually_curated]","longName":"2768205v1.0:2613867v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"52AFED9A-8FA6-2724-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-17","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-07-23","modifiedBy":"CHILLIJ","dateModified":"2013-08-12","changeNote":"2/13/13 jc Removed caBIG ACRIN CSI references; added ACRIN Context CS/CSI.  Changed context to ACRIN.  10/14/10 released as part of draft CDE cleanup activity.  7/24/08 Added to ACRIN GYN CT-MRI CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2775554","version":"1","preferredName":"Primary Tumor Lower Uterus Segment Indicator","preferredDefinition":"The original tumor._Lower; the bottom one of two._The hollow muscular organ in which the impregnated ovum is developed into the child; it is about 7.5 cm in length in the nonpregnant woman, and consists of a main portion (body) with an elongated lower part (neck), at the extremity of which is the opening (os). The upper rounded portion of the uterus, opposite the os, is the fundus, at each extremity of which is the horn marking the part where the uterine tube joins the uterus and through which the ovum reaches the uterine cavity after leaving the ovary. The organ is supported in the pelvic cavity by the broad ligaments, round ligaments, cardinal ligaments, and rectouterine and vesicouterine folds or ligaments. SYN metra, womb._One of the parts into which something naturally divides._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"2774869v1.0:2774650v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54F6EC70-ED1C-05DC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-21","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-08-21","modifiedBy":"TSESU","dateModified":"2018-07-02","changeNote":"10/20/11 released for reuse by TCGA.  8/21/08   - Created to support curation of ACRIN GYN MRI data elements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"2950086","version":"1","preferredName":"Person Malignant Neoplasm Clinical Trial Eligibility Criteria Type","preferredDefinition":"The type of a person's cancer, diseases in which abnormal cells divide without control, as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"MALNEO_ELIG_TP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74F8AF0F-ECB1-C21E-E040-BB89AD430CC6","latestVersionIndicator":"Yes","beginDate":"2009-10-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-10-02","modifiedBy":"TSESU","dateModified":"2023-05-09","changeNote":"2/8/18 edit to short name to allow ownership transfer from CTEP to ECOG-ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3151936","version":"1","preferredName":"Radiofrequency Ablation Not Complete Reason","preferredDefinition":"A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._An operation in which a term denies or inverts the meaning of another term or construction._A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates._An operation in which a term denies or inverts the meaning of another term or construction._Complete; having every necessary or normal part or component or step; or having come or been brought to a conclusion._An explanation of the cause of some phenomenon or action.","longName":"3151931v1.0:2830685v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9302DC8C-2C1D-549E-E040-BB89AD432202","latestVersionIndicator":"Yes","beginDate":"2010-10-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-10-19","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 1/23/13 jc Removed caBIG ACRIN CSI references; change context to \"ACRIN\"; add to Under Review -> Old caBIG content CSI.  10/19/10 CDE created using orphan VD as part of content cleanup activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3151937","version":"1","preferredName":"Radiofrequency Ablation Not Complete Other Specify","preferredDefinition":"A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates._Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"3151931v1.0:2666713v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9302DC8C-2C4C-549E-E040-BB89AD432202","latestVersionIndicator":"Yes","beginDate":"2010-10-19","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-10-19","modifiedBy":"CHILLIJ","dateModified":"2013-01-25","changeNote":"1/23/13 jc Removed caBIG ACRIN CSI references; change context to \"ACRIN\"; add to Under Review -> Old caBIG content CSI.  10/19/10 CDE created using orphan VD as part of content cleanup activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3268680","version":"1","preferredName":"Hepatocellular Carcinoma (HCC) Barcelona Criteria Confirmation Barcelona Criteria Type","preferredDefinition":"A malignant tumor that arises from hepatocytes._A method to diagnosis hepatocellular carcinoma based on radiological findings, alfa-fetoprotein level and biopsy._Having been established or verified._A method to diagnosis hepatocellular carcinoma based on radiological findings, alfa-fetoprotein level and biopsy._Type; a subdivision of a particular kind of thing.","longName":"2834291v1.0:2834421v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABF789AC-7B23-F38D-E040-BB89AD436BF3","latestVersionIndicator":"Yes","beginDate":"2011-09-02","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2011-09-02","modifiedBy":"CHILLIJ","dateModified":"2013-11-12","changeNote":"11/12/13 retired as part of draft content review. jc  11/27/12 jc   Old caBIG ACRIN content moved to ACRIN context; Disease Site -> Abdominal  9/2/11 created as part of orphan content cleanup.  To be reviewed by ACRIN.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3343150","version":"1","preferredName":"PET Preparation Performed Code","preferredDefinition":"A coded numeric response to ask if the patient was prepped for the PET procedure.","longName":"3342757v1.0:3342470v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5BC642C-C2C3-EE70-E040-BB89AD434150","latestVersionIndicator":"Yes","beginDate":"2012-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-04","modifiedBy":"GARRIDOJ","dateModified":"2021-05-27","changeNote":"9/18/13 edit to definition and CSI. tt 2/27/13 jc new ACRIN Code VD associated with CDE.  1/4/12: ACRIN 6700","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3357837","version":"1","preferredName":"Patient Gender Age Assessment No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) related to the gender and age of a patient.","longName":"3357819v1.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E49C51-B2A1-51A6-E040-BB89AD4318A6","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-19","modifiedBy":"TAYLORT","dateModified":"2017-12-15","changeNote":"12/15/17 t changed registration status to Application/BR. 1/19/12-Curated for 6701. 3/14/12 Approved for Release.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3364903","version":"1","preferredName":"PET Peak Aorta SUV Value","preferredDefinition":"A numeric value to represent the peak aorta Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_PK_AOR_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B760FF6C-6CD0-BBA5-E040-BB89AD437721","latestVersionIndicator":"Yes","beginDate":"2012-01-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-25","modifiedBy":"TAYLORT","dateModified":"2017-06-14","changeNote":"6/14/17 tt edit to LN, SN, def, CSI and released CDE. 1/25/12 - created for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3364907","version":"1","preferredName":"PET Maximum Aorta SUV Value","preferredDefinition":"A numeric value to represent the maximum aorta Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_MAX_AOR_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B760FF6C-6D24-BBA5-E040-BB89AD437721","latestVersionIndicator":"Yes","beginDate":"2012-01-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-25","modifiedBy":"COOPERM","dateModified":"2017-07-13","changeNote":"6/14/17 tt, edit to LN, SN, def, and CSI. Released CDE. 1/25/12-created for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3365783","version":"1","preferredName":"PET Peak Normal Liver SUV Value","preferredDefinition":"A numeric value to represent the peak normal liver Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_PK_NL_LVR_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B770E734-E5E2-A6CD-E040-BB89AD4312BC","latestVersionIndicator":"Yes","beginDate":"2012-01-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-26","modifiedBy":"TAYLORT","dateModified":"2017-06-14","changeNote":"6/14/17 tt edit to LN, SN, def, CSI and released CDE. 1/26/12 - created for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3365920","version":"1","preferredName":"PET Maximum Normal Liver SUV Value","preferredDefinition":"A numeric value to represent the maximum normal liver Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_MAX_NL_LVR_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B771AF0F-45D2-01C6-E040-BB89AD430F54","latestVersionIndicator":"Yes","beginDate":"2012-01-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-26","modifiedBy":"COOPERM","dateModified":"2017-07-13","changeNote":"6/14/17 tt edit to LN, SN, def, CSI and released CDE. 6/6/17 jk added MCL CSI. 1/26/12-curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3366222","version":"1","preferredName":"PET Peak SUV Value","preferredDefinition":"A numeric value to represent the peak Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_PK_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7751881-D0A3-80B4-E040-BB89AD4306A7","latestVersionIndicator":"Yes","beginDate":"2012-01-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-01-26","modifiedBy":"TAYLORT","dateModified":"2017-06-14","changeNote":"6/14/17 tt edit to LN, SN, def, CSI and released CDE. 1/26/12-created for PET.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3373295","version":"1","preferredName":"Transrectal Ultrasound Biopsy of Prostate Performed Date","preferredDefinition":"The date of the prostate transrectal ultrasound guided biopsy.","longName":"3373290v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B876EBB1-CBA7-482B-E040-BB89AD431EF9","latestVersionIndicator":"Yes","beginDate":"2012-02-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-08","modifiedBy":"CHILLIJ","dateModified":"2013-08-12","changeNote":"2/8/12 Curated for 6701. 3/15/12 Approved for realease 3/14/12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3373508","version":"1","preferredName":"Minimal Tumor Burden Gleason Score for Prostate Cancer Criteria No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) related to the personal medical history Minimal Tumor Burden Gleason Score criteria of a specific clinical trial.","longName":"3373501v1.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B87AA3B1-709B-42EC-E040-BB89AD431805","latestVersionIndicator":"Yes","beginDate":"2012-02-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-08","modifiedBy":"CHILLIJ","dateModified":"2013-08-12","changeNote":"2/8/12 Curated for 6701. 3/15/12 Approved for release 3/14/12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3377229","version":"1","preferredName":"Image Exam Negation Commence Reason Image Negation Commence Reason","preferredDefinition":"Any record of an imaging event whether physical or electronic._An appraisal or evaluation of a patient's condition by a physician or registered nurse, based on clinical and laboratory data, medical history, and the patient's account of symptoms.  2. The process by which a patient's condition is appraised or evaluated. (Taber's)_An operation in which a term denies or inverts the meaning of another term or construction._To cause to start._An explanation of the cause of some phenomenon or action._A grouping to describe why the imaging exam was not initiated.","longName":"3377218v1.0:3377228v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B8A25445-0B55-EFF7-E040-BB89AD4372E4","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-10","modifiedBy":"TAYLORT","dateModified":"2013-06-12","changeNote":"6/12/13 - released, updated CSIs. tt  2/19/13 - added 6701 CSI. jc  2/10/12 curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3377604","version":"1","preferredName":"PET Foley Catheter Placed No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) which indicates if the Foley catheter was in place for the scan.","longName":"2717431v2.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8EEC817-0236-4924-E040-BB89AD431763","latestVersionIndicator":"Yes","beginDate":"2012-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-14","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/14/12-curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3377627","version":"1","preferredName":"PET Urination Prior Imaging Agent No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) which indicates if the patient voided prior to injection of an imaging agent [e.g. FDG] and imaging.","longName":"2716518v2.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8EE9528-271E-ECE1-E040-BB89AD4354FD","latestVersionIndicator":"Yes","beginDate":"2012-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-14","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/14/12-curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3377628","version":"1","preferredName":"PET Urination Post Imaging Agent No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) which indicates if the patient voided post injection of an imaging agent [e.g. FDG] and imaging.","longName":"2717427v2.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8EE9528-274A-ECE1-E040-BB89AD4354FD","latestVersionIndicator":"Yes","beginDate":"2012-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-14","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/14/12-curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3379101","version":"1","preferredName":"PET Isotope Begin Dose Assay 24 HR Time","preferredDefinition":"Time at which dose assay was drawn.  An example of time is 23:59:59 which represents the time one second before midnight.","longName":"2716501v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9163F61-AAC6-188C-E040-BB89AD435BED","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-16","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/16/12_new time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3379114","version":"1","preferredName":"PET Blood Glucose Measurement 24 HR Time","preferredDefinition":"Time at which the blood sample was obtained for glucose measurement._An example time is 23:59:59 which represents the time one second before midnight.","longName":"3162382v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9163F61-AC3B-188C-E040-BB89AD435BED","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-16","modifiedBy":"TAYLORT","dateModified":"2015-07-24","changeNote":"7/24/15 edit to CSI, released as part of the 3Q2015 draft content review/TT_ E2410_2/16/12_new time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3379115","version":"1","preferredName":"PET Isotope Injection 24 HR Time","preferredDefinition":"Time at which the imaging agent was injected.  An example of time is 23:59:59 which represents the time one second before midnight.","longName":"2685137v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9163F61-AC62-188C-E040-BB89AD435BED","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-16","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/16/12 new time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3379149","version":"1","preferredName":"PET Isotope Residual Dose Assay 24 HR Time","preferredDefinition":"Time at which the radioactivity measurement of the syringe after injection was performed. An example of time is 23:59:59 which represents the time one second before midnight.","longName":"2716770v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B918418C-40AC-2C3C-E040-BB89AD430EB9","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-16","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/16/12 New time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3379343","version":"1","preferredName":"Injection Administered 24 HR Time","preferredDefinition":"Time at which the agent was injected._An example of time is 23:59:59 which represents the time one second before midnight.","longName":"3110292v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B91A08CE-C9CE-784E-E040-BB89AD435DD1","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-16","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 8/2/13 removed CSI to CRF Standard module; using CDE 2718362.  7/3/13 associated with CT Imaging Agent CRF CSI; added alt question. jc  2/16/12 New time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3380276","version":"1","preferredName":"Emission Scan Start Time","preferredDefinition":"The emission scan start time recorded in the 24 hour format.  Precision can be truncated by omitting the seconds or both the seconds and minutes (23:59 or 23).","longName":"2716731v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B97CA559-A366-BAA9-E040-BB89AD430252","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-21","modifiedBy":"RICHARDS","dateModified":"2020-04-02","changeNote":"10/9/13 added to PET Emission CRF CSI. jc 10/8/13 - definition updated; comment added to support Round 4 community comments. jc  2/21/12 New time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3380277","version":"1","preferredName":"Emission Scan Stop Time","preferredDefinition":"The emission scan stop time recorded in the 24 hour format. Precision can be truncated by omitting the seconds or both the seconds and minutes (23:59 or 23).","longName":"2716734v1.0:3379100v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B97CA559-A38D-BAA9-E040-BB89AD430252","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-21","modifiedBy":"TAYLORT","dateModified":"2021-06-08","changeNote":"6/8/21 TL corrected typo in definition. 10/8/13 - definition updated; comment added to support Round 4 community comments. jc   2/21/12 Curated for new time format.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3382544","version":"1","preferredName":"Imaging Case Report Form Data Completed Received No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) to confirm the completeness and receipt of the imaging related data.","longName":"3382539v1.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9903CB2-BE00-A3CE-E040-BB89AD43018B","latestVersionIndicator":"Yes","beginDate":"2012-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-22","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 2/22/12 Core lab QC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3382779","version":"1","preferredName":"PET Prior To Image Fasting Ind","preferredDefinition":"A response to ask if the patient abstained from food intake prior to a PET imaging event.","longName":"2714881v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B992C3D9-6E6B-EBAF-E040-BB89AD4335BB","latestVersionIndicator":"Yes","beginDate":"2012-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-02-22","modifiedBy":"TAYLORT","dateModified":"2015-10-26","changeNote":"10/26/15 edit to draft new long name and def.; released as part of draft new content review.tt_2/22/12 Core lab QC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3399876","version":"1","preferredName":"Agent Administered Prior to FDG Hour Count","preferredDefinition":"A numerical quantity to represent the number of hours an agent or drug was given to an individual prior to FDG administration.","longName":"3399866v1.0:3399893v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA4A5DD5-2B8B-64D7-E040-BB89AD433773","latestVersionIndicator":"Yes","beginDate":"2012-03-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-02","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/2/12 Curated for 6700.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3399919","version":"1","preferredName":"Minimal Tumor Burden PSA Criteria No Yes Coded Indicator","preferredDefinition":"A coded numeric response for No (1) or Yes (2) related to the personal medical history Minimal Tumor Burden PSA criteria of a specific clinical trial.","longName":"3399918v1.0:2598021v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BA575F47-F589-6028-E040-BB89AD436132","latestVersionIndicator":"Yes","beginDate":"2012-03-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-03","modifiedBy":"TAYLORT","dateModified":"2012-03-15","changeNote":"3/3/12 Curated for 6701. 3/15/12 Approved for release 3/14/12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3399945","version":"1","preferredName":"Image Submission Mode Type","preferredDefinition":"A response to represent how the image was submitted (transferred) from one organization or institution to another.","longName":"3399940v1.0:3399942v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA6DF582-4530-8442-E040-BB89AD43325F","latestVersionIndicator":"Yes","beginDate":"2012-03-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-04","modifiedBy":"TAYLORT","dateModified":"2015-07-23","changeNote":"7/23/15 released as part of the 3Q2015 draft content review/TT_3/21/14 edit to draft new CDE. tt  3/4/12 Curated for Core Lab. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3407238","version":"1","preferredName":"Imaging Agent Hypersensitivity Pretreatment Ind","preferredDefinition":"A response for questions related to premedication regimen(s) to reduce the frequency and/or severity of reactions to imaging contrast agents. The premedication regimen may be dictated by any of the following: research protocol, institution policy, American College of Radiology (ACR), or other governing agencies.","longName":"3407235v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA9AFF68-9A9A-7F57-E040-BB89AD434DAF","latestVersionIndicator":"Yes","beginDate":"2012-03-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-06","modifiedBy":"FORMBUILDER","dateModified":"2018-05-14","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14 edit to def. tt 1/14/14 changed VD and def. cb 3/6/12 Curated for imaging trials.tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3419980","version":"1","preferredName":"PET Isotope Time Dose Assay Value","preferredDefinition":"The quantity of a substance (such as a radioisotope) drawn/extracted into a syringe measured in milliCuries (mCi).","longName":"3419979v1.0:2716752v2.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"BBC72239-4598-7571-E040-BB89AD43452C","latestVersionIndicator":"Yes","beginDate":"2012-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-21","modifiedBy":"TSESU","dateModified":"2017-03-08","changeNote":"11/1/13 released. jc 10/13/13 Associated with PET Imaging Agent CRF per round 4 comments. jc  3/21/12 Curated for PET","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3419986","version":"1","preferredName":"PET Isotope Injection Time Dose Assay Value","preferredDefinition":"The quantity of a substance (such as a radioisotope) at the time of injection measured in milliCuries (mCi).","longName":"3419985v1.0:2716752v2.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"BBC72239-468F-7571-E040-BB89AD43452C","latestVersionIndicator":"Yes","beginDate":"2012-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-21","modifiedBy":"TSESU","dateModified":"2017-03-08","changeNote":"11/1/13 released. jc 10/13/13 associated w/PET Imaging CRF CSI, added DICOM Alt Name and definition. jc 3/21/12 Curated for PET","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3423505","version":"1","preferredName":"PET Maximum SUV Value","preferredDefinition":"A numeric value to represent the maximum Standard Uptake Value (SUV) for PET imaging assessment.","longName":"PET_MAX_SUV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC51AB54-C941-9172-E040-BB89AD4342FE","latestVersionIndicator":"Yes","beginDate":"2012-03-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-28","modifiedBy":"TAYLORT","dateModified":"2017-06-14","changeNote":"6/14/17 tt edit to LN, SN, def, and released CDE.  6/6/17 jk Added MCL CSI. 3/28/12 Curated for PET.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3424155","version":"2","preferredName":"Image Submission Type","preferredDefinition":"The type of image method or procedure submitted.","longName":"3424103v1.0:2201767v1.1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D917E208-3419-1158-E053-4EBD850AB1F5","latestVersionIndicator":"Yes","beginDate":"2012-03-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-28","modifiedBy":"KUMMEROA","dateModified":"2022-02-28","changeNote":"2022-2-28 ak Versioned for VD v1.1 association. 7/23/15 released as part of the 3Q2015 draft content review/TT_3/28/12 Core Lab QC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3425312","version":"1","preferredName":"Image Submission Other Specify Text","preferredDefinition":"A textual reason not listed describing the image(s) submitted.","longName":"3424103v1.0:2857322v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC62B6C9-DDB8-A712-E040-BB89AD432413","latestVersionIndicator":"Yes","beginDate":"2012-03-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-03-29","modifiedBy":"TAYLORT","dateModified":"2015-07-23","changeNote":"7/23/15 edit to long name, released as part of the 3Q2015 draft content review/TT_3/29/12 Core Lab QC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3628821","version":"1","preferredName":"Imaging Agent Prior Administered Ind","preferredDefinition":"A response for questions addressing the previous administration of imaging agent(s).","longName":"3625360v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEEF3173-5BC0-B93D-E040-BB89AD430A39","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2012-11-20","modifiedBy":"TAYLORT","dateModified":"2015-07-23","changeNote":"7/22/15 edit to long name and def. released/2015 clean up/TT_2/19/13-added 6701 CSI. jc 11/20/12 Curated for MRI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3666959","version":"1","preferredName":"Malignant Neoplasm Confirmation Surgical Procedure Assessment Ind","preferredDefinition":"A response for questions related to the confirmation of malignant disease and surgical procedure evaluations.","longName":"3666958v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D46F3152-DB94-606C-E040-BB89AD431120","latestVersionIndicator":"Yes","beginDate":"2013-01-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-01-29","modifiedBy":"TAYLORT","dateModified":"2015-07-24","changeNote":"7/24/15 edit/released as part of the 3Q2015 draft content review/TT_1/29/13 Curated for imaging trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3756780","version":"1","preferredName":"Protocol Therapy Second Treatment Step Protocol Treatment Arm Assignment Type","preferredDefinition":"the type of treatment assigned during the specific treatment protocol used in the second arm or stage of progression through a sequential treatment protocol_Type; a subdivision of a particular kind of thing","longName":"ST2_PROT_TX_REC","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC999977-833A-DF0D-E040-BB89AD435D9D","latestVersionIndicator":"Yes","beginDate":"2013-05-13","endDate":null,"createdBy":"VIENNEAM","dateCreated":"2013-05-13","modifiedBy":"GARRIDOJ","dateModified":"2019-09-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3788242","version":"1","preferredName":"Dynamic Enhanced CT Scan Late Arterial Indicator","preferredDefinition":"A response of yes or no to indicate if the dynamic enhanced CT scan occured after an advanced period of time or after a usual or expected time in the vessels carrying blood away from the heart.","longName":"3788234v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF785C19-CF73-374A-E040-BB89AD4351BA","latestVersionIndicator":"Yes","beginDate":"2013-06-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-06-18","modifiedBy":"TAYLORT","dateModified":"2015-07-06","changeNote":"7/6/15 released as part of the 3Q2015 draft content review /tt_6/18/13 created for Round 5 Imaging CRF variable. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3788243","version":"1","preferredName":"Dynamic Enhanced CT Scan Portal Venous Indicator","preferredDefinition":"A response of yes or no to indicate if the dynamic enhanced CT scan occured in the system of vessels in which blood, after passing through one capillary bed, is conveyed through a second set of capillaries before it returns to the systemic circulation.","longName":"3788238v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF785C19-CF94-374A-E040-BB89AD4351BA","latestVersionIndicator":"Yes","beginDate":"2013-06-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-06-18","modifiedBy":"TAYLORT","dateModified":"2015-07-09","changeNote":"7/9/15 released as part of the 3Q2015 draft content review/TT_6/18/13 created for Round 5 Imaging CRF variable. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3788244","version":"1","preferredName":"Dynamic Enhanced CT Scan Delayed Phase Indicator","preferredDefinition":"A response of yes or no to indicate if the dynamic enhanced CT scan occured after some perscribed time in a sequence of events.","longName":"3788241v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF785C19-CFB5-374A-E040-BB89AD4351BA","latestVersionIndicator":"Yes","beginDate":"2013-06-18","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-06-18","modifiedBy":"TAYLORT","dateModified":"2015-07-06","changeNote":"7/6/15 released as part of the 3Q2015 draft content review/tt_ 6/18/13 created for Round 5 Imaging CRF variable. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3809557","version":"1","preferredName":"Squamous Cell Carcinoma Confirmation Ind","preferredDefinition":"A response to address the confirmation of squamous cell carcinoma (SCC).","longName":"3809553v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E1055E6D-D576-080A-E040-BB89AD431B58","latestVersionIndicator":"Yes","beginDate":"2013-07-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-08","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 released DEC. tt 1/14/14 changed VD and def. tt 9/17/13 changed in VD. tt 7/8/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813682","version":"1","preferredName":"Lymph Node Dissection Planned Ind","preferredDefinition":"A response to address whether lymph node dissection is planned.","longName":"3813681v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E22F9419-A79E-9CC4-E040-BB89AD435459","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt 9/17/13 change in VD. tt 7/23/13 curated for ACRIN trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813696","version":"1","preferredName":"Prior Image Performed Ind","preferredDefinition":"A response to address if previous imaging was performed.","longName":"3813695v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E230491E-AC0B-A33F-E040-BB89AD434A25","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"LOWMAND","dateModified":"2016-04-25","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt  9/17/13 change to VD.  tt  7/23/13 curated for ACRIN trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813723","version":"1","preferredName":"Head and Neck Neoplasm Assessment Ind","preferredDefinition":"A response to questions related to the assessment of head and neck tumor(s).","longName":"3828955v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E230491E-AE37-A33F-E040-BB89AD434A25","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt 9/17/13 change to VD. tt  7/23/13 curated for 6685.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813740","version":"1","preferredName":"Squamous Cell Carcinoma T1 Stage Finding Ind","preferredDefinition":"A response for questions related to T stage findings of Squamous Cell Carcinoma (SCC).","longName":"3813739v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E23149E3-F4DD-3C08-E040-BB89AD434FB8","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; release CDE. tt 1/14/14 change to VD and def. tt 9/17/13 change to VD. tt  7/23/13 curated for 6685.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813768","version":"1","preferredName":"Neck Dissection Clinical Assessment Ind","preferredDefinition":"A response regarding the clinical assessment of neck dissection.","longName":"3813767v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E23149E3-F523-3C08-E040-BB89AD434FB8","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_1/14/14 changed VD and def. tt 9/17/13 change to VD. tt  7/23/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3813824","version":"1","preferredName":"Malignant Neoplasm Diagnosis Anatomic Site","preferredDefinition":"A respsonse related to the site(s) of cancer diagnosis.","longName":"3813790v1.0:3813817v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E234DFE3-4DCA-EF02-E040-BB89AD435584","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_1/14/14 change to VD and def. tt 7/23/13 curated for 6685.tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3821170","version":"1","preferredName":"Sinonasal Carcinoma Diagnosis Ind","preferredDefinition":"A response related to the diagnosis of sinonasal carcinoma.","longName":"3821166v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E246759E-4EF6-8CF4-E040-BB89AD431380","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"MORENOC","dateModified":"2017-09-21","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/17/13 change to VD. tt  7/24/13 curated for 6685.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3821190","version":"1","preferredName":"Squamous Cell Carcinoma Diagnosis Negation Ind","preferredDefinition":"A response related to the absence of Squamous Cell Carcinoma (SCC).","longName":"3821185v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E246759E-4FA7-8CF4-E040-BB89AD431380","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt 7/24/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3821198","version":"1","preferredName":"Salivary Gland Malignant Neoplasm Diagnosis Ind","preferredDefinition":"A response related to the diagnosis of salivary gland malignancies.","longName":"3821197v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E246E39C-AACC-59FC-E040-BB89AD436B49","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt 7/24/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3821201","version":"1","preferredName":"Thyroid Gland Carcinoma Diagnosis Ind","preferredDefinition":"A response related to the diagnosis of thyroid cancer.","longName":"3821200v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E246E39C-AB0C-59FC-E040-BB89AD436B49","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt  7/23/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3822968","version":"1","preferredName":"Skin Carcinoma Advanced Malignant Neoplasm Diagnosis Ind","preferredDefinition":"A response related to the diagnosis of advanced skin cancer.","longName":"3822954v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E247D1AF-E47E-3B28-E040-BB89AD435C97","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt  7/24/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3822973","version":"1","preferredName":"Nasopharyngeal Carcinoma Diagnosis Ind","preferredDefinition":"A response related to the diagnosis of nasopharyngeal carcinoma.","longName":"3822972v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E247D1AF-E4B5-3B28-E040-BB89AD435C97","latestVersionIndicator":"Yes","beginDate":"2013-07-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-24","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt  7/24/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3827032","version":"1","preferredName":"Equipment Body Weight Assessment Ind","preferredDefinition":"A response for questions related to the patient's body weight meeting the requirements of the imaging system or other types of equipment.","longName":"3826694v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E270AA46-A8E2-57BE-E040-BB89AD43286E","latestVersionIndicator":"Yes","beginDate":"2013-07-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-26","modifiedBy":"FORMBUILDER","dateModified":"2018-05-14","changeNote":"2/7/14 ADSC approved & released. tt 1/14/14 change to VD and def. tt 7/26/13 curated for imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3830634","version":"1","preferredName":"Hepatocellular Carcinoma Unifocal Lesion Measurement Ind","preferredDefinition":"A response for questions related to the unifocal lesion measurement of HCC.","longName":"3830633v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2C1C6D1-460D-C3BD-E040-BB89AD430D9A","latestVersionIndicator":"Yes","beginDate":"2013-07-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-30","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; CDE released. tt 1/14/14 change to DEC, VD and def. tt 7/30/13 Curated for imaging trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3835451","version":"1","preferredName":"Surgery Contraindication Ind","preferredDefinition":"A response related to contraindication(s) to surgery.","longName":"3835429v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2D4EE9A-C589-6D35-E040-BB89AD431416","latestVersionIndicator":"Yes","beginDate":"2013-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-31","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 change to VD and def. tt 9/18/13 change to VD. tt  7/31/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3837333","version":"1","preferredName":"Multifocal Hepatocellular Carcinoma Present Ind","preferredDefinition":"A response for questions related to the presence of multifocal HCC.","longName":"3837324v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2FB0FAF-A536-1085-E040-BB89AD435DED","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-02","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE tt 1/23/14 edit to def. tt 1/15/14 changed VD and def. cb 8/2/13 curated for 6690.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3837338","version":"1","preferredName":"Multiple Hepatocellular Carcinoma Tumor Measurement Ind","preferredDefinition":"A response for questions related to the presence of multiple HCCs and tumor size.","longName":"3837337v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2FB0FAF-A5BC-1085-E040-BB89AD435DED","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-02","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; CDE released. tt 1/23/14 edit to def. tt 1/15/14 changed VD and def. cb 9/26/13 edit to draft new long name.  tt 8/2/13 curated for 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3837371","version":"1","preferredName":"Liver Ablation Performed Ind","preferredDefinition":"A response for questions related to liver ablation therapy.","longName":"3837353v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2FC901F-D74C-8AFB-E040-BB89AD4328FF","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-02","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; CDE released - TT. 1/23/14 edit to def. tt 1/15/14 changed VD and def. cb 8/2/13 curated for 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3858517","version":"1","preferredName":"Imaging Agent Risk Reduction Assessment Ind","preferredDefinition":"A response for questions related to the implementation of risk reduction strategies addressing imaging agents in order to prevent complications.  These strategies may be dictated by any of the following: research protocol, institution policy, American College of Radiology (ACR), or other governing agencies.","longName":"3858022v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4537F48-8F0A-FD74-E040-BB89AD43451E","latestVersionIndicator":"Yes","beginDate":"2013-08-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-19","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14 edit to def. tt 1/14/14 changed VD and def. cb 8/19/13 curated to support imaging trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3860544","version":"1","preferredName":"Eovist Clinical Trial Consent Ind","preferredDefinition":"A response as to whether the participant agreed to participate in the Eovist trial.","longName":"3860543v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E466D2AD-C6CE-A1F9-E040-BB89AD436277","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-20","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14 edit to def. tt 1/14/14 changed VD and def. cb 8/20/13 curated for imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3860902","version":"1","preferredName":"Claustrophobia Sedation Administration Ind","preferredDefinition":"A response for questions related to the use of sedatives for the treatment of claustrophobia.","longName":"3860890v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4757F65-DC71-5609-E040-BB89AD433F9C","latestVersionIndicator":"Yes","beginDate":"2013-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-21","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt 8/21/13 curated to support imaging trials.tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3860911","version":"1","preferredName":"Sickle Cell Disease Diagnosis Ind","preferredDefinition":"A response for questions related to the diagnosis of sickle cell disease.","longName":"3856572v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4757F65-DCB9-5609-E040-BB89AD433F9C","latestVersionIndicator":"Yes","beginDate":"2013-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-21","modifiedBy":"SORENSENS","dateModified":"2020-05-08","changeNote":"1/13/16 tt, corrected typo in def. 2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt 8/21/13 curated for 6690. tt 10/31/13 edit to draft new definition. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3861016","version":"1","preferredName":"Serum Creatinine Result mg/dL Float","preferredDefinition":"The laboratory results of serum creatinine.","longName":"3860962v1.0:3880532v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E47A9363-0FF1-AEC2-E040-BB89AD437D65","latestVersionIndicator":"Yes","beginDate":"2013-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-21","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; CDE released. tt 8/21/13 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3863251","version":"1","preferredName":"Imaging Instruction Assessment Ind","preferredDefinition":"A response for questions related to patient assessments in following the instructions of the imaging procedure.","longName":"3863153v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4A38FF1-34D1-183D-E040-BB89AD437640","latestVersionIndicator":"Yes","beginDate":"2013-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-23","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14 edit to def. tt 1/14/14 changed VD and def. cb 8/23/13 curated to support imaging trials.tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3863571","version":"1","preferredName":"Contrast Agent Hypersensitivity Assessment Ind","preferredDefinition":"A response for questions related to allergic reaction(s) to contrast media.","longName":"3857654v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4DF2D56-AD11-78D8-E040-BB89AD43383F","latestVersionIndicator":"Yes","beginDate":"2013-08-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14 edit to def. tt 1/14/14 changed VD and def. cb 8/26/13 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3865399","version":"1","preferredName":"Hepatocellular Carcinoma Image Diagnosis Ind","preferredDefinition":"A response for questions related to the diagnosis of HCC in the liver lesion(s) by imaging.","longName":"3865384v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E4EF1F29-AB93-C6E9-E040-BB89AD431331","latestVersionIndicator":"Yes","beginDate":"2013-08-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-08-27","modifiedBy":"ZHANGWE","dateModified":"2021-09-07","changeNote":"2/7/14 ADSC approved and status changed to released. tt 1/14/14 changed VD and def. tt 8/27/13 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874391","version":"1","preferredName":"Laboratory Procedure Analysis Submission Notification Performed Yes No Indicator","preferredDefinition":"information related to the notification that an examination or results conducted in a  medical procedure that involves testing a sample of blood, urine, or other substance from the body has been executed and carried through to completion._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"LAB_ANALYSIS_PERF_NOTIF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5923F1D-05FB-42EE-E040-BB89AD434351","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"VIENNEAM","dateCreated":"2013-09-04","modifiedBy":"MORENOC","dateModified":"2021-10-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3874595","version":"1","preferredName":"Protocol Worksheet Complete Ind","preferredDefinition":"A response for questions related the completion of protocol specific worksheets.","longName":"3874461v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5938D85-29F7-1480-E040-BB89AD430B87","latestVersionIndicator":"Yes","beginDate":"2013-09-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-04","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. tt 9/4/13 curated to support 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3875471","version":"1","preferredName":"Pregnancy Not Applicable Reason","preferredDefinition":"A reason for why pregnancy would not be applicable.","longName":"3874673v1.0:3875455v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A472A5-118F-227B-E040-BB89AD436554","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-05","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_2/11/14 edit to long name and def. tt 9/5/13 curated to support 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3875551","version":"1","preferredName":"OPTN UNOS Liver Transplant Waiting List Ind","preferredDefinition":"A response for questions related to assessments for the OPTN/UNOS liver transplant waitlist.","longName":"3875521v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A472A5-1483-227B-E040-BB89AD436554","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-05","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; status changed to released. tt 1/14/14 changed VD and def. tt 9/5/13 curated to support 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3875873","version":"1","preferredName":"eGFR Calculated Value","preferredDefinition":"The calculated value for eGFR (mL/Min/1.73m2).","longName":"3875630v1.0:3875733v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A5D0CA-1DE5-AD7A-E040-BB89AD437259","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-05","modifiedBy":"ZHWENDY","dateModified":"2023-04-03","changeNote":"2/7/14 ADSC approved; CDE released. tt 9/5/13 curated to support 6690. tt","administrativeNotes":"4/3/2023: Added AQT per CADSR0002247.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3880718","version":"1","preferredName":"Estimated Glomerular Filtration Rate Result Requirement Ind","preferredDefinition":"A response for whether the required results of the eGFR lab test were met.","longName":"3880641v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5B9909E-98DA-2993-E040-BB89AD4328F7","latestVersionIndicator":"Yes","beginDate":"2013-09-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-06","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/14/14 changed VD and def. cb 9/6/13 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3880917","version":"1","preferredName":"Informed Consent Negation Ability Ind","preferredDefinition":"A response as to whether the patient is unable to provide informed consent.","longName":"3880909v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5B9909E-99BA-2993-E040-BB89AD4328F7","latestVersionIndicator":"Yes","beginDate":"2013-09-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-06","modifiedBy":"RODGERSC","dateModified":"2019-04-24","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/23/14/ edit to def. tt 1/14/14 changed VD and def. cb 9/6/13 curated to support 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3883055","version":"1","preferredName":"OPTN UNOS Transplant Waiting List Date","preferredDefinition":"Application date for the OPTN/UNOS transplant waitlist.","longName":"3875521v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5F3BD56-2E24-45A0-E040-BB89AD434122","latestVersionIndicator":"Yes","beginDate":"2013-09-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-09","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; status changed to released. tt 9/9/13 curated to support 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3886811","version":"1","preferredName":"Cancer Therapeutic Procedure Prior To Imaging Ind","preferredDefinition":"A response for questions addressing treatment(s) for cancer prior to the imaging procedure.","longName":"3886801v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E608D34C-9AAA-475F-E040-BB89AD431E8B","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-10","modifiedBy":"SBR","dateModified":"2018-10-26","changeNote":"7/15/15 edits to DE & released as part of the 3Q2015 draft content review/TT_9/10/13 curated for 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3886891","version":"1","preferredName":"BI-RADS Lesion Assessment Ind","preferredDefinition":"A response for questions related to BI-RADS and lesion assessments.","longName":"3886873v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60C105D-26EF-0645-E040-BB89AD43506E","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-10","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/6/14 edit to definition. tt 1/3/14: edits to draft new DE; edit to definition and changed VD for OPEN. tt 10/8/13 edits to draft new DE.  tt 9/10/13 curated to support 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3889831","version":"1","preferredName":"Imaging Acquisition Protocol Complete Ind","preferredDefinition":"A response as to whether the imaging procedure was completed according to the acquistion protocol.","longName":"3889424v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60CF88E-9939-F250-E040-BB89AD436160","latestVersionIndicator":"Yes","beginDate":"2013-09-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-10","modifiedBy":"FORMBUILDER","dateModified":"2018-07-11","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/3/14 change to draft new DE; edit to definition and changed VD for OPEN. tt10/8/13 edits to Draft New DEC. tt  9/10/13 curated to support 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906891","version":"1","preferredName":"DCIS Core Biopsy Confirmation Ind","preferredDefinition":"A response for questions related to the confirmation of DCIS obtained by core biopsy.","longName":"3906873v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E729A9AF-38C8-F762-E040-BB89AD437B27","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-24","modifiedBy":"TAYLORT","dateModified":"2015-03-02","changeNote":"3-2-15 ADSC approved-tt_6/5/14 edit to VD, long name and def. tt 10/18/13 edits to Draft New DE. tt  9/25/13 edit to Draft New CDE. tt  9/24/13 curated to support 4112.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906935","version":"1","preferredName":"DCIS Surgical Excision Confirmation Ind","preferredDefinition":"A response for questions related to the confirmation of DCIS obtained by surgical excision.","longName":"3906934v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E734B434-261E-6034-E040-BB89AD435105","latestVersionIndicator":"Yes","beginDate":"2013-09-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-25","modifiedBy":"TAYLORT","dateModified":"2015-03-02","changeNote":"3-2-15 ADAC approved-tt_6/5/14 edit to VD, long name and def. tt 9/25/13 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3906993","version":"1","preferredName":"Diagnostic Imaging Bilateral Mammogram Performed Ind","preferredDefinition":"A response for questions related to diagnostic bilateral mammograms.","longName":"3467349v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E735DEDE-3F48-C2C6-E040-BB89AD4355E7","latestVersionIndicator":"Yes","beginDate":"2013-09-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-09-25","modifiedBy":"TSESU","dateModified":"2022-11-22","changeNote":"11/26/14 released.  tt 6/5/14 edit to VD, long name and def. tt 9/25/13 curated to support imaging trials (4112). tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3910076","version":"1","preferredName":"Mitotic Count Cell Percentage Value","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._information related to the percentage value for a cell count.","longName":"MITOS_INDEX","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E79B323D-277B-13E9-E040-BB89AD435C18","latestVersionIndicator":"Yes","beginDate":"2013-09-30","endDate":null,"createdBy":"VIENNEAM","dateCreated":"2013-09-30","modifiedBy":"DAVISJ","dateModified":"2016-03-18","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3912400","version":"1","preferredName":"Mitotic Count Assessment Ind-2","preferredDefinition":"The yes/no indicator to ask if any mitotic index has been reported for a patient on a clinical trial.","longName":"MITOS_INDEX_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B0A028-7F3F-FB64-E040-BB89AD43619D","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-01","modifiedBy":"ROUILLAS","dateModified":"2013-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913171","version":"1","preferredName":"Functioning Endocrine Neoplasm Indicator","preferredDefinition":"The yes/no indicator that asks if the patient's tumor is functional (a hormone producing neoplasm).","longName":"TUM_FUCT_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7C41D55-DB65-C247-E040-BB89AD436867","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-02","modifiedBy":"MORENOC","dateModified":"2020-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913238","version":"1","preferredName":"Contraception Intercourse Assessment Ind","preferredDefinition":"A response for assessments related to contraception and/or intercourse.","longName":"3913202v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7C48557-583B-E85A-E040-BB89AD43536D","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-02","modifiedBy":"TAYLORT","dateModified":"2016-04-25","changeNote":"3-2-15 ADSC approved_tt._6/5/14 edit to VD and long name. tt 10/2/13 curated for E4112. tt 10/31/13 change to preferred question text. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913290","version":"1","preferredName":"Hormone Therapy Breast Cancer Prevention Ind","preferredDefinition":"A response for questions related to hormone therapy for breast cancer prevention.","longName":"3913286v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7C58CCC-E0F5-6ED6-E040-BB89AD43162A","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-02","modifiedBy":"COOPERM","dateModified":"2018-02-08","changeNote":"3-2-15 ADSC approved. tt_6/5/14 edit to VD, long name and def. tt 10/2/13 curated for E4112.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913334","version":"1","preferredName":"Prior Ipsilateral Breast Carcinoma Assessment Ind","preferredDefinition":"A response for assessments related to previous ipsilateral breast cancer(s).","longName":"3913323v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7C63677-7D47-0BBB-E040-BB89AD43564C","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-02","modifiedBy":"SARAHB","dateModified":"2019-04-10","changeNote":"3-2-15 ADSC approved-tt._6/5/14 edit to VD, long name and def. tt 10/2/13 curated for E4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913414","version":"1","preferredName":"Synchronous Bilateral Breast Disease Assessment Ind","preferredDefinition":"A response related to the assessments of synchronous bilateral breast disease.","longName":"3913397v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7C76CC3-83A6-3152-E040-BB89AD430EF2","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-02","modifiedBy":"FINCHAMB","dateModified":"2023-02-23","changeNote":"3-2-14 ADSC approved-tt._11/26/14 edit to Long name and question text. tt 6/5/14 edit to VD, long name and def. tt 10/2/13 curated for E4112, tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913451","version":"1","preferredName":"Disease or Disorder Excision Ability Ind-2","preferredDefinition":"The yes/no indicator to the question resectable?","longName":"RESECTABLE_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7C787D4-6C88-7FCC-E040-BB89AD432EBA","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-02","modifiedBy":"ROUILLAS","dateModified":"2013-11-05","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913500","version":"1","preferredName":"Multicentric Breast Carcinoma Lumpectomy Assessment Ind","preferredDefinition":"A response for questions related to the assessments of  multicentric breast cancer and lumpectomy procedures.","longName":"3913497v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7C851F9-0C6B-C1C3-E040-BB89AD436267","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-02","modifiedBy":"BOWSERC","dateModified":"2021-02-04","changeNote":"3-2-15 ADSC approved-tt._6/5/14 edit to VD, long name and def. tt 10/28/13 curated for 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913811","version":"1","preferredName":"Prior Chemotherapy Temozolomide Administered Yes No Indicator","preferredDefinition":"The yes/no indicator whether there was prior administration of temozolomide (A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04))","longName":"PRIOR_TEMOZOLOMIDE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D6522B-6621-5853-E040-BB89AD43598A","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"GDEEN","dateModified":"2023-09-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913825","version":"1","preferredName":"Prior Chemotherapy Dacarbazine Administered Yes No Indicator","preferredDefinition":"the yes/no indicator whether there was prior administration of DTIC (A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04)_The act of having given something (e.g., a medication or test).)","longName":"PRIOR_DTIC_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D66DB8-61B0-D8BA-E040-BB89AD436B36","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913831","version":"1","preferredName":"Prior Chemotherapy Capecitabine Administered Yes No Indicator","preferredDefinition":"the yes/no indicator whether there was prior administration of Capecitabine (a fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites.  As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells.  FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate. (NCI04))","longName":"PRIOR_CAPECITABINE_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D6522B-669E-5853-E040-BB89AD43598A","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"SARAHB","dateModified":"2016-08-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913842","version":"1","preferredName":"Prior Chemotherapy Somatostatin Analog Therapy Administered Yes No Indicator","preferredDefinition":"the yes/no indicator whether there was prior administration of Somatostatin Analogue.","longName":"PRIOR_SOMATOSTATIN_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D66DB8-623B-D8BA-E040-BB89AD436B36","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913862","version":"1","preferredName":"Chemotherapy Continue Administration Somatostatin Analog Therapy Yes No Indicator","preferredDefinition":"the yes/no indicator that asks whether somatostatin analogue chemotherapy is continuing while on study.","longName":"PRIOR_TX_SOMATOSTATIN_CONT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D66DB8-6391-D8BA-E040-BB89AD436B36","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"CLOHNES","dateModified":"2022-12-21","changeNote":"Replaced VD Therapy Ind-2 2018279v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"12/21/22 added AQT and alt OID, CCTG for ticket number CADSR0001818 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913868","version":"1","preferredName":"Patient Stable Dose Administered Yes No Indicator","preferredDefinition":"The yes/no indicator to whether the patient reached a stable dose for 8 weeks.","longName":"STABLE_DOSE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D729D8-58CF-D3FE-E040-BB89AD432BB2","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"SPRINGERL","dateModified":"2020-04-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3913874","version":"1","preferredName":"Radiation Therapy Radioembolization Performed Yes No Indicator","preferredDefinition":"the yes/no indicator to whether radioembolization was performed.","longName":"PRIOR_LVR_RX_EMBOL","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D7937D-3F07-AB6A-E040-BB89AD4346C2","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":"Released per approval by T.Lichtenberg. mc 7/29/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914056","version":"1","preferredName":"Non Nodal Target Lesion Present Yes No Indicator","preferredDefinition":"The yes/no indicator to whether a non nodal (any bulge or swelling of an anatomical structure or part) target lesion is present.","longName":"NON_NODAL_TARG_LESION_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D81BB5-8A19-0872-E040-BB89AD431878","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914060","version":"1","preferredName":"Nodal Lesion Present Yes No Indicator","preferredDefinition":"The yes/no indicator to whether a nodal target lesion is present.","longName":"NODAL_TARG_LESION_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D81BB5-8A9F-0872-E040-BB89AD431878","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914345","version":"1","preferredName":"Dose Hold Administration Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not an agent administered was held.","longName":"DOSE_HOLD","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D93427-80ED-94F4-E040-BB89AD437279","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914347","version":"1","preferredName":"Dose Delayed Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not the administration of a dose of an agent or treatment regimen was delayed.","longName":"DOSE_DELAY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D94A94-52CD-FB93-E040-BB89AD4358A0","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914393","version":"1","preferredName":"Dose Escalation Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not the administration of a dose of an agent or treatment regimen was escalated.","longName":"DOSE_ESCL","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D9F5DD-5C1E-0A68-E040-BB89AD432AE0","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914396","version":"1","preferredName":"Missed Dose Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not the administration of a dose of an agent or treatment regimen was missed.","longName":"DOSE_MISS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D9F5DD-5C3D-0A68-E040-BB89AD432AE0","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914421","version":"1","preferredName":"Dose Discontinued Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not the administration of a dose of an agent or treatment regimen was discontinued.","longName":"DOSE_DISCONT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D9F5DD-5D4E-0A68-E040-BB89AD432AE0","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914445","version":"1","preferredName":"Dose Reduced Checkbox Indicator","preferredDefinition":"Checkbox indicator determining whether or not the administration of a dose of an agent or treatment regimen was reduced.","longName":"DOSE_REDUCE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7DA6E22-F88A-C1DE-E040-BB89AD437924","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914499","version":"1","preferredName":"Lesion Non-Measurable Evaluation Checkbox Indicator","preferredDefinition":"Checkbox indicator to whether a lesion was evaluated but unable to be measured.","longName":"NO_MEAS_CBXX","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7DB49BC-C97F-2CDD-E040-BB89AD4315BB","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ROUILLAS","dateModified":"2013-10-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3914969","version":"1","preferredName":"Pathology Report Upload Text","preferredDefinition":"The free-text field related to transfer a pathology report that contains information to a central computer from a smaller computer or a computer at a remote location.","longName":"CYTO_REPORT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EDB2C8-D363-672C-E040-BB89AD43143B","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-04","modifiedBy":"SOKKERL","dateModified":"2019-02-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3915410","version":"1","preferredName":"Prior Chemotherapy Administered Ind","preferredDefinition":"A response related to the prior administration of chemotherapy.","longName":"2188711v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E82FB071-2795-9893-E040-BB89AD433CE6","latestVersionIndicator":"Yes","beginDate":"2013-10-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-07","modifiedBy":"GARRIDOJ","dateModified":"2018-02-09","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/3/14 edit to draft new DE; changed VD for OPEN. tt 10/7/13 curated for 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3915414","version":"1","preferredName":"Neoadjuvant Chemotherapy Prior Pathologic Confirmation Ind","preferredDefinition":"A response related to the administration of neoadjuvant chemotherapy prior to pathologic confirmation.","longName":"3915413v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E8315EC4-29B1-B643-E040-BB89AD43068D","latestVersionIndicator":"Yes","beginDate":"2013-10-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-07","modifiedBy":"TAYLORT","dateModified":"2014-02-10","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/4/13 edit to draft new DE; changed VD for OPEN. tt  10/7/13 curated for 6702.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3915783","version":"1","preferredName":"Agent Administered Checkbox Indicator","preferredDefinition":"Check all that apply checkbox indicator determining whether or not certain agents were administered.","longName":"CHECK_ALL_APPLY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E83F6B0B-65E9-E262-E040-BB89AD437D5C","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-08","modifiedBy":"ROUILLAS","dateModified":"2013-10-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3919905","version":"1","preferredName":"Prior Chemotherapy Somatostatin Analog Therapy Administered Type","preferredDefinition":"Type of prior Somatostatin analog therapy administered.","longName":"SOMATOSTATIN_ANALOGUE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8CB55D2-F4E3-CDF9-E040-BB89AD434310","latestVersionIndicator":"Yes","beginDate":"2013-10-15","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-15","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923077","version":"1","preferredName":"Institution Patient Blinatumomab Outpatient Infusion Procedure Home Health Nursing Ind","preferredDefinition":"the yes/no indicator whether a site would utilize home health care for outpatient infusions if a patient is randomized to a blinatumomab arm","longName":"INST_PT_BLINAT_INF_HOME_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8F30331-8868-3508-E040-BB89AD433325","latestVersionIndicator":"Yes","beginDate":"2013-10-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-17","modifiedBy":"ROUILLAS","dateModified":"2013-10-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923100","version":"1","preferredName":"Institution Patient Blinatumomab Home Health Nursing Ind","preferredDefinition":"the yes/no indicator whether a site plans to use home health care for patients randomized to blinatumomab arm","longName":"INST_PT_BLINAT_HOME_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8F50327-83C0-DC4A-E040-BB89AD433C87","latestVersionIndicator":"Yes","beginDate":"2013-10-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-17","modifiedBy":"ROUILLAS","dateModified":"2013-10-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3923978","version":"1","preferredName":"Breast Conservation Treatment Eligibility Assessment Ind","preferredDefinition":"A response related to eligibility assessments of Breast Conservation Therapy (BCT). ","longName":"3923974v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E90832FE-6876-76E9-E040-BB89AD433923","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-18","modifiedBy":"TAYLORT","dateModified":"2015-03-02","changeNote":"3-2-15 ADSC approved.tt_6/19/14 edit to question text. tt 6/13/14 edit to long name. tt 6/5/14 edit to VD, long name and def. tt 10/18/13 curated for 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3939896","version":"1","preferredName":"Deleterious Mutation BRCA1 BRCA2 Ind","preferredDefinition":"A response for questions related to deleterious mutations in BRCA genes.","longName":"3939895v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9FBC012-6757-CA83-E040-BB89AD434F70","latestVersionIndicator":"Yes","beginDate":"2013-10-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-10-30","modifiedBy":"TAYLORT","dateModified":"2015-03-02","changeNote":"3-2-15 ADSC approved;tt_6/5/14 edit to VD, long name and def. tt 10/30/13 curated for 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"3956005","version":"1","preferredName":"Time Since Smoldering Myeloma Diagnosis","preferredDefinition":"The period of time since the diagnosis of smoldering myeloma, a plasma cell myeloma lacking clinical manifestations and organ impairment, as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.","longName":"3335219v1.0:3955998v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBB5C86D-EA43-B31B-E040-BB89AD4350C2","latestVersionIndicator":"Yes","beginDate":"2013-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-11-21","modifiedBy":"ROUILLAS","dateModified":"2013-11-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030091","version":"1","preferredName":"Primary Tumor Resection with Metastasectomy or Prior to Metastasectomy","preferredDefinition":"information related to primary tumor resection._an outcome after a surgical procedure intended to remove organs and tissues containing cancer with metastasectomy or prior to metastasectomy.","longName":"PRM_TUMOR_RES_TP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE4942A6-F870-DC69-E040-BB89AD43144E","latestVersionIndicator":"Yes","beginDate":"2013-12-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-12-24","modifiedBy":"ROUILLAS","dateModified":"2013-12-24","changeNote":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4030131","version":"1","preferredName":"Surgical Excision Ablation Therapy Resection With or Without Ablation Type","preferredDefinition":"the type of resection; with or without ablation therapy","longName":"RESECTION_ABLATION","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE49CDE1-56C6-A5E6-E040-BB89AD434DBA","latestVersionIndicator":"Yes","beginDate":"2013-12-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-12-24","modifiedBy":"ROUILLAS","dateModified":"2013-12-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4050971","version":"1","preferredName":"Minimal Tumor Burden Two Or Greater Core Biopsy Prostate Criteria Ind","preferredDefinition":"A response to address the minimal tumor burden criteria of two or more cores in the prostate.","longName":"3402719v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF67D8C3-66F9-CA02-E040-BB89AD43513B","latestVersionIndicator":"Yes","beginDate":"2014-01-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-07","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_1/7/14 curated/OPEN non-coded PV requirements; 6701 Eligibility Form. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4051211","version":"1","preferredName":"Prostate Adenocarcinoma Minimal Tumor Burden Ind","preferredDefinition":"A response for questions related to the minimal tumor burden for prostate adenocarcinoma.","longName":"4051152v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF68A442-1CD2-D3AE-E040-BB89AD434B7B","latestVersionIndicator":"Yes","beginDate":"2014-01-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-07","modifiedBy":"TAYLORT","dateModified":"2015-07-23","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/7/14 curated for 6701 eligibility.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4068212","version":"1","preferredName":"Gleason Score for Prostate Cancer Tumor Burden Ind","preferredDefinition":"A response for questions related to Gleason Score and tumor burden for prostate cancer.","longName":"4067798v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF9FC81C-342C-3039-E040-BB89AD436625","latestVersionIndicator":"Yes","beginDate":"2014-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-10","modifiedBy":"WELSHE","dateModified":"2016-07-25","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/10/14 curated for 6701. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4068575","version":"1","preferredName":"PSA Value Ind","preferredDefinition":"A response for questions related to PSA level values.","longName":"4068571v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFA0824D-AA7D-4B8C-E040-BB89AD434569","latestVersionIndicator":"Yes","beginDate":"2014-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-10","modifiedBy":"MORENOC","dateModified":"2019-12-05","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/10/14 curated for 6701. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4083137","version":"1","preferredName":"Gender Age Ind","preferredDefinition":"A response for questions related to gender and age of the patient.","longName":"4083093v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFDDDE49-25BE-4D4E-E040-BB89AD434658","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"TAYLORT","dateModified":"2017-12-15","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/13/14 curated for 6701. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4083172","version":"1","preferredName":"Prostate Carcinoma TRUS Diagnosis Ind","preferredDefinition":"A response as to whether transrectal ultrasound was the method utilized to guide the prostate biopsy procedure which yielded a diagnosis of prostate cancer.","longName":"3351666v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFDDDE49-25E5-4D4E-E040-BB89AD434658","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"TAYLORT","dateModified":"2014-02-10","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/13/14 change to VD and definition.  tt 1/18/2012 Curated for 6701.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4083273","version":"1","preferredName":"Patient MRI Tolerance Ind","preferredDefinition":"A response related to the ability of the patient to tolerate MR imaging procedure requirements.","longName":"3357759v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFDDDE49-260C-4D4E-E040-BB89AD434658","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"FINCHAMB","dateModified":"2023-10-25","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/13/14 reuse of DEC for new VD. tt 1/19/12 - Curated for 6701.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4086052","version":"1","preferredName":"Medical History  Severe Claustrophobia Ind","preferredDefinition":"A response for questions related to severe claustrophobia.","longName":"3376222v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFDEAD65-3831-4B16-E040-BB89AD437676","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"TAYLORT","dateModified":"2016-02-18","changeNote":"2/10/14 ADSC approved; released CDE tt. 1/13/14 Changed VD and definition. tt 2/9/12-curated for 6701.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4086053","version":"1","preferredName":"Non-MRI Compatible Metal Or Medical Device Implantation Ind","preferredDefinition":"A response for questions related to the presence of MR imaging incompatible objects and/or devices.","longName":"3376289v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFDF1276-AFF7-ED31-E040-BB89AD436BB5","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"RODGERSC","dateModified":"2019-07-24","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/13/14 New CDE for VD and def. tt 2/9/12-curated for 6701.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4086054","version":"1","preferredName":"Patient Renal Failure Assessment Ind","preferredDefinition":"A response for questions related to assessments for renal failure.","longName":"3407189v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFDF1276-B024-ED31-E040-BB89AD436BB5","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"WISEM","dateModified":"2019-02-14","changeNote":"2/7/14 ADSC approved; released CDE. tt 1/13/14 New CDE for change to VD and def. tt 3/6/12 Curated for 6701","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4086160","version":"1","preferredName":"Medical History Prostate Therapy Ind","preferredDefinition":"A response for questions related to the medical history of prostate therapy.","longName":"3369103v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"EFDF5C58-43EB-B875-E040-BB89AD432E3E","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"MORENOC","dateModified":"2017-02-20","changeNote":"2/10/14 ADSC approved; released CDE. tt 1/13/14 new DE for VD and def. tt  2/1/12: created for 6701.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4086176","version":"1","preferredName":"Medical History Orthopedic Or Surgical Procedure Ind","preferredDefinition":"A response for questions related to the medical history of surgical procedures.","longName":"3373560v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFDF5C58-4415-B875-E040-BB89AD432E3E","latestVersionIndicator":"Yes","beginDate":"2014-01-13","endDate":"2015-07-14","createdBy":"TAYLORT","dateCreated":"2014-01-13","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released&supersedes CDE 3374408/tt_1/13/14 Change to VD and def.  2/8/12: ACRIN 6701. 3/15/12 Approved for release 3/14/12.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4115092","version":"1","preferredName":"Extrahepatic Metastasis Diagnosis Ind","preferredDefinition":"A response for questions related to evidence of cancer that has spread to locations outside of the liver.","longName":"3108906v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0BDF3BA-1390-F412-E040-BB89AD431B05","latestVersionIndicator":"Yes","beginDate":"2014-01-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-24","modifiedBy":"HLAINGY","dateModified":"2018-03-28","changeNote":"2/7/14 ADSC approved; CDE released. tt 1/24/14 Created new CDE using existing DEC. tt Moved content from CTEP to SWOG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4117309","version":"1","preferredName":"BI-RADS Lesion Assessment Count","preferredDefinition":"A response for questions related to the number of BI-RADS assessed lesions.","longName":"3886873v1.0:2018596v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FBC3F3-D865-8E62-E040-BB89AD4356FB","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-27","modifiedBy":"TAYLORT","dateModified":"2014-05-21","changeNote":"5/21/14 edit to def. tt 4/28/14 corrected typo in definition. 2/7/14 ADSC approved; released CDE. tt 2/7/14 edits to definition and question text. tt 1/27/14 curated for 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4117796","version":"1","preferredName":"Non-Measurable Lesion Resolution Indicator","preferredDefinition":"Text indictor to signify the return to the normal structure and/or function, e.g. the subsidence of a pathologic process, in non-measurable lesions.","longName":"NMEAS_LES_RESL_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10A457A-C740-4C7F-E040-BB89AD43235D","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-01-28","modifiedBy":"ROUILLAS","dateModified":"2014-01-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4118413","version":"1","preferredName":"Non-Measurable Lesion Baseline Present Indicator","preferredDefinition":"The yes/no indicator of the non-measurable lesion(s) being present at a starting point to which things may be compared.","longName":"NONMEAS_BSLN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10CC885-D7FE-B7B1-E040-BB89AD4322ED","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-01-28","modifiedBy":"GALITG","dateModified":"2019-01-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119891","version":"1","preferredName":"Local Minimal Residual Disease Assessment Performed Ind","preferredDefinition":"the yes/no indicator that asks whether a local MRD assessment of the patient was done.","longName":"MRD_ASSESS_PERF_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F12137BF-B911-6257-E040-BB89AD434C83","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-01-29","modifiedBy":"ROUILLAS","dateModified":"2014-02-20","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4119991","version":"1","preferredName":"Central Nervous System Involvement Category","preferredDefinition":"the category related to central nervous system (CNS) involvement.","longName":"CNS_INVOLV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F121FD15-800A-4112-E040-BB89AD435CF5","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-01-29","modifiedBy":"LEEBUMJ","dateModified":"2019-12-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4122213","version":"1","preferredName":"Imaging Procedure Performed Ind","preferredDefinition":"A response for questions related to the performance of imaging procedures.","longName":"3061540v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F136E662-A1EC-376F-E040-BB89AD4357E9","latestVersionIndicator":"Yes","beginDate":"2014-01-30","endDate":null,"createdBy":"CBROWN","dateCreated":"2014-01-30","modifiedBy":"TYRRELLM","dateModified":"2023-11-09","changeNote":"12/9/14 released. tt 2/5/14 Changed VD. cb 1/30/14 Curated DE. cb","administrativeNotes":"11.09.2023 Added AQT per request ticket CADSR0003062_mmt\r\n10/31/23 Added AQT for CCTG ticket number CADSR0003018 cjl; 2022.8.30 Added AQT and Alt Name for ticket request CADSR0001468. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4130771","version":"1","preferredName":"Breast Imaging Procedure Performed Type Code","preferredDefinition":"A coded numeric response for the type of breast imaging procedure performed.","longName":"4255301v1.0:4136308v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1871D8A-5763-EF0F-E040-BB89AD4322F9","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"CBROWN","dateCreated":"2014-02-03","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 7/31/14 edit to long name and def. tt 5/22/14 edit to long name and def. tt 3/28/14 edits to DEC and def. tt 2/6/14 Changed VD & edits to def. cb 2/3/14 Curated a new DE. cb.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4132741","version":"1","preferredName":"EDRN Clinical Trial Consent Ind","preferredDefinition":"A response as to whether the participant agreed to participate in the EDRN study.","longName":"4132721v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F19A12C5-EB8E-015A-E040-BB89AD431E94","latestVersionIndicator":"Yes","beginDate":"2014-02-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-04","modifiedBy":"TAYLORT","dateModified":"2014-02-07","changeNote":"2/7/14 CDE released. tt 2/4/14 curated for 6690. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4144058","version":"1","preferredName":"Lesion Distance From Nipple Measurement Millimeter Float","preferredDefinition":"A response for questions capturing the measured distance from the lesion to the nipple in millimeters.","longName":"4144031v1.0:4282731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1D62D18-2508-0F66-E040-BB89AD43766C","latestVersionIndicator":"Yes","beginDate":"2014-02-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-07","modifiedBy":"LISU","dateModified":"2020-06-02","changeNote":"11/4/15 edit to long name; tt_4/29/14 edit to long name and def. tt 4/14/14 edit to Draft New long name. tt 2/7/14 curated to support imaging trials (6702). tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4147832","version":"1","preferredName":"Measurement First Dimension Millimeter Float","preferredDefinition":"A response for questions capturing the measurement or location in the \"X\" (first or length) dimension in millimeters; this is the longest measurement or largest value if only one measurement is captured.","longName":"4321815v1.0:4282731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2265D30-E8D8-9E6B-E040-BB89AD43227B","latestVersionIndicator":"Yes","beginDate":"2014-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-11","modifiedBy":"COLBERTM","dateModified":"2019-11-06","changeNote":"3/23/16 tt, released CDE. 5/20/14 edit to def. tt 5/19/14 curate new DEC. cb 4/29/14 edit to VD and long name. tt 4/28/14 edits to long name and def. tt 4/16/14 changed VD, long name and edit to def. tt 2/21/14 edit to definition. tt 2/21/14 Made changes to DEC. cb 2/20/14 edit to Draft New DEC and long name. tt 2/20/14 Made changes to DEC. cb 2/11/14 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4148731","version":"1","preferredName":"Pregnancy Not Applicable Reason Other Specify Text","preferredDefinition":"A textual reason not listed describing why pregnancy is not applicable.","longName":"3874673v1.0:2857322v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F229AA10-430A-4B52-E040-BB89AD437737","latestVersionIndicator":"Yes","beginDate":"2014-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-11","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_2/11/14 curated to support 6902.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4163215","version":"1","preferredName":"Unrelated Umbilical Cord Blood Type","preferredDefinition":"The type of unrelated umbilical cord blood (Blood present in the umbilical vessels at the time of delivery. If cryopreserved at birth, cord blood can serve as a source of autologous lymphocytes for transplantation to a patient later diagnosed and treated for leukemia or lymphoma).","longName":"UNRLTD_CORD_BLOOD_SP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2C77610-5A89-ACE8-E040-BB89AD4306CF","latestVersionIndicator":"Yes","beginDate":"2014-02-19","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-02-19","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4163977","version":"1","preferredName":"Transplant Compatible Indicator","preferredDefinition":"the yes/no indicator that asks whether a patient and a transplant donor are compatible.","longName":"TSPL_CMPT_IND3","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2D8222C-409F-C836-E040-BB89AD436474","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-02-20","modifiedBy":"ROUILLAS","dateModified":"2014-02-20","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4164131","version":"1","preferredName":"Minimal Residual Disease Assessment Date","preferredDefinition":"The date an MRD assessment of the patient was done.","longName":"MRD_ASSESS_DATE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2D8CF9C-2CF2-A73A-E040-BB89AD430448","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-02-20","modifiedBy":"MORENOC","dateModified":"2018-10-10","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4167855","version":"1","preferredName":"HCC OPTN Imaging Criteria Ind","preferredDefinition":"A response for questions related to the OPTN imaging criteria and/or requirements for HCC.","longName":"4167848v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2DC16D2-3725-5893-E040-BB89AD430749","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-20","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released as part of the 3Q2015 draft content review/TT_2/20/14 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4168178","version":"1","preferredName":"Measurement Second Dimension Millimeter Float","preferredDefinition":"A response for questions capturing the \"Y\" or second measurement (diameter or size) or location in millimeters.","longName":"4168160v1.0:4282731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2DD85AE-AE36-9996-E040-BB89AD435CB1","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-20","modifiedBy":"COLBERTM","dateModified":"2019-11-06","changeNote":"3/23/16 tt, released CDE. 4/29/14 change to VD and long name. tt 4/28/14 change to DEC and def. tt 4/16/14 changed VD, long name and edit to def. tt 2/21/14 edit to definition. tt 2/20/14 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4168179","version":"1","preferredName":"Measurement Third Dimension Millimeter Float","preferredDefinition":"A response for questions capturing the \"Z\" or third measurement (diameter or size) or location in millimeters.","longName":"4321819v1.0:4282731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2DCD5C8-505B-48C9-E040-BB89AD436635","latestVersionIndicator":"Yes","beginDate":"2014-02-20","endDate":null,"createdBy":"CBROWN","dateCreated":"2014-02-20","modifiedBy":"COLBERTM","dateModified":"2019-11-06","changeNote":"3/23/16 tt, released CDE. 5/20/14 edit to def. tt 5/19/14 make changes to DEC. cb 4/29/14 change to VD and long name. tt 4/28/14 edits to long name and def. tt 4/16/14 changed VD, long name and edit to def. tt 2/21/14 edit to definition. tt 2/20/14 Curated to support imaging trials. cb","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4187967","version":"1","preferredName":"Target Gene Identifier","preferredDefinition":"Name of target gene.","longName":"TARGET_GENE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3B89417-7E73-628D-E040-BB89AD430528","latestVersionIndicator":"Yes","beginDate":"2014-03-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-03-03","modifiedBy":"ROUILLAS","dateModified":"2014-03-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4188891","version":"1","preferredName":"Non-Steroidal Aromatase Inhibitor Resistance Process Patient Description","preferredDefinition":"Description of the setting in which the patient developed resistance to prior non-steroidal aromatase inhibitor (AI) treatment.","longName":"4188857v1.0:3775432v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CDFFE2-5CA1-7991-E040-BB89AD43762C","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-03-04","modifiedBy":"ROUILLAS","dateModified":"2014-03-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4213711","version":"1","preferredName":"Minimal Tumor Burden Three Or Greater Core Biopsy Prostate Criteria Ind","preferredDefinition":"A response to signify whether or not the patient met the minimal tumor burden criteria of three or more cores positive for prostate cancer (of any magnitude of cancer burden) in the same prostate region.","longName":"3402737v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46B2891-0267-1A27-E040-BB89AD431E41","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-03-12","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeNote":"7/14/15 released/tt_3/13/14 curated for 6701. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4232611","version":"2","preferredName":"Image Submission Date","preferredDefinition":"The date when the images were submitted (or transferred) from one organization or institution to another.","longName":"IMG_SUB_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"540DB930-AEAB-720F-E053-F662850AEAE5","latestVersionIndicator":"Yes","beginDate":"2017-07-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-07-11","modifiedBy":"CLOHNES","dateModified":"2022-06-30","changeNote":"1/23/18 jk changed from Draft Mod to Released.  7/11/17 jk versioned CDE to use generic Date VD as part of Round 5 finalization task per tt.  7/23/15: Note - this CDE is generic due to the fact that all imaging is not considered \"diagnostic\"/tt_7/23/15 released as part of the 3Q2015 draft content review/TT_3/21/14 edit to definition. tt 3/18/14 curated to support imaging trials. tt","administrativeNotes":"6/30/22 added alt OID, CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4255351","version":"1","preferredName":"Biopsy of Breast Method Use Code","preferredDefinition":"Coded numeric responses for questions related to the method of guidance used for the breast biopsy.","longName":"4255331v1.0:4136308v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5AC8904-5B10-FD1C-E040-BB89AD4340BB","latestVersionIndicator":"Yes","beginDate":"2014-03-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-03-28","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/24/15 edit to DEC, VD, long name and def.tt_7/31/14 edit to long name and def. tt 3/28/14 curated for 6702.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4277191","version":"1","preferredName":"Memory Dysfunction Assessment Medication Indicator","preferredDefinition":"A response of yes or no to indicate if a patient sometimes forgets to take their cancer medication.","longName":"MEMORY_DYS_MED_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A655EE-9C49-FEBB-E040-BB89AD433B41","latestVersionIndicator":"Yes","beginDate":"2014-04-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-22","modifiedBy":"MORENOC","dateModified":"2016-06-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4281970","version":"1","preferredName":"Breast Clockface Hours Location Code","preferredDefinition":"A coded numeric response for questions related to the anatomic location within the breast based on clockface numbering.","longName":"4282036v1.0:4242566v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81BF6EB-A9BC-A570-E040-BB89AD43639B","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-04-28","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 4/28/14 curated to support breast interventions and procedures; supercedes CDE 4143711. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4282021","version":"1","preferredName":"Medication Continued Administration Checkbox Indicator","preferredDefinition":"the checkbox indicator determining whether the agent or medication listed is still being administered at the end of the reporting period.","longName":"MEDS_CONT_ADM_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81D1D5D-79B3-5FB6-E040-BB89AD43249A","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-28","modifiedBy":"ROUILLAS","dateModified":"2014-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4282074","version":"1","preferredName":"Disease Progression Non-Steroidal Aromatase Inhibitor Indicator","preferredDefinition":"the yes/no indicator used to determine whether disease progression occurred after non-steroidal aromatase inhibitor use in the locally advanced or metastatic setting.","longName":"PRIOR_PD_AI_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81EE605-C883-D8A4-E040-BB89AD430B23","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-28","modifiedBy":"ROUILLAS","dateModified":"2014-04-29","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4282178","version":"1","preferredName":"Disease Progression Recurrence Adjuvant Non-Steroidal Aromatase Inhibitor Indicator","preferredDefinition":"the yes/no indicator used to determine whether disease recurrence occurred on or within <= 12 months of end of adjuvant non-steroidal aromatase inhibitor (AI) therapy.","longName":"PRIOR_RECUR_AI_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F81F93A8-8981-7537-E040-BB89AD43470D","latestVersionIndicator":"Yes","beginDate":"2014-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-04-28","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4307479","version":"1","preferredName":"Patient Cancel Withdraw Consent Ind","preferredDefinition":"A response as to whether the participant rescinded consent withdrawal.","longName":"3475326v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94B098C-4E1F-02DF-E040-BB89AD435490","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-05-13","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; 5/13/14 curated to support 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4308167","version":"1","preferredName":"Patient Specimen Research Activity Consent Ind","preferredDefinition":"A response related to the patient's consent regarding the use of specimens for research activity.","longName":"4308165v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E57ED-FC6C-35BE-E040-BB89AD430D0C","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-05-13","modifiedBy":"TAYLORT","dateModified":"2017-09-26","changeNote":"5/14/14 edit to long name. tt 5/13/14 curated to support 6702. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320723","version":"1","preferredName":"Medication Negation Taken Patient Compliance Yes No Indicator","preferredDefinition":"the yes/no indicator related to a patient not taking their medication over a two week time period for reasons other than forgetting to.","longName":"MED_PT_COMPL_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9896E8D-658F-7E29-E040-BB89AD435FDA","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-16","modifiedBy":"ROUILLAS","dateModified":"2014-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4320752","version":"1","preferredName":"Short Period Patient Compliance Medication Yes No Indicator","preferredDefinition":"the yes/no indicator that asks whether a patient took their cancer medicine for a shorter period of time than prescribed because they felt worse while taking it.","longName":"S_P_PT_COMPL_MED_Y_N","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F98A098D-50FF-102A-E040-BB89AD437664","latestVersionIndicator":"Yes","beginDate":"2014-05-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-16","modifiedBy":"MORENOC","dateModified":"2016-06-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4321813","version":"1","preferredName":"Patient Travel Memory Dysfunction Assessment Medication Yes No Indicator","preferredDefinition":"the yes/no indicator that asks whether a patient sometimes forgets to bring cancer medication with them when they travel or leave home.","longName":"PT_TRAVEL_MEMORY_DYS_MED_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9C51A57-AA58-EF74-E040-BB89AD43202E","latestVersionIndicator":"Yes","beginDate":"2014-05-19","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-19","modifiedBy":"ROUILLAS","dateModified":"2014-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4321820","version":"1","preferredName":"Medication Past Day Use Ind-2","preferredDefinition":"the yes/no indicator whether the patient took their cancer medicine yesterday.","longName":"MED_P_D_USE_IND2","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9C51A57-AB0C-EF74-E040-BB89AD43202E","latestVersionIndicator":"Yes","beginDate":"2014-05-19","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-19","modifiedBy":"ROUILLAS","dateModified":"2014-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4322038","version":"1","preferredName":"Patient Malignant Neoplasm Satisfaction Medication Discontinue Ind-2","preferredDefinition":"the yes/no indicator whether a patient sometimes stops taking their medicine when they feel like their cancer in under control.","longName":"PT_SAT_ILL_DXD_MED","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9D6E3E5-AE8E-36A4-E040-BB89AD435CB0","latestVersionIndicator":"Yes","beginDate":"2014-05-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-20","modifiedBy":"MORENOC","dateModified":"2016-06-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4325501","version":"1","preferredName":"Convenience of Taking Medication as Instructed Malignant Neoplasm Treatment Plan Ind-2","preferredDefinition":"the yes/no indicator that asks whether the patient feels hassled about sticking to their cancer treatment plan.","longName":"CONV_CANCER_TREATMENT_PLAN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9D6E3E5-AEE3-36A4-E040-BB89AD435CB0","latestVersionIndicator":"Yes","beginDate":"2014-05-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-20","modifiedBy":"ROUILLAS","dateModified":"2014-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4325514","version":"1","preferredName":"Medication Memory Dysfunction Recurrence Assessment Person Quality of Life Scale","preferredDefinition":"the quality of life assessment scale relating to how often the patient has difficulty remembering to take all their medication.","longName":"DIFF_REMEMBER","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9D86B18-4FCB-9065-E040-BB89AD432E05","latestVersionIndicator":"Yes","beginDate":"2014-05-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-05-20","modifiedBy":"ROUILLAS","dateModified":"2014-05-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4353699","version":"1","preferredName":"Additional Imaging Procedures Performed Ind","preferredDefinition":"A response as to whether the additional imaging procedures were performed.","longName":"4353698v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB1C4F84-253F-87C0-E040-BB89AD437855","latestVersionIndicator":"Yes","beginDate":"2014-06-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-05","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/5/14 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4353700","version":"1","preferredName":"Additional Biopsy Performed Ind","preferredDefinition":"A response as to whether the additional biopsy procedures were performed.","longName":"3669363v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB1C4F84-258A-87C0-E040-BB89AD437855","latestVersionIndicator":"Yes","beginDate":"2014-06-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-05","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/5/14 reused DEC to curate new CDE for 4112. tt /29/13 Curated for 6694.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4353777","version":"1","preferredName":"Breast Intervention or Procedure Decision Ind","preferredDefinition":"A response for questions regarding the decisions made for breast surgical interventions or procedures.","longName":"4353776v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB1D4386-D3FD-BE07-E040-BB89AD430D15","latestVersionIndicator":"Yes","beginDate":"2014-06-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-05","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/5/14 curated for 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4353778","version":"1","preferredName":"Invasive Breast Carcinoma Or Microinvasive Breast Carcinoma Present Ind","preferredDefinition":"A response for the presence of invasive or microinvasive breast carcinoma.","longName":"4360333v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB1D4386-D430-BE07-E040-BB89AD430D15","latestVersionIndicator":"Yes","beginDate":"2014-06-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-05","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/19/14 edit to long name and def. tt 6/5/14 curated for 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4358114","version":"1","preferredName":"DCIS Breast Conservation Treatment Clear Surgical Margin Outcome Ind","preferredDefinition":"A response for questions addressing breast conservation surgery and clear margins for DCIS.","longName":"4358093v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBA44CD-0957-94FB-E040-BB89AD4335A5","latestVersionIndicator":"Yes","beginDate":"2014-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-13","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/t_6/16/14 edit to long name. tt 6/13/14 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4358294","version":"1","preferredName":"DCIS Score Report Received Ind","preferredDefinition":"A response as to whether the OncotypeDX Patient Report of the DCIS Score was received.","longName":"4358273v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBC171E-2568-358F-E040-BB89AD430F61","latestVersionIndicator":"Yes","beginDate":"2014-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-13","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/13/14 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4358300","version":"1","preferredName":"DCIS Score Result Value","preferredDefinition":"The numerical value of the OncotypeDX DCIS score.","longName":"4358296v1.0:4358298v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBD84C1-09AA-D1C5-E040-BB89AD431CD4","latestVersionIndicator":"Yes","beginDate":"2014-06-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-13","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_6/13/14 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4360253","version":"1","preferredName":"Patient Oncotype DX Breast Cancer Assay Identifier","preferredDefinition":"A response for the 7 character identifier assigned to the person's Oncotype DX Breast Cancer Assay result.","longName":"2453382v1.0:4360252v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC32BE77-E09F-7CB2-E040-BB89AD4304CD","latestVersionIndicator":"Yes","beginDate":"2014-06-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-19","modifiedBy":"TAYLORT","dateModified":"2015-07-13","changeNote":"7/13/15 released/tt_3-3-15 edit to draft new def and question text- tt_6/19/14 curated to support breast trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4360301","version":"1","preferredName":"Current DCIS Radiation Therapy Assessment Ind","preferredDefinition":"A response for questions addressing radiation therapy for the present DCIS.","longName":"4360294v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FC344B1F-5BE0-A2DB-E040-BB89AD430E4B","latestVersionIndicator":"Yes","beginDate":"2014-06-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-06-19","modifiedBy":"TAYLORT","dateModified":"2015-03-02","changeNote":"3-2-15 ADSC approved-tt_6/19/14 curated to support 4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4362920","version":"2","preferredName":"Ipsilateral Diagnostic Mammogram Performed Ind","preferredDefinition":"A response for questions addressing ipsilateral (affected breast) mammograms.","longName":"4362916v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08C539E2-C05A-3B4A-E050-BB89AD436D64","latestVersionIndicator":"Yes","beginDate":"2014-06-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-11-26","modifiedBy":"HARTLEYG","dateModified":"2018-07-20","changeNote":"11/26/14 Retired V1 and released V2. Changes made to long name and def. tt 6/20/14 curated to support breast imaging. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4363631","version":"1","preferredName":"Metastatic Disease  Anatomic Location Count","preferredDefinition":"(MET-uh-STAT-ik) Having to do with metastasis, which is the spread of cancer from one part of the body to another._A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown._Relating to anatomy._the quantity of the specified item.","longName":"MET_DZ_STE_TTL_Number","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC959792-2796-61C2-E040-BB89AD4370C2","latestVersionIndicator":"Yes","beginDate":"2014-06-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-06-24","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386076","version":"1","preferredName":"Breast Surgical Procedure Type","preferredDefinition":"A response for the type of a breast surgical procedure.","longName":"4385692v1.0:4386073v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE512D80-E994-3F78-E040-BB89AD436B60","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-07-16","modifiedBy":"ZHWENDY","dateModified":"2022-07-20","changeNote":"7/13/15 released/tt_7/16/14 curated for 4112. tt","administrativeNotes":"7/20/2022: fixed the box symbol in AQT.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386152","version":"1","preferredName":"Consent Withdrawn Change Reason","preferredDefinition":"information related to the reason the patient is making a change to the consent.","longName":"REAS_CHNG_CNSNT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE512D80-EADB-3F78-E040-BB89AD436B60","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386214","version":"1","preferredName":"ALK Gene Assessment Submission Date","preferredDefinition":"the date the ALK genotyping assessment was sent to site","longName":"ALK_GENO_SNT_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE527A4E-0FF2-3455-E040-BB89AD430312","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386238","version":"1","preferredName":"ALK Gene Specimen Quality Control Approval Indicator","preferredDefinition":"indicator to signify whether specimens passed ALK quality control.","longName":"ALK_QCNTRL_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52B933-B15E-01D2-E040-BB89AD436F72","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386312","version":"1","preferredName":"ALK Gene Rearrangement Finding Indicator","preferredDefinition":"the indicator related to ALK rearrangement findings","longName":"ALK_REARRANGE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-2879-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"COLBERTM","dateModified":"2019-11-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386337","version":"1","preferredName":"Rearrangement Type","preferredDefinition":"The type of rearrangement.","longName":"REARRANGE_TYPE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-2911-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386371","version":"1","preferredName":"Quality Control Failure Type","preferredDefinition":"the type of quality control failure","longName":"QCNTRL_FAIL","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE541964-2952-347B-E040-BB89AD431B98","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-16","modifiedBy":"ROUILLAS","dateModified":"2014-08-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386476","version":"1","preferredName":"Prior Whipple Procedure Performed Indicator","preferredDefinition":"the yes/no indicator that asks whether the patient had previous Whipple surgery as treatment for this cancer.","longName":"WHIPPLE_SURG_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE650C61-BD1C-48D9-E040-BB89AD434DC3","latestVersionIndicator":"Yes","beginDate":"2014-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-17","modifiedBy":"ROUILLAS","dateModified":"2014-07-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386477","version":"1","preferredName":"Prior Whipple Procedure Performed Date","preferredDefinition":"the date the patient had previous Whipple surgery as treatment for this cancer.","longName":"WHIPPLE_SURG_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE650C61-BD3E-48D9-E040-BB89AD434DC3","latestVersionIndicator":"Yes","beginDate":"2014-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-17","modifiedBy":"ROUILLAS","dateModified":"2014-07-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386478","version":"1","preferredName":"Preoperative Biliary Stenting Performed Date","preferredDefinition":"The date preoperative placement of a plastic or metal tube into the bile duct was performed.","longName":"PREOP_BIL_STENT_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE650C61-BD5D-48D9-E040-BB89AD434DC3","latestVersionIndicator":"Yes","beginDate":"2014-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-17","modifiedBy":"ROUILLAS","dateModified":"2014-07-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386482","version":"1","preferredName":"Prior WEE1 Inhibitor MK-1775 Administered Ind","preferredDefinition":"the yes/no indicator that asks whether the patient received prior WEE1 inhibitors.","longName":"PRIOR_WEE_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE650C61-BD9E-48D9-E040-BB89AD434DC3","latestVersionIndicator":"Yes","beginDate":"2014-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-17","modifiedBy":"ROUILLAS","dateModified":"2014-07-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4386495","version":"1","preferredName":"Prior Paclitaxel Albumin-Stabilized Nanoparticle Formulation Administered Ind","preferredDefinition":"the yes/no indicator that asks whether the patient received prior Nab-paclitaxel.","longName":"PRIOR_NAB_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE650C61-BE23-48D9-E040-BB89AD434DC3","latestVersionIndicator":"Yes","beginDate":"2014-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-17","modifiedBy":"ROUILLAS","dateModified":"2014-07-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4471897","version":"1","preferredName":"13q Abnormal Type","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._Loss of a genomic DNA sequence. The extent of a deletion ranges from the loss of a single nucleotide to the loss of a substantial portion of an entire chromosome. Thus, deletions may alter the function of a single gene or multiple genes.__Distal (long) arm of chromosome 13_Being or existing in a specified place or at the specified time._Distal (long) arm of chromosome 13_Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._Something distinguishable as an identifiable class based on common qualities.","longName":"3371764v1.0:4471890v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B309DF-E1CD-102A-E050-BB89AD437487","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4471923","version":"1","preferredName":"Fluorescence in Situ Hybridization Chromosome 14 Chromosome 18 Translocation Assessment Fluorescence in situ Hybridization Outcome","preferredDefinition":"Information related to the FISH assessment showing chromosomal translocation (a genetic exchange where a piece of one chromosome is transferred to another chromosome) of chromosomes 14 and 18._The result of an action.","longName":"t(14:18)(IGH) result","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B37913-A2CC-94F3-E050-BB89AD43181C","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472182","version":"1","preferredName":"Fluorescence in Situ Hybridization Chromosome 14 Chromosome 19 Translocation Assessment Fluorescence in situ Hybridization Outcome","preferredDefinition":"Information related to the FISH assessment showing chromosomal translocation (a genetic exchange where a piece of one chromosome is transferred to another chromosome) of chromosomes 14 and 19._The result of an action.","longName":"t(14:19)(IGH) result","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B3F7F3-0D25-A4D6-E050-BB89AD434CDC","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472186","version":"1","preferredName":"Fluorescence in Situ Hybridization Immunoglobulin Heavy Locus Other Result","preferredDefinition":"Information related to other IGH result.","longName":"IGH_OTH_RS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B3F7F3-0D84-A4D6-E050-BB89AD434CDC","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472252","version":"1","preferredName":"Morphologic Finding Leukemia Indicator","preferredDefinition":"the yes/no indicator to ask if there is morphologic evidence of Leukemia.","longName":"MORPH_EVID_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B516DB-2114-FA0F-E050-BB89AD4354CC","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeNote":null,"administrativeNotes":"2/23/23 added AQT and alt OID for CCTG ticket number CADSR0002081 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472268","version":"1","preferredName":"Specimen Lymphocyte Infiltration Greater Than 30% Indicator","preferredDefinition":"the yes/no indicator to ask if the lymphocyte percentage is greater than 30.","longName":"LYMPH_30_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01B516DB-21DB-FA0F-E050-BB89AD4354CC","latestVersionIndicator":"Yes","beginDate":"2014-08-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-08-28","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472574","version":"1","preferredName":"Diffuse Pattern Bone Marrow Present Indicator","preferredDefinition":"the yes/no indicator to ask if a diffuse pattern is evident in the bone marrow.","longName":"DIFF_PATT_EVID_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02151FA8-FDF9-4561-E050-BB89AD43420F","latestVersionIndicator":"Yes","beginDate":"2014-09-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-02","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472614","version":"1","preferredName":"Chronic Lymphocytic Leukemia Progression Documented Type","preferredDefinition":"the description of disease signs which show progression or relapse of CLL disease after treatment.","longName":"BASIS_PD","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02168A5E-A3A8-2D7C-E050-BB89AD437857","latestVersionIndicator":"Yes","beginDate":"2014-09-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-02","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472682","version":"1","preferredName":"Progressive Lymphocytosis Assessment Indicator","preferredDefinition":"the yes/no indicator to determine if the patient has progressive lymphocytosis with an increase of > 50% over a two-month period or an anticipated doubling time of less than six months.","longName":"LYMPHOCYTOSIS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02196EA0-6975-F0A6-E050-BB89AD433801","latestVersionIndicator":"Yes","beginDate":"2014-09-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-02","modifiedBy":"MORENOC","dateModified":"2019-09-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472877","version":"1","preferredName":"Computed Tomography Reason","preferredDefinition":"the reason a CT scan was performed.","longName":"CT_REAS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0228A387-2BA6-9E1D-E050-BB89AD4310DB","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-03","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4472895","version":"1","preferredName":"Timed Up and Go Functional Test Performed Indicator","preferredDefinition":"the yes/no indicator whether the Timed Get Up and Go Functional (TUG) Test was performed.","longName":"TIMED_GET_UP_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0228A387-2C01-9E1D-E050-BB89AD4310DB","latestVersionIndicator":"Yes","beginDate":"2014-09-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-03","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4477984","version":"1","preferredName":"No Disease Involvement Checkbox Indicator","preferredDefinition":"Checkbox indicator to signify that an anatomic site is not a location of disease.","longName":"NO_DZ_INVLT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02A315AA-1ABC-A1E1-E050-BB89AD4315E2","latestVersionIndicator":"Yes","beginDate":"2014-09-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-09","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4478494","version":"1","preferredName":"Image Injection To Scan Interval Time Ind","preferredDefinition":"A response as to whether or not the number of minutes from injection time to scan time adhered to the imaging guidelines of a specific trial.","longName":"3384684v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02A479A1-9C7D-AC77-E050-BB89AD434C47","latestVersionIndicator":"Yes","beginDate":"2014-09-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-09-09","modifiedBy":"PATELV","dateModified":"2014-09-09","changeNote":"9/9/14 curated to support imaging trials.  tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4478511","version":"1","preferredName":"Imaging Case Report Form Data Completed Received Ind","preferredDefinition":"A response to confirm the completeness and receipt of the imaging related data.","longName":"3382539v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02A479A1-9CB9-AC77-E050-BB89AD434C47","latestVersionIndicator":"Yes","beginDate":"2014-09-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-09-09","modifiedBy":"TAYLORT","dateModified":"2014-09-09","changeNote":"9/9/14 curated to support imaging trials. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4478640","version":"1","preferredName":"Pneumococcal 13-valent Conjugate Vaccine Administered Indicator","preferredDefinition":"the indicator to whether Pneumococcal 13-valent Conjugate Vaccine was administered.","longName":"PNEUM_VACC_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02A672D0-8E9F-5818-E050-BB89AD434DCE","latestVersionIndicator":"Yes","beginDate":"2014-09-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-09","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4484534","version":"1","preferredName":"Protocol Non-Assigned Treatment  Arm Indicator","preferredDefinition":"the yes/no indicator that asks whether the patient was treated on the non-assigned protocol treatment arm.","longName":"4484533v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"031E2B82-5C3F-C802-E050-BB89AD437B86","latestVersionIndicator":"Yes","beginDate":"2014-09-15","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-15","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4492376","version":"1","preferredName":"Clinical Study Status Type","preferredDefinition":"Information related to the study status type.","longName":"STUDY_STAT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03D00AE0-CCEC-64F7-E050-BB89AD4304E8","latestVersionIndicator":"Yes","beginDate":"2014-09-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-24","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4493217","version":"1","preferredName":"Clinician Signature Consent Indicator","preferredDefinition":"the yes/no indicator that asks if written informed consent has been obtained from a clinician.","longName":"4493216v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03FB8027-920C-A497-E050-BB89AD43552C","latestVersionIndicator":"Yes","beginDate":"2014-09-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-09-26","modifiedBy":"ROUILLAS","dateModified":"2014-10-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4514695","version":"1","preferredName":"Metastatic Disease Timing Type","preferredDefinition":"Text term to describe the timing of metastatic disease relative to diagnosis of primary.","longName":"4514692v1.0:3895687v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-761F-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-07","modifiedBy":"FINCHAMB","dateModified":"2023-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4514757","version":"1","preferredName":"Nephrectomy Date","preferredDefinition":"The date of a nephrectomy.","longName":"NEPH_DATE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7DAB-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-07","modifiedBy":"MORENOC","dateModified":"2019-08-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4520454","version":"1","preferredName":"Metastatic Disease or Disorder Present At Nephrectomy Ind","preferredDefinition":"The yes/no indicator related to metastatic disease being present at the time of nephrectomy/partial nephrectomy.","longName":"METS_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EA072D-F508-FCC2-E050-BB89AD432697","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-08","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4521413","version":"1","preferredName":"Excision Site Count","preferredDefinition":"The number of sites resected.","longName":"SITE_RESECT_NUMBER","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EA072D-F723-FCC2-E050-BB89AD432697","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-08","modifiedBy":"KRYSTKIA","dateModified":"2018-06-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4521526","version":"1","preferredName":"Patient Pregnancy Status","preferredDefinition":"information related to the pregnancy status of a patient.","longName":"PT_STATUS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EE5CE2-7707-AF7B-E050-BB89AD436310","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-08","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4528129","version":"1","preferredName":"Recurrent Disease Location Checkbox Indicator","preferredDefinition":"Check all that apply checkbox indicator determining whether or not certain recurrent disease sites exist.","longName":"MARK_ALL_APPLY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04FE22BC-53B1-2CBF-E050-BB89AD4367AE","latestVersionIndicator":"Yes","beginDate":"2014-10-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-09","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4529028","version":"1","preferredName":"Adverse Event Occurrence Day Count","preferredDefinition":"The total number of days the patient experienced a grade 3 or higher adverse event.","longName":"AE_OCUR_COUNT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0500D613-6561-6BFF-E050-BB89AD437EE4","latestVersionIndicator":"Yes","beginDate":"2014-10-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-09","modifiedBy":"SOKKERL","dateModified":"2023-05-04","changeNote":null,"administrativeNotes":"5/4/23:classified and added CTDC ALTname for ECOG/DD. LS","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4541097","version":"1","preferredName":"Surgical Procedure Location Checkbox Indicator","preferredDefinition":"information related to location of a procedure to remove or repair a part of the body or to find out whether disease is present.","longName":"mark_all","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A2787C-3BF5-D84A-E050-BB89AD4368AB","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-17","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4551521","version":"1","preferredName":"Fuhrman Nuclear Grade","preferredDefinition":"A 4-point scale that indicates the level of protein synthesis activity in malignant cells based on the appearance of the nuclei. The grading ranges from I (best prognosis) to IV (worst prognosis)._A position on a scale of intensity or amount or quality._Permissible values for FuhrmanNuclearGradeGradeVD","longName":"FURHMAN_GR","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"061BFF4A-CE2A-D605-E050-BB89AD4343B4","latestVersionIndicator":"Yes","beginDate":"2014-10-23","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-23","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4567771","version":"1","preferredName":"Melanoma Not Otherwise Specified Disease or Disorder Present Indicator","preferredDefinition":"the yes/no/unknown indicator that asks whether the patient's simplified disease code is Melanoma, NOS.","longName":"DZ_CODE_MEL_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06BBEEEF-A3D0-EFB5-E050-BB89AD436511","latestVersionIndicator":"Yes","beginDate":"2014-10-31","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-31","modifiedBy":"ROUILLAS","dateModified":"2015-02-20","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4567793","version":"1","preferredName":"Uveal Melanoma Disease or Disorder Type Indicator","preferredDefinition":"Indicator to signify whether or not the disease type is uveal melanoma.","longName":"UVEAL_TYPE_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06BBEEEF-A410-EFB5-E050-BB89AD436511","latestVersionIndicator":"Yes","beginDate":"2014-10-31","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-10-31","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4604276","version":"1","preferredName":"Laboratory Procedure NRAS Gene Outcome Ind-2","preferredDefinition":"the yes/no indicator related to result of a gene that is involved in signal transduction and cell cycle regulation.","longName":"NRAS_ANALYSIS_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0860CA67-580D-9FEA-E050-BB89AD432FA3","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4604293","version":"1","preferredName":"Laboratory Procedure NRAS Gene Outcome Type","preferredDefinition":"information related to result of a gene that is involved in signal transduction and cell cycle regulation","longName":"NRAS_RSLT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0860A569-F0B6-C1EC-E050-BB89AD432374","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4604315","version":"1","preferredName":"Laboratory Procedure KIT Gene Outcome Yes No Indicator","preferredDefinition":"the yes/no indicator related to result of a gene that is involved in cellular hematopoiesis and differentiations.","longName":"KIT_ANALYSIS_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0861328A-511D-F2B1-E050-BB89AD436FFD","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4604335","version":"1","preferredName":"Laboratory Procedure KIT Gene Outcome Type","preferredDefinition":"information related to result of a gene that is involved in cellular hematopoiesis and differentiations.","longName":"KIT_RSLT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0861328A-51DE-F2B1-E050-BB89AD436FFD","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4604353","version":"1","preferredName":"Melanoma Neoplasm First Diagnosis Date","preferredDefinition":"the date of the initial diagnosis (investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms) of melanoma.","longName":"MEL_NEO_DX_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08621A03-1B2A-129B-E050-BB89AD43574C","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2015-03-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4605451","version":"1","preferredName":"Laboratory Procedure KIT Gene Outcome Date","preferredDefinition":"the date related to result of a gene that is involved in cellular hematopoiesis and differentiations.","longName":"KIT_RSLT_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08623B82-09D9-F23E-E050-BB89AD4336DB","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4605491","version":"1","preferredName":"Tumor Immune Response Evaluation Ind-2","preferredDefinition":"Indicator of whether or not the participant was assessed for immune response.","longName":"IMMUNE_RESP_EVAL_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0862A53C-1117-EB9A-E050-BB89AD43061A","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4606914","version":"1","preferredName":"PDL1/PD1 Pharmacologic Substance Administered Specify Text","preferredDefinition":"Information related to PDL1/PD1 inhibitor administered.","longName":"SPECIFY_AGNT_PDL1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0863F54C-59A9-CD5D-E050-BB89AD431363","latestVersionIndicator":"Yes","beginDate":"2014-11-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-21","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4613089","version":"1","preferredName":"Resectable Melanoma Therapeutic Procedure Administration Ind","preferredDefinition":"The indicator that describes whether or not treatment was administered for resectable melanoma.","longName":"RESCT_MELA_TX_ADMIN_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08B2943E-6787-697A-E050-BB89AD43571B","latestVersionIndicator":"Yes","beginDate":"2014-11-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-25","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4613093","version":"1","preferredName":"Unresectable Melanoma Therapeutic Procedure Administration Ind","preferredDefinition":"The indicator that describes whether or not treatment was administered for uresectable melanoma.","longName":"UNRESCT_MELA_TX_ADMIN_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08B2943E-67CA-697A-E050-BB89AD43571B","latestVersionIndicator":"Yes","beginDate":"2014-11-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-11-25","modifiedBy":"ROUILLAS","dateModified":"2014-12-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4621654","version":"1","preferredName":"Specimen collection Kit Use Ind","preferredDefinition":"the yes/no indicator related to whether or not a specimen collection kit is needed.","longName":"SPEC_KIT_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B6DFAA-3EAF-38A5-E050-BB89AD432351","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-12-08","modifiedBy":"ROUILLAS","dateModified":"2015-01-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4630114","version":"1","preferredName":"Serum Immunologic Laboratory Procedure Performed Type","preferredDefinition":"Pertaining to serologic tests to determine the presence of immunologic factors or evidence of an immune response._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion._The study of the immune system and its reaction to pathogens, as well as its malfunctions (autoimmune diseases, allergies, rejection of organ transplants)._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.Type; a subdivision of a particular kind of thing.","longName":"SRIMM_LBPR_PRF_TP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09CC2583-F956-B9B0-E050-BB89AD4311EB","latestVersionIndicator":"Yes","beginDate":"2014-12-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-12-09","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4630125","version":"1","preferredName":"Current Melanoma Status Type","preferredDefinition":"A description of the disease status of myeloma.","longName":"2528340v1.0:4630120v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09CC8A4B-6366-CFA3-E050-BB89AD433D8B","latestVersionIndicator":"Yes","beginDate":"2014-12-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-12-09","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4630137","version":"1","preferredName":"Protocol Agent Administered Calendar Complete Ind","preferredDefinition":"the yes/no indicator that asks whether the patient completed the study drug calendar.","longName":"DRUG_CALENDAR_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09CD125B-E5C6-21F8-E050-BB89AD431AC8","latestVersionIndicator":"Yes","beginDate":"2014-12-09","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-12-09","modifiedBy":"ROUILLAS","dateModified":"2015-01-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4631554","version":"1","preferredName":"Additional Surgical Margin Collected Specimen Count","preferredDefinition":"The number of additional surgical margins obtained.","longName":"4631553v1.0:2535655v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09E0920D-0E50-8B7C-E050-BB89AD431555","latestVersionIndicator":"Yes","beginDate":"2014-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-12-10","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 12/10/14 curated for E4112. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4669132","version":"1","preferredName":"Melanoma Treatment Prior Regimen Type","preferredDefinition":"information related to the type of prior treatment regimen administered to a patient with melanoma.","longName":"MEL_TX_PRI_RGM_TP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0CCB1F22-2C86-2758-E050-BB89AD43676F","latestVersionIndicator":"Yes","beginDate":"2015-01-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-01-16","modifiedBy":"ROUILLAS","dateModified":"2015-04-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4683851","version":"1","preferredName":"Surgical Procedure Planned Ind","preferredDefinition":"A response as to whether there is a plan for surgery.","longName":"4903807v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0DA65529-4D96-DC99-E050-BB89AD430196","latestVersionIndicator":"Yes","beginDate":"2015-01-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-01-27","modifiedBy":"FINCHAMB","dateModified":"2024-02-15","changeNote":"7/17/15 edits/caDSR clean up/tt_1/27/15 curated for 4112 - tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4683989","version":"1","preferredName":"Radiation Therapy Planned Ind","preferredDefinition":"A response as to whether there is a plan for the patient to have or receive radiation therapy.","longName":"3865425v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0DA6F9CA-6713-761C-E050-BB89AD434926","latestVersionIndicator":"Yes","beginDate":"2015-01-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-01-27","modifiedBy":"TSESU","dateModified":"2023-06-06","changeNote":"TL released 2/23/22.; 7/17/15 edit to DEC and def/tt_1/27/15 curated for 4112 -tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4717489","version":"1","preferredName":"Acute Myeloid Leukemia Treatment Plan Assessment Ind","preferredDefinition":"A response for questions related to the treatment plan for AML.","longName":"4717484v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0EE789CA-A4AD-0E17-E050-BB89AD43499D","latestVersionIndicator":"Yes","beginDate":"2015-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-02-12","modifiedBy":"LEEW","dateModified":"2018-01-22","changeNote":"3-2-15 ADSC approved-tt._2/27/2015 edit to draft new VD and Long Name. tt2-12-15 curated for EAI141 - tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4718155","version":"1","preferredName":"Person Ability Imaging Procedure Length Requirement Ind","preferredDefinition":"A response for questions related to the patient's ability to meet the requirement for the length of the imaging procedure.","longName":"4718154v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0EF84B16-28D2-C79F-E050-BB89AD43775B","latestVersionIndicator":"Yes","beginDate":"2015-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-02-13","modifiedBy":"TAYLORT","dateModified":"2015-12-04","changeNote":"3/2/215 edit to Long name, def and preferred question text; ADSC approved. 2-25-15 edit to draft new long name.  tt 2-13-15 curated for imaging trials - tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4718173","version":"1","preferredName":"Institution ECOG ACRIN Agreement And Approval Ind","preferredDefinition":"A response for questions to ensure that the institution agrees to the ACRIN, ECOG-ACRIN imaging protocol and equipment qualification requirements and meets ACRIN, ECOG-ACRIN approval enabling patient and site participation in the imaging trial.","longName":"4718172v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0EF948FC-5566-B87C-E050-BB89AD431B26","latestVersionIndicator":"Yes","beginDate":"2015-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-02-13","modifiedBy":"FINCHAMB","dateModified":"2023-04-03","changeNote":"3-2-15 ADSC approved-tt._2-13-15 curated for imaging trials - tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723700","version":"1","preferredName":"Baseline Clinical Evaluation Performed Yes No Indicator","preferredDefinition":"the yes/no indicator which describes if a baseline clinical evaluation was performed.","longName":"BSLN_CLIN_ASMNT_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FD7F006-A579-E3AE-E050-BB89AD4367E9","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723735","version":"1","preferredName":"Neck Margin Closest Distance Measurement","preferredDefinition":"the measurement in millimeters of the distance from the closest point of the lesion to the closest point of the surgical margin.","longName":"NK_MAR_CL_DIS_MEA","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FD7F006-A5E8-E3AE-E050-BB89AD4367E9","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723748","version":"1","preferredName":"Head and Neck Tumor Pathology M Stage","preferredDefinition":"the pathologic M stage, the presence of metastasis based on pathologic evaluation of a tissue specimen, of a malignant neoplasm originating in the head and neck.","longName":"2854464v1.0:2854442v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FD8EEC1-CC0C-E5AA-E050-BB89AD436A88","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723772","version":"1","preferredName":"Treatment Cycle","preferredDefinition":"A repeating period of activity involving treatment and rest. Several cycles can make up a course.","longName":"TX_CYCLE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FD9EC5A-940D-C20A-E050-BB89AD433D2F","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723773","version":"1","preferredName":"Malignant Neoplasm Nodal Involvement Checkbox Indicator","preferredDefinition":"the checkbox indicator to determine whether or not a malignant neoplasm is involved with or pertaining to a node, any bulge or swelling of an anatomical structure or part.","longName":"NODE_PD_CB","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FD9EC5A-942C-C20A-E050-BB89AD433D2F","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723777","version":"1","preferredName":"Malignant Neoplasm Primary Involvement Checkbox Indicator","preferredDefinition":"the checkbox indicator to determine whether or not a malignant neoplasm is involved with or pertaining to a primary neoplasm.","longName":"PRIM_PD_CB","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDAAFE2-9904-FD05-E050-BB89AD4341A1","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723782","version":"1","preferredName":"Malignant Neoplasm New Anatomic Site Local Involvement Checkbox Indicator","preferredDefinition":"the checkbox indicator to determine whether or not a malignant neoplasm is involved with or pertaining to a new local site.","longName":"NEW_LOC_PD_CB","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDAC505-396E-75B0-E050-BB89AD430E57","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723788","version":"1","preferredName":"Malignant Neoplasm New Anatomic Site Regional Involvement Checkbox Indicator","preferredDefinition":"the checkbox indicator to determine whether or not a malignant neoplasm is involved with or pertaining to a new regional site.","longName":"NEW_REG_PD_CB","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDB06BA-2F47-46B7-E050-BB89AD430896","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723794","version":"1","preferredName":"Malignant Neoplasm New Anatomic Site Distant Involvement Checkbox Indicator","preferredDefinition":"the checkbox indicator to determine whether or not a malignant neoplasm is involved with or pertaining to a new distant site.","longName":"NEW_DIST_PD_CB","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDAC505-3A1D-75B0-E050-BB89AD430E57","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723837","version":"1","preferredName":"Distant New Site Description","preferredDefinition":"the text field to describe a distant new site.","longName":"4723822v1.0:4723835v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FDAC505-3C37-75B0-E050-BB89AD430E57","latestVersionIndicator":"Yes","beginDate":"2015-02-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4723940","version":"1","preferredName":"Employment Past Integer::12 Month Count","preferredDefinition":"the count related to past 12 months of employment.","longName":"WORK_MO_PRIOR_DIAG_NUM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FEB3D55-3306-1B5D-E050-BB89AD433E9C","latestVersionIndicator":"Yes","beginDate":"2015-02-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-25","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4724016","version":"1","preferredName":"Patient Emergency Care Evaluation Indicator","preferredDefinition":"a yes/no indicator to ask if an individual has used an ambulance or visited the emergency department.","longName":"EMRGNCY_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FED032F-B9AA-3F24-E050-BB89AD435FE4","latestVersionIndicator":"Yes","beginDate":"2015-02-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-25","modifiedBy":"MORENOC","dateModified":"2017-09-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4724033","version":"1","preferredName":"Disease or Disorder Histologically Confirmation Ind","preferredDefinition":"A response for questions related to the histological confirmation of disease(s).","longName":"4724032v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FEEAE78-40ED-6D4A-E050-BB89AD43227E","latestVersionIndicator":"Yes","beginDate":"2015-02-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-02-25","modifiedBy":"CARPIOJ","dateModified":"2022-04-28","changeNote":"2/27/15 corected typo in preferred question text. tt 2/25/15 curated for EAI142-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725008","version":"1","preferredName":"Patient Family Member Or Friend Employment Absent Patient Assistance Indicator","preferredDefinition":"a yes/no indicator to ask if a family member or friend had to take time off from work to assist the patient.","longName":"FAM_TIME_OFF_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FFE60AA-8D7C-5617-E050-BB89AD4365C9","latestVersionIndicator":"Yes","beginDate":"2015-02-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-26","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725014","version":"1","preferredName":"Patient Cancer Treatment Home Health Nursing Assistance Ind","preferredDefinition":"the yes/no indicator whether a home health nurse visits the patient for care related to cancer treatment.","longName":"NURSE_VISIT_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FFE60AA-8E04-5617-E050-BB89AD4365C9","latestVersionIndicator":"Yes","beginDate":"2015-02-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-26","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725040","version":"1","preferredName":"Patient Visit Expense Type","preferredDefinition":"The patient's office visit expense type.","longName":"COST_LIST","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"100036D3-9BFB-6023-E050-BB89AD433E0A","latestVersionIndicator":"Yes","beginDate":"2015-02-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-26","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725052","version":"1","preferredName":"Patient Cost Estimate","preferredDefinition":"The patient's estimated cost.","longName":"COST","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1000A6AB-B244-8AE1-E050-BB89AD43493C","latestVersionIndicator":"Yes","beginDate":"2015-02-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-26","modifiedBy":"BONANNIR","dateModified":"2015-09-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725085","version":"1","preferredName":"Continue Patient Observation Ind","preferredDefinition":"the yes/no indicator related to the patient continuing on observation.","longName":"NEXT_OBS_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1000A6AB-B29C-8AE1-E050-BB89AD43493C","latestVersionIndicator":"Yes","beginDate":"2015-02-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-26","modifiedBy":"MORENOC","dateModified":"2017-03-21","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4725893","version":"1","preferredName":"Protocol Patient Off-Observation Reason Specify Other","preferredDefinition":"The free text field to specify a reason or event that caused a participant to be removed from observation.","longName":"3090346v1.0:2015199v6.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1012F4A2-C01C-7B01-E050-BB89AD431A9C","latestVersionIndicator":"Yes","beginDate":"2015-02-27","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-02-27","modifiedBy":"MORENOC","dateModified":"2017-03-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4730639","version":"1","preferredName":"Non-Protocol Intervention or Procedure Assessment Ind","preferredDefinition":"A response for questions related to non-protocol interventions and/or procedures.","longName":"4730578v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1053EDCC-3F12-7F24-E050-BB89AD432E25","latestVersionIndicator":"Yes","beginDate":"2015-03-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-03-02","modifiedBy":"TAYLORT","dateModified":"2016-09-06","changeNote":"9/6/16 tt, reinserted preferred question text. 4/27/15 Committee approved, released CDE/tt_4/23/15 edit to draft new DE/tt_3/2/15 curatd for EAI412_tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4735754","version":"1","preferredName":"Modified Barium Swallow Evaluation Date","preferredDefinition":"The date on which the Modified Barium Swallow was performed.","longName":"MBS_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"108FE035-BF7C-253F-E050-BB89AD437954","latestVersionIndicator":"Yes","beginDate":"2015-03-05","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-05","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4735771","version":"1","preferredName":"Modified Barium Swallow Evaluation Time","preferredDefinition":"The time at which the Modified Barium Swallow study was performed.","longName":"MBS_TIME","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"108FFF1F-1F2B-1C1B-E050-BB89AD433664","latestVersionIndicator":"Yes","beginDate":"2015-03-05","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-05","modifiedBy":"ROUILLAS","dateModified":"2015-03-09","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745674","version":"1","preferredName":"Nephroureterectomy Performed Ind","preferredDefinition":"The yes/no indicator of whether the subject had nephroureterectomy.","longName":"NEPH_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116B1AD6-89B0-1F06-E050-BB89AD433B66","latestVersionIndicator":"Yes","beginDate":"2015-03-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-16","modifiedBy":"ROUILLAS","dateModified":"2015-03-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745700","version":"1","preferredName":"Prior Surgery Neoadjuvant Therapy NED Duration","preferredDefinition":"Information related to the duration of time patient was NED from prior surgery or neoadjuvant chemotherapy.","longName":"4745693v1.0:4745695v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116B1AD6-8AA3-1F06-E050-BB89AD433B66","latestVersionIndicator":"Yes","beginDate":"2015-03-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-16","modifiedBy":"ROUILLAS","dateModified":"2015-03-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4745814","version":"1","preferredName":"Therapy Malignant Neoplasm Recurrence Administered Ind","preferredDefinition":"the yes/no indicator to ask whether a patient had therapy administered for a tumor recurrence.","longName":"TX_MALIG_REC_ADM_YES_NO_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CC131-FC8E-2212-E050-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2015-03-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-16","modifiedBy":"CHANGP","dateModified":"2016-03-30","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4749192","version":"1","preferredName":"Residual Cancer Tumor Burden Post Neoadjuvant Therapy Category","preferredDefinition":"Distinct grouping or class based on result of the Residual Cancer Burden after neoadjuvant chemotherapy.","longName":"4749188v1.0:4749189v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-36DB-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4751131","version":"1","preferredName":"Nephroureterectomy Performed Date","preferredDefinition":"the date on which nephroureterectomy was performed.","longName":"4745673v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1209C988-EDEB-F92D-E050-BB89AD43221B","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-24","modifiedBy":"ROUILLAS","dateModified":"2015-03-24","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4768891","version":"1","preferredName":"Lymph Node Dissection Ind","preferredDefinition":"the yes/no indicator that asks whether lymph nodes were removed according to a standard surgical dissection technique.","longName":"LN_DISSEC_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12ADD6BF-5E28-627C-E050-BB89AD436830","latestVersionIndicator":"Yes","beginDate":"2015-04-01","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-01","modifiedBy":"ROUILLAS","dateModified":"2015-04-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4769093","version":"1","preferredName":"Clavien-Dindo Classification Grade","preferredDefinition":"A classification of adverse events that grades complications according to the treatment that is induced to treat the complication. The classification is designed to eliminate subjective interpretation of serious adverse events and tendency to down-rate complications, being based on data that is usually well documented and easy to verify. It is also well suited for retrospective analyses.","longName":"CD_GRADE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12ADD6BF-60DF-627C-E050-BB89AD436830","latestVersionIndicator":"Yes","beginDate":"2015-04-01","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-01","modifiedBy":"ROUILLAS","dateModified":"2015-04-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4792931","version":"1","preferredName":"Pathologic M Stage Collection Status Indicator","preferredDefinition":"Indicator of Yes or No to the status of whether or not pathologic M stage was obtained.","longName":"PATH_M_ST_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13ECF490-6E90-EF7A-E050-BB89AD437EB2","latestVersionIndicator":"Yes","beginDate":"2015-04-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-17","modifiedBy":"ROUILLAS","dateModified":"2015-04-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4792973","version":"1","preferredName":"Off-Treatment Therapy Administered Indicator","preferredDefinition":"Information related to off-treatment therapy being administered.","longName":"OTX_TX_ADM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13EDCD36-4785-8A9D-E050-BB89AD433EE6","latestVersionIndicator":"Yes","beginDate":"2015-04-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-17","modifiedBy":"ROUILLAS","dateModified":"2015-04-17","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4798411","version":"1","preferredName":"Patient Stable Medical Condition Confirmation Ind","preferredDefinition":"A response of yes/no/unknown/not applicable for questions confirming the stable medical condition of the patient.","longName":"4798373v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"14568B41-DF18-C9F8-E050-BB89AD432A03","latestVersionIndicator":"Yes","beginDate":"2015-04-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-04-22","modifiedBy":"CARPIOJ","dateModified":"2021-03-12","changeNote":"7/11/16 tt/dl, released approved content.  4/22/15 curated for EAI142/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4798655","version":"1","preferredName":"Effusion Disease or Disorder Present Ind","preferredDefinition":"Response of yes/no/unknown/not applicable for questions related to the presence of effusion disease.","longName":"4798654v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"14660FA5-7585-DF4D-E050-BB89AD432D44","latestVersionIndicator":"Yes","beginDate":"2015-04-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-04-23","modifiedBy":"MORENOC","dateModified":"2019-03-29","changeNote":"7/11/16 tt/dl, released approved content.  7/11/16 T, corrected typo in def. 4/23/2015 curated for EAI142/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4801311","version":"1","preferredName":"Patient ALK Gene Rearrangement Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to ALK gene rearrangement as determined by the MATCH screening assessment.","longName":"4798834v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14CB02D9-623D-309A-E050-BB89AD434CB5","latestVersionIndicator":"Yes","beginDate":"2015-04-28","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-28","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4804953","version":"1","preferredName":"Patient Non-Small Cell Lung Carcinoma Anaplastic Large Cell Lymphoma Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of Non-Small Cell Lung Cancer or Anaplastic Large Cell Lymphoma.","longName":"NSLC_ALCL_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14DE4764-7323-21A3-E050-BB89AD435DCE","latestVersionIndicator":"Yes","beginDate":"2015-04-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-29","modifiedBy":"ROUILLAS","dateModified":"2015-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4805505","version":"1","preferredName":"Patient Interstitial Disease Lung Personal Medical History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of interstitial lung or severe interstitial fibrosis.","longName":"PT_INDZ_LNG_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14E153AC-FF5A-A78C-E050-BB89AD436AEB","latestVersionIndicator":"Yes","beginDate":"2015-04-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-29","modifiedBy":"ROUILLAS","dateModified":"2015-08-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4805561","version":"1","preferredName":"Patient Eligibility Status","preferredDefinition":"information that identifies whether eligibility criteria have been met for the patient to participate in the clinical study.","longName":"PT_ELIG_STATUS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14E15681-D4CE-267D-E050-BB89AD437449","latestVersionIndicator":"Yes","beginDate":"2015-04-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-29","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4805626","version":"1","preferredName":"Patient Hypersensitivity Crizotinib Clinical Trial Eligibility Criteria Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to Crizotinib or compounds of similar chemical or biologic composition","longName":"PT_CRIZOT_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14E1EF63-5F33-ACEC-E050-BB89AD43341D","latestVersionIndicator":"Yes","beginDate":"2015-04-29","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-29","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4806294","version":"1","preferredName":"Patient Prior ALK Gene Targeted Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of prior therapy with ALK-targeted inhibitors including crizotinib, ceritinib, alectinib, AP26113, TSR-011, X-396, RXDX-101, CEP-37440, PF-06463922.","longName":"PT_ALK_INHIB_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14F3A02B-8CD4-0AA0-E050-BB89AD4327C8","latestVersionIndicator":"Yes","beginDate":"2015-04-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-30","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4806371","version":"1","preferredName":"Patient Brain Metastasis Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a history of brain metastases.","longName":"3227859v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14F4E84D-1264-6368-E050-BB89AD4377F2","latestVersionIndicator":"Yes","beginDate":"2015-04-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-30","modifiedBy":"RODGERSC","dateModified":"2019-05-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4806391","version":"1","preferredName":"Patient Strong Cytochrome P450 3A4 Induction Medication Eligibility Determination Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the use of drugs or foods that are known potent CYP3A4 inhibitors or inducers.","longName":"3153625v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14F4E84D-1283-6368-E050-BB89AD4377F2","latestVersionIndicator":"Yes","beginDate":"2015-04-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-30","modifiedBy":"GDEEN","dateModified":"2022-09-28","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4806418","version":"1","preferredName":"Patient ROS1 Gene Translocation Inversion Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient being positive for translocation or inversion events involving the ROS1 gene.","longName":"4806417v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"14F5E9CD-D7F1-9383-E050-BB89AD4369A4","latestVersionIndicator":"Yes","beginDate":"2015-04-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-30","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4809657","version":"1","preferredName":"Patient Prior ROS1 Gene Targeted Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of prior therapy with any ROS1 inhibitor including crizotinib, ceritinib, foretinib, cabozantinib, AP26113, ASP3026, WZ-5-126, TAE684, KIST301072, KIST301080, AZD1480, PF-06463922, RXDX-101 and PF-3922.","longName":"4809653v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15418464-C971-940F-E050-BB89AD436363","latestVersionIndicator":"Yes","beginDate":"2015-05-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-04","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4810331","version":"1","preferredName":"Patient Prior Randomization Electrocardiography Eligibility Determination Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having an electrocardiogram (ECG) within 8 weeks prior to randomization.","longName":"4809875v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15553224-75C9-235F-E050-BB89AD43656D","latestVersionIndicator":"Yes","beginDate":"2015-05-05","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-05","modifiedBy":"SARAHB","dateModified":"2018-06-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4824994","version":"1","preferredName":"Patient Philadelphia Chromosome Negative Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"a yes/no applicable indicator related to a patient with negative lab test confirmation of a translocation between chromosomes 9 and 22 to allow a subject to participate in a clinical study.","longName":"PhilChmNv","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"160A083A-81E4-60DD-E050-BB89AD437883","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-14","modifiedBy":"ZHWENDY","dateModified":"2023-04-06","changeNote":null,"administrativeNotes":"2023/4/5: Added AQT for Alliance.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4826261","version":"1","preferredName":"Person Therapeutic Procedure Administration Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions related to the action or administration of therapeutic agents that produce an effect intended to alter or stop a pathologic process in order to determine eligibility for clinical trial participation.","longName":"TX_TRL_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"160F368D-0FB5-4402-E050-BB89AD430232","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-05-14","modifiedBy":"TAYLORT","dateModified":"2016-07-11","changeNote":"7/11/16 tt/dl, released approved content. 12/4/15 edit to DEC/tt_5/14/15 curated/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4826453","version":"1","preferredName":"Person Off Treatment Prior Imaging Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol related to off treatment requirements prior to an imaging procedure.","longName":"4826446v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1611BF82-8251-E1C7-E050-BB89AD4370CF","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-05-14","modifiedBy":"LOWMAND","dateModified":"2016-07-11","changeNote":"7/11/16 tt/dl, released approved content.   12/4/15 edits to DE/tt_5/14/15 curated to support imaging trials/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4826716","version":"1","preferredName":"Patient BRAF Gene Mutation Abnormality Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to BRAF gene mutation as determined by the MATCH screening assessment.","longName":"PT_BRAF_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16209366-54F8-AFB4-E050-BB89AD435F28","latestVersionIndicator":"Yes","beginDate":"2015-05-15","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-15","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4826733","version":"1","preferredName":"Patient Melanoma Diagnosis Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient being diagnosed with Melanoma.","longName":"PT_MEL_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16209366-5561-AFB4-E050-BB89AD435F28","latestVersionIndicator":"Yes","beginDate":"2015-05-15","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-15","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4827394","version":"1","preferredName":"Patient Thyroid Gland Papillary Carcinoma Diagnosis Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient being diagnosed with papillary thyroid cancer.","longName":"PT_THY_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"165FB348-F852-F8C6-E050-BB89AD43695B","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-18","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4827398","version":"1","preferredName":"Patient Colorectal Malignant Neoplasm Diagnosis Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient being diagnosed with colorectal cancer.","longName":"PT_COL_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"165FD37C-F726-7A0F-E050-BB89AD4329DD","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-18","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4828071","version":"1","preferredName":"Patient Organ Bone Marrow Function Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having normal organ and marrow function.","longName":"PT_ORG_BONE_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16701883-4E9D-725E-E050-BB89AD4320EC","latestVersionIndicator":"Yes","beginDate":"2015-05-19","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-19","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4828219","version":"1","preferredName":"Patient Heart Function Echocardiogram Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient being assessed for cardiac function by ECHO or a nuclear study.","longName":"4828153v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1671C91E-4B5F-B52F-E050-BB89AD437D8E","latestVersionIndicator":"Yes","beginDate":"2015-05-19","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-19","modifiedBy":"SARAHB","dateModified":"2018-06-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4835811","version":"1","preferredName":"Patient Hypersensitivity Dabrafenib Trametinib Dimethyl Sulfoxide Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to Dabrafenib and Trametinib or compounds of similar chemical or biologic composition or Dimethyl Sulfoxide.","longName":"4835793v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"169BF887-9F72-D13D-E050-BB89AD433910","latestVersionIndicator":"Yes","beginDate":"2015-05-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-21","modifiedBy":"ROUILLAS","dateModified":"2015-06-02","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4835891","version":"1","preferredName":"Patient Retinal Vein Occlusion Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient's history or current evidence/risk of retinal vein occlusion (RVO)","longName":"4835843v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"169CAB8D-08AF-FC42-E050-BB89AD43224E","latestVersionIndicator":"Yes","beginDate":"2015-05-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836114","version":"1","preferredName":"Patient  Prior Mitogen-Activated Protein Kinase Inhibitor Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior MEK inhibitor exposure.","longName":"4926993v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B05119-4FDA-F9E7-E050-BB89AD4334A8","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"SPRINGERL","dateModified":"2020-05-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836134","version":"1","preferredName":"Patient Prior Exposure DabrafenibTrametinib Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior exposure to Dabrafenib or Trametinib.","longName":"4836133v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B085D8-E8AD-522E-E050-BB89AD4315AD","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836135","version":"1","preferredName":"Patient Strong CYP3A CYP2C8 Induction Inhibition Clinical Trial Eligibility Criteria Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on any medications or substances the patient is receiving that are strong inhibitors or inducers of CYP3A or CYP2C8.","longName":"4473475v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B085D8-E8CC-522E-E050-BB89AD4315AD","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"ROUILLAS","dateModified":"2015-06-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836151","version":"1","preferredName":"Patient Monoclonal Antibody Personal Medical History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior monoclonal antibody therapy.","longName":"4461733v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B0F3EA-A113-42AA-E050-BB89AD430544","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"COOPERJ","dateModified":"2022-02-01","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836152","version":"1","preferredName":"Hepatitis B Hepatitis C Infection Personal Medical History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a history of Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV) infection.","longName":"2419430v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B0F3EA-A132-42AA-E050-BB89AD430544","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836171","version":"1","preferredName":"Patient RAS Family Gene Mutation Personal Medical History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a history of RAS mutation-positive tumors.","longName":"4648193v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16B0F3EA-A151-42AA-E050-BB89AD430544","latestVersionIndicator":"Yes","beginDate":"2015-05-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836514","version":"1","preferredName":"Patient BRAF Gene Mutation Abnormality KIAA1549/BRAF Fusion Gene Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to BRAF non-V600 mutation or BRAF fusion.","longName":"4836513v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16FBC7B6-EBE3-B9F4-E050-BB89AD437E11","latestVersionIndicator":"Yes","beginDate":"2015-05-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-26","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836538","version":"1","preferredName":"Patient Prior Mitogen-Activated Protein Kinase Kinase Inhibitor Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior MEK inhibitor exposure.","longName":"4723661v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16FBC7B6-EC02-B9F4-E050-BB89AD437E11","latestVersionIndicator":"Yes","beginDate":"2015-05-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-26","modifiedBy":"SPRINGERL","dateModified":"2020-05-25","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4836753","version":"1","preferredName":"Plasmacytoma Soft Tissue Baseline Use Ind-2","preferredDefinition":"the yes/no indicator related to the use of soft tissue plasmacytoma lesions from baseline.","longName":"4836752v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16FE00DC-275B-5824-E050-BB89AD43775F","latestVersionIndicator":"Yes","beginDate":"2015-05-26","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-05-26","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4844494","version":"1","preferredName":"Patient Lung Adenocarcinoma Clinical Trial Eligibility Criteria Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of adenocarcinoma of the lung.","longName":"4844493v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"178C9BEE-931C-C0D5-E050-BB89AD433B48","latestVersionIndicator":"Yes","beginDate":"2015-06-02","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-02","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845231","version":"1","preferredName":"Serum Immunofixation Laboratory Procedure Performed Ind","preferredDefinition":"Indicator to represent if a Serum Immunofixation has been performed.","longName":"4187722v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179E5DE8-34B5-2DAA-E050-BB89AD4319AD","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845232","version":"1","preferredName":"Serum Immunologic Laboratory Procedure Performed Ind","preferredDefinition":"Indicator to represent if a Serum Quantitative Immunoglobulins assessment has been performed.","longName":"2756913v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179E6DD0-F568-44C7-E050-BB89AD4319CF","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ZIEGLERK","dateModified":"2016-02-16","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845251","version":"1","preferredName":"Urine Immunofixation Laboratory Procedure Performed Ind","preferredDefinition":"the yes/no indicator to ask if a Urine Immunofixation was performed.","longName":"4170392v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179E6DD0-F58D-44C7-E050-BB89AD4319CF","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845273","version":"1","preferredName":"Circulating Plasma Cell Assessment Indicator","preferredDefinition":"the indicator relating to whether circulating plasma cells were assessed.","longName":"4845272v1.0:4845291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179E6DD0-F5BD-44C7-E050-BB89AD4319CF","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845277","version":"1","preferredName":"Plasma Cell Myeloma Genetic Assessment Performed Ind","preferredDefinition":"the yes/no indicator whether a Myeloma genetic assessment has been performed.","longName":"4845276v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179EF123-A656-AF29-E050-BB89AD435194","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845311","version":"1","preferredName":"Flow Cytometry Administered Checkbox Ind","preferredDefinition":"Checkbox indicator determining whether or not flow cytometry was administered.","longName":"2181325v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179EF123-A6E2-AF29-E050-BB89AD435194","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845314","version":"1","preferredName":"Immunohistochemistry Performed Checkbox Ind","preferredDefinition":"Checkbox indicator determining whether or not immunohistochemistry was performed.","longName":"4845313v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179EF123-A71B-AF29-E050-BB89AD435194","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-07-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845318","version":"1","preferredName":"Fluorescent Antibody Procedure Performed Checkbox Ind","preferredDefinition":"Indicator determining whether or not Immunofluorescence was performed.","longName":"4845317v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179EF123-A75C-AF29-E050-BB89AD435194","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845334","version":"1","preferredName":"Other Clonality Plasma Cell Bone Marrow Assessment Performed Checkbox Ind","preferredDefinition":"Indicator determining whether or not an unspecified bone marrow plasma cell clonality assessment was performed.","longName":"4845333v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"179FE0A1-7CC5-D626-E050-BB89AD433942","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845351","version":"1","preferredName":"Circulating Plasma Cell Assessment Method Type","preferredDefinition":"The circulating plasma cell method of evaluation.","longName":"4845272v1.0:2015230v3.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A002C8-AE49-F740-E050-BB89AD430DAF","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845376","version":"1","preferredName":"Cytogenetic Abnormality Deletion Mutation 13q Present Checkbox Ind","preferredDefinition":"Indicator determining whether or not the result included deletion 13.","longName":"3371764v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A0BE55-6A86-E39C-E050-BB89AD436158","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845378","version":"1","preferredName":"Specimen Hypodiploidy Cytogenetic Abnormality Present Checkbox Ind","preferredDefinition":"Indicator determining determining whether or not there is presence of the cytogenetic abnormality, hypodiploidy (a chromosomal abnormality in which the chromosomal number is less than the normal diploid number).","longName":"3921564v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A0A81E-470D-035A-E050-BB89AD433E51","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845380","version":"1","preferredName":"Other Cytogenetic Abnormality Present Checkbox Ind","preferredDefinition":"Indicator determining if there is a genomic DNA sequence by cytogenetic testing that is different than the options previously specified.","longName":"3194087v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A0A81E-472C-035A-E050-BB89AD433E51","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":"Curated for Lombardi Cancer Center mutation lab test panel","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845396","version":"1","preferredName":"Cytogenetic Abnormality Monosomy 13 Present Checkbox Ind","preferredDefinition":"Indicator determining whether or not there was a Monosomy 13/Del 13q result.","longName":"4178691v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A10BC5-EE15-5FE8-E050-BB89AD436817","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845400","version":"1","preferredName":"Cytogenetic Abnormality Monosomy Chromosome 17 Present Checkbox Ind","preferredDefinition":"Indicator determining whether or not there was a Monosomy 17/Deletion 17p result.","longName":"2987699v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A10BC5-EE34-5FE8-E050-BB89AD436817","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4845401","version":"1","preferredName":"Cytogenetics Karyotype Mutation Abnormality Cell Checkbox Ind","preferredDefinition":"Indicator determining whether or not there was an alteration in genetic material of individual cells that are reproduced in culture (as clones) as detected by tests for irregularity in chromosome number and structure.","longName":"2009395v3.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A0A81E-47C4-035A-E050-BB89AD433E51","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4846212","version":"1","preferredName":"Gene Microarray Analysis Risk Assessment Risk Status","preferredDefinition":"The GEP70 Risk Status of a patient.","longName":"4845409v1.0:4846211v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A10BC5-EEE2-5FE8-E050-BB89AD436817","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4847052","version":"1","preferredName":"Patient Increased FDG Uptake Bone Marrow Present Ind","preferredDefinition":"the yes/no indicator that asks whether increased FDG uptake was present in or outside bone marrow.","longName":"4847047v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A0A81E-48D5-035A-E050-BB89AD433E51","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-03","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4848531","version":"1","preferredName":"Lytic Lesion Present Checkbox Ind","preferredDefinition":"indicator determining if a lytic lesion is present.","longName":"2196037v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17A1F74D-4159-799B-E050-BB89AD43582C","latestVersionIndicator":"Yes","beginDate":"2015-06-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-03","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851571","version":"1","preferredName":"Osteopenia Diagnosis Checkbox Ind","preferredDefinition":"Indicator determining whether or not there is a diagnosis of osteopenia.","longName":"2195990v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B06FD2-3EF5-89DD-E050-BB89AD4322CE","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851575","version":"1","preferredName":"Compression Fracture Present Checkbox Ind","preferredDefinition":"Indicator determining whether or not a compression fracture is present.","longName":"4851574v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B06FD2-3F36-89DD-E050-BB89AD4322CE","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851593","version":"1","preferredName":"Bone Normal Present Checkbox Ind","preferredDefinition":"Indicator determining whether or not a normal bone survey is present.","longName":"4851592v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-47D4-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851594","version":"1","preferredName":"Recombinant Granulocyte Colony-Stimulating Factor Administered Checkbox Ind","preferredDefinition":"Indicator determining whether or not (G-CSF) was administered.","longName":"2873951v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-47F3-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851595","version":"1","preferredName":"Cyclophosphamide Administered Checkbox Ind","preferredDefinition":"Indicator determining whether or not Cyclophosphamide was administered.","longName":"2867138v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-4813-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851596","version":"1","preferredName":"Plerixafor Administered Checkbox Ind","preferredDefinition":"Indicator determining whether or not Plerixafor was administered.","longName":"3837076v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-4832-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851611","version":"1","preferredName":"Other Growth Factor Or Stem Cell Mobilization Therapy Administered Checkbox Ind","preferredDefinition":"Indicator determining whether or not other growth factor or stem cell mobilization therapy were administered.","longName":"3863087v1.0:2185839v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-4851-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851631","version":"1","preferredName":"Peripheral Blood Stem Cell CD34+ Cell Harvest Performed Count","preferredDefinition":"The number of days related to a peripheral blood stem CD34+ cell harvest performed.","longName":"2014800v1.0:2018392v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B0C185-4870-0AB4-E050-BB89AD436B08","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-07-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4851655","version":"1","preferredName":"FDG Avid Lesion Count","preferredDefinition":"the number of the patient's FDG avid lesions.","longName":"4851634v1.0:4851651v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B163CF-4461-A219-E050-BB89AD430CAE","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-04","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4883877","version":"1","preferredName":"Patient Engraftment Occurrence Date","preferredDefinition":"The date of engraftment.","longName":"4883802v1.0:2017121v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191F9751-4BA3-C5E7-E050-BB89AD434D94","latestVersionIndicator":"Yes","beginDate":"2015-06-22","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-06-22","modifiedBy":"ROUILLAS","dateModified":"2015-06-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890854","version":"1","preferredName":"Patient  EGFR Activating Mutation Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to a patient's tumor containing EGFR activating mutations.","longName":"4890853v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A34C105-A679-F91F-E050-BB89AD4309CE","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890874","version":"1","preferredName":"Patient Hypersensitivity Afatinib Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to Afatinib or compounds of similar chemical or biologic composition","longName":"4890873v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A34FFF0-BF7D-DD80-E050-BB89AD434054","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890974","version":"1","preferredName":"Patient Kidney Function Creatinine Outcome Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on <= grade 1 renal function and acceptable creatinine results.","longName":"4890973v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A387FFB-37D4-5FE9-E050-BB89AD4377FD","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890978","version":"1","preferredName":"Patient Prior EGFR Tyrosine Kinase Inhibitor Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior treatment with an EGFR TKI.","longName":"4890977v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A390E24-A8B2-2167-E050-BB89AD432A55","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"ROUILLAS","dateModified":"2015-07-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890982","version":"1","preferredName":"Patient Non-Small Cell Small Cell Lung Carcinoma Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of Non-Small Cell Lung Carcinoma and small cell lung cancer.","longName":"4890981v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A390E24-A8F7-2167-E050-BB89AD432A55","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4890994","version":"1","preferredName":"Patient HER2 Mutation Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to a patient's tumor containing HER2 activating mutations.","longName":"4890993v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A397DCD-8761-F310-E050-BB89AD432702","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"PATELV","dateModified":"2022-01-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891020","version":"1","preferredName":"Patient Less Than or Equal To CTCAE Grade 1 Diarrhea Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to a patient having less than or equal to grade 1 diarrhea.","longName":"4891017v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A39AF3D-6295-8920-E050-BB89AD433FF7","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-06","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891394","version":"1","preferredName":"Patient c-MET Gene Amplification Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to a patient's MET Gene Amplification.","longName":"4891393v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4B44FA-66DF-39C2-E050-BB89AD437D62","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891401","version":"1","preferredName":"Patient Hypersensitivity c-Met Inhibitor AMG 337 Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to AMG337 or compounds of similar chemical or biologic composition","longName":"4891400v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4B44FA-6724-39C2-E050-BB89AD437D62","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891411","version":"1","preferredName":"Patient Prior MET Gene Tyrosine Kinase Inhibitor Targeted Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of prior therapy with any MET TKI including AMG 337, BMS 777607, Cabozantinib (XL184), Crizotinib (PF02341066), EMD1214063, Foretinib (GSK1363089) (XL880), Golvatinib (E7050), IncB28060 (INC280), JNJ 8877605, MGCD265, MK2461, MSC2156119J, PF 04217903, SGX523, Tivantinib (ARQ197).","longName":"4891410v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4BF543-25AB-D5A6-E050-BB89AD434C1F","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891503","version":"1","preferredName":"Patient NF2 Gene Mutation Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study according to a patient's tumor containing NF2 Gene Mutations.","longName":"4891502v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4CC198-C14A-A027-E050-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891509","version":"1","preferredName":"Patient Left Ventricular Ejection Fraction Less Than 50 Percent Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having left ventricular ejection fraction < 50% prior to consent.","longName":"4891508v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4CC198-C197-A027-E050-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891523","version":"1","preferredName":"Patient Hypersensitivity Defactinib Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to defactinib or compounds of similar chemical or biologic composition","longName":"4891522v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4D2B90-4E8C-7077-E050-BB89AD432F81","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891528","version":"1","preferredName":"Patient Prior Upper gastrointestinal hemorrhage Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a history of upper GI bleeding, ulceration, or perforation.","longName":"4891527v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4CC198-C1E6-A027-E050-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891535","version":"1","preferredName":"Person Gilbert Syndrome Personal Medical History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a person having a history of Gilbert Syndrome, an autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice","longName":"3702855v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4D2B90-4EDA-7077-E050-BB89AD432F81","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"TYRRELLM","dateModified":"2023-10-24","changeNote":null,"administrativeNotes":"10.24.2023 Added Alt Short Name per request ticket CADSR0002996_mmt","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891537","version":"1","preferredName":"Patient Cerebrovascular Accident History Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a patient's cerebrovascular accident history.","longName":"2195406v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4CC198-C205-A027-E050-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891539","version":"1","preferredName":"Antihypertensive Agent Administered Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having hypertension that cannot be controlled by medications.","longName":"2762695v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4CC198-C22D-A027-E050-BB89AD43499A","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"KUMMEROA","dateModified":"2022-08-31","changeNote":null,"administrativeNotes":"2022.8.31 AQT added per ticket request CADSR-TASK0001488. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891555","version":"1","preferredName":"Patient Prior Therapy FAK Inhibitor Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior treatment with a FAK inhibitor.","longName":"4891554v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A4DA940-CB4E-14FB-E050-BB89AD434D92","latestVersionIndicator":"Yes","beginDate":"2015-07-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4897492","version":"1","preferredName":"Agent Administered Occurrence Medication Timepoint Type","preferredDefinition":"the status of whether a medication began before or after protocol treatment started.","longName":"2012894v5.0:4897491v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AC0D4FA-872E-8919-E050-BB89AD432E8B","latestVersionIndicator":"Yes","beginDate":"2015-07-13","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-13","modifiedBy":"ROUILLAS","dateModified":"2015-07-13","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4898695","version":"1","preferredName":"Patient Hypersensitivity EGFR Inhibitor AZD9291 Clinical Trial Eligibility Criteria Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to EGFR Inhibitor AZD9291 or compounds of similar chemical or biologic composition.","longName":"4898694v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AD6F64D-91EB-C65B-E050-BB89AD4375C1","latestVersionIndicator":"Yes","beginDate":"2015-07-14","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-14","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4898818","version":"1","preferredName":"Patient Prior EGFR Inhibitor Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior exposure to the following EGFR Inhibitors AZD9291, WZ4002, CO-1686, HM61713, EGF816 or ASP8273.","longName":"4898817v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AD75C89-52AB-ED1E-E050-BB89AD437407","latestVersionIndicator":"Yes","beginDate":"2015-07-14","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-14","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4898991","version":"1","preferredName":"Mutation Abnormality EGFR T790M Present Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of germline EGFR T790M mutations.","longName":"4172258v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1ADB1A09-271D-5ACB-E050-BB89AD433DA9","latestVersionIndicator":"Yes","beginDate":"2015-07-14","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-14","modifiedBy":"ROUILLAS","dateModified":"2015-07-14","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903051","version":"1","preferredName":"Mutation Abnormality EGFR G719X T790M Present Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of the following mutations in a tumor: EGFR T790M, EGFR G719A, G719C, G719D, G719S EGFR L861Q, or an EGFR exon 19 in frame insertion mutation.","longName":"4902910v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B025E71-2E02-CECE-E050-BB89AD4314F4","latestVersionIndicator":"Yes","beginDate":"2015-07-16","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903391","version":"1","preferredName":"Patient HER2/neu Positive Finding Eligibility Determination Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on a tumor sample having HER2 amplification > 7 based on targeted custom Ampliseq panel on the Ion Torrent PGM","longName":"2778121v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8D85-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903392","version":"1","preferredName":"Hematology Hemoglobin Assessment Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on adequate hematologic function as defined by: Hemoglobin >= 9.0g/dL.","longName":"3533989v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8DA4-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903416","version":"1","preferredName":"Anticoagulant Agent Administration Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the subject being on an anticoagulation agent (except warfarin and other coumarin derivatives) or on aspirin 81 mg by mouth daily.","longName":"4473461v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8DC3-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903434","version":"1","preferredName":"Patient  Breast Carcinoma Gastric Carcinoma Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having breast cancer or gastric/GEJ cancer.","longName":"4903433v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8E1C-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903474","version":"1","preferredName":"Patient Hypersensitivity Trastuzumab Emtansine Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to Ado-Trastuzumab Emtansine or compounds of similar chemical or biologic composition.","longName":"4903473v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8E61-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903478","version":"1","preferredName":"Patient Peripheral Neuropathy Severe Adverse Event Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of grade 3 or greater peripheral neuropathy.","longName":"4903477v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8EA6-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4903514","version":"1","preferredName":"Patient Prior ERBB2 Gene Targeted Therapy Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the absence of prior therapy with Trastuzumab, Pertuzumab, Ado-trastuzumab emtansine, Margetuximab, PF-05280014 (Pfizer, Trastuzumab Biosimilar), CT-P6 (Celltrion, Trastuzumab Biosimilar), ABP-980 (Amgen, Trastuzumab Biosimilar).","longName":"4903513v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B11FE69-8EF3-5AB1-E050-BB89AD434A5B","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4913431","version":"1","preferredName":"Patient Somatic cKIT Mutation Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having a somatic cKIT mutation in exon 9, 11, 13 or 14.","longName":"4913423v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B62E732-2C48-2A58-E050-BB89AD433464","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915196","version":"1","preferredName":"Patient Injury Complication Abdomen Fistula Perforation Abscess Cerebrovascular Accident Myocardial Infarction Pulmonary Embolism Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having any of the following conditions: Serious or non-healing wound, ulcer, or bone fracture, history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 28 days of treatment, any history of cerebrovascular accident (CVA) or transient ischemic attack within 12 months prior to study entry, history of myocardial infarction, cardiac arrhythmia, stable/unstable angina, symptomatic congestive heart failure, or coronary/peripheral artery bypass graft or stenting within 12 months prior to study entry, or history of pulmonary embolism within the past 12 months.","longName":"4915178v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B63F996-0A76-6749-E050-BB89AD4361B2","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915213","version":"1","preferredName":"Patient Hypersensitivity Sunitinib Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the presence of a hypersensitivity to Sunitinib or compounds of similar chemical or biologic composition.","longName":"4915212v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B63F996-0ABC-6749-E050-BB89AD4361B2","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915237","version":"1","preferredName":"Prior Sunitinib Chemotherapy Administered Eligibility Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior therapy with sunitinib.","longName":"3380280v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B63F996-0ADB-6749-E050-BB89AD4361B2","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915313","version":"1","preferredName":"Patient Gastrointestinal Stromal Tumor Renal Cell Carcinoma Pancreatic Neuroendocrine Tumor Eligibility Determination Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having GIST, renal cell carcinoma, or a pancreatic neuroendocrine tumor.","longName":"4915293v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B64A671-C6E0-472F-E050-BB89AD4314DE","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915351","version":"1","preferredName":"Person Serious Adverse Event Hemorrhage Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having a grade 3 hemorrhage within 4 weeks of starting study treatment.","longName":"3183057v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B64EE41-6534-3B0B-E050-BB89AD433710","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915382","version":"1","preferredName":"Person Control Thyroid Gland Function Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having a pre-existing thyroid abnormality with thyroid function that cannot be maintained in the normal range with medication.","longName":"3178987v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B64EE41-660B-3B0B-E050-BB89AD433710","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4915389","version":"1","preferredName":"Person Surgical Procedure Injury Eligibility Determination Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on the patient having a major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to starting treatment.","longName":"2744526v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B64EE41-6714-3B0B-E050-BB89AD433710","latestVersionIndicator":"Yes","beginDate":"2015-07-21","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-07-21","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4927000","version":"1","preferredName":"Patient  Prior BRAF Gene Inhibitor Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of whether a subject is suitable for enrollment in a study based on prior BRAF inhibitor exposure.","longName":"4836113v1.0:4801291v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C6CC54F-6C31-BEEB-E050-BB89AD432CAD","latestVersionIndicator":"Yes","beginDate":"2015-08-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-08-03","modifiedBy":"GARRIDOJ","dateModified":"2017-10-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4944351","version":"1","preferredName":"Relapse Refractory Hodgkin Lymphoma Type","preferredDefinition":"Text term that describes the type of Hodgkin's Lymphoma the patient has.","longName":"4944333v1.0:4944334v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D0CED6F-9BCC-82C6-E050-BB89AD43195A","latestVersionIndicator":"Yes","beginDate":"2015-08-11","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-08-11","modifiedBy":"ROUILLAS","dateModified":"2015-08-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5023592","version":"1","preferredName":"Main Clinical Trial Registration Healthcare Facility Name","preferredDefinition":"the name or identifier of the main healthcare facility or institution registering a person on a research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","longName":"3506024v1.0:5023591v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"206D26AA-6B1E-DA82-E050-BB89AD433646","latestVersionIndicator":"Yes","beginDate":"2015-09-23","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-09-23","modifiedBy":"ROUILLAS","dateModified":"2015-09-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5025958","version":"1","preferredName":"Patient Imaging Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response as to whether all eligibility criteria addressing imaging procedures were met in order for the patient to participate in the clinical trial.","longName":"5025934v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D216F6-0CC9-68A9-E050-BB89AD433988","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-09-28","modifiedBy":"CLOHNES","dateModified":"2023-09-29","changeNote":"10/28/15 approved & released; tt_9/28/15 curated for imaging trials.tt.","administrativeNotes":"9/28/23 Added AQT and alt OID, CCTG for ticket number CADSR0002884 cjl. 2022.11.8 added AQT for ticket request CADSR0001669. cjl; 2022.9.26 AQT and Alt SN added for ticket request CADSR0001542. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027214","version":"1","preferredName":"Patient Therapeutic Procedure Exclusion Criteria Yes No Indicator","preferredDefinition":"A response for questions addressing therapeutic agents that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","longName":"5027213v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20F85C1C-B75D-F045-E050-BB89AD432400","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-09-30","modifiedBy":"TAYLORT","dateModified":"2015-10-28","changeNote":"10/28/15 approved & released; tt_9/30/15 EA5123/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5027234","version":"1","preferredName":"Patient Imaging Procedure Medical Contraindication Ind","preferredDefinition":"A response for questions addressing medical contraindications with regards to imaging procedures.","longName":"5027233v1.0:3506035v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20F8D2EF-362F-3E49-E050-BB89AD437B6B","latestVersionIndicator":"Yes","beginDate":"2015-09-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-09-30","modifiedBy":"SERIANNJ","dateModified":"2017-05-15","changeNote":"10/28/15 approved & released; tt_9/30/15 imaging trials/tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5099871","version":"1","preferredName":"Patient Imaging Breast Density Category Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response necessary to allow a subject to participate in a clinical study, as outlined in the study protocol, for questions related to the categories regarding the amount of different tissues present in the breast by utilizing any technology or method that aids in the visualization of breast tissue.","longName":"5099833v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2927D1DF-625D-CDC0-E050-BB89AD4343FE","latestVersionIndicator":"Yes","beginDate":"2016-01-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-12","modifiedBy":"LOWMAND","dateModified":"2017-03-29","changeNote":"7/11/16 tt/dl, released approved content.   2/10/16 tt, edit to long name and def.2/3/16 dl, changed question text. 1/12/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5099911","version":"1","preferredName":"Person Asymptomatic Breast Disease And Breast Cancer Screening Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine clinical trial eligibility for questions related to breast disease and the early detection of breast cancer as outlined in the study protocol.","longName":"5099893v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2928BF91-86D7-0C29-E050-BB89AD430A30","latestVersionIndicator":"Yes","beginDate":"2016-01-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-12","modifiedBy":"LOWMAND","dateModified":"2016-07-11","changeNote":"7/11/16 tt/dl, released approved content.  2/16/16 t, edit to long name and def. 2/3/16 dl, changed question text. 1/12/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5099917","version":"1","preferredName":"Breast Disease or Disorder Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing abnormal conditions of the breast in order to determine eligibility for clinical trial participation.","longName":"4976692v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2928BF91-8724-0C29-E050-BB89AD430A30","latestVersionIndicator":"Yes","beginDate":"2016-01-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-12","modifiedBy":"HARTLEYG","dateModified":"2020-12-11","changeNote":"7/11/16 tt/dl, released approved content.  2/3/16 dl, changed question text. 1/12/16 tt, curated for EA1141","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100351","version":"1","preferredName":"Person Prior Imaging Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response as to whether a person meets the eligibility criteria, as outlined in the clinical study protocol, for questions related to previous imaging procedures.","longName":"5100350v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"292962AA-52AB-C244-E050-BB89AD431D67","latestVersionIndicator":"Yes","beginDate":"2016-01-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-12","modifiedBy":"LOWMAND","dateModified":"2016-07-11","changeNote":"7/11/16 tt/dl, released approved content.  2/17/16 tt, edit to long name. 2/4/16 dl, changed question text. 1/12/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100391","version":"1","preferredName":"Person Disease or Disorder High Risk Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response as to whether a person meets the eligibility criteria to participate in a clinical trial with regards to any abnormal condition of the body or mind at risk for potential future harm that may arise from some present action or attribute or condition.","longName":"5100373v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"292A3840-59D7-8C83-E050-BB89AD433992","latestVersionIndicator":"Yes","beginDate":"2016-01-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-12","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeNote":"2/4/16 dl, changed question text. 1/12/16 tt, curated for EA1141.","administrativeNotes":"9/26/23 Added alt OID, CCTG and AQT for CCTG ticket CADSR0002884 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100623","version":"1","preferredName":"Person Imaging Agreement Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions related to the patient's agreement to any technology or method that aids in the visualization of any biological process, cell, tissue or organ, as outlined in the study protocol in order to allow participation in a clinical trial.","longName":"5100592v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"29388459-49EE-7CED-E050-BB89AD43257A","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-13","modifiedBy":"HARTLEYG","dateModified":"2021-01-25","changeNote":"1/30/17 dl, added alt text.  7/12/16 tt/dl, released approved content.  2/4/16 dl, changed question text. 1/13/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5100690","version":"1","preferredName":"Person Intervention or Procedure Ability Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing the patient's ability to any activity that produces an effect, or that is intended to alter the course of a disease in a patient or population, as outlined in the study protocol to allow participation in the clinical trial.","longName":"5100686v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"29394FE6-5331-B1AA-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-13","modifiedBy":"CARTERS","dateModified":"2022-04-11","changeNote":"7/12/16 tt/dl, released approved content.  2/4/16 dl, changed question text. 1/13/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5108335","version":"1","preferredName":"Person Breast Unilateral Examination Performed Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions addressing breast evaluations performed on one side of the body as outlined in the study protocol for clinical trial participation.","longName":"5108327v1.0:3506036v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"29F17307-2BDC-0AB7-E050-BB89AD43478E","latestVersionIndicator":"Yes","beginDate":"2016-01-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-22","modifiedBy":"LOWMAND","dateModified":"2016-07-12","changeNote":"7/12/16 tt/dl, released approved content.  1/26/16 tt, edit to long name and def. 1/22/16 tt, curated for E4112.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5109157","version":"1","preferredName":"Person Breast Intervention or Procedure Disease Disorder or Finding Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing activities that produce an effect, or intended to alter the course of breast disease that can have preventive, therapeutic, or palliative effects related to neoplasms and non-neoplastic disorders including observations, test results, history and other concepts relevant to the characterization of pathologic conditions, as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"5109154v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A2E9B77-B468-BD47-E050-BB89AD431587","latestVersionIndicator":"Yes","beginDate":"2016-01-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-25","modifiedBy":"TAYLORT","dateModified":"2017-11-02","changeNote":"7/12/16 tt/dl, released approved content.  1/27/16 tt, edit to def.  1/26/16 tt, edit to def. 1/25/16 tt, curated for E4112.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5114214","version":"1","preferredName":"Person Breast Intervention or Procedure Outcome Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing the results of breast interventional activities that produce an effect, or intended to alter the course of disease that can have preventive, therapeutic, or palliative effects as outlined in the study protocol to allow a person to participate in the clinical trial.","longName":"5113750v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A56F0BE-7D0C-5F55-E050-BB89AD43636A","latestVersionIndicator":"Yes","beginDate":"2016-01-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-01-27","modifiedBy":"TAYLORT","dateModified":"2017-11-02","changeNote":"7/12/16 tt/dl, released approved content.  1/27/16 tt, curated for 4112.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5121419","version":"1","preferredName":"Person Breast Density Known Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions for recognized density of breast tissue in order to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"5121396v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B6FD30B-5DC3-81F9-E050-BB89AD433AD1","latestVersionIndicator":"Yes","beginDate":"2016-02-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-02-10","modifiedBy":"LOWMAND","dateModified":"2017-04-19","changeNote":"7/12/16 tt/dl, released approved content.  2/10/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5122931","version":"1","preferredName":"Person Renal Impairment Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing diminished kidney function as outlined in the study protocol in order to allow a person to participate in the clinical trial.","longName":"5122914v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BD24CD9-DBFB-3DB6-E050-BB89AD4367CD","latestVersionIndicator":"Yes","beginDate":"2016-02-15","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-02-15","modifiedBy":"MORENOC","dateModified":"2021-06-21","changeNote":"2/15/16 dl, created for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5122938","version":"1","preferredName":"Person Medical History Claustrophobia Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response for questions addressing a person's medical history of an irrational fear of being in a confined space as outlined in the study protocol, in order to allow clinical trial participation.","longName":"5122934v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BD2E8E9-2D80-BA27-E050-BB89AD434AD5","latestVersionIndicator":"Yes","beginDate":"2016-02-15","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-02-15","modifiedBy":"RODGERSC","dateModified":"2019-04-24","changeNote":"12/1/16 dl, released. 2/15/16 dl, created for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5123071","version":"1","preferredName":"Person Breast Carcinoma Chemoprevention Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine clinical trial eligibility for questions related to breast cancer chemotherapeutic agents as outlined in the study protocol.","longName":"5123055v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BD69DE7-CB1A-0AF1-E050-BB89AD4328C8","latestVersionIndicator":"Yes","beginDate":"2016-02-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-02-15","modifiedBy":"LOWMAND","dateModified":"2016-07-12","changeNote":"7/12/16 tt/dl, released approved content.  2/16/16 tt, edit to long name and def. 2/15/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5123351","version":"1","preferredName":"Person Breast Cancer Current Therapeutic Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine clinical trial eligibility for questions related to the current treatment of breast cancer as outlined in the study protocol.","longName":"5123333v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BE6D7BE-87A0-80F6-E050-BB89AD434C27","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-02-16","modifiedBy":"LOWMAND","dateModified":"2017-04-19","changeNote":"2/16/16 tt, edit to long name and def. 2/16/16 dl, created for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5123394","version":"1","preferredName":"Person Planning High Risk Lesion Surgical Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine clinical trial eligibility for questions related to surgical plans addressing high risk lesions as outlined in the study protocol.","longName":"5123393v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BE8391E-A543-85B1-E050-BB89AD433262","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-02-16","modifiedBy":"LOWMAND","dateModified":"2017-10-10","changeNote":"10/10/17 dl released approved context. 2/16/16 edit to long name and def. 2/16/16 dl, created for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5123432","version":"1","preferredName":"Person Medical History Disease or Disorder Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine clinical trial eligibility for questions related to the background health and occurrence of any abnormal condition(s) of the body or mind that causes discomfort, dysfunction, or distress to the person, as outlined in the study protocol.","longName":"5123415v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BE8391E-A5E0-85B1-E050-BB89AD433262","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-02-16","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"7/12/16 tt/dl, released approved content.  2/16/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5126393","version":"1","preferredName":"Person p53 Mutation Status","preferredDefinition":"A response for questions addressing the status of changes in the nucleotide sequence of the TP53 gene.","longName":"5126386v1.0:5126391v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C219B85-66AA-00F6-E050-BB89AD435B54","latestVersionIndicator":"Yes","beginDate":"2016-02-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-02-19","modifiedBy":"SPRINGERL","dateModified":"2022-04-20","changeNote":"3-3-16 JG, edit to definition. 2-19-16 JG, created for EA3132.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5126455","version":"1","preferredName":"Person Basal-Like Breast Carcinoma Subtype Ind","preferredDefinition":"A response for questions addressing the subtype of basal-like breast carcinoma.","longName":"5126454v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C23B842-919B-F361-E050-BB89AD436365","latestVersionIndicator":"Yes","beginDate":"2016-02-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-02-19","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"2-19-16 JG, created for EA1131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5139411","version":"1","preferredName":"Person Disease or Disorder Discover Code","preferredDefinition":"A numeric coded response for questions addressing the initial identification of any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the patient.","longName":"CURR_DZ_DISC","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CADE47C-D4B0-26DB-E050-BB89AD4371B3","latestVersionIndicator":"Yes","beginDate":"2016-02-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-02-26","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"2-26-16 JG, created for EA8143. 4/13/16 JG, added short name","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5153232","version":"1","preferredName":"Kidney Laterality Anatomic Site Code","preferredDefinition":"A numeric coded response for questions addressing the named location of the kidney.","longName":"KIDN_SURG_SIDE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DA318B7-4DF0-8060-E050-BB89AD43317E","latestVersionIndicator":"Yes","beginDate":"2016-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-03-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"3-9-16 JG, created for EA8143. 4/13/16 JG, added short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5204282","version":"1","preferredName":"Person Prior Adjuvant Therapy Administered Type","preferredDefinition":"A response for the type of previous therapy that was administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence subsequent to the main treatment plan.","longName":"5204084v1.0:5204246v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EE17C72-7EA1-1C75-E050-BB89AD431128","latestVersionIndicator":"Yes","beginDate":"2016-03-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-03-25","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"3-26-16 JG, created for EA5142","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5219942","version":"1","preferredName":"Image Guided Biopsy Performed Type","preferredDefinition":"A response for questions related to type of imaging procedure used in the removal of tissue or fluid.","longName":"BX_GUIDE_IMAG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30620F9F-212B-979C-E050-BB89AD437D1B","latestVersionIndicator":"Yes","beginDate":"2016-04-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-04-13","modifiedBy":"GARRIDOJ","dateModified":"2016-07-14","changeNote":"4/13/16 tt, curated for EA8143. 4/13/16 JG, added short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5220036","version":"1","preferredName":"Uncontrolled Adrenocortical Insufficiency Disease or Disorder Present Code","preferredDefinition":"A numeric coded response for questions related to the presence of uncontrolled endocrine or hormonal disorder.","longName":"ADRL_INSUFF_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30621F4F-736B-F508-E050-BB89AD43580B","latestVersionIndicator":"Yes","beginDate":"2016-04-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-04-13","modifiedBy":"GARRIDOJ","dateModified":"2016-07-14","changeNote":"4/13/16 tt, curated for 8143. 4/13/16 JG, added short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5228891","version":"1","preferredName":"Intervention or Procedure Complication Severity Code","preferredDefinition":"A coded numeric coded response to describe the severity of procedure complications.","longName":"COMP_MAJ_MIN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30EEBD2A-F3E0-381A-E050-BB89AD43157C","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-04-20","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"4/20/16 JG, created for EA8143","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5241794","version":"1","preferredName":"Person Race White Category Ind","preferredDefinition":"A yes/no response to determine whether or not a participant's race classification is categorized as white (a person having origins in any of the original peoples of Europe, the Middle East, or North Africa. (OMB)).","longName":"RACE_WHT_CATEG_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31DC44C0-DA9A-CA58-E050-BB89AD430BE2","latestVersionIndicator":"Yes","beginDate":"2016-05-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-02","modifiedBy":"GARRIDOJ","dateModified":"2017-04-28","changeNote":"5/2/16 JG, curated for EAQ152","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5242668","version":"1","preferredName":"Person Primary Study Randomized Clinical Trial Participation Ind","preferredDefinition":"A yes/no response to determine whether or not the participant registering is randomized in the Primary Study (RCT).","longName":"PRIM_ST_RCT_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31F084B9-CC60-C1E6-E050-BB89AD430DA2","latestVersionIndicator":"Yes","beginDate":"2016-05-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"5/3/16 JG, curated for EAQ152","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5251139","version":"1","preferredName":"Person Internet Access And E-mail Address Ind","preferredDefinition":"The yes/no response for questions related to a person's use of the internet and email delivery.","longName":"INT_EML_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"320A183B-7F66-63CD-E050-BB89AD43675F","latestVersionIndicator":"Yes","beginDate":"2016-05-04","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-05-04","modifiedBy":"FINCHAMB","dateModified":"2023-06-27","changeNote":"5/4/15 tt, edits to CDE. Created for EA1141, dl 5/4/16.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5257505","version":"1","preferredName":"Mutation Analysis Outcome Treatment Agent Chosen Code","preferredDefinition":"A numeric coded response to determine if the agent chosen for treatment was based on the outcome of mutation testing.","longName":"5257501v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3296CFED-7DA1-5A59-E050-BB89AD437C30","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-11","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"5/11/2016 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5258494","version":"1","preferredName":"Person Clinical Trial Agent Administration Code","preferredDefinition":"A numeric coded response as to whether an agent was administered within a specific research study.","longName":"5260656v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3296FED6-0BA9-4B47-E050-BB89AD434A0A","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-11","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"5/12/16 tt/jg - edit to long name and def. 5/11/2016 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5259767","version":"1","preferredName":"Person Receive Future Treatment Code","preferredDefinition":"A numeric coded response to determine whether or not a person will be receiving treatment.","longName":"5259766v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32A67255-AA94-5FA7-E050-BB89AD433707","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"5/12/16 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260256","version":"1","preferredName":"Person No Therapeutic Procedure Plan Reason Code","preferredDefinition":"A numeric coded response to determine the anticipated outcome of the patient's treatment plan.","longName":"5259773v1.0:5259775v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32A7DEB3-11DF-8B40-E050-BB89AD4378B0","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-12","modifiedBy":"COOPERM","dateModified":"2020-03-04","changeNote":"5/12/16 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260278","version":"1","preferredName":"Person Treatment Planned Type Code","preferredDefinition":"A numeric coded response to determine the type of treatment devised for the patient.","longName":"5260273v1.0:5260276v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32A8C5BE-499A-3B5B-E050-BB89AD433F3A","latestVersionIndicator":"Yes","beginDate":"2016-05-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"5/12/16 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5260834","version":"1","preferredName":"Person Multiple Myeloma Diagnosis Ind","preferredDefinition":"A yes/no response used to determine whether a person has a diagnosis of multiple myeloma.","longName":"5260659v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B8FD4D-9018-9C68-E050-BB89AD434DAB","latestVersionIndicator":"Yes","beginDate":"2016-05-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-13","modifiedBy":"MORENOC","dateModified":"2018-12-17","changeNote":"5/13/16 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5270435","version":"1","preferredName":"Person Prior Treatment Administered Integer","preferredDefinition":"The number of treatments the patient has previously received including negative and positive numbers.","longName":"5270432v1.0:5270433v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"331F774A-D06F-A06F-E050-BB89AD436F42","latestVersionIndicator":"Yes","beginDate":"2016-05-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-05-18","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"5/18/2016 JG, curated for EAY131","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5288352","version":"1","preferredName":"Clinical Study Protocol Therapy Begin Administration Code","preferredDefinition":"A numeric coded response as to whether or not the patient will begin protocol treatment.","longName":"STRT_TX_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"34C44E65-4B7F-2E74-E050-BB89AD435C11","latestVersionIndicator":"Yes","beginDate":"2016-06-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-06-08","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"6/8/16 JG, created for EA3132","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5294252","version":"1","preferredName":"Surgical Margin Distance Measurement Code","preferredDefinition":"A coded response used to determine the numerical distance from the closest point of the lesion to the closest point of the surgical margin.","longName":"SURG_FINAL_MARG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3556EEA5-3B91-3BA6-E050-BB89AD432C47","latestVersionIndicator":"Yes","beginDate":"2016-06-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-06-15","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA3132, 06/15/2016 JG.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5385664","version":"1","preferredName":"Clinical Study Site Treatment Step Enrollment Approved By Sponsor Ind","preferredDefinition":"A response to determine sponsor approval of the study site for treatment step enrollment.","longName":"5385641v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"399221E6-CB58-592D-E050-BB89AD4323F3","latestVersionIndicator":"Yes","beginDate":"2016-08-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-08-08","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EAQ152, JG 08/08/2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427714","version":"1","preferredName":"Baseline Pretreatment Biospecimen Submission Ind","preferredDefinition":"A response for questions related to the submission of the baseline sample prior to treatment.","longName":"BSLN_PRTX_SMPL_SBMN_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AAA139A-0415-6A4B-E050-BB89AD435992","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-08-22","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 12/1/16 edit to draft new def. 8/22/16 tt, curated for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427832","version":"1","preferredName":"Baseline Pretreatment Biospecimen Submission Type","preferredDefinition":"A response for the kind of baseline pretreatment sample to be submitted.","longName":"BSLN_PRTX_SMPL_SBMN_TYP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AAC3C22-1594-E028-E050-BB89AD432625","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-08-22","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 8/22/16 tt, created for EA!141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5429975","version":"1","preferredName":"Health Insurance Portability and Accountability Act Authorization Obtained Date","preferredDefinition":"The date that HIPAA authorization was obtained.","longName":"HIPAA_OBTN_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AC3B204-51E3-7006-E050-BB89AD435BDF","latestVersionIndicator":"Yes","beginDate":"2016-08-23","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-08-23","modifiedBy":"TAYLORT","dateModified":"2021-03-10","changeNote":"3/10/21 TL corrected typo in definition and PQT.  8/23/16 dl, created for ECOG-ACRIN trials.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5431211","version":"1","preferredName":"Patient Voucher Contact Person Name","preferredDefinition":"The words to identity a person acting as the channel for communication with regards to patient related documents exchanged for particular goods or services.","longName":"5431160v1.0:2746719v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE7B78B-9DE6-CC07-E050-BB89AD430AA8","latestVersionIndicator":"Yes","beginDate":"2016-08-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-08-25","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for E2112, JG 08/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5431251","version":"1","preferredName":"Patient Voucher Shipping Address Text","preferredDefinition":"The location for where to ship the patient related documents exchanged for particular goods or services.","longName":"5431215v1.0:2192759v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE737E2-2B0F-33A9-E050-BB89AD435E0B","latestVersionIndicator":"Yes","beginDate":"2016-08-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-08-25","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for E2112, JG 08/25/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5440191","version":"1","preferredName":"Participant Imaging Procedure Agreement American College of Radiology Storage Future Research Consent Ind","preferredDefinition":"A yes/no response as to whether the participant agreed with the protocol plan and consented to allow the ACR to store his/her medical images for future research.","longName":"5440134v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B4BF59D-2A78-6C5A-E050-BB89AD43231B","latestVersionIndicator":"Yes","beginDate":"2016-08-30","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-08-30","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for E2112, JG 08/30/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5491307","version":"1","preferredName":"Person Survey Receive Method Preference Type","preferredDefinition":"A response for questions related to a person's preferred means of receiving a document used in data collection that involves interviewing (or giving questionnaires to) a representative and often large group of people.","longName":"SRVY_RECV_MTHD_PRFC","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DABE032-76A5-6C35-E053-F662850AB79B","latestVersionIndicator":"Yes","beginDate":"2016-09-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-09-29","modifiedBy":"FINCHAMB","dateModified":"2023-09-22","changeNote":"10/5/16 tt, approved/released. 10/4/16 tt, edit to CDE. 9/29/16 tt, created for EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5509641","version":"1","preferredName":"Renal Cell Carcinoma Histologic Classification Code","preferredDefinition":"A numeric coded response for the histologic classification of renal cell carcinoma.","longName":"2430076v1.0:5509637v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EAAD682-B240-295F-E053-F662850AE05E","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, JG 10/12/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5510791","version":"1","preferredName":"Imaging Procedure Reason Code","preferredDefinition":"A numeric response used to explain why a technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy was performed.","longName":"5510787v1.0:5510783v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EB0E7F8-723C-6069-E053-F662850A7149","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, JG 10/12/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5514989","version":"1","preferredName":"Hematoma Present Code","preferredDefinition":"A numeric response for the presence of localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel.","longName":"HEMATOMA_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EC0ABEB-52E3-2875-E053-F662850AE06B","latestVersionIndicator":"Yes","beginDate":"2016-10-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-13","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, JG 10/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5515047","version":"1","preferredName":"Hemorrhage Blood Transfusion Required Code","preferredDefinition":"A numeric response for the necessity of the infusion of components of blood or whole blood into the bloodstream due to the flow of blood from a ruptured blood vessel.","longName":"5515023v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EC09928-DDA8-2B1A-E053-F662850A1238","latestVersionIndicator":"Yes","beginDate":"2016-10-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-13","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, JG 10/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5515053","version":"1","preferredName":"Pneumothorax Present Code","preferredDefinition":"A numeric response for the abnormal presence of air in the pleural cavity.","longName":"PTX_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EC09928-DE1F-2B1A-E053-F662850A1238","latestVersionIndicator":"Yes","beginDate":"2016-10-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-13","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, JG 10/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5515058","version":"1","preferredName":"Intervention or Procedure Adjacent Organ Injury Occurrence Code","preferredDefinition":"A coded numeric response used to indicated whether or not damage to an adjoining anatomical structure occurred during or as a result of an intervention or a procedure.","longName":"ADJA_ORG_INJ_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EC13CE7-BAF2-1087-E053-F662850A942A","latestVersionIndicator":"Yes","beginDate":"2016-10-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-13","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, JG 10/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5515237","version":"1","preferredName":"Intervention or Procedure Arteriovenous Fistula or Pseudoaneurysm Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not an unintended connection between an artery and vein or the creation of hematoma outside the arterial wall following bleeding due to puncture of the arterial wall occurred during or as a result of an intervention or a procedure.","longName":"AVF_PSDOANEU_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EC251B1-28AB-440D-E053-F662850ACFC2","latestVersionIndicator":"Yes","beginDate":"2016-10-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-13","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, JG 10/13/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5544750","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factor Clinical T Stage","preferredDefinition":"Selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a renal cell carcinoma clinical protocol based on their clinical T stage criteria from the TNM staging system.","longName":"5544739v1.0:5544741v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD90CD1-3F94-2345-E053-F662850AC8A4","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5544751","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factor Clinical N Stage","preferredDefinition":"Selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a renal cell carcinoma clinical protocol based on their clinical N stage criteria from the TNM staging system.","longName":"5544739v1.0:5544746v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD966AC-980F-5FF9-E053-F662850A1F7A","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5544952","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factor Histologic Category","preferredDefinition":"Selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a renal cell carcinoma clinical protocol based on defined characteristics of combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","longName":"5544739v1.0:5544949v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDB0CB2-F854-6185-E053-F662850A29D4","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5559899","version":"1","preferredName":"Intervention or Procedure Needle Tract Seeding Occurrence Code","preferredDefinition":"A coded numeric response to an incident in which tumor cells are implanted into the surrounding tissue along the course of a contaminated instrument such as a biopsy needle or laparoscope.","longName":"5559898v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"403E7EBD-8FFF-3555-E053-F662850ADF8E","latestVersionIndicator":"Yes","beginDate":"2016-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-01","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, JG 11/1/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566341","version":"1","preferredName":"Confirmation Clinician Participant Eligibility Determination Name","preferredDefinition":"The name of an individual, such as a physician or nurse practitioner, who verified patient eligibility.","longName":"5566339v1.0:5406151v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B75028-B66A-1A4A-E053-F662850A301A","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566380","version":"1","preferredName":"Person Negation Clinical Study Protocol Consent Criterion Specify","preferredDefinition":"A field to clearly define items outlined in the study protocol that a patient denies permission to evaluate.","longName":"5566345v1.0:5566342v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B83F61-81C9-3B13-E053-F662850A0CA3","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566418","version":"1","preferredName":"Disease Burden Risk Category","preferredDefinition":"A response for the group related to the quality of potential future harm carried by an individual for any abnormal condition of the body.","longName":"5566401v1.0:5566402v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B9162E-FEF3-36B6-E053-F662850A27A8","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566427","version":"1","preferredName":"Radiologic Evidence Macroscopic Pelvic Lymph Node Involvement Ind","preferredDefinition":"A response as to whether there is radiologic knowledge of lymph node association visible to the naked eye within the abdominal pelvic region.","longName":"5566422v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B908C6-E8E2-36B3-E053-F662850A7CC1","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566464","version":"1","preferredName":"Laboratory Procedure Glomerular Filtration Rate Outcome","preferredDefinition":"The result of a kidney function test that measures fluid volume filtered from the kidney glomeruli to the Bowman's capsule per unit of time.","longName":"5566439v1.0:5566447v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B9E007-0143-3421-E053-F662850AB297","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566470","version":"1","preferredName":"Laboratory Procedure Glomerular Filtration Rate Value","preferredDefinition":"The numerical quantity of a kidney function test that measures fluid volume filtered from the kidney glomeruli to the Bowman's capsule per unit of time.","longName":"5566439v1.0:5566466v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40BA1578-189E-2018-E053-F662850AEDE7","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"HLAINGY","dateModified":"2018-03-07","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566475","version":"1","preferredName":"Investigator Judgment Patient Clinical Trial Enrollment Ind","preferredDefinition":"A response as to whether patient registration in the research study was assessed by the individual who conducts and/or supervises the clinical investigation and study-related procedures.","longName":"5566473v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40B9162F-0008-36B6-E053-F662850A27A8","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566489","version":"1","preferredName":"Disease or Disorder Laterality Type","preferredDefinition":"A response identifying the side of the body affected by an abnormal condition.","longName":"5566477v1.0:5566481v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40BA891C-844C-59BE-E053-F662850AA166","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"ZHANGWE","dateModified":"2022-02-05","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566493","version":"1","preferredName":"Person Previous Neoadjuvant Therapy Protocol Treatment Arm Randomization Ind","preferredDefinition":"A yes/no response to indicate the prior allocation of an individual into a specific treatment plan within a clinical trial that involved the administration of therapeutic agents prior to the primary treatment.","longName":"5566492v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40BA891C-84A9-59BE-E053-F662850AA166","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566506","version":"1","preferredName":"Prior Therapeutic Procedure Administered Confirmation Type","preferredDefinition":"A response verifying the administration of therapeutic agents previously given.","longName":"5566496v1.0:5566497v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40BA891C-859F-59BE-E053-F662850AA166","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5566510","version":"1","preferredName":"Person Receive Neoadjuvant Chemoradiotherapy Ind","preferredDefinition":"A yes/no response to the administration of treatment that combines chemotherapy with radiation therapy that was given prior to the primary treatment.","longName":"5566509v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40BB4258-EC2B-443B-E053-F662850A6E9B","latestVersionIndicator":"Yes","beginDate":"2016-11-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-07","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8134, JG 11/07/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5582080","version":"1","preferredName":"Person Therapeutic Procedure Assignment Clinical Trial Eligibility Criteria Type","preferredDefinition":"A response for allotting the administration of particular therapeutic agents in a clinical study.","longName":"5581642v1.0:5582017v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4277E96E-8CAA-1926-E053-F662850ACBA9","latestVersionIndicator":"Yes","beginDate":"2016-11-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-11-29","modifiedBy":"GARRIDOJ","dateModified":"2021-06-22","changeNote":"Created for EA8134, 11/29/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5584484","version":"1","preferredName":"Person Progressive Disease Response Assessment in Neuro-Oncology Criteria Therapeutic Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to cancer that is increasing in scope or severity by RANO criteria and the administration of therapeutic agents that produce an effect intended to alter or stop a pathologic process as outlined in the protocol.","longName":"PRDZ_RANO_TX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42A01435-14C0-3920-E053-F662850AC0D5","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-12-01","modifiedBy":"TAYLORT","dateModified":"2021-03-12","changeNote":"12/2/16 tt, edit to draft new. 12/1/16 dl, EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5586940","version":"1","preferredName":"Intratumoral Hemorrhage Imaging Procedure Visualized Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to intratumoral hemorrhage seen on an imaging procedure as outlined in the protocol.","longName":"IMLHG_IMAG_VZD_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42AE8C44-41DD-4466-E053-F662850AB62D","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-12-02","modifiedBy":"HARTLEYG","dateModified":"2021-01-25","changeNote":"12/2/16 dl, EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5587845","version":"1","preferredName":"Imaging Enhancement Description Intervention or Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to imaging enhancement and any activity that produces an effect, or that is intended to alter the course of disease as outlined in the protocol.","longName":"IMG_ENMT_IVNPDR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42AF0C89-9050-2407-E053-F662850A38BD","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-12-02","modifiedBy":"TAYLORT","dateModified":"2020-05-04","changeNote":"1/12/17 tt, edit to question. 12/2/16 dl, EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5588003","version":"1","preferredName":"Therapeutic Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to any action or administration of therapeutic agents that produce an effect intended to alter or stop a pathologic process as outlined in the protocol.","longName":"TX_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42AF1178-6ECE-24F5-E053-F662850AA442","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"LOWMAND","dateCreated":"2016-12-02","modifiedBy":"TAYLORT","dateModified":"2021-03-12","changeNote":"12/2/16 dl, EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589530","version":"1","preferredName":"Personal Medical History Medication Induction Pulmonary Fibrosis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of drug induced pulmonary fibrosis.","longName":"5589529v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430031D6-D243-4246-E053-F662850AE87C","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589547","version":"1","preferredName":"Personal Medical History Other Lung Disorder Prior Therapy Relationship Code","preferredDefinition":"A numeric code response as to whether the patient has medical history of other pulmonary disease(s) related to prior treatment(s).","longName":"5589534v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430031D6-D299-4246-E053-F662850AE87C","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/2016 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589556","version":"1","preferredName":"Personal Medical History Idiopathic Interstitial Pneumonia Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of non-infectious inflammation of interstitial lung tissue.","longName":"5589555v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430031D6-D323-4246-E053-F662850AE87C","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589560","version":"1","preferredName":"Personal Medical History Other Lung Disorder Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of other pulmonary disease(s).","longName":"5589559v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4300A583-FB2F-2346-E053-F662850ADF21","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589602","version":"1","preferredName":"Personal Medical History Medication Induction Pneumonitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of drug induced inflammation of the lungs.","longName":"5589589v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4300A583-FBB4-2346-E053-F662850ADF21","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589606","version":"1","preferredName":"Personal Medical History Radiation Therapy Induction Pneumonitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of an inflammatory process affecting the lung parenchyma brought on by radiotherapy.","longName":"5589605v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4300E58C-4F1B-514A-E053-F662850A0AD2","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589623","version":"1","preferredName":"Personal Medical History Acute Renal Failure Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of sudden and sustained deterioration of the kidney function.","longName":"5589622v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4301068E-734A-5F9E-E053-F662850AC1AA","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589634","version":"1","preferredName":"Personal Medical History Contrast - Induced Nephropathy Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of kidney damage resulting from exposure to contrast agents.","longName":"5589633v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4300E58C-5037-514A-E053-F662850A0AD2","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589638","version":"1","preferredName":"Personal Medical History Allergic Rhinitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of inflammation of the nasal mucous membranes due to allergens.","longName":"5589637v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430133E8-3D68-06D9-E053-F662850AF6AE","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589656","version":"1","preferredName":"Personal Medical History Seasonal Allergic Rhinitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of allergic rhinitis caused by seasonal allergies.","longName":"5589641v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43014080-7581-1B22-E053-F662850A09B2","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589673","version":"1","preferredName":"Personal Medical History Atopic Conjunctivitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of allergic conjunctivitis.","longName":"5589660v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430150AE-DA4B-2322-E053-F662850A3236","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589677","version":"1","preferredName":"Personal Medical History Drug Induced Liver Injury Code","preferredDefinition":"A numeric response as to whether the patient has a medical history of damage to the liver tissue due to drug overdose.","longName":"5589676v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43016161-044C-6EB1-E053-F662850A23F1","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589681","version":"1","preferredName":"Personal Medical History Type 1 Diabetes Mellitus Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of minimal or absent production of insulin by the pancreas.","longName":"5589680v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430150AE-DABA-2322-E053-F662850A3236","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589685","version":"1","preferredName":"Personal Medical History Type 2 Diabetes Mellitus Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of insulin resistance or desensitization and increased blood glucose levels.","longName":"5589684v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43016161-0494-6EB1-E053-F662850A23F1","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589701","version":"1","preferredName":"Personal Medical History Vasculitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of inflammation involving the wall of the vessels in the vascular wall.","longName":"5589700v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430150AE-DADB-2322-E053-F662850A3236","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589757","version":"1","preferredName":"Personal Medical History Pancreatitis Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of inflammation of the pancreas.","longName":"5589717v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"430150AE-DB23-2322-E053-F662850A3236","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5593137","version":"1","preferredName":"Personal Medical History Autoimmune Disease Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history in which the body recognizes its own tissue as foreign and directs an immune response against them.","longName":"5593133v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43036D6C-BB05-0AB5-E053-F662850AC9EB","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2018-08-28","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5593231","version":"1","preferredName":"Personal Medical History Hyperthyroidism Code","preferredDefinition":"A numeric coded response as to whether the patient has a medical history of overactivity of the thyroid gland resulting in overproduction in thyroid hormone and increased metabolic rate.","longName":"5593146v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43037130-BCF3-7FAD-E053-F662850AE8F0","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5593286","version":"1","preferredName":"Personal Medical History Chronic Liver Disease Code","preferredDefinition":"A numeric coded response as to whether a patient has a history of hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months.","longName":"5593276v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4303A7D6-8A0C-3BE7-E053-F662850A2E12","latestVersionIndicator":"Yes","beginDate":"2016-12-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/06/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5595999","version":"1","preferredName":"Disease or Disorder Biospecimen Submission Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to determine patient eligibility for clinical trial participation for questions related to the submission of specimens of any abnormal condition of the body as outlined in the study protocol.","longName":"5595993v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4313E6D7-4AA0-788C-E053-F662850ADD1D","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-07","modifiedBy":"TAYLORT","dateModified":"2017-11-15","changeNote":"Created for MATCH, 12/07/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599502","version":"1","preferredName":"Elevated Alkaline Phosphatase Present Code","preferredDefinition":"A coded numeric response for the presence of elevated concentration of alkaline phosphatase in the the blood.","longName":"5599501v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433F01E2-8A4F-29D5-E053-F662850ACC8B","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/09/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599506","version":"1","preferredName":"Leukocytosis Present Code","preferredDefinition":"A coded numeric response for the presence of elevated concentration of white blood cells in the peripheral blood.","longName":"5599505v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433F01E2-8A94-29D5-E053-F662850ACC8B","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/09/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599510","version":"1","preferredName":"Thrombocytosis Present Code","preferredDefinition":"A coded numeric response for the presence of elevated concentrations of platelets in the peripheral blood.","longName":"5599509v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433F01E2-8AB5-29D5-E053-F662850ACC8B","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/09/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599514","version":"1","preferredName":"Elevated Absolute Neutrophil Count Present Code","preferredDefinition":"A coded numeric response for the presence of elevated concentration of the real number of white cells that are neutrophils.","longName":"5599513v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433F01E2-8AD6-29D5-E053-F662850ACC8B","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/09/06 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599518","version":"1","preferredName":"Current Steroid Compound Administration Code","preferredDefinition":"A coded numeric response as to whether steroids are used in the present time.","longName":"5599517v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433F01E2-8B38-29D5-E053-F662850ACC8B","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/09/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5599524","version":"1","preferredName":"Hypertension Type Code","preferredDefinition":"A coded numeric response to identify whether blood pressure is abnormally high.","longName":"5599520v1.0:5599521v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"433FF180-FFE8-588A-E053-F662850A224A","latestVersionIndicator":"Yes","beginDate":"2016-12-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-09","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/09/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5606704","version":"1","preferredName":"Recurrent Disease Lung Present Code","preferredDefinition":"A coded numeric response for the presence of the return of a disease after a period of remission in the organ(s) of respiration.","longName":"5606703v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43C7CF31-181B-29E6-E053-F662850A5856","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-16","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/16/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5606708","version":"1","preferredName":"Recurrent Disease Subcutaneous And Lymph Node Present Code","preferredDefinition":"A coded numeric response for the presence of the return of a disease after a period of remission beneath the skin and organ(s) that is part of the lymphatic system that is found throughout the body.","longName":"5606707v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43C7CF31-1869-29E6-E053-F662850A5856","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-16","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/16/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5606722","version":"1","preferredName":"Recurrent Disease Other Organ Present Code","preferredDefinition":"A coded response for the presence of the return of a disease after a period of remission in a macroscopic anatomic structure different than the ones previously specified.","longName":"5606721v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43C8D5D3-8579-5856-E053-F662850AADBF","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-16","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/16/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5606755","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Grade Description Adverse Events Text","preferredDefinition":"A free-text field of the CTCAE description of the scale of intensity of adverse events.","longName":"5606751v1.0:2411376v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"43C9BBC5-6737-691A-E053-F662850A0A3E","latestVersionIndicator":"Yes","beginDate":"2016-12-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-16","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for GL AR, 12/16/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608181","version":"1","preferredName":"Recurrent Disease First Treatment Planned Code","preferredDefinition":"A coded response as to the initial planned action or administration of therapeutic agents intended to alter or stop the pathologic process of a disease that has returned after a period of remission.","longName":"5608059v1.0:5608114v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"440A2456-60EF-3BCF-E053-F662850AA5D8","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-19","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/19/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608402","version":"1","preferredName":"Recurrent Disease Renal Bed Present Code","preferredDefinition":"A coded numeric response for the presence of the return of a disease after a period of remission in the cavity evident following excision of a kidney.","longName":"5608401v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"441D0BF8-BACE-2F60-E053-F662850A30EA","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-20","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/20/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608409","version":"1","preferredName":"Clinical Disease Assessment Performed Code","preferredDefinition":"A coded numeric response as to whether an examination of an abnormal condition of the body or mind was done.","longName":"5608407v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"441D4C30-4B6B-5D0E-E053-F662850A708E","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-20","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/20/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608413","version":"1","preferredName":"Immune-Mediated Adverse Event Occurrence Code","preferredDefinition":"A coded numeric response as to whether an adverse event resulting from an immune system reaction occurred.","longName":"5608412v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"441E6D8F-BFDA-7353-E053-F662850A51B8","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-20","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/20/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608416","version":"1","preferredName":"Hematology Test Not Performed Text","preferredDefinition":"A text field response at to whether a hematopoietic laboratory test was not done.","longName":"5608415v1.0:2200608v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"442C198E-B2FA-7CA8-E053-F662850AA4FB","latestVersionIndicator":"Yes","beginDate":"2016-12-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-21","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/21/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5608444","version":"1","preferredName":"Laboratory Procedure Collection Time Code","preferredDefinition":"A coded response as to the time at which a laboratory specimen was collected.","longName":"2012662v3.0:5608441v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"442C043D-FB49-46B0-E053-F662850AF73B","latestVersionIndicator":"Yes","beginDate":"2016-12-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-21","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/21/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5609916","version":"1","preferredName":"Agent Administered Volume Value","preferredDefinition":"A numerical quantity of a given substance which is defined as the amount of three dimensional space occupied by an object or the capacity of a space or container.","longName":"5609915v1.0:4271972v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4431AFD2-20E8-7D79-E053-F662850A40AC","latestVersionIndicator":"Yes","beginDate":"2016-12-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-21","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/21/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5609920","version":"1","preferredName":"Agent Prepared Volume Value","preferredDefinition":"A numerical quantity of a prepared substance which is defined as the amount of three dimensional space occupied by an object or the capacity of a space or container.","longName":"5609919v1.0:4271972v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4431A750-8BD4-7A2A-E053-F662850AD510","latestVersionIndicator":"Yes","beginDate":"2016-12-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-21","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/21/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610266","version":"1","preferredName":"Therapeutic Procedure Interruption Reason Code","preferredDefinition":"A coded explanation as to why the administration of a therapeutic agent(s) was temporarily ceased.","longName":"5610020v1.0:5610254v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44433564-71EC-5E52-E053-F662850A6F16","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/22/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610280","version":"1","preferredName":"Therapeutic Procedure Restart Code","preferredDefinition":"A coded numeric response as to whether the administration of therapeutic agents were resumed.","longName":"5610279v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4443CF48-BBDC-4E17-E053-F662850A40EB","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/22/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610286","version":"1","preferredName":"Therapeutic Procedure Interruption Duration","preferredDefinition":"A text field to capture the hour and/or minutes in which the administration of therapeutic agents were disrupted.","longName":"5610284v1.0:5610285v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4443CF48-BC35-4E17-E053-F662850A40EB","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/21/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610294","version":"1","preferredName":"Therapeutic Procedure Infusion Rate Reduced Code","preferredDefinition":"A coded numeric response as to whether the unit time of the volume of a therapeutic agent(s) injected into a subject was decreased.","longName":"5610291v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"444329EB-AE03-6710-E053-F662850A4EE0","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/22/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610298","version":"1","preferredName":"Therapeutic Procedure Infusion Rate Reduction Reason Code","preferredDefinition":"A coded numeric response explaining why the unit time of a volume of a therapeutic agent(s) injected into a subject was decreased.","longName":"5610297v1.0:5610254v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4443CF48-BC5E-4E17-E053-F662850A40EB","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/22/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5610309","version":"1","preferredName":"Adverse Event Immune-mediated Etiology Component Present Code","preferredDefinition":"A coded numeric response as to whether an unfavorable or unintended disease, sign, or symptom is caused by the immune system or is part of the result of the activity of the immune system.","longName":"5610308v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44462577-6A69-5617-E053-F662850AE4AA","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 12/22/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5611061","version":"1","preferredName":"Study Site Contact Person Person Role Title Code","preferredDefinition":"A coded numeric response to identify the person acting as a channel for communication at the facility in which a study/protocol is conducted.","longName":"5611052v1.0:5611053v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44BAE8AE-69F6-1BD8-E053-F662850AA513","latestVersionIndicator":"Yes","beginDate":"2016-12-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-28","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/28/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5611259","version":"1","preferredName":"Person Concomitant Medication Assessment Performed Code","preferredDefinition":"A coded numeric response as whether a subject's use of a pharmaceutical agent other than agent(s) tested in a given protocol prior to or during the study was determined.","longName":"5611256v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44CF895F-4B1F-2067-E053-F662850A4DF3","latestVersionIndicator":"Yes","beginDate":"2016-12-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-29","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/29/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5611301","version":"1","preferredName":"Patient Self-Report Other Concerns Code","preferredDefinition":"A coded response as to whether a patient subjectively reported a matter of interest or importance different than the one(s) previously specified.","longName":"5611300v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44D38251-15E9-4CC2-E053-F662850A0B46","latestVersionIndicator":"Yes","beginDate":"2016-12-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-29","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/29/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5611305","version":"1","preferredName":"Patient Self-Report Concerns Action Text","preferredDefinition":"A free-text field describing what was done in response a subjective report made by a patient regarding a matter of interest or importance.","longName":"5611304v1.0:3380089v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44D3CADC-516A-1296-E053-F662850AE65B","latestVersionIndicator":"Yes","beginDate":"2016-12-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-29","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143,","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5611391","version":"1","preferredName":"Surgical Procedure Approach Type Changed Code","preferredDefinition":"A coded response as to whether the procedure used during surgery was modified.","longName":"5611390v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E50ECF-CBFA-76F5-E053-F662850AA5DA","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-12-30","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 12/30/16 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5615828","version":"1","preferredName":"Intervention or Procedure Diaphragm Injury Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not damage to the fibromuscular tissue that separates the thoracic from the abdominal cavity occurred during or as a result of an intervention or a procedure.","longName":"5615827v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"456FA595-7F36-460B-E053-F662850A64A0","latestVersionIndicator":"Yes","beginDate":"2017-01-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-06","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/06/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5615836","version":"1","preferredName":"Intervention or Procedure Colon or Small Intestine Injury Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not damage to the part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions or the section of the intestines between the pylorus and cecum occurred during or as a result of an intervention or a procedure.","longName":"5615831v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"456FA595-7F96-460B-E053-F662850A64A0","latestVersionIndicator":"Yes","beginDate":"2017-01-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-06","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/06/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5616998","version":"1","preferredName":"Ischemia Procedure Performed Code","preferredDefinition":"A coded numeric response as to whether a surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished was done.","longName":"5611368v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4572D95F-C909-2C3D-E053-F662850A4E37","latestVersionIndicator":"Yes","beginDate":"2017-01-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 01/06/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5617006","version":"1","preferredName":"Ischemia Procedure Type Performed Code","preferredDefinition":"A coded numeric response to identify the kind of surgical procedure during which the blood supply to an organ or tissue is interrupted and then later reestablished was used.","longName":"5617000v1.0:5617001v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45727D04-9537-607A-E053-F662850A3CD6","latestVersionIndicator":"Yes","beginDate":"2017-01-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-06","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 01/06/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622108","version":"1","preferredName":"Nephrectomy Laparoscopic Surgery Type Code","preferredDefinition":"A coded response to identify the kind of surgery using a laparoscope was carried out during a surgical procedure to completely or partially remove a kidney.","longName":"5617009v1.0:5617010v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45BF6A56-2BD0-7DEC-E053-F662850A253C","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-10","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 01/10/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622130","version":"1","preferredName":"Bilateral Hilar Lymphadenectomy Performed Code","preferredDefinition":"A coded numeric response as to whether lymph nodes on both sides of the hilum were surgically excised.","longName":"5622129v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C02FCD-6B70-1FA2-E053-F662850AA93E","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-10","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for Lymph Node Dissection section of EA8143 Surgery Form, 01/10/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622151","version":"1","preferredName":"Person Previous Imaging Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine patient eligibility for clinical trial participation for questions, as outlined in the study protocol, related to any technology or method that aids in the visualization of any biological process, cell, tissue or organ that occurred prior to enrollment.","longName":"PR_IMG_ELG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C16E8E-6DBF-192F-E053-F662850A4445","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-01-10","modifiedBy":"LOWMAND","dateModified":"2017-04-19","changeNote":"1/10/17 tt/dl, EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622166","version":"1","preferredName":"Person Pregnant Exclusion Criteria Indicator","preferredDefinition":"A response to questions that prevent a patient from being allowed to participate in a clinical study, if pregnant, as outlined in the study protocol.","longName":"PRGT_EXC_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C15195-EA62-0965-E053-F662850A941F","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-01-10","modifiedBy":"LOWMAND","dateModified":"2017-04-19","changeNote":"1/10/17 tt dl, EA1141","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622186","version":"1","preferredName":"Person Karnofsky Performance Status Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to the patient's Karnofsky Performance Status as outlined in the protocol.","longName":"KPS_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C253B7-69CD-7A34-E053-F662850A257F","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-01-10","modifiedBy":"SOKKERL","dateModified":"2023-11-15","changeNote":"1/10/17 tt dl, EAF151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622192","version":"1","preferredName":"First Recurrent Disease Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to the first recurrence of any abnormal condition of the body or mind as outlined in the protocol.","longName":"DZ_RCRN_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C2CD83-12EC-49F4-E053-F662850A023F","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-01-10","modifiedBy":"LOWMAND","dateModified":"2017-04-24","changeNote":"3/2/17 tt, edit to Long Name. 1/10/17 tt dl, EAF151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622198","version":"1","preferredName":"Person Receive Bevacizumab Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine eligibility for clinical trial participation for questions related to the receipt of bevacizumab as outlined in the protocol.","longName":"RCV_BEVMB_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45C2CD83-1395-49F4-E053-F662850A023F","latestVersionIndicator":"Yes","beginDate":"2017-01-10","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-01-10","modifiedBy":"TAYLORT","dateModified":"2021-03-12","changeNote":"1/10/17 tt dl, EAF151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5622785","version":"1","preferredName":"Enhancing Lesion Neoplasm Measurement Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine patient eligibility for clinical trial participation for questions related to the measurements of contrast-enhancing lesions (tumors) as outlined in the protocol.","longName":"ENHLES_NPM_MSRMT_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45D54189-9C66-775E-E053-F662850A3E18","latestVersionIndicator":"Yes","beginDate":"2017-01-11","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-01-11","modifiedBy":"FORMBUILDER","dateModified":"2018-05-14","changeNote":"1/11/17 tt dl, EAF151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626229","version":"1","preferredName":"Tumor Cell Invasion Type Present Code","preferredDefinition":"A numeric coded response to distinguish the kind of local spread of tumor cells of malignant neoplasm was found.","longName":"5626225v1.0:5626226v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45E65E78-EF5A-439F-E053-F662850A9863","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-25","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626644","version":"1","preferredName":"Renal Fat Tissue Type Invaded Code","preferredDefinition":"A coded numeric response to distinguish the kind of connective tissue consisting primarily of adipocytes (fat cells) in the kidney that were penetrated.","longName":"5626399v1.0:5626403v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45EA1B0E-EA10-3384-E053-F662850A9B61","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626648","version":"1","preferredName":"Intervention or Procedure Pancreas Injury Occurrence Code","preferredDefinition":"A coded numeric response as to whether an incident occurred during an intervention or procedure in which damage is inflicted on the compound gland composed of both exocrine and endocrine tissues which is located behind the lower part of the stomach.","longName":"5626647v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45EA3688-77B7-4F63-E053-F662850AA573","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626686","version":"1","preferredName":"Intervention or Procedure Liver Injury Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not damage to the triangular-shaped organ located under the diaphragm in the right hypochondrium which cleanses the blood and aids in digestion by secreting bile occurred during or as a result of an intervention or a procedure.","longName":"5626675v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45EADCD2-AECE-28BB-E053-F662850A668C","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626694","version":"1","preferredName":"Intervention or Procedure Vascular Injury Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not damage to blood vessels occurred during or as a result of an intervention or a procedure.","longName":"5626693v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45EB3DE4-8726-6432-E053-F662850AA7D5","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5626700","version":"1","preferredName":"Intervention or Procedure Complication Other Occurrence Code","preferredDefinition":"A coded numeric response used to indicated whether or not any disease or disorder different than the ones previously specified  occurred during or as a result of an intervention or a procedure.","longName":"5633355v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45EB6138-B5EB-0B59-E053-F662850A02AE","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5627141","version":"1","preferredName":"Intervention or Procedure Urinary Leakage Urinary Fistula Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not extravasation of urine outside the urinary collecting system or an abnormal communication between any part of the urinary system and another organ or cavity occurred during or as a result of an intervention or a procedure.","longName":"5627134v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"45ECF006-87E4-13EA-E053-F662850AE0BC","latestVersionIndicator":"Yes","beginDate":"2017-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-12","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/12/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5633325","version":"1","preferredName":"Intervention or Procedure Thromboembolic Event Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream occurred during or as a result of an intervention or a procedure.","longName":"5633324v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46DCF862-7EB6-31CF-E053-F662850A8F9A","latestVersionIndicator":"Yes","beginDate":"2017-01-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-24","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5633330","version":"1","preferredName":"Intervention or Procedure Cardiovascular Complication Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not an incident in which any heart or vascular disorder occurred as a consequence of injury to the cardiovascular system during or as a result of an intervention or a procedure.","longName":"5633329v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46DF2B16-0FEC-0BC5-E053-F662850A78CE","latestVersionIndicator":"Yes","beginDate":"2017-01-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-24","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5633369","version":"1","preferredName":"Intervention or Procedure Pulmonary Complication Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not any pulmonary disorder occurred as a consequence of injury to the lungs during or as a result of occurred during or as a result of an intervention or a procedure.","longName":"5633367v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46ECC850-F783-185C-E053-F662850A160D","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-25","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/25/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5633377","version":"1","preferredName":"Intervention or Procedure Gastrointestinal Complication Occurrence Code","preferredDefinition":"A coded numeric response used to indicate whether or not any disorder of the organs of the digestive system occurred as a consequence of injury to the digestive system during or as a result of an intervention or a procedure.","longName":"5633376v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46EB2762-55BC-2DC1-E053-F662850ABCE9","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-25","modifiedBy":"GARRIDOJ","dateModified":"2018-09-10","changeNote":"Created for EA8143, 01/25/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5647786","version":"1","preferredName":"Patient Diary Completed Code","preferredDefinition":"A coded numeric response as to whether an instrument used either to capture a subject's condition or symptoms, or to monitor compliance during a clinical trial or disease treatment while away from the clinical site was completed.","longName":"5647703v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"477B9B06-0AD3-2D4F-E053-F662850A0ADD","latestVersionIndicator":"Yes","beginDate":"2017-02-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-02-01","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA2161, 02/01/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5675793","version":"1","preferredName":"Registration Study Site Type","preferredDefinition":"A response used to distinguish the kind of facility in which one is officially enrolled for a study/protocol.","longName":"5675527v1.0:5675790v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"491F7041-A4B4-703C-E053-F662850AB928","latestVersionIndicator":"Yes","beginDate":"2017-02-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-02-22","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for EA9131, 02/22/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5676295","version":"1","preferredName":"Subject Unblinding Occurrence Date","preferredDefinition":"A response used to determine the date in which a previously masked component of a study was revealed to the individual taking part in the study.","longName":"5676293v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4928200A-47EF-4184-E053-F662850AA748","latestVersionIndicator":"Yes","beginDate":"2017-02-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-02-23","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for blind studies, 2/23/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5676299","version":"1","preferredName":"Subject Unblinding Occurrence Reason","preferredDefinition":"A coded numeric response used to explain the rational for the revealing of a previously masked component of a study to an individual taking part in the study.","longName":"5676293v1.0:5676296v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4934AF34-6D37-5C53-E053-F662850AFA3C","latestVersionIndicator":"Yes","beginDate":"2017-02-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-02-23","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for blinded studies, 2/23/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5695710","version":"1","preferredName":"Study Site Stop Clinical Study Participation Code","preferredDefinition":"A coded numeric response to determine whether a facility that conducts study/protocol activities has ceased to take part a study.","longName":"5695697v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D50375-73F3-2257-E053-F662850A3980","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for added section in Lost to Follow-Up form. 3/3/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5695719","version":"1","preferredName":"Study Site Stop Clinical Study Participation Date","preferredDefinition":"A response used to determine the date on which a facility that conducts study/protocol activities ceased to take part in a study.","longName":"5695697v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D46258-477A-2B9E-E053-F662850AF031","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for an added section in the Lost to Follow-Up form. 3-3-17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5695945","version":"1","preferredName":"Study Site Stop Clinical Study Participation Reason","preferredDefinition":"A coded numeric explanation of what caused a facility that conducts study/protocol activities to cease from taking part in a study.","longName":"5695697v1.0:5695725v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49D82050-89C8-5168-E053-F662850A4D8B","latestVersionIndicator":"Yes","beginDate":"2017-03-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-03","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeNote":"Created for additional section in Lost to Follow-Up, 3/3/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700768","version":"2","preferredName":"Female Gender Age Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"A response to confirm female gender and age status in order to allow a person to participate in a clinical study, as outlined in the study protocol.","longName":"FEM_AGE_CONF_STS","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43FC9-BD4E-5668-E053-4EBD850AD07E","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-05-19","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 12/15/17 tt released. 3/8/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700844","version":"2","preferredName":"Female Gender Childbearing Potential Negation Pregnancy Lactating Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study confirming that a female with the potential of becoming pregnant, is not pregnant or producing milk as outlined in the study protocol.","longName":"FEM_NGN_PREG_LCT_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D42414-B417-566C-E053-4EBD850A073C","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/15/18 tt released/review of metrics report. 3/8/17 tt, EA1151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700862","version":"2","preferredName":"Screening Mammogram Scheduled Or Intent Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time that a screening mammogram is scheduled, or anticipated, as outlined in the study protocol, in order to allow a patient to participate in a clinical trial.","longName":"SCRMAM_SCHD_INT_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43FC9-BD7C-5668-E053-4EBD850AD07E","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-05-19","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/15/18 tt released. 3/8/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700866","version":"2","preferredName":"Breast Imaging Procedure Tolerance Ability Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time that the patient is able to tolerate breast imaging procedures, as outlined in the study protocol, in order to participate in a clinical trial.","longName":"BRIMG_TOL_ABLY_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D45DC5-A3A6-7E2A-E053-4EBD850ABA09","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/14/18 tt released/metrics report. 3/8/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700877","version":"2","preferredName":"Breast Disease or Disorder Negation Sign or Symptom Diagnostic Mammography Requirement Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time that the patient does not have signs or symptoms of any abnormal conditions of the breasts that would require a diagnostic mammogram, as outlined in the study protocol, in order to participate in a clinical study.","longName":"BRDZ_NGN_SNSYM_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D46BC2-38EF-04EC-E053-4EBD850A075B","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 3/8/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5700885","version":"2","preferredName":"Negation Screening Mammogram Prior To Randomization Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time that the patient did not have a screening mammogram prior to randomization, as outlined in the study protocol, in order to participate in a clinical study.","longName":"NGN_BLMAM_PR_RAND_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7CE834E-F7E3-0CD3-E053-4EBD850AF522","latestVersionIndicator":"Yes","beginDate":"2017-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/14/18 tt released/metrics report. 3/8/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5701687","version":"2","preferredName":"Personal Medical History Negation Prior Breast Carcinoma Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time the patient does not have a previous history of breast cancer, as outlined in the study protocol, in order to participate in a clinical study.","longName":"NGN_HX_BR_CA_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D47958-C7E4-5EAC-E053-4EBD850AC8BB","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5701692","version":"2","preferredName":"Negation Breast Enhancement Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"Verification at a particular time the patient does not have breast enhancements, as outlined in the study protocol, in order to participate in a clinical study.","longName":"NGN_BRENH_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D48D26-54B0-0889-E053-4EBD850AC19E","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5701693","version":"1","preferredName":"Patient Future Research Cancer Biobank Storage Consent Authorization Indicator","preferredDefinition":"A response as to whether the patient gives permission to provide specimen(s) for future research and storage in a Biobank.","longName":"BIOBK_CON","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4D3A46-8D50-2398-E053-F662850A2160","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"FINCHAMB","dateModified":"2023-12-01","changeNote":"5/18/18 tt edit to draft new CDE; released. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5701699","version":"1","preferredName":"First Menstrual Cycle Age Value","preferredDefinition":"The age at which a person had their first menstrual period.","longName":"FST_MENS_AGE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A471826-00A6-1CC4-E053-F662850AEA4F","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5701746","version":"1","preferredName":"Live Birth Number Count","preferredDefinition":"Information pertaining to the patient's number of live children born.","longName":"2486641v1.0:5701700v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4D4BB2-0174-23A0-E053-F662850A0451","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released/review of metrics report. 3/9/17 tt, EA115,","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702062","version":"1","preferredName":"Person Breast Feeding History Indicator","preferredDefinition":"A response as to whether or not the patient breastfed any of her children.","longName":"BR_FED_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4E5EC9-3131-7BB7-E053-F662850A0E63","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702095","version":"1","preferredName":"Breast Feeding Total Month Count","preferredDefinition":"A response for the number of months the patient breastfed.","longName":"5702080v1.0:5701700v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4DDB8E-9CE3-2B98-E053-F662850A5BE5","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/0/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702142","version":"1","preferredName":"Disease or Disorder Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study related to the diagnosis of any abnormal condition of the body or mind as outlined in the study protocol.","longName":"DZDR_DX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4E6F4C-00D3-2369-E053-F662850A31DE","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"FINCHAMB","dateModified":"2023-12-22","changeNote":"10/17/17 tt released for reuse.  3/9/17 tt, EA1151.","administrativeNotes":"2023.9.26 AQT added per ticket request CADSR0002860. ak 9/18/23 Added CSI and AQT for URMC ticket number 5702142 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702146","version":"1","preferredName":"Ovarian Disease or Disorder Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study related to the diagnosis of any abnormal condition of the ovaries as outlined in the study protocol.","longName":"OVN_DZDS_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4DE040-F9DD-2F1F-E053-F662850A016B","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702181","version":"1","preferredName":"Hysterectomy Performed Age Value","preferredDefinition":"A response to capture the patient's age at hysterectomy.","longName":"HYST_AGE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4DC6BE-1088-1A18-E053-F662850A6EF0","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702194","version":"1","preferredName":"Oophorectomy Performed Indicator","preferredDefinition":"A response as to whether the patient had an oophorectomy.","longName":"OOPH_PRF_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4DCA9F-4C4A-2363-E053-F662850AC237","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702208","version":"1","preferredName":"Oophorectomy Performed Age Value","preferredDefinition":"A response to capture the patient's age at oophorectomy.","longName":"OOPH_AGE","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A504FED-E4B8-43CC-E053-F662850ABE13","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702299","version":"1","preferredName":"Physical Activity Occurrence Per Week Count","preferredDefinition":"A response to capture the amount of exercise during the timespan of one week.","longName":"5702292v1.0:5701700v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A532AAD-78B5-4C4E-E053-F662850AF742","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702315","version":"1","preferredName":"First Degree Relative Diagnosis Breast Carcinoma Count","preferredDefinition":"A response to determine the number of first degree relatives associated with a diagnosis of breast cancer.","longName":"FR_DGR_REL_BR_CA_CNT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A548796-5095-3620-E053-F662850ADE52","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702330","version":"1","preferredName":"Person Diethylstilbestrol Receive Indicator","preferredDefinition":"A response as to whether the patient has taken diethylstilbestrol (DES).","longName":"PT_DES_RCV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A5530B3-8FFA-3567-E053-F662850AE19F","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702335","version":"1","preferredName":"Person Mother Pregnancy Diethylstilbestrol Receive Indicator","preferredDefinition":"A human being._A female parent._The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._A synthetic, nonsteroidal form of estrogen. A well-known teratogen and carcinogen, diethylstilbestrol inhibits the hypothalamic-pituitary-gonadal axis, thereby blocking the testicular synthesis of testosterone, lowering plasma testosterone, and inducing a chemical castration._To take, accept, or get something offered._The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"MTHR_PGNY_DES_RCV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A54A6CF-27EF-2CCB-E053-F662850A5DA3","latestVersionIndicator":"Yes","beginDate":"2017-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-09","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/9/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702413","version":"1","preferredName":"Person Breast Carcinoma Chemoprevention Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to determine clinical trial eligibility for questions related to breast cancer chemotherapeutic agents as outlined in the study protocol.","longName":"BR_CA_CHEPR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A61D10D-2EE3-440F-E053-F662850A42B1","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2020-02-03","changeNote":"11/15/18 tt released. 3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702424","version":"1","preferredName":"Therapeutic Procedure Continue Checkbox Indicator","preferredDefinition":"Indicator to determine the continuation of any type of therapy.","longName":"TX_ONG_CKBOX","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A6285D2-D6DD-365B-E053-F662850AFCB3","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 dl, 3/11/ tt, edits.  3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702434","version":"1","preferredName":"Radiation Therapy Administered Reason","preferredDefinition":"A response to explain the reason for radiation therapy.","longName":"RT_RSN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A631BCC-C4B4-143F-E053-F662850AD7A1","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702480","version":"1","preferredName":"Female Prior Malignant Neoplasm Diagnosis Type","preferredDefinition":"A response for the type of prior female cancer.","longName":"FEML_PRR_CA_TYP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A63BC7D-AE9D-160B-E053-F662850A88EB","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released/review of metrics report. 3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702492","version":"1","preferredName":"Other Disease or Disorder Diagnosis Age Value","preferredDefinition":"A response to capture the patient's age when the presence of other disease was diagnosed.","longName":"OTR_DZ_AGE_VAL","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A604B1A-655F-75F6-E053-F662850AD13C","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 4/6/17 tt, Edit/CRF edits. 3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702572","version":"1","preferredName":"Anatomic Site Side Identifier","preferredDefinition":"A response for the side of named locations within the body.","longName":"ATMC_SIDE_ID","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A651656-9F3C-724B-E053-F662850A68A5","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"MMADDINENI","dateModified":"2022-08-03","changeNote":"11/14/18 tt released/metrics report. 4/7/17 tt, DEC edits/CRF edits. 3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5702573","version":"1","preferredName":"Biopsy Anatomic Site Performed Count","preferredDefinition":"A response to capture the number of biopsies performed on the named locations of or within the body.","longName":"2638260v1.0:5701700v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A654BAD-C0B8-72FE-E053-F662850AE9B5","latestVersionIndicator":"Yes","beginDate":"2017-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-10","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report.  3/10/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5704160","version":"1","preferredName":"Biopsy Outcome Atypical Hyperplasia of the Breast Positive Finding Indicator","preferredDefinition":"A response for questions related to the biopsy finding of atypical hyperplastic proliferations of epithelial cells in breast parenchyma.","longName":"BRBX_ATHYP_POSV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A75CCA1-8DAD-0BE1-E053-F662850A4D01","latestVersionIndicator":"Yes","beginDate":"2017-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-11","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/11/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5704174","version":"1","preferredName":"Biopsy Outcome Lobular Breast Carcinoma In Situ Positive Finding Indicator","preferredDefinition":"A response for questions related to the biopsy finding of a non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.","longName":"BRBX_LCIS_POSV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A764A26-B571-0DC7-E053-F662850AA02D","latestVersionIndicator":"Yes","beginDate":"2017-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-11","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/11/17 t, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5705026","version":"1","preferredName":"Genetic Testing for Cancer Risk Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study, as outlined in the study protocol, that address the analyzation of DNA to look for genetic alterations that may indicate an increased risk for developing a cancer.","longName":"GTCR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A771BD1-4525-7721-E053-F662850ABCE3","latestVersionIndicator":"Yes","beginDate":"2017-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-11","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/11/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709516","version":"1","preferredName":"Patient Biomarker Analysis Positive Finding Other Specify Text","preferredDefinition":"The free text field to capture other markers with positive results.","longName":"PT_BMRKR_POS_SPFY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA0124F-066A-1D84-E053-F662850A1D56","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 tt, edits. 3/13/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709522","version":"1","preferredName":"First Degree Relative Biomarker Analysis Positive Finding Other Specify Text","preferredDefinition":"The free text field to provide other positive biological assays of any relative who is one meiosis away from a particular individual in a family.","longName":"FST_DEG_REL_POS_BRMKR_SPFY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA01C0C-6D52-2061-E053-F662850A2D37","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 tt, edit to CDE. 3/13/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709524","version":"1","preferredName":"Other Relative Biomarker Analysis Positive Finding Specify Text","preferredDefinition":"The free text field to capture markers with positive results for other persons related by blood or marriage.","longName":"OTH_RELV_BMRKR_POS_SPFY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA0143E-733D-1E78-E053-F662850A3C22","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 tt, edits. 3/13/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709639","version":"1","preferredName":"Alcohol Consumption Year Duration","preferredDefinition":"The period of time in years for the consumption of liquids containing ethanol.","longName":"ALCPTN_TR_DURN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA0AD11-4801-108D-E053-F662850AF0CF","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/13/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5709643","version":"1","preferredName":"Alcohol Consumption Weekly Count","preferredDefinition":"A response to determine the weekly consumption of liquids containing ethanol.","longName":"5709642v1.0:5701700v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AA0D95F-B9B5-1E6F-E053-F662850AA307","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-13","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/13/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5725097","version":"1","preferredName":"Clinical Trial Eligibility Criteria Breast Imaging Screening Method Frequency","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol, for questions related to the frequency of screening breast imaging procedures.","longName":"BRT_IMG_SCRN_FRQY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B7EC29F-1EB1-7224-E053-F662850A8A74","latestVersionIndicator":"Yes","beginDate":"2017-03-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-24","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/24/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5725474","version":"1","preferredName":"Clinical Trial Eligibility Criteria Biospecimen Collection Consent Authorization Ind","preferredDefinition":"Characteristics which are necessary to allow participation in a clinical study, as outlined in the study protocol, for questions related to the patient's consent of biospecimen collection.","longName":"SPEC_CNST_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B7F6D78-9BEE-0C2F-E053-F662850A59FB","latestVersionIndicator":"Yes","beginDate":"2017-03-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-24","modifiedBy":"TAYLORT","dateModified":"2017-09-26","changeNote":"3/24/17 tt, EA1151. 4/18/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5725483","version":"1","preferredName":"Clinical Trial Eligibility Criteria Hormone Replacement Therapy Indicator","preferredDefinition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol, for questions related to HRT.","longName":"HRT_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B7FB05B-EC64-3A31-E053-F662850A74EB","latestVersionIndicator":"Yes","beginDate":"2017-03-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-24","modifiedBy":"TSESU","dateModified":"2022-11-28","changeNote":"11/15/18 tt released. 3/24/17 tt, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5725735","version":"1","preferredName":"Clinical Trial Eligibility Criteria Other Therapeutic Procedure Begin Year Checkbox Indicator","preferredDefinition":"Indicator to determine other treatment start year for questions that are necessary to allow a person to participate in a clinical study, as outlined in the study protocol.","longName":"TX_BEG_YR_OTHR_CHKBX","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BB923D7-3423-25A5-E053-F662850A2329","latestVersionIndicator":"Yes","beginDate":"2017-03-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-27","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 3/27/17 tt/dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5726299","version":"1","preferredName":"Clinical Trial Eligibility Criteria Therapeutic Procedure Begin Year Data Unknown Text","preferredDefinition":"The study eligibility text field to record if treatment start year data is unknown or not available.","longName":"TX_BEG_YR_UNK","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BBC59B7-FAF2-55FD-E053-F662850A6C11","latestVersionIndicator":"Yes","beginDate":"2017-03-27","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-03-27","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"4/7/17 tt, edit/CRF edit. 3/27/17, 3/28/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5727023","version":"1","preferredName":"Clinical Trial Eligibility Criteria Therapeutic Procedure End Year Data Unknown Text","preferredDefinition":"The study eligibility text field to record if treatment end year data is unknown or not available.","longName":"TX_END_YR_UNK","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BC1AA8A-2523-72F2-E053-F662850AAD67","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-03-28","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"4/7/17 edit/CRF edit. 3/28/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5727108","version":"1","preferredName":"Patient Biomarker Analysis Positive Finding Name","preferredDefinition":"A response to capture the patient's positive biomarker name(s).","longName":"PT_MRKR_POS_FIND_NM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCFF70D-EFF9-1138-E053-F662850A7758","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-03-28","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5727110","version":"1","preferredName":"First Degree Relative Biomarker Analysis Positive Finding Name","preferredDefinition":"A response to capture the names of positive biological assays for any relatives who are one meiosis away from a particular individual in a family.","longName":"FST_DEG_REL_BRMKR_POS_FIND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCCA61B-3E2A-454B-E053-F662850A2EA2","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-03-28","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/28/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5727111","version":"1","preferredName":"Other Relative Biomarker Analysis Positive Finding Name","preferredDefinition":"A response to capture the names of positive biological assays for other persons that are related by blood or marriage.","longName":"OTH_REL_BMRKR_POS_FIND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BCF1A8F-F46D-7D1F-E053-F662850AB017","latestVersionIndicator":"Yes","beginDate":"2017-03-28","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-03-28","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/28/17 dl, edits/tt EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5727900","version":"1","preferredName":"Protocol Agent Therapeutic Procedure Prior Administration Or Planned Occurrence Ind","preferredDefinition":"A yes/no response used to determine whether a therapeutic agent tested in a clinical trial was administered or is intended for administration during the clinical trial.","longName":"5727899v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BE6C4BC-6BED-05FB-E053-F662850AAA36","latestVersionIndicator":"Yes","beginDate":"2017-03-30","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-03-30","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for new E1910 strat factor, 3/30/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5728047","version":"1","preferredName":"Unknown Hormone Replacement Therapy Pharmaceutical Formulation Taken Reason","preferredDefinition":"The explanation for why an unknown form of HRT was taken.","longName":"UNK_HRT_FORM_TKN_RSN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4BF351B5-5FCF-6BD7-E053-F662850ADB60","latestVersionIndicator":"Yes","beginDate":"2017-03-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-03-30","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 3/30/17 tt, EA1151","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5736958","version":"1","preferredName":"Clinical Trial Eligibility Criteria Mammographically Dense Breast Present Indicator","preferredDefinition":"A response to questions which are necessary to allow a subject to participate in a clinical study that are related to the presence of mammographic heterogeneously or extremely dense breast composition, based on updated editions of the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS).","longName":"DNS_BRST_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C6E366B-C5CD-66E9-E053-F662850A6F47","latestVersionIndicator":"Yes","beginDate":"2017-04-05","endDate":"2017-10-11","createdBy":"LOWMAND","dateCreated":"2017-04-05","modifiedBy":"LOWMAND","dateModified":"2017-10-11","changeNote":"10/11/17 dl, released. 4/5/17 dl , EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5749989","version":"1","preferredName":"Clinical Trial Eligibility Criteria Personal Medical History Data Collection Post Enrollment Indicator","preferredDefinition":"A response to questions which are necessary to allow a subject to participate in a clinical study that are related to the act or process of gathering personal medical history data for testing or research purposes after enrollment.","longName":"MEDHX_DATA_CLT_POST_ENR","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CD4034B-4B10-6B21-E053-F662850A66AE","latestVersionIndicator":"Yes","beginDate":"2017-04-10","endDate":null,"createdBy":"LOWMAND","dateCreated":"2017-04-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"4/10/17 dl, EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5778167","version":"1","preferredName":"Eligibility Determination Checklist Complete And Uploaded To Clinical Trial Patient Database Ind","preferredDefinition":"A yes/no response used to indicate whether the list of criteria used to determine eligibility of patients for a clinical trial has been completed and a file of this information has been transferred to a central database used in a research study.","longName":"5778166v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9BEF0E-40AC-7EC8-E053-F662850AD0EB","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-04-20","modifiedBy":"GARRIDOJ","dateModified":"2017-08-22","changeNote":"Created for MATCH, 4/20/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5779978","version":"1","preferredName":"Study Site Notification Ind","preferredDefinition":"A yes/no response used to indicated whether a facility in which study/protocol activities are conducted was informed of a situation.","longName":"5779977v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DEDE366-250B-6BD7-E053-F662850AF17B","latestVersionIndicator":"Yes","beginDate":"2017-04-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-04-24","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for EAY131, 4/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5780056","version":"1","preferredName":"Screening Assessment External Performing Laboratory Outcome Ind","preferredDefinition":"A yes/no response used to determine an whether an analysis of a sample(s) collected for assessment was provided by an outside laboratory.","longName":"5780037v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DEEDFA0-054F-0451-E053-F662850A1C5D","latestVersionIndicator":"Yes","beginDate":"2017-04-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-04-24","modifiedBy":"GARRIDOJ","dateModified":"2017-06-28","changeNote":"Created for EAY131, 4/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5781369","version":"1","preferredName":"Performing Laboratory Name","preferredDefinition":"A response used to identify which laboratory provided analysis of samples collected in clinical care or research.","longName":"2555508v1.0:5781366v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DFE3BB8-39BE-635B-E053-F662850A55B3","latestVersionIndicator":"Yes","beginDate":"2017-04-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-04-25","modifiedBy":"ZHANGWE","dateModified":"2020-05-06","changeNote":"Created for EAY131, 4/25/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5800745","version":"1","preferredName":"B-Lymphocyte Antigen CD20 Binding Intensity Type","preferredDefinition":"A response used to determine the degree or magnitude of strength of the B-lymphocyte antigen CD20 bond.","longName":"5800495v1.0:5800497v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E7B3BDB-39D9-6E84-E053-F662850A420B","latestVersionIndicator":"Yes","beginDate":"2017-05-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-01","modifiedBy":"GARRIDOJ","dateModified":"2017-08-22","changeNote":"Created for E1910, 5/1/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5806944","version":"1","preferredName":"Laboratory Test Result Discussion With Patient Occurrence Code","preferredDefinition":"A coded response used to determine the outcome of a laboratory test was communicated to a person who is receiving medical attention, care, or treatment.","longName":"5806927v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EB57AD5-068E-3071-E053-F662850A00A9","latestVersionIndicator":"Yes","beginDate":"2017-05-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-04","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for EAQ152, 5/4/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5807016","version":"1","preferredName":"Laboratory Test Result Discussion With Patient Occurrence Date","preferredDefinition":"A response used to indicated the date in which the outcome of a laboratory test was communicated to a person who is receiving medical attention, care or treatment.","longName":"5806927v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EB623EF-220F-0BF4-E053-F662850A358B","latestVersionIndicator":"Yes","beginDate":"2017-05-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-04","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for EAQ152, 5/4/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5808654","version":"1","preferredName":"Anti-CD20 Monoclonal Antibody-FITC Laboratory Test Result Status","preferredDefinition":"A response used to determine the outcome of a laboratory test which consists of an immunoconjugate composed of a monoclonal antibody directed against the human antigen CD20 that is conjugated to the fluorescein derivative and fluorochrome fluorescein isothiocyanate (FITC), with potential use for imaging and detection of CD20-expressing cells.","longName":"5808628v1.0:5808650v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4ECC1F05-E9C8-6CDC-E053-F662850A0B4C","latestVersionIndicator":"Yes","beginDate":"2017-05-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-05","modifiedBy":"GARRIDOJ","dateModified":"2017-08-22","changeNote":"Created for E1910, 5/5/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5813055","version":"1","preferredName":"Imaging Procedure Laboratory Test Requirement Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study that are related to required lab tests for imaging procedures as outlined in the protocol.","longName":"IMG_LAB_REQ_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F30E186-FD21-295E-E053-F662850A51AF","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-10","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 5/10/17 tt, EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5813060","version":"1","preferredName":"Intervention or Procedure Screening Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a patient to participate in a clinical study that are related to screening  interventions or procedures as outlined in the clinical trial protocol.","longName":"INT_PROC_SCRN_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3136CD-E43F-7472-E053-F662850A9A14","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-05-10","modifiedBy":"TAYLORT","dateModified":"2017-11-03","changeNote":"5/10/17 tt, EA1141.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5829910","version":"1","preferredName":"Laboratory Test Result Upload Notification Ind","preferredDefinition":"A response used to indicate whether one was notified that a file of the outcome of a laboratory test was transferred to a central computer.","longName":"5829892v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FBB74AA-937C-54FE-E053-F662850A178C","latestVersionIndicator":"Yes","beginDate":"2017-05-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-17","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for E1910, 5/17/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892339","version":"1","preferredName":"Patient Informed Laboratory Procedure Result Ind","preferredDefinition":"A response used to determine whether a person receiving medical attention, care, or treatment has been acquainted with knowledge of the results of a procedure that involves testing of a sample of blood, urine, or other body substance in a laboratory setting.","longName":"5892277v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5305F559-9609-170D-E053-F662850AE02A","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-06-28","modifiedBy":"GARRIDOJ","dateModified":"2017-06-28","changeNote":"Created for EAQ152, 6/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5892458","version":"1","preferredName":"Registration Institution Additional Participating Study Site Ind","preferredDefinition":"A response used to determine whether the registering institution was an organization that was added to participated in a clinical trial.","longName":"5892447v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53062A91-0994-4526-E053-F662850A1236","latestVersionIndicator":"Yes","beginDate":"2017-06-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-06-28","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for EAQ152, 6/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893181","version":"1","preferredName":"ECOG Performance Status Outcome Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, as outlined in the study protocol, that address the patient's results of a performance status scale designed to assess disease progression and its affect on the daily living abilities of the patient.","longName":"ECOG_PERF_STAT_OCM_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53201F3F-AB00-4F66-E053-F662850AEF67","latestVersionIndicator":"Yes","beginDate":"2017-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-06-29","modifiedBy":"CLOHNES","dateModified":"2023-09-18","changeNote":"6/30/17 tt, approved/released. 6/29/17 tt, EAQ162CD.","administrativeNotes":"9/18/23 Added CSI and AQT for URMC ticket number CADSR0002862 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893205","version":"1","preferredName":"Disease or Disorder Newly Diagnosed And Negation Therapeutic Procedure Received Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, as outlined in the study protocol, to address disease that is newly diagnosed and has not been treated.","longName":"DZ_NEWDX_NEG_TX_RCV_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5321688B-D5BF-2226-E053-F662850A3427","latestVersionIndicator":"Yes","beginDate":"2017-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-06-29","modifiedBy":"TAYLORT","dateModified":"2017-06-30","changeNote":"6/30/17 tt, approved/released.  6/29/17 tt, EAQ162CD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893229","version":"1","preferredName":"Therapeutic Clinical Trial Current Enrollment At Registration Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions necessary to allow a person to participate in a clinical study, as outlined in the study protocol, that address current enrollment in a treatment clinical trial at the time of study registration.","longName":"TX_CLTR_ENR_REG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53221F00-949A-5DC0-E053-F662850AFFD0","latestVersionIndicator":"Yes","beginDate":"2017-06-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-06-29","modifiedBy":"FINCHAMB","dateModified":"2023-08-09","changeNote":"6/30/17 tt, approved/released.  6/29/17 tt, EAQ162CD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893232","version":"1","preferredName":"Patient Plan Therapeutic Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, as outlined in the study protocol, to address the patient's plan for therapy.","longName":"PT_PLAN_TX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"532CEA67-61D3-7269-E053-F662850AD42B","latestVersionIndicator":"Yes","beginDate":"2017-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-06-30","modifiedBy":"KUMMEROA","dateModified":"2022-11-04","changeNote":"6/30/17 tt, EAQ162CD; approved/released.","administrativeNotes":"2022.11.4 AQT added for ticket request CADSR0001656. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5893240","version":"1","preferredName":"Disease or Disorder Present Current Curative Intent Therapeutic Procedure Administration Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow clinical study participation, as outlined in the study protocol, to address the patient's existing disease and the current administration of therapy with curative intent.","longName":"DZ_PRES_CURTX_INT_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"532CD5A9-19FB-7265-E053-F662850A1AA4","latestVersionIndicator":"Yes","beginDate":"2017-06-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-06-30","modifiedBy":"DWARZEL","dateModified":"2020-03-24","changeNote":"6/30/17 tt, approved/released.  6/30/17 tt, EAQ162CD. fix special character in definition 03-24-2020 DW","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5897021","version":"1","preferredName":"Minimal Residual Disease Detection Outcome Ind","preferredDefinition":"A response used to determine whether a test result has identified evidence for remaining tumor following primary treatment.","longName":"5897020v1.0:2774650v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F89C8A-AE3D-6016-E053-F662850AFFFD","latestVersionIndicator":"Yes","beginDate":"2017-07-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-07-10","modifiedBy":"GARRIDOJ","dateModified":"2018-06-04","changeNote":"Created for EA4151, 7/10/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5913654","version":"1","preferredName":"Therapeutic Procedure Curative Intent Administration Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study that are related to the administration of treatment with curative intent as outlined in the protocol.","longName":"TX_CURINT_ADMN_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54993A69-351E-1148-E053-F662850A48A6","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-18","modifiedBy":"FINCHAMB","dateModified":"2023-12-22","changeNote":"7/18/17 tt, EAQ162CD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5913679","version":"1","preferredName":"Clinical Trial Eligibility Criteria Colorectal Cancer by AJCC v8 Stage","preferredDefinition":"A response to questions which are necessary to allow a person to participate in a clinical study, as outlined in the protocol, that address his/her stage of colorectal cancer according to the American Joint Committee on Cancer, 8th edition.","longName":"ELIG_CRC_AJCC_V8_STG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"549C0698-8055-7BE3-E053-F662850A4228","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-18","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 7/18/17 tt EAQ162CD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5917044","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index Risk Assessment Category","preferredDefinition":"A response used to estimate a patient's risk of mantle cell lymphoma progression or relapse and overall survival following therapy using a scoring system. It uses the criteria of patient's age, ECOG performance status, serum LDH activity, WBC count and Ki-67 index to classify patients into low risk, medium risk or high risk groups. The MIPIb score is calculated using the formula: [0.03535 x age (years)] + 0.6978 (if ECOG > 1) + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC count)] + [0.02142 x Ki-67 (%)]. A score < 5.7 indicates low risk disease, 5.7 - 6.5 indicates intermediate risk, and 6.5 or greater high risk.","longName":"5836958v1.0:5917037v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C7DFA3-4379-1E82-E053-F662850AFDCF","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeNote":"Created for EA4151, JG 8/2/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935516","version":"1","preferredName":"Person Specimen Tumor Marker Central Pathology Review Clinical Trial Eligibility Criteria Status","preferredDefinition":"A response used to determine whether the condition or state of a substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids that were sent to a central lab for confirmatory analysis met the characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"5935514v1.0:5935515v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56DFC85E-94B9-7AA3-E053-F662850A5547","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA4151, 8/16/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935522","version":"1","preferredName":"Person Minimal Residual Disease Assessment Clinical Trial Eligibility Criteria Status","preferredDefinition":"A response used to determine whether an individual met the characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol which is determined by the existence of the remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","longName":"5935520v1.0:5935521v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56E069A9-B215-5FB4-E053-F662850AC97F","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA4151, 8/16/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935686","version":"1","preferredName":"Bone Marrow Transplantation Performed FACT Certified Site Ind","preferredDefinition":"A response used to determine whether a procedure to replace bone marrow that has been destroyed by treatment with high doses of anticancer drugs or radiation has been executed at a site that has been through the process by which a person demonstrates specific knowledge, skills, or abilities in the view of the Foundation for the Accreditation of Cellular Therapy (FACT), a non-profit corporation co-founded by the International Society for Cellular Therapy and the American Society of Blood and Marrow Transplantation for the purposes of voluntary inspection and accreditation in the field of cellular therapy.","longName":"5935672v1.0:5935673v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5709F543-1AFE-7866-E053-F662850A6ABA","latestVersionIndicator":"Yes","beginDate":"2017-08-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-18","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA4151, 8/18/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935695","version":"1","preferredName":"Neoadjuvant Therapy Cytarabine Dose Administration Status","preferredDefinition":"A response used to determine the quantity of cytarabine administered prior to the primary treatment for the purpose of making the primary treatment for effective.","longName":"5935690v1.0:5935693v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"570A2D78-540A-7DEA-E053-F662850A65BD","latestVersionIndicator":"Yes","beginDate":"2017-08-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-18","modifiedBy":"RODELAA","dateModified":"2019-10-25","changeNote":"Created for EA4151, 8/18/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5935981","version":"1","preferredName":"Baseline Lesion Reuse Ind","preferredDefinition":"A yes/no response used to indicate whether or not to reuse a lesion present at baseline.","longName":"5935980v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57453AD1-BB4B-5E06-E053-F662850A2779","latestVersionIndicator":"Yes","beginDate":"2017-08-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-21","modifiedBy":"MMADDINENI","dateModified":"2022-06-06","changeNote":"Created for F/U Disease Evaluation Forms (for all studies with tumor measurement), 8/21/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5936366","version":"1","preferredName":"Disease or Disorder Subcategory Applicable Code","preferredDefinition":"A coded response used to determine whether a subdivision that has common differentiating characteristics of an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to a person is relevant or capable of being applied.","longName":"5936365v1.0:3854731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"575B3E44-FBBB-6C37-E053-F662850A5DAF","latestVersionIndicator":"Yes","beginDate":"2017-08-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161, 8/22/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5936380","version":"1","preferredName":"Personal Medical History Human Immunodeficiency Virus Or Acquired Immunodeficiency Syndrome Positive Finding Ind","preferredDefinition":"A response used to determine whether there is a record of a positive finding of Human immunodeficiency virus (HIV) or Acquired Immunodeficiency Syndrome in a patient's background.","longName":"5936379v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"575D5F6A-DDFA-6C47-E053-F662850AC60E","latestVersionIndicator":"Yes","beginDate":"2017-08-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161. 8/22/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5936619","version":"1","preferredName":"Leptomeningeal Neoplasm Present Ind","preferredDefinition":"A response used to determine whether a malignant neoplasm that has spread from its original site to the innermost layers of tissue that cover the brain and spinal cord exists.","longName":"5936515v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"576BA04F-E6B0-5195-E053-F662850A9F8F","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-23","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161, 8/23/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5936698","version":"1","preferredName":"Prior Chemotherapy Or Biological Therapy First-Line Treatment Administered Ind","preferredDefinition":"A response used to indicate whether synthetic or naturally-occurring chemicals or substances which produce a biological reaction that are the preferred standard treatment for a particular condition were given at an earlier time.","longName":"5936695v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"576C559B-1444-5040-E053-F662850AB65E","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-23","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161, 8/23/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5937370","version":"1","preferredName":"Prior Therapeutic Procedure Intent Category","preferredDefinition":"A response used to determine the anticipated outcome that was intended or that guided the delivery of a treatment plan that was previously administered.","longName":"5937358v1.0:3137978v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57863F4D-C79E-741C-E053-F662850AD051","latestVersionIndicator":"Yes","beginDate":"2017-08-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-24","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161, 8/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943174","version":"1","preferredName":"Prior Chemoradiotherapy Administered Ind","preferredDefinition":"A yes/no response used to determine whether treatment that combines chemotherapy with radiation therapy was given earlier in time.","longName":"5943137v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D0199D-837A-6DCC-E053-F662850A1942","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"ZHWENDY","dateModified":"2022-09-28","changeNote":"Created for multiple Prior TX forms, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943175","version":"1","preferredName":"Prior Chemoradiotherapy Administered End Date","preferredDefinition":"A response used to indicate the date that previously given treatment that combines chemotherapy with radiation therapy ended.","longName":"5943137v1.0:2179471v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D19F01-4F7B-6DBC-E053-F662850A1E4D","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"ZHWENDY","dateModified":"2022-09-28","changeNote":"Created for Prior TX forms, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943332","version":"1","preferredName":"Candidate Systemic Therapy Administration Ind","preferredDefinition":"A yes/no response used to determine whether someone is considered suitable to be administered treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","longName":"5943178v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D19F01-4FA4-6DBC-E053-F662850A1E4D","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5161, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943336","version":"1","preferredName":"Prior Antibody Therapy Administered Ind","preferredDefinition":"A yes/no response used to determine whether treatment with injections of antibodies were given earlier in time?","longName":"5943335v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D03F00-8E97-6DC4-E053-F662850A51E6","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"GARRIDOJ","dateModified":"2021-09-13","changeNote":"Created for EA5161, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943653","version":"1","preferredName":"Therapeutic Procedure Agent Administration Decision Name","preferredDefinition":"A response used to determine the therapeutic agent was decided on for administration to produced an effect intended to alter or stop a pathologic process.","longName":"5943340v1.0:5342171v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D360D1-8949-20D6-E053-F662850AD788","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"KRYSTKIA","dateModified":"2018-05-08","changeNote":"Created for EA5161, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5943785","version":"1","preferredName":"New York Institution Location Clinical Trial Eligibility Criteria Ind","preferredDefinition":"A yes/no response used to indicate whether an established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research is located in New York, a state in the northeastern United States, in order to determine whether characteristics which are necessary to allow a subject to participate in a clinical study are met.","longName":"5943784v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D46A9F-4DD4-765F-E053-F662850A61CD","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-28","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Create for EA4151, 8/28/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5973134","version":"1","preferredName":"EGFR Exon 20 Insertion Mutation Subtype Type","preferredDefinition":"A response used to identify the type of mutation located after the C-helix of the tyrosine kinase domain of EGFR.","longName":"5971462v1.0:5973096v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"589F647A-633E-47CA-E053-F662850A40F3","latestVersionIndicator":"Yes","beginDate":"2017-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-09-07","modifiedBy":"GARRIDOJ","dateModified":"2017-10-06","changeNote":"Created for EA5162, 9/7/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5983574","version":"1","preferredName":"Prior Lung Radiation Therapy Administered Ind","preferredDefinition":"A response used to determine whether treatment of a disease by means of exposure to radiation of one or both viscera occupying the pulmonary cavities of the thorax (the organs of respiration in which aeration of the blood takes place) was given at an earlier time.","longName":"5983573v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A08B4D1-4000-5CEC-E053-F662850A973C","latestVersionIndicator":"Yes","beginDate":"2017-09-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-09-25","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeNote":"Created for EA5162, JG 9/25/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5987424","version":"1","preferredName":"Clinical Disease or Disorder Assessment Interpretation Code","preferredDefinition":"A coded response used as an explanation of a final result of an examination used to determine whether any abnormal condition of the body that was directly observed.","longName":"5610868v1.0:5611044v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5ACF202F-34CC-5C85-E053-F662850A7779","latestVersionIndicator":"Yes","beginDate":"2017-10-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-05","modifiedBy":"GARRIDOJ","dateModified":"2017-10-06","changeNote":"Created for EA8143, 10/05/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010035","version":"1","preferredName":"Pill Count Source Description Type","preferredDefinition":"A response used to indicate how one determined the number of pills that were taken or remaining.","longName":"6009464v1.0:2429998v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C4A5FFD-EF2F-1479-E053-F662850A0FD4","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-24","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for pill agent tx forms. 10/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010067","version":"1","preferredName":"Baseline Electrocardiography Performed Ind","preferredDefinition":"A response used to determine whether or not a procedure which records the electrical current in the heart in the form of a continuous strip graph was completed at baseline.","longName":"6010064v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3B0F64-7589-0543-E053-F662850AF356","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-24","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA5162, 10/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010081","version":"1","preferredName":"Electrocardiography Performed Date","preferredDefinition":"A response used to indicate the date on which a procedure which records the electrical current in the heart in the form of a continuous strip graph was completed.","longName":"6010074v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C4C017B-D80D-0D61-E053-F662850A177C","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-24","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA5162, 10/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010082","version":"1","preferredName":"Electrocardiography Performed Ind","preferredDefinition":"A response used to determine whether or not a procedure which records the electrical current in the heart in the form of a continuous strip graph was completed.","longName":"6010074v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C4B3B27-CF3F-6FA7-E053-F662850A144B","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-24","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA5162, 10/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6010083","version":"1","preferredName":"Baseline Electrocardiography Performed Date","preferredDefinition":"A response used to indicate the date on which a baseline procedure which records the electrical current in the heart in the form of a continuous strip graph was completed.","longName":"6010064v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C3DEED8-6DA0-7880-E053-F662850AC78E","latestVersionIndicator":"Yes","beginDate":"2017-10-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-24","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA5162, 10/24/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6013675","version":"1","preferredName":"Lactate Dehydrogenase Result Stratification Factor Status","preferredDefinition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on the outcome of their lactate dehydrogenase laboratory test.","longName":"6013655v1.0:6013656v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CF022ED-EED9-4A4F-E053-F662850AAE20","latestVersionIndicator":"Yes","beginDate":"2017-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-01","modifiedBy":"TAYLORT","dateModified":"2018-05-18","changeNote":"Created for EA5161, 11/1/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6028366","version":"1","preferredName":"Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Clinical T Stage","preferredDefinition":"A response used to determine the extent of tumor involvement at the primary site of a rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.","longName":"6028241v1.0:6028242v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E075625-B5F0-22A1-E053-F662850A26A9","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA3163, 11/15/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6028374","version":"1","preferredName":"Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Disease Involvement Anatomic Site","preferredDefinition":"A response used to determine the locations within the body of an abnormal condition connected to a rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.","longName":"6028373v1.0:6028367v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E07A277-1A65-228C-E053-F662850A1C8D","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA3163, 11/15/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6041591","version":"1","preferredName":"Additional Participating Clinical Study Site Name","preferredDefinition":"A response used to determine the name of an added organization that is participating in activities conducted in a framework of a particular clinical trial.","longName":"6041590v1.0:3506025v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6010A631-5F30-27C6-E053-F662850A914D","latestVersionIndicator":"Yes","beginDate":"2017-12-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-11","modifiedBy":"GARRIDOJ","dateModified":"2017-12-11","changeNote":"Created for EAQ152, 12/11/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6042937","version":"1","preferredName":"Evaluable Patient RECIST Version Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for patients whose response to treatment can be measured by a version of RECIST as outlined in the study protocol.","longName":"EVAL_RCST_VRSN_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6052A3B4-6555-353F-E053-F662850A5B9A","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-14","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 12/14/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6042943","version":"1","preferredName":"Patient Have Conventional Imaging Perfusion CT Target Lesion Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the patients state of perfusion computed tomography target lesion based on conventional imaging procedure(s).","longName":"CNVL_IMG_PCTTL_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6053D060-A152-5B13-E053-F662850A96AB","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-14","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 12/29/17 tt edit to DN CDE. 12/14/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6042947","version":"1","preferredName":"Conventional Imaging Anatomic Site Recurrent Tumor Core Lab Image Submission Timepoint Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the timepoint when conventional images for recurrent tumor of named location(s) within the body are submitted to the imaging core lab.","longName":"CNVL_IMG_RCT_TMR_SUB_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6053A93F-5720-50E4-E053-F662850A64C8","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-14","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 12/29/17 tt edit to DN CDE. 12/14/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043014","version":"1","preferredName":"Medical Contraindication Known Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to symptoms or medical conditions that make specific treatments or procedures inadvisable because a person is likely to have a bad reaction.","longName":"MED_CON_KNO_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6060368C-F330-62E8-E053-F662850AF0CF","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeNote":"11/15/18 tt released. 12/15/17 tt/EAE161.","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl; 9/18/23 Added CSI and AQT per URMC ticket request CADSR0002862 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043018","version":"1","preferredName":"Platinum Compound Suspected Refractory Disease Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to suspected disease that resists a chemotherapy compound containing platinum.","longName":"PLAT_SUS_REFTY_DZ","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60600249-D202-630D-E053-F662850A7A01","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 12/15/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043024","version":"1","preferredName":"Patient Laboratory Procedure Outcome Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the results of lab tests.","longName":"6043023v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60600249-D22A-630D-E053-F662850A7A01","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"STARGELM","dateModified":"2020-09-03","changeNote":"11/15/18 tt released. 1/31/18 tt edits/changes to question text. 12/15/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043027","version":"1","preferredName":"Anatomic Site Prior Major Intervention or Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to major interventions or procedures of named location(s) within the body, earlier in time or order.","longName":"ANAT_SITE_MAJ_INTV_PROC","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6060368C-F35D-62E8-E053-F662850AF0CF","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 12/15/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043099","version":"1","preferredName":"Imaging Agent Medical Contraindication Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to symptoms or medical conditions that make imaging agents or procedures inadvisable because a person is likely to have a bad reaction.","longName":"IMG_AGT_MED_CON_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60668D9C-9CC1-791C-E053-F662850A9DF9","latestVersionIndicator":"Yes","beginDate":"2017-12-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-15","modifiedBy":"FINCHAMB","dateModified":"2023-11-30","changeNote":"11/14/18 tt released/metrics report. 12/15/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043232","version":"1","preferredName":"Patient Amended Specimen Collection Consent Date","preferredDefinition":"The date related to the patient's altered consent for specimen collection.","longName":"6043231v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"609DA733-3765-49FD-E053-F662850A9114","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for WOC Form, 12/18/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043233","version":"1","preferredName":"Patient Receive Therapeutic Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the patient's receipt of therapeutic agents intended to alter or stop a pathologic process.","longName":"PT_RCV_TX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"609EFEC6-2165-646F-E053-F662850AC5D3","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-18","modifiedBy":"CLOHNES","dateModified":"2023-09-18","changeNote":"11/14/18 tt released/metrics report. 12/18/17 tt/EAE161","administrativeNotes":"9/18/23 Added CSI and AQT for URMC ticket number CADSR0002862 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043304","version":"1","preferredName":"Disease Unresectable Ind","preferredDefinition":"A response used to determine whether an abnormal condition of the body is unable to be removed with surgery.","longName":"6043300v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A09B4A-1D48-6273-E053-F662850ACD09","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12-18-2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043307","version":"1","preferredName":"Metastatic Disease Diagnosis Date","preferredDefinition":"A response used to determine the date on which on which a tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site was observed.","longName":"6043306v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A0E6C2-3B45-70FE-E053-F662850A1E70","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"MORENOC","dateModified":"2019-01-29","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043320","version":"1","preferredName":"Tumor Functional Ind","preferredDefinition":"A response used to determine whether or not normal actions are being performed by a benign or malignant tissue growth resulting from uncontrolled cell proliferation.","longName":"6043316v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"609FF62B-FC24-3D91-E053-F662850A9B3D","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043338","version":"1","preferredName":"TAK-228 Prescription Dose Code","preferredDefinition":"A coded numeric response used to determine the dose prescribed of an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.","longName":"6043337v1.0:6043330v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A239BA-40DC-38F5-E053-F662850AE6C5","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043368","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Histology Grade","preferredDefinition":"A response used to determine the position on a scale of intensity of a well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.","longName":"6043367v1.0:6043357v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A296C6-E3D4-7497-E053-F662850AC930","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043414","version":"1","preferredName":"Pancreatic Carcinoma Histology Code","preferredDefinition":"A coded response used to determine the microscopic process of identifying normal and abnormal morphologic characteristics in a carcinoma arising from the exocrine pancreas.","longName":"6043413v1.0:6043406v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A301A9-63D6-1489-E053-F662850A3070","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043423","version":"1","preferredName":"Disease Pancreatic Neuroendocrine Tumor Anatomic Site Involvement Code","preferredDefinition":"A coded response used to determine the location within the body that has abnormal condition of the body that is associated with a low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.","longName":"6043417v1.0:6043419v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A36574-0E1A-63B8-E053-F662850AD2C1","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/20147 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043428","version":"1","preferredName":"Anatomic Site Disease Involvement Specify Text","preferredDefinition":"A written response used to determine the location within the body associated with an abnormal condition of the body that causes discomfort, dysfunction, or distress to the person affected.","longName":"6043426v1.0:6043427v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A3546D-0A58-4C86-E053-F662850AFD26","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043494","version":"1","preferredName":"Disease Resectable Ind","preferredDefinition":"A response used to determine whether or not an abnormal condition of the body that causes discomfort, dysfunction, or distress to the person affected is capable of being removed by surgery.","longName":"6043432v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A3EB18-4F0E-12CF-E053-F662850AD3A1","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"STARGELM","dateModified":"2019-07-10","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043580","version":"1","preferredName":"Prior mTOR Inhibitor Administered Ind","preferredDefinition":"A response used to determine whether a substance that inhibits mammalian target of rapamycin (mTOR or FK506 binding protein 12-rapamycin associated protein 1 (FRAP1)), a serine/threonine protein kinase that is active in the control of cell growth, cell proliferation, and cell motility was given at an earlier time.","longName":"6043568v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41C79-E191-469D-E053-F662850AEA25","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043581","version":"1","preferredName":"Prior mTOR Inhibitor Administered Type","preferredDefinition":"A response used to determine the type of mTOR inhibitor given at an earlier in time.","longName":"6043568v1.0:2789942v2.1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41BD7-C717-3657-E053-F662850AAD91","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043638","version":"1","preferredName":"Prior mTOR Inhibitor Administered End Date","preferredDefinition":"A response used to determine the date when prior mTOR inhibitor usage ended.","longName":"6043568v1.0:2179511v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41C79-E1BC-469D-E053-F662850AEA25","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043670","version":"1","preferredName":"Prior Sunitinib Administered End Date","preferredDefinition":"A response used to determine the date when prior subitinib usage ended.","longName":"3380280v1.0:2179511v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41C79-E1E4-469D-E053-F662850AEA25","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6043955","version":"1","preferredName":"Prior Strong Protein Kinase Inhibitor Cytochrome Inducer Administered Ind","preferredDefinition":"A response used to determine whether or not a strong protein kinase inhibitor and/or a cytochrome inducer were given at an earlier time.","longName":"6043944v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A47BFF-84D9-4693-E053-F662850AF2FC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044002","version":"1","preferredName":"Prior CYP3A4 Administered End Date","preferredDefinition":"A response used to determine the date when prior CYP3A4 usage ended.","longName":"6044001v1.0:2179511v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41C79-E20F-469D-E053-F662850AEA25","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"MORENOC","dateModified":"2020-04-30","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044248","version":"1","preferredName":"Prior CYP2C19 Administered End Date","preferredDefinition":"A response used to determine the date when prior CYP2C19 usage ended.","longName":"6044184v1.0:2179511v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41BD7-C74F-3657-E053-F662850AAD91","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044283","version":"1","preferredName":"Prior Somatostatin Analog Therapy Administered End Date","preferredDefinition":"A response used to determine the date when prior somatostatin analogue usage ended.","longName":"3913841v1.0:2179511v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A41BD7-C777-3657-E053-F662850AAD91","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044298","version":"1","preferredName":"Prior Somatostatin Analog Therapy Administered Start Date","preferredDefinition":"A response used to determine the date when prior somatostatin analogue usage began.","longName":"3913841v1.0:2179512v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4C3B9-5C17-56DE-E053-F662850A739B","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044388","version":"1","preferredName":"Prior Octreotide Administered Ind","preferredDefinition":"A response used to determine whether or not octreotide was give at an earlier time.","longName":"6044387v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4EC23-EB40-5F62-E053-F662850A5615","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044395","version":"1","preferredName":"Prior Sandostatin Administered Ind","preferredDefinition":"A response used to determine whether or not the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin was given at an earlier time.","longName":"6044391v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4F357-25B1-5FD4-E053-F662850ABD65","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044399","version":"1","preferredName":"Prior Lanreotide Administered Ind","preferredDefinition":"A response used to determine whether or not a synthetic cyclic octapeptide analogue of somatostatin was given earlier in time.","longName":"6044398v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A47BFF-8530-4693-E053-F662850AF2FC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044403","version":"1","preferredName":"Prior Pasireotide Administered Ind","preferredDefinition":"A response used to determine whether or not a synthetic long-acting cyclic peptide with somatostatin-like activity was given earlier in time.","longName":"6044402v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4C3B9-5C6E-56DE-E053-F662850A739B","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044408","version":"1","preferredName":"Somatostatin Analog Therapy Stable Dose Received Ind","preferredDefinition":"A response used to determine whether or not a stable dose of an endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors was reached.","longName":"6044407v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A47BFF-8558-4693-E053-F662850AF2FC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044412","version":"1","preferredName":"Somatostatin Analog Therapy Administration Continuing Ind","preferredDefinition":"A response used to determine whether or not an endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors will continue to be given.","longName":"6044411v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4F357-25D9-5FD4-E053-F662850ABD65","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044560","version":"1","preferredName":"Prior Hepatic Artery Embolization Performed Ind","preferredDefinition":"A response used to determine whether or not a therapeutic procedure involving the injection or deployment of blocking agents in the hepatic artery to treat tumors was performed at an earlier time.","longName":"6044559v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A8B38E-FCC7-1197-E053-F662850AB4B8","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044561","version":"1","preferredName":"Prior Hepatic Artery Embolization Performed Date","preferredDefinition":"A response used to determine the date on which a therapeutic procedure involving the injection or deployment of blocking agents in the hepatic artery to treat tumors was performed.","longName":"6044559v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D674-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044565","version":"1","preferredName":"Prior Hepatic Cryoablation Performed Ind","preferredDefinition":"A response used to determine whether or not a procedure using extreme cold to damage or destroy a part of the liver, it's pathway, or function was performed at an earlier time.","longName":"6044564v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D69C-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044566","version":"1","preferredName":"Prior Hepatic Cryosurgery Performed Date","preferredDefinition":"A response used to determine the date of which a procedure using extreme cold to damage or destroy a part of the liver, it's pathway, or function was performed.","longName":"6044564v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D6C4-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044570","version":"1","preferredName":"Prior Hepatic Radiofrequency Ablation Performed Ind","preferredDefinition":"A response used to determine whether or not a therapeutic procedure to kill tissue using radiowaves to generate heat was performed on the liver at an earlier time.","longName":"6044569v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D721-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044571","version":"1","preferredName":"Prior Hepatic Radiofrequency Ablation Performed Date","preferredDefinition":"A response used to determine the date on which a therapeutic procedure to kill tissue using radiowaves to generate heat was performed on the liver.","longName":"6044569v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D749-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044575","version":"1","preferredName":"Prior Transarterial Chemoembolization Performed Ind","preferredDefinition":"A response used to determine whether or not a hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers was performed at an earlier time.","longName":"6044574v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A94B4C-5EF9-571E-E053-F662850A7A62","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044576","version":"1","preferredName":"Prior Transarterial Chemoembolization Performed Date","preferredDefinition":"A response used to determine the date of which a hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers was performed.","longName":"6044574v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A4C3B9-5CE0-56DE-E053-F662850A739B","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044580","version":"1","preferredName":"Prior Bland Embolization Performed Ind","preferredDefinition":"A response used to determine whether or not a non-chemotherapeutic embolization involving the injection of small particles through a catheter in the hepatic artery was performed at an earlier time.","longName":"6044579v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A74E37-D7A0-6379-E053-F662850A61CC","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044581","version":"1","preferredName":"Prior Bland Embolization Performed Date","preferredDefinition":"A response used to determine the date on which a non-chemotherapeutic embolization involving the injection of small particles through a catheter in the hepatic artery. It is performed to block the blood supply to liver cancer was performed.","longName":"6044579v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A8B38E-FCEF-1197-E053-F662850AB4B8","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044582","version":"1","preferredName":"Prior Therapy Other Administered End Date","preferredDefinition":"A response used to determine the date on which other prior therapy was completed.","longName":"2189782v1.0:2179471v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A8B38E-FD17-1197-E053-F662850AB4B8","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"GARRIDOJ","dateModified":"2017-12-18","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6044587","version":"1","preferredName":"Prior Systemic Therapy Regimen Administered Number","preferredDefinition":"A response to used to determine the number of treatment plans using substances that travel through the bloodstream, reaching and affecting cells all over the body were given at an earlier time.","longName":"6044586v1.0:6044583v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"60A8B38E-FDA1-1197-E053-F662850AB4B8","latestVersionIndicator":"Yes","beginDate":"2017-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-18","modifiedBy":"SOKKERL","dateModified":"2020-04-02","changeNote":"Created for EA2161, 12/18/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6046220","version":"1","preferredName":"Perfusion Computed Tomography Target Lesion Imaging Core Lab Eligibility Confirmation Timepoint Ind","preferredDefinition":"The indicator for questions related to the timepoint when eligibility of a perfusion CT target lesion is confirmed by the imaging core lab.","longName":"PCTTL_ICL_ELIG_CONF_TMPT_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"617E0A65-D008-0250-E053-F662850A06F0","latestVersionIndicator":"Yes","beginDate":"2017-12-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-12-29","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 12/29/17 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6046542","version":"1","preferredName":"Continued Protocol Agent Administration Post Progressive Disease Diagnosis Agreement Ind","preferredDefinition":"A response used to determine whether a participant agreed to the continuation administration of a medical product, practice, or application that is tested in a clinical trial subsequent to the recognition of the presence of a disease process that is increasing in scope or severity.","longName":"6046541v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"61E0E733-6EB5-6981-E053-F662850A52BC","latestVersionIndicator":"Yes","beginDate":"2018-01-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-03","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA5162, 01/03/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6046566","version":"1","preferredName":"Chemoradiotherapy Administration Status","preferredDefinition":"A response used to determine the state of administration of treatment that combines chemotherapy with radiation therapy.","longName":"6046561v1.0:6046562v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"61E303EC-6867-5CFC-E053-F662850A0FFF","latestVersionIndicator":"Yes","beginDate":"2018-01-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-03","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA2165, 01/03/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6047052","version":"1","preferredName":"Clinical Nodal Assessment Status","preferredDefinition":"A response used to indicate the final results of the condition of a node or nodes determined by an examination dependent on direct observation.","longName":"6047046v1.0:6047051v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"61E67E7E-82CE-5389-E053-F662850A84CB","latestVersionIndicator":"Yes","beginDate":"2018-01-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-03","modifiedBy":"ZHWENDY","dateModified":"2023-04-03","changeNote":"Created for EA2165, 01/03/2018 JG","administrativeNotes":"4/3/2023: Added AQT per CADSR0002247.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6047245","version":"1","preferredName":"Therapeutic Procedure Initiation Disease or Disorder Development Timespan Interval","preferredDefinition":"A response used to determine the period of time between the act of starting an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process and the process that involves and promote formation of any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected.","longName":"6047232v1.0:6047234v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F6AB46-667D-4EB7-E053-F662850ABF2E","latestVersionIndicator":"Yes","beginDate":"2018-01-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-04","modifiedBy":"GARRIDOJ","dateModified":"2018-01-17","changeNote":"Created for EA8153, 01/04/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6047482","version":"1","preferredName":"Assessment Not Done Text","preferredDefinition":"A response used to indicate that the final result of a determination of the value, significance, or extent of an examination was not obtained.","longName":"6047478v1.0:2200608v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"62096297-F71D-1FE6-E053-F662850AE299","latestVersionIndicator":"Yes","beginDate":"2018-01-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-05","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for Global Library, 01/05/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6050289","version":"1","preferredName":"Imaging Research Clinical Study Consent Ind","preferredDefinition":"A response used to determine whether permission was given to conduct a systemic investigation using technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.","longName":"6050262v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"625E63C5-5FE8-3F0D-E053-F662850AF818","latestVersionIndicator":"Yes","beginDate":"2018-01-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-09","modifiedBy":"ZHWENDY","dateModified":"2023-04-13","changeNote":"2/6/18 tt released for reuse.  Created for EA8153, 01/09/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053511","version":"1","preferredName":"Tumor High Level MET Amplification Or Other MET Mutations With Predicted Sensitivity To Met Inhibitor Or RET Rearrangement Present Ind","preferredDefinition":"A response used to indicate the presence of benign or malignant tissue growth resulting from uncontrolled cell proliferation or the presence of other changes in the nucleotide sequence of the MET gene with predictive sensitivity different than the one(s) previously speficied or mentioned or the presence of a gene rearrangement involving the RET proto-oncogene.","longName":"6053509v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6323DB81-FAC5-0973-E053-F662850AD368","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA5152, 01/19/2018, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053516","version":"1","preferredName":"Prior Targeted Therapy Administered Ind","preferredDefinition":"A response used to determine whether a type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells was previously given.","longName":"6053514v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6324A481-82F1-774A-E053-F662850A8BA4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"TSESU","dateModified":"2023-05-25","changeNote":"Created for EA5152, 01/19/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053528","version":"1","preferredName":"Person Target Cohort Protocol Treatment Arm Registration Ind","preferredDefinition":"A response used to indicate whether or not an individual was enrolled into a specific treatment plan which consists of a group of individuals identified by a common charateristic being examined within a clinical trial.","longName":"6053526v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6327850C-79BC-2602-E053-F662850AA2C6","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA5152, 01/09/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053532","version":"1","preferredName":"Tumor ROS1 Gene Rearrangement Or MET Exon 14 Splice Mutation Present Ind","preferredDefinition":"A response used to indicate the presence of a molecular abnormality indicating rearrangement of the ROS1 gene of a benign or malignant tissue growth resulting from uncontrolled cell proliferation or the presence of a molecular genetic abnormality indicating the presence of a splice site mutation that results in a loss of transcription of exon 14 of the MET gene.","longName":"6053531v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"63279EB7-CF12-7A81-E053-F662850AB3FA","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA5152, 01/19/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053540","version":"1","preferredName":"PD-L1 IHC Result Status","preferredDefinition":"A response used to determine the whether or not the presense of the programmed cell death 1 ligand 1 (290 aa, ~33 kDa) protein that is encoded by the human CD274 gene was observed by immunohistochemical staining techniques which allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate.","longName":"6053539v1.0:6053533v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"632803CA-836E-2AA6-E053-F662850A2EC4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA5152, 01/19/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059505","version":"1","preferredName":"Bone Assessment Performed Ind-3","preferredDefinition":"A response used to indicate whether or not an examination of connective tissue that forms the skeletal components of the body was completed.","longName":"6059504v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6414C27A-D258-3FCC-E053-F662850AF520","latestVersionIndicator":"Yes","beginDate":"2018-01-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-31","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 1/31/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059514","version":"1","preferredName":"First Assessment Post-Baseline Performed Ind","preferredDefinition":"A response used to indicate whether or not the first evaluation after baseline was completed.","longName":"6059510v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6414C27A-D2E1-3FCC-E053-F662850AF520","latestVersionIndicator":"Yes","beginDate":"2018-01-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-31","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 1/31/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059518","version":"1","preferredName":"Bone Scan Metastatic Disease Present Ind","preferredDefinition":"A response used to determine whether or not the existence of a tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site was observed on a nuclear imaging method used to evaluate pathological bone metabolism.","longName":"6059517v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6414C27A-D309-3FCC-E053-F662850AF520","latestVersionIndicator":"Yes","beginDate":"2018-01-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-31","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 1/31/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059526","version":"1","preferredName":"Metastatic Lesion Present Total Number","preferredDefinition":"A response used to determine the quantity of existing tumors that arose at a location distant the primary lesion.","longName":"6059524v1.0:6059525v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64155D9B-8F8D-3FBE-E053-F662850AA795","latestVersionIndicator":"Yes","beginDate":"2018-01-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-31","modifiedBy":"KENNISHM","dateModified":"2021-08-03","changeNote":"Created for EA8153, 1/31/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059538","version":"1","preferredName":"Laboratory Procedure First Diagnosis Prostate-Specific Antigen Outcome Date","preferredDefinition":"A response used to indicate the particular day, month and year in which the initial result from a procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting recognized the presence of prostate-specific antigen (261 aa, ~29 kDa) encoded by the human KLK3 gene.","longName":"2188821v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"641773D0-255A-449D-E053-F662850ACDDF","latestVersionIndicator":"Yes","beginDate":"2018-01-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-01-31","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 1/30/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059584","version":"1","preferredName":"Castration-Resistant Prostate Carcinoma Development PSA Level Outcome Value","preferredDefinition":"A response used to indicate the numerical quantity result of the concentration of prostate specific antigen in a sample at the time of the formation of prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.","longName":"6059581v1.0:6059577v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64281870-A7D4-6CAF-E053-F662850A3CBE","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-01","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 2/1/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6059592","version":"1","preferredName":"Castration-Resistant Prostate Carcinoma Development PSA Level Outcome Date","preferredDefinition":"A response used to indicate the date on which the result of the concentration of prostate specific antigen in a sample at the time of the formation of prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production was observed.","longName":"6059581v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64281870-A81D-6CAF-E053-F662850A3CBE","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-01","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 2/1/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060050","version":"1","preferredName":"Diagnostic Procedure Electrocardiography QTc Interval Assessment Value","preferredDefinition":"A response used to determine to determine the result value of the time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula obtained from a procedure that records the electrical current in the heart in the form of a continuous strip graph.","longName":"6059602v1.0:2847442v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6478E7B7-5603-0747-E053-F662850A65B0","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060051","version":"1","preferredName":"Diagnostic Procedure Electrocardiography QTc Interval Assessment Ind","preferredDefinition":"A response used to determine whether or not the time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula was assessed through a procedure which records the electrical current in the heart in the form of a continuous strip graph.","longName":"6059602v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6478D222-DD04-77E7-E053-F662850A6105","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060052","version":"1","preferredName":"Diagnostic Procedure Electrocardiography QTc Interval Assessment Date","preferredDefinition":"A response used to determine the date on which a procedure which records the electrical current in the heart in the form of a continuous strip graph was performed and the time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula was observed.","longName":"6059602v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64797435-847B-3D38-E053-F662850A723C","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060064","version":"1","preferredName":"Disease or Disorder Development Diagnosis Date","preferredDefinition":"The response used to determine the date on which the presence of the development of an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected was observed.","longName":"6060063v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64791CD9-7EF6-1506-E053-F662850A2041","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060078","version":"1","preferredName":"Primary Gleason Pattern Assessment Grade Code","preferredDefinition":"A numeric coded response used to determine the score of the most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen which is derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977.","longName":"6063628v1.0:6060077v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BB9FD-62AF-0A7A-E053-F662850A91F4","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060080","version":"1","preferredName":"Secondary Gleason Pattern Assessment Grade Code","preferredDefinition":"A numeric coded response used to determine the score of the second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen which is derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977.","longName":"6063631v1.0:6060077v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647BF251-4586-0A74-E053-F662850A3FBE","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060087","version":"1","preferredName":"Laboratory Procedure PSA Level Performed Date","preferredDefinition":"A response used to determine the date in which a procedure, conducted in a laboratory setting, to find the concentration of prostate specific antigen in a sample was completed.","longName":"6060108v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647C269E-409E-5562-E053-F662850A984D","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"MORENOC","dateModified":"2020-09-21","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060088","version":"1","preferredName":"Laboratory Procedure PSA Level Outcome Value","preferredDefinition":"A response used to determine the a numerical quantity measured result of the concentration of prostate specific antigen in a sample tested in a laboratory setting.","longName":"6060086v1.0:6059577v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647C3713-D040-5F6D-E053-F662850AB3E9","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"MORENOC","dateModified":"2020-09-21","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6060280","version":"1","preferredName":"Laboratory Procedure PSA Level Performed Ind","preferredDefinition":"A response used to determine whether or not a laboratory procedure was done to find the concentration of prostate specific antigen in a sample.","longName":"6060108v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2E9A-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-05","modifiedBy":"CLOHNES","dateModified":"2023-12-12","changeNote":"Created for EA8153, 02/05/18 JG","administrativeNotes":"12/12/23 Added alt OID and AQT for CCTG ticket number CADSR0003182 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062015","version":"1","preferredName":"Prior Adjuvant Therapy Neoadjuvant Therapy Hormone Therapy Administered Ind","preferredDefinition":"A response used to indicate whether or not a therapy which changes a hormone(s) level was previously administered to augment or stimulate other treatment modalities or to minimize or prevent disease recurrence subsequent to the main treatment plan or administered prior to the primary treatment for the purpose of making the primary treatment more effective.","longName":"6061939v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648F3362-CB97-134F-E053-F662850AEE07","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-06","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/06/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062356","version":"1","preferredName":"Docetaxel Total Cycle Complete Count","preferredDefinition":"A response used to indicate the numeric value for the absolute number of cycles of Docetaxel was administered to a patient.","longName":"6062351v1.0:2180126v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64910D20-5A8B-0737-E053-F662850A38ED","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-06","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/06/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062383","version":"1","preferredName":"Prior Therapy Docetaxel Administered End Date","preferredDefinition":"A response used to indicated the date that prior Docetaxel therapy ended.","longName":"4242132v1.0:2179471v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64912B78-DA99-03CB-E053-F662850A9B4C","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-06","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/06/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062407","version":"1","preferredName":"Prior Antiandrogen Therapy Recurrent Disease Metastatic Neoplasm Administered Ind","preferredDefinition":"A response used to determine whether or not treatment with drugs used to block production or interfere with the action of male sex hormones was previously given to treat either the return of a disease after a period of remission or for a tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.","longName":"6062400v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64914CA7-20B0-1506-E053-F662850AEED9","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-06","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/06/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6062410","version":"1","preferredName":"Patient Screening Authorization Informed Consent Ind","preferredDefinition":"The yes/no indicator as to whether informed consent was obtained by the patient to permit screening.","longName":"PT_SCRN_AUZTN_INFCON_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64918FC3-10B2-10A4-E053-F662850A6A72","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-06","modifiedBy":"TAYLORT","dateModified":"2018-11-14","changeNote":"11/14/18 tt released/metrics report. 2/6/18 tt/EAE161.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063531","version":"1","preferredName":"Preventive Therapy Skeletal Related Adverse Event Administered Ind","preferredDefinition":"A response used to determine whether or not therapeutic agents were administered to decrease the chance of having any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that are associated with the framework that supports the soft tissues of vertebrate animals and protects many of their internal organs.","longName":"6063528v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4B28A-3955-6433-E053-F662850A483D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063540","version":"1","preferredName":"Antiandrogen Therapy Discontinued Ind","preferredDefinition":"A response used to determine whether treatment with drugs used to block production or interfere with the action of male sex hormones was stopped.","longName":"6063539v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4B28A-3983-6433-E053-F662850A483D","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063541","version":"1","preferredName":"Antiandrogen Therapy Discontinued Date","preferredDefinition":"A response used to determine the date on which treatment with drugs used to block production or interfere with the action of male sex hormones was stopped.","longName":"6063539v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A47BD5-E6BE-7BC4-E053-F662850AB9D5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063544","version":"1","preferredName":"Laboratory Procedure Lowest Level Prostate-Specific Antigen Result Date","preferredDefinition":"A response used to indicate the date on which a laboratory sample used to determine the value related to the medical procedure that involves the lowest level of a sample of blood serum for a tissue kallikrein-related sequence enzyme used as a biomarker for prostate cancer was obtained.","longName":"2475186v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A58219-9F4C-38E6-E053-F662850A33A7","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063545","version":"1","preferredName":"Prior Hormonal Therapy Administered End Date","preferredDefinition":"A response used to determine the date on which a previously administered treatment that produce the desired therapeutic effect by means of change of hormone/hormones level ended.","longName":"2188728v1.0:2179471v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4A0E2-C98C-0388-E053-F662850A1448","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"ZHWENDY","dateModified":"2023-09-11","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063577","version":"1","preferredName":"Intervention or Procedure Prostate Carcinoma Histologic Confirmation Performed Type","preferredDefinition":"A response used to indicate the procedure used to verify the class of the most common type of malignant tumors afflicting men that arises in the prostate gland by identifying the common qualities in the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","longName":"6063566v1.0:6063562v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4969D-594F-46D4-E053-F662850A8F09","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063594","version":"1","preferredName":"New Malignant Neoplasm Skull Occurrence Ind","preferredDefinition":"A response used to indicate the presences of a tumor composed of atypical neoplastic, often pleomorphic cells that invade the bones that form the head, made up of the bones of the braincase and face that was previously not seen.","longName":"6063593v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A70F67-47A3-530D-E053-F662850A0CBD","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063599","version":"1","preferredName":"New Malignant Thoracic Neoplasm Occurrence Ind","preferredDefinition":"A response used to determine whether or not a new primary or metastaitic neneoplasm affecting the tissues of the thorax.","longName":"6063598v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A70F67-47FB-530D-E053-F662850A0CBD","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063603","version":"1","preferredName":"New Malignant Neoplasm Spine Occurrence Ind","preferredDefinition":"A response used to indicate the presences of a tumor composed of atypical neoplastic, often pleomorphic cells that invade series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone that was previously not seen.","longName":"6063602v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A570E0-B959-417E-E053-F662850A23B7","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063607","version":"1","preferredName":"New Malignant Neoplasm Pelvis Occurrence Ind","preferredDefinition":"A response used to indicate the presences of a tumor composed of atypical neoplastic, often pleomorphic cells that invade the bones that form the head, made up of the bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans that was previously not seen.","longName":"6063606v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A570E0-B9B2-417E-E053-F662850A23B7","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063611","version":"1","preferredName":"New Malignant Neoplasm Limb Occurrence Ind","preferredDefinition":"A response used to indicate the presences of a tumor composed of atypical neoplastic, often pleomorphic cells that invade a body region referring to an upper or lower extremity that was previously not seen.","longName":"6063610v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A7E08E-2651-4AA4-E053-F662850AD065","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063615","version":"1","preferredName":"Malignant Neoplasm Bone Metastatic Involvement Response Status","preferredDefinition":"A response used to indicate the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site of a tumor composed of atypical neoplastic often pleomorphic cells that invade connective tissue that forms the skeletal components of the body.","longName":"2188267v1.1:6063612v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A7E08E-26F0-4AA4-E053-F662850AD065","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063620","version":"1","preferredName":"New Bone Lesion Occurrence Ind","preferredDefinition":"A response used to indicated the presence of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone that was previously not seen.","longName":"6063619v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4969D-597D-46D4-E053-F662850A8F09","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063625","version":"1","preferredName":"Bone Lesion External Spine Pelvis Present Ind","preferredDefinition":"A response used to determine the presence of a localized pathological or traumatic structural change, damage, deformity, or discontinuity located outside of a series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone and the bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.","longName":"6063624v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A81839-1765-616C-E053-F662850AC2C9","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063636","version":"1","preferredName":"Tertiary Gleason Pattern Gleason Grade 5 Outcome Ind","preferredDefinition":"A response used to indicate whether or not results show the prostate carcinoma patterns occupying less than 5% of the tumor lacks gland formation (or with necrosis) with or without poorly formed/fused/cribriform glands.","longName":"6063635v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A3ED7B-595D-5355-E053-F662850A90B3","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/17/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063639","version":"1","preferredName":"Laboratory Procedure PSA Level Outcome Response Status","preferredDefinition":"A response used to indicate the result of a procedure that involves testing a sample of blood to determine the concentration of prostate specific agent in that sample.","longName":"6060086v1.0:2181963v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A70F67-4828-530D-E053-F662850A0CBD","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063642","version":"1","preferredName":"Dose Modification Planned Ind","preferredDefinition":"A response used to determine whether or not a change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.","longName":"6063641v1.0:2015152v3.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A81D08-1F9D-6823-E053-F662850A9E19","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA8153, 02/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063791","version":"1","preferredName":"Protocol Patient Observation Begin Administration Ind","preferredDefinition":"A response used to determine whether the activity of closely watching a patient's condition but not giving treatment, per protocol guidelines, had begun per protocol guidelines.","longName":"6063790v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B6E7BF-EB01-7B4E-E053-F662850A20E3","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-03-02","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063838","version":"1","preferredName":"Personal Medical History Other Renal Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other abnormal conditions of or pertaining to the kidney different than the one(s) previously specified or mentioned.","longName":"6063837v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B6E7BF-EB29-7B4E-E053-F662850A20E3","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063839","version":"1","preferredName":"Personal Medical History Immune System Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of any abnormal condition of the complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease.","longName":"5204856v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B43DB9-D405-5B29-E053-F662850A3CEA","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063843","version":"1","preferredName":"Personal Medical History Other Endocrine Metabolic Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other abnormal conditions of the body of a collective designation for those tissues capable of secreting hormones having to do with metabolism different than the one(s) previously specified or mentioned.","longName":"6063842v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B83EE3-1678-5277-E053-F662850AB0DE","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063848","version":"1","preferredName":"Personal Medical History Other Liver Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other abnormal conditions of a triangular-shaped organ located under the diaphragm in the right hypochondrium different than the one(s) previously specified or mentioned.","longName":"6063847v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B85246-286F-621F-E053-F662850A887A","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063852","version":"1","preferredName":"Personal Medical History Other Diabetes Mellitus Related Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other metabolic disorders characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization different than the one(s) previously specified or mentioned.","longName":"6063851v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B85246-28D2-621F-E053-F662850A887A","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063856","version":"1","preferredName":"Personal Medical History Other Cardiovascular Disease or Disorder Code","preferredDefinition":"A coded response used to determine whether a record of a patient's background regarding health and the occurrence of disease events of the individual indicate a personal medical history of any abnormal condition pertaining to the heart or blood vessels other than the one(s) previously specified or mentioned.","longName":"6063855v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B85246-2932-621F-E053-F662850A887A","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-03-02","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063860","version":"1","preferredName":"Personal Medical History Other Vascular Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other abnormal conditions of the body relating to or containing blood vessels different than the one(s) previously specified or mentioned.","longName":"6063859v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B88E13-80EE-42D7-E053-F662850AE55F","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063866","version":"1","preferredName":"Personal Medical History Other Relevant Disease or Disorder Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of other abnormal conditions of the body or mind in relation of something to the matter at hand that causes discomfort, dysfunction, or distress to the person affected that is different than the one(s) previously specified or mentioned.","longName":"6063864v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B88E13-8116-42D7-E053-F662850AE55F","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6063926","version":"1","preferredName":"Personal Medical History Human Papillomavirus Positive Result Code","preferredDefinition":"A numeric coded response used to determine whether there is a record in the patient's medical history of a positive finding that indicates that human papillomavirus has been detected in a sample.","longName":"6063925v1.0:3385536v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64B92279-D5CC-673E-E053-F662850AE53D","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA2165, 02/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072771","version":"1","preferredName":"Salvage Surgery Performed Ind","preferredDefinition":"A response used to determine whether or not a surgical treatment undertaken after failure of initial surgery or failure of other modalities was completed.","longName":"6072770v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65588716-C3A9-184A-E053-F662850A36B8","latestVersionIndicator":"Yes","beginDate":"2018-02-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-16","modifiedBy":"CLOHNES","dateModified":"2022-06-16","changeNote":"Created for EA2165, 02/16/2018 JG","administrativeNotes":"6/16/22 added alt quest text, alt OID, CCTG, designated to CCTG per Chad Winch cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072772","version":"1","preferredName":"Salvage Surgery Performed Date","preferredDefinition":"A response used to determine the date on which surgical treatment undertaken after failure of initial surgery or failure of other modalities was completed.","longName":"6072770v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6557FF0F-00E1-41FC-E053-F662850A807A","latestVersionIndicator":"Yes","beginDate":"2018-02-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-02-16","modifiedBy":"CLOHNES","dateModified":"2022-06-16","changeNote":"Created for EA2165, 02/16/2018 JG","administrativeNotes":"6/16/22 designated to CCTG, added AQT and alt OID, CCTG for Chad Winch cjl","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113763","version":"1","preferredName":"Intervention or Procedure Echocardiogram Performed Ind","preferredDefinition":"A response used to determine whether or not an activity that produces an image of the heart by ultrasonography was completed.","longName":"6113762v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D24FDC-18E6-68D2-E053-F662850A5FF7","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-07","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6113775","version":"1","preferredName":"Intervention or Procedure MUGA Scan Performed Ind","preferredDefinition":"A response used to determine whether or not a diagnostic test used to evaluate the pumping function of the heart's ventricles was completed.","longName":"6113771v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D7A371-3300-7322-E053-F662850AE4A3","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-07","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115677","version":"1","preferredName":"Laboratory Procedure Urine Dipstick Test Performed Ind","preferredDefinition":"A response used to determine whether or not a procedure which involves using a test strop designed to detect one or more specific substances in urine was completed.","longName":"6113746v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D7BEA4-ACD0-0259-E053-F662850ACCF5","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"ZHWENDY","dateModified":"2024-01-19","changeNote":"Created for EA5152, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115720","version":"1","preferredName":"Intervention or Procedure MUGA Scan LVEF Percentage Value","preferredDefinition":"A response used to indicated the percentage value of the fraction of the left ventricular end diastolic volume ejected with each beat using a diagnostic test used to evaluate the pumping function of the heart's ventricles.","longName":"6115719v1.0:2180234v1.1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D5E613-8757-1B8E-E053-F662850AB166","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2019-05-24","changeNote":"Created for cardiac forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115729","version":"1","preferredName":"Intervention or Procedure MUGA Scan LVEF Lower Limit of Normal Percentage Value","preferredDefinition":"A response used to indicated the lowest percentage value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for the fraction of the left ventricular end diastolic volume ejected with each beat using a diagnostic test used to evaluate the pumping function of the heart's ventricles.","longName":"6115719v1.0:2195809v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D760BF-2971-01B0-E053-F662850A1C9E","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115746","version":"1","preferredName":"Intervention or Procedure Echocardiogram LVEF Percentage Value","preferredDefinition":"A response used to indicated the percentage value of the fraction of the left ventricular end diastolic volume ejected with each beat using an image of the heart produced by ultrasonography.","longName":"6115743v1.0:2180234v1.1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D67E16-C748-7C45-E053-F662850AE881","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"KNABLEJ","dateModified":"2019-05-24","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115748","version":"1","preferredName":"Intervention or Procedure Echocardiogram LVEF Lower Limit of Normal Percentage Value","preferredDefinition":"A response used to indicated the lowest percentage value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for the fraction of the left ventricular end diastolic volume ejected with each beat using an image of the heart produced by ultrasonography.","longName":"6115743v1.0:2195809v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D7BEA4-AD11-0259-E053-F662850ACCF5","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6115761","version":"1","preferredName":"Intervention or Procedure MUGA Scan Performed Date","preferredDefinition":"A response used to indicate the date on which a diagnostic test used to evaluate the pumping function of the heart's ventricles was completed.","longName":"6113771v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66DA10D5-9D61-0D24-E053-F662850A6FFA","latestVersionIndicator":"Yes","beginDate":"2018-03-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-07","modifiedBy":"GARRIDOJ","dateModified":"2018-03-07","changeNote":"Created for cardiac assessment forms, 03/07/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6117939","version":"1","preferredName":"Laboratory Procedure Urine Protein to Creatinine Ratio Measurement Performed Ind","preferredDefinition":"A response used to determine whether or not a procedure that involves testing the fluid that is excreted by the kidney to determine the ratio of total protein compared to creatinine present in a sample was completed.","longName":"6117922v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EC36BD-D282-2414-E053-F662850A4AB8","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6117962","version":"1","preferredName":"Laboratory Procedure Urine Protein to Creatinine Ratio Measurement Performed Date","preferredDefinition":"A response used to indicated the date on which a procedure that involves testing the fluid that is excreted by the kidney to determine the ratio of total protein compared to creatinine present in a sample was completed.","longName":"6117922v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EC3687-BC7D-241C-E053-F662850A39BD","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118077","version":"1","preferredName":"Laboratory Procedure Urine Protein to Creatinine Ratio Measurement Outcome Value","preferredDefinition":"A response used to determine the ratio of total protein compared to creatinine present that was tested from a sample of fluid that is excreted by the kidney.","longName":"6118035v1.0:2183349v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66EC8965-2A1B-21FF-E053-F662850AA364","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-08","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/08/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6118560","version":"1","preferredName":"Malignant Neoplasm Sum Target Lesion Present Count","preferredDefinition":"A response used to determine the final aggregate number of tumors composed of atypical neoplastic, often pleomorphic cells that invade other tissues that are the primary target of the therapeutic intervention.","longName":"6118357v1.0:2018392v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FA82FA-0CF4-086F-E053-F662850A1524","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-09","modifiedBy":"SOKKERL","dateModified":"2023-07-05","changeNote":"Created for EA5152, 03/09/18 JG","administrativeNotes":"5/4/23 :classified and added CTDC ALTname for ECOG/DD. LS","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6120723","version":"1","preferredName":"Metastatic Lymph Node Short Axis Measurement Requirement Met Ind","preferredDefinition":"A response used to determine whether or not the line through and perpendicular to the long axis of a tumor which has extended from it's original site of grown to another anatomic site met a specific size expectation.","longName":"6120152v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6700AB2F-A693-7DD6-E053-F662850AA588","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-09","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/09/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6132320","version":"1","preferredName":"Intervention or Procedure Metastatic Malignant Neoplasm in the Brain Administered Type","preferredDefinition":"A response used to determine the type of intervention or procedure that was used to treat a malignant neoplasm that has spread to the brain from another anatomic site or system.","longName":"6132221v1.0:6132318v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"673924B1-76D9-2687-E053-F662850AB692","latestVersionIndicator":"Yes","beginDate":"2018-03-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-12","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/12/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133436","version":"1","preferredName":"Prior First-Line Therapy Administered Begin Date","preferredDefinition":"A response used to indicate the date on which the preferred standard treatment for a particular condition that was previously given began.","longName":"6133435v1.0:2188673v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"675FD56E-5B29-6A61-E053-F662850A5078","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-14","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/14/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133440","version":"1","preferredName":"Prior First-Line Therapy Administered End Date","preferredDefinition":"A response used to indicate the date on which the preferred standard treatment for a particular condition that was previously given ended.","longName":"6133435v1.0:2179425v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6761B125-62B9-2BB6-E053-F662850A5295","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-14","modifiedBy":"TAYLORT","dateModified":"2022-01-22","changeNote":"Created for EA5152, 03/14/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133445","version":"1","preferredName":"Prior Second-Line Therapy Administered Ind","preferredDefinition":"A response used to determine whether or not the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs was previously given.","longName":"6133444v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67609E43-FA60-2BBE-E053-F662850AAC65","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-14","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/14/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133448","version":"1","preferredName":"Prior Second-Line Therapy Administered Begin Date","preferredDefinition":"A response used to indicate the date on which the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs that previously given began.","longName":"6133444v1.0:2188673v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"675FD56E-5B5E-6A61-E053-F662850A5078","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-14","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/14/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133449","version":"1","preferredName":"Prior Second-Line Therapy Administered End Date","preferredDefinition":"A response used to indicate the date on which the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs that previously given ended.","longName":"6133444v1.0:2179425v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6761A082-6F4C-4C90-E053-F662850AB6B7","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-14","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/14/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133713","version":"1","preferredName":"Prior First-Line Therapy Carboplatin Administered Ind","preferredDefinition":"A response used to determine whether or not a second-generation platinum compound with a broad spectrum of antineoplastic properties was previously given as the preferred standard treatment for a particular condition.","longName":"6133452v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6767CAF5-B598-7E56-E053-F662850AEBB0","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-15","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/15/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6134069","version":"1","preferredName":"Prior First-Line Therapy Cisplatin Administered Ind","preferredDefinition":"A response used to determine whether or not an alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity was previously given as the preferred standard treatment for a particular condition.","longName":"6133455v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"677875DD-FA4D-282C-E053-F662850AF02B","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-15","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/15/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6134076","version":"1","preferredName":"Prior First-Line Therapy Pemetrexed Administered Ind","preferredDefinition":"A response used to determine whether or not a synthetic pyrimidine-based antifolate was previously given as the preferred standard treatment for a particular condition.","longName":"6133458v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6778C947-D402-2890-E053-F662850A6F1D","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-15","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/15/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6134091","version":"1","preferredName":"Prior First-Line Therapy Paclitaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity was previously given as the preferred standard treatment for a particular condition.","longName":"6133461v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6778BBB9-94B8-19E5-E053-F662850A1888","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-15","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/15/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141375","version":"1","preferredName":"Prior First-Line Therapy Bevacizumab Administered Ind","preferredDefinition":"A response used to determine whether or not a recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-androgenic cytokine was previously given as the preferred standard treatment for a particular condition.","longName":"6133472v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C4C81E-66F2-459E-E053-F662850AFD98","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"CARTERS","dateModified":"2021-01-08","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141381","version":"1","preferredName":"Prior First-Line Therapy Docetaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata was previously given as the preferred standard treatment for a particular condition.","longName":"6133475v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C4C81E-671A-459E-E053-F662850AFD98","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141388","version":"1","preferredName":"Prior First-Line Therapy Gemcitabine Administered Ind","preferredDefinition":"A response used to determine whether or not a broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity was previously given as the preferred standard treatment for a particular condition.","longName":"6133490v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C45407-D373-7DFE-E053-F662850A0097","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141389","version":"1","preferredName":"Prior First-Line Therapy Nab-paclitaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity was previously given as the preferred standard treatment for a particular condition.","longName":"6133492v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C48D6F-5EF3-45BC-E053-F662850AD21C","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141394","version":"1","preferredName":"Prior First-Line Therapy Crizotinib Administered Ind","preferredDefinition":"A response used to determine whether or not an orally available aminopyridine-based inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity was previously given as the preferred standard treatment for a particular condition.","longName":"6133495v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C48D6F-5F1B-45BC-E053-F662850AD21C","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141398","version":"1","preferredName":"Prior First-Line Therapy Other Administered Ind","preferredDefinition":"A response used to determine whether or not a therapy different than the ones previously specified was given at an earlier time as the preferred standard treatment for a particular condition.","longName":"6133497v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C4CB4D-9146-72C6-E053-F662850A7F44","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-19","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141659","version":"1","preferredName":"Person Receive Prior Treatment Regimen Containing Bevacizumab Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the prior receipt of any bevacizumab-containing regimen as outlined in the study protocol.","longName":"PRTX_CONTAIN_BEVZB_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C735A3-1ABC-05C2-E053-F662850AB43E","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-19","modifiedBy":"TAYLORT","dateModified":"2021-03-12","changeNote":"11/14/18 tt released/metrics report. 3/19/18 tt/EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141692","version":"1","preferredName":"Person Treatment Plan Immunotherapeutic Agent Administration Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the planned treatment with immunotherapies as outlined in the study protocol.","longName":"TXPLN_IMUTX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C771B3-00CD-3439-E053-F662850A7B3B","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-19","modifiedBy":"KUMMEROA","dateModified":"2023-08-02","changeNote":"11/14/18 tt released/metrics report. 3/19/18 TT/EAF151.","administrativeNotes":"2023.8.2 AQT added per ticket request CADSR0002685. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6141822","version":"1","preferredName":"Person Medical Clearance Immunotherapy Administration And Post Surgery Imaging Confirmed Measurable Residual Disease Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation, as outlined in the study protocol, to address the medical clearance for the administration of immunotherapeutic agents, and the confirmation of measurable residual disease by post-surgery imagining procedures.","longName":"MEDCLR_IMUTX_IMG_CONF_DZ","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67C8C862-C8A4-7302-E053-F662850A25D8","latestVersionIndicator":"Yes","beginDate":"2018-03-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-19","modifiedBy":"TAYLORT","dateModified":"2021-03-12","changeNote":"11/14/18 tt released/metrics report. 3/19/18 tt/EAF151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6144291","version":"1","preferredName":"Prior Second-Line Therapy Carboplatin Administered Ind","preferredDefinition":"A response used to determine whether or not a second-generation platinum compound with a broad spectrum of antineoplastic properties was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133500v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67ECA841-C944-3686-E053-F662850A0705","latestVersionIndicator":"Yes","beginDate":"2018-03-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-21","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/21/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6144292","version":"1","preferredName":"Prior Second-Line Therapy Cisplatin Administered Ind","preferredDefinition":"A response used to determine whether or not an alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133513v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67ECA841-C96C-3686-E053-F662850A0705","latestVersionIndicator":"Yes","beginDate":"2018-03-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-21","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/21/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6144293","version":"1","preferredName":"Prior Second-Line Therapy Pemetrexed Administered Ind","preferredDefinition":"A response used to determine whether or not a synthetic pyrimidine-based antifolate was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133515v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67EB8119-AE0F-3693-E053-F662850AEAA6","latestVersionIndicator":"Yes","beginDate":"2018-03-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-21","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Create for EA5152, 03/21/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6144294","version":"1","preferredName":"Prior Second-Line Therapy Paclitaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133517v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67ECE6D7-4F7D-19FD-E053-F662850A7146","latestVersionIndicator":"Yes","beginDate":"2018-03-21","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-21","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/21/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6145113","version":"1","preferredName":"Prior Second-Line Therapy Bevacizumab Administered Ind","preferredDefinition":"A response used to determine whether or not a recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133674v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68069045-FBCB-5231-E053-F662850AA344","latestVersionIndicator":"Yes","beginDate":"2018-03-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-22","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/22/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148939","version":"1","preferredName":"Prior Second-Line Therapy Docetaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133676v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6852F158-6D59-568D-E053-F662850AFC3D","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-26","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/26/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148946","version":"1","preferredName":"Prior Second-Line Therapy Gemcitabine Administered Ind","preferredDefinition":"A response used to determine whether or not a broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133679v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"685306A0-011C-7944-E053-F662850A89D7","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-26","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/26/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148954","version":"1","preferredName":"Prior Second-Line Therapy Nab-paclitaxel Administered Ind","preferredDefinition":"A response used to determine whether or not a Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133700v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68530C6E-0EA5-4618-E053-F662850ACA27","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-26","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/26/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148955","version":"1","preferredName":"Prior Second-Line Therapy Crizotinib Administered Ind","preferredDefinition":"A response used to determine whether or not an orally available aminopyridine-based inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity was previously given as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133703v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68533F4B-4AC8-51FF-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-26","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/26/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6148956","version":"1","preferredName":"Prior Second-Line Therapy Other Administered Ind","preferredDefinition":"A response used to determine whether or not a therapy different than the ones previously specified was given at an earlier time as the second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133705v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68527B9D-4426-4A2B-E053-F662850A1F5B","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-26","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/26/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6154742","version":"1","preferredName":"Future Pregnancy Intent Ind","preferredDefinition":"A response used to determine whether or not one the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth is anticipated to occur in the future.","longName":"6154736v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"687A867C-91EF-1758-E053-F662850A6312","latestVersionIndicator":"Yes","beginDate":"2018-03-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-28","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for E1Q11, 03/28/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6155928","version":"1","preferredName":"First Dose Additional Prior Therapy Administered Date","preferredDefinition":"A response used to determine the date on which the initial dose of an additional prior therapeutic agent(s) that produced an effect that is intended to alter or stop a pathologic process was administered.","longName":"6155924v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68913A2B-B996-1F2D-E053-F662850A045A","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-29","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/29/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6155929","version":"1","preferredName":"Last Dose Additional Prior Therapy Administered Date","preferredDefinition":"A response used to determine the date on which the final dose of an additional prior therapeutic agent(s) that produced an effect that is intended to alter or stop a pathologic process was administered.","longName":"6155927v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68923BD1-0C25-707E-E053-F662850A75F6","latestVersionIndicator":"Yes","beginDate":"2018-03-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-29","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5152, 03/29/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6156355","version":"1","preferredName":"Prior Therapy Number Treatment Regimen Count","preferredDefinition":"A response used to determine the number of therapeutic agents that were previously administered to produce an effect that is intended to alter or stop a pathologic process.","longName":"6156352v1.0:6156350v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4799D-11C3-51D0-E053-F662850AEBF2","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-30","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeNote":"Created for EA5152, 03/30/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160592","version":"1","preferredName":"Prior First-Line Therapy Administered Agent Name","preferredDefinition":"A response used to determine which therapeutic agents that produced an effect that is intended to alter or stop a pathologic process was previously given as the preferred standard treatment for a particular condition.","longName":"6133435v1.0:2939030v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68EA3C2F-67C8-6F1C-E053-F662850A1B2C","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-03","modifiedBy":"COLLIED","dateModified":"2022-02-22","changeNote":"Created for EA5162, 04/03/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160593","version":"1","preferredName":"Prior Second-Line Therapy Administered Agent Name","preferredDefinition":"A response used to determine which therapeutic agents that produced an effect that is intended to alter or stop a pathologic process was previously given as the  second preferred therapy for a particular condition, used after first-line treatment fails or if a person cannot tolerate first-line drugs.","longName":"6133444v1.0:2939030v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F21174-67F6-6F12-E053-F662850A0CAD","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-03","modifiedBy":"COLLIED","dateModified":"2022-02-22","changeNote":"Created for EA5162, 04/03/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160594","version":"1","preferredName":"Prior Lung Radiation Therapy Administered End Date","preferredDefinition":"A response used to determine the date on which previously given treatment of a disease by means of exposure to radiation of one or both viscera occupying the pulmonary cavities of the thorax (the organs of respiration in which aeration of the blood takes place) ended.","longName":"5983573v1.0:2179425v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68EA1BB0-46EC-195B-E053-F662850A56E5","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-03","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeNote":"Created for EA5162, 04/03/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160598","version":"1","preferredName":"Prior Palliative Radiation Therapy Administered Ind","preferredDefinition":"A response used to determine whether or not any radiation treatment done with the intent to relieve symptoms and reduce the suffering caused by the cancer, and not with the intent of curing the cancer was previously given.","longName":"6160597v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F2C584-256F-07E1-E053-F662850A81C9","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-03","modifiedBy":"COBARRUBIAK","dateModified":"2020-10-09","changeNote":"Created for prior therapy forms, 04/03/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6160599","version":"1","preferredName":"Prior Palliative Radiation Therapy Administered End Date","preferredDefinition":"A response used to determine the date on which any previously given radiation treatment done with the intent to relieve symptoms and reduce the suffering caused by the cancer, and not with the intent of curing the cancer ended.","longName":"6160597v1.0:2179425v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68E9BE63-694C-083C-E053-F662850A717E","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-03","modifiedBy":"CLOHNES","dateModified":"2022-08-11","changeNote":"Created for EA5162, 04/03/2018 JG","administrativeNotes":"8/10/22 added AQT for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6161033","version":"1","preferredName":"Clinical Study Protocol Planned Treatment Regimen Stratification Type","preferredDefinition":"A response used to indicate which devised treatment plan from the formal document that describes a complete plan of research activity in the framework of a clinical study to which a patient is assigned through the process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","longName":"3630989v1.0:6161027v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6905D8F2-E3AB-0F23-E053-F662850AF6FD","latestVersionIndicator":"Yes","beginDate":"2018-04-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-04-04","modifiedBy":"GARRIDOJ","dateModified":"2021-06-25","changeNote":"Created for EA2165 OPEN checklist, 04/04/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6260947","version":"1","preferredName":"Additional Participating Clinical Study Site Name","preferredDefinition":"A response used to determine the name of an added organization that is participating in activities conducted in a framework of a particular clinical trial.","longName":"6041590v1.0:6260946v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3F48C6-2BDC-271A-E053-F662850ACD44","latestVersionIndicator":"Yes","beginDate":"2018-05-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-05-03","modifiedBy":"GARRIDOJ","dateModified":"2018-05-03","changeNote":"Created for OPEN Checklist. 05/03/2018 - JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6261233","version":"1","preferredName":"Performing Laboratory Name","preferredDefinition":"A response used to identify which laboratory provided analysis of samples collected in clinical care or research.","longName":"2555508v1.0:5406151v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B5162AD-FEB5-26CF-E053-F662850ADBDA","latestVersionIndicator":"Yes","beginDate":"2018-05-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-05-03","modifiedBy":"GARRIDOJ","dateModified":"2018-05-03","changeNote":"Created for MATCH OPEN checklist. 05/03/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6270782","version":"1","preferredName":"Radiation Therapy Early Discontinue Reason Code","preferredDefinition":"A coded response used to determine whether treatment of disease by means of exposure of the target or the whole body to radiation was stopped early.","longName":"6063952v1.0:6270775v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BB5B49A-0A35-6FF2-E053-F662850A24AC","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-05-08","modifiedBy":"GARRIDOJ","dateModified":"2018-05-08","changeNote":"Created for EA2165, 02/09/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6279939","version":"1","preferredName":"Disease or Disorder Intervention or Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to activities that produce an effect, or intended to alter the course of a disease in a patient.","longName":"DZ_INTPRO_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C30DC80-C3E9-625B-E053-F662850A116E","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released. 5/14/18 tt/EA8171.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6279947","version":"1","preferredName":"Orthopedic Surgical Procedure Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicate to determine clinical trial eligibility for questions related to any surgical procedure to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.","longName":"ORTHO_SGY_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C30D772-0618-75A1-E053-F662850A40FF","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"TAYLORT","dateModified":"2018-11-15","changeNote":"11/15/18 tt released/review of metrics report. 5/14/18 tt/EA8171.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6280959","version":"1","preferredName":"Patient Gender Age Disease Intervention Clinical Trial Eligibility Criteria Ind","preferredDefinition":"The indicator to determine clinical trial participation for questions related to patient gender, age, abnormal conditions of the body or mind, and activities that produce an effect (or intended to alter the course of disease), as outlined in the eligibility criteria of the protocol.","longName":"PT_GEN_AGE_DZ_INTV_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C3F127F-F35A-4FC3-E053-F662850A0D72","latestVersionIndicator":"Yes","beginDate":"2018-05-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-15","modifiedBy":"TAYLORT","dateModified":"2019-07-26","changeNote":"11/14/18 tt released/metrics report. 5/15/18 tt/EA8171.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6333898","version":"1","preferredName":"Adult Female Premenopausal Perimenopausal Ind","preferredDefinition":"A yes or no response used to indicate that an adult female's menopausal status is at the time before menopause or at the time when menstrual periods become irregular as she approaches menopause.","longName":"6333892v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E737E36-6D62-3738-E053-F662850A0B1B","latestVersionIndicator":"Yes","beginDate":"2018-06-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-06-12","modifiedBy":"TSESU","dateModified":"2023-06-06","changeNote":"Created for E2112 - 06/12/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6336227","version":"1","preferredName":"Protocol Treatment Arm Minimum Cycle Completed Ind","preferredDefinition":"A response used to indicate whether or not the smallest possible quantity of cycles of a specific treatment plan within a clinical trial was completed.","longName":"6336222v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F045A58-1B1E-4738-E053-F662850A1417","latestVersionIndicator":"Yes","beginDate":"2018-06-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-06-19","modifiedBy":"GARRIDOJ","dateModified":"2018-06-20","changeNote":"Created for E1A11, 06/19/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6355951","version":"1","preferredName":"Tumor Histologic Subtype Specify","preferredDefinition":"A response used to clearly define the subtype of combined microscopic physical features of cells and their surrounding extracellular environment in benign or malignant tissue growth resulting from uncontrolled cell proliferation.","longName":"2830866v1.0:5566342v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70E18366-56D8-0FB8-E053-F662850A5088","latestVersionIndicator":"Yes","beginDate":"2018-07-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-07-13","modifiedBy":"GARRIDOJ","dateModified":"2018-07-13","changeNote":"CDE created to replace retired - archived CDE 4723273. 07/12/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6356060","version":"1","preferredName":"External Healthcare Facility Clinical Study Data Element Collection Submission Agreement Ind","preferredDefinition":"A response used to determine whether or not an outside organization where healthcare services are provided has agreed to gather and submit data elements associated with a clinical trial.","longName":"6356058v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70E6E066-56CC-09DF-E053-F662850A68FE","latestVersionIndicator":"Yes","beginDate":"2018-07-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-07-13","modifiedBy":"GARRIDOJ","dateModified":"2018-07-16","changeNote":"Created for EA4151 OPEN Checklist, 07/13/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6356095","version":"1","preferredName":"Clinical Trial Data Collection Contact Person Name","preferredDefinition":"A text response used to identify the person acting as a channel of communication between groups that with be gathering data for testing or research purposed for a research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","longName":"6356094v1.0:5406151v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70E582A0-E5BA-2E7B-E053-F662850AC46D","latestVersionIndicator":"Yes","beginDate":"2018-07-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-07-13","modifiedBy":"SHEARMA","dateModified":"2019-03-11","changeNote":"Created for EA4151 OPEN Checklist, 07/13/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6381229","version":"1","preferredName":"Informed Consent Version Signed Type","preferredDefinition":"A response used to determine which the variant of form that documents the consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved was signed.","longName":"6381008v1.0:6381024v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"726585E3-9631-52F2-E053-F662850A716D","latestVersionIndicator":"Yes","beginDate":"2018-08-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5161, 08/01/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6400794","version":"1","preferredName":"Patient New Malignant Neoplasm Diagnosis And Intervention or Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The indicator to determine patient eligibility for clinical trial participation for questions related to newly diagnosed cancer and any activities that produce an effect, or intended to alter the course of a disease in a patient or population, as outlined in the protocol.","longName":"NEW_CA_DX_INTVPR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7378B7A5-46A5-2030-E053-F662850A0558","latestVersionIndicator":"Yes","beginDate":"2018-08-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"TAYLORT","dateModified":"2018-11-13","changeNote":"8-15-18 Protocol EAQ162CD; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6404432","version":"1","preferredName":"Disease Pathologic Stage Grouping Stratification Factor Type","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on the pathologic assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6404342v1.0:6404393v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E2376A-47AB-0FEA-E053-F662850A527E","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-20","modifiedBy":"SOKKERL","dateModified":"2023-06-12","changeNote":"Created for EA6174 and future studies, 08/20/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6421694","version":"1","preferredName":"Upper Gastrointestinal Tract Neoplasm Histologic Grade Code","preferredDefinition":"A coded response used to determine the degree of abnormality of cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type of malignant tissue growth located in the upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","longName":"6421685v1.0:6421677v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7480E137-A5DD-0EA8-E053-F662850A2C87","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/28/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6421741","version":"1","preferredName":"Upper Gastrointestinal Tract Neoplasm Histologic Type","preferredDefinition":"A response used to indicate the histologic type of malignant tissue growth located in the upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.","longName":"6421735v1.0:6421737v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7483255E-E691-0AD2-E053-F662850A2F8F","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-28","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/28/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6422498","version":"1","preferredName":"First Recurrent Disease Diagnosis Ind","preferredDefinition":"A response used to determine whether a diagnosis of the first reemergence of a disease after a period of remission was made.","longName":"6422497v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7493217B-9F64-4297-E053-F662850AA270","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-29","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for recurrence Disease F/U Status form, 08/29/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6422804","version":"1","preferredName":"Recurrent Disease Confirmation Method Type","preferredDefinition":"A response used to determine the means, manner of procedure, or systematic course of actions that have to be performed in order to verify the reemergence of a disease after a period of remission.","longName":"6422800v1.0:6422802v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7498CA1C-6F48-6C2F-E053-F662850A3978","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-29","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/28/2018, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423015","version":"1","preferredName":"Current Therapy Autoimmune Disease Administration Ind","preferredDefinition":"A response used to determine whether or not therapeutic agents are currently being administered to produce an effect that is intended to alter or stop a pathologic process of a condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","longName":"6423014v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BB9ABF-F76A-3F56-E053-F662850AB0C8","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"ZHWENDY","dateModified":"2022-06-24","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423025","version":"1","preferredName":"Gastrointestinal Tract Primary Tumor Location Site","preferredDefinition":"A response used to indicate the anatomic position of the primary gastrointestinal tract tumor.","longName":"6423019v1.0:6423022v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC6737-C28D-402C-E053-F662850AED6E","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423034","version":"1","preferredName":"Regional Lymph Node Disease Present Ind-3","preferredDefinition":"A response used to indicate if any abnormal condition of a lymph node that drains lymph from a region of interest exists.","longName":"6423030v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BCF680-353B-45D5-E053-F662850A361B","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA 2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423042","version":"1","preferredName":"Other Anatomic Site Disease Present Ind-3","preferredDefinition":"A response used to indicate if any abnormal condition exists within the body different than the one(s) previously specified.","longName":"6423041v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC6B80-B04B-4443-E053-F662850A2505","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423114","version":"1","preferredName":"Positron Emission Tomography and Computed Tomography Scan Performed Ind","preferredDefinition":"A response used to indicate whether or not an imaging technique that utilizes positron emission tomography and computed tomography in a single machine was performed.","longName":"6423049v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC6B80-B08A-4443-E053-F662850A2505","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423115","version":"1","preferredName":"Positron Emission Tomography Performed Ind","preferredDefinition":"A response used to indicated whether or not a technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue was performed.","longName":"6423047v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BBC0E7-206D-21C8-E053-F662850A14C0","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423116","version":"1","preferredName":"Computed Tomography Performed Ind","preferredDefinition":"A response used to indicate whether or not a method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis was performed.","longName":"6423098v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BD1DFD-42CE-44DE-E053-F662850A95E3","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2018-11-12","changeNote":"Created for EA2174, 08/31/2018, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423117","version":"1","preferredName":"Magnetic Resonance Imaging Performed Ind","preferredDefinition":"A response used to indicate whether or not imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues was performed.","longName":"6423103v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BBC0E7-209B-21C8-E053-F662850A14C0","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423119","version":"1","preferredName":"Other Assessment Method Performed Date","preferredDefinition":"A response used to determine the date on which an assessment method different than the one(s) previously specified was performed.","longName":"5544961v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BB9FB0-F6E7-3F63-E053-F662850A0C3A","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423120","version":"1","preferredName":"Positron Emission Tomography Performed Date","preferredDefinition":"A response used to indicate the date on which a technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue was performed.","longName":"6423047v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BCAC57-515F-50BF-E053-F662850A12EF","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423121","version":"1","preferredName":"Positron Emission Tomography and Computed Tomography Scan Performed Date","preferredDefinition":"A response used to indicate the date on which an imaging technique that utilizes positron emission tomography and computed tomography in a single machine was performed.","longName":"6423049v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC1F55-A474-3F51-E053-F662850AE9A3","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423151","version":"1","preferredName":"Recurrent Disease Peritoneum Present Ind","preferredDefinition":"A response used to indicate whether or not disease in the tissue that lines the wall of the abdominal cavity, intestine, and mesentery has returned after a period of remission.","longName":"6423150v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74C11EA8-DE37-4158-E053-F662850AA8B8","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423171","version":"1","preferredName":"Recurrent Disease Regional Lymph Node Present Ind","preferredDefinition":"A response used to indicate whether or not disease in a lymph node that drains lymph from a region of interest has returned after a period of remission.","longName":"6423170v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BCAC57-51C0-50BF-E053-F662850A12EF","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423177","version":"1","preferredName":"Recurrent Disease Bone Present Ind","preferredDefinition":"A response used to indicate whether or not disease in connective tissue that forms the skeletal components of the body has returned after a period of remission.","longName":"6423174v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC3A5E-E14E-3F5E-E053-F662850A28F4","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423197","version":"1","preferredName":"Recurrent Disease Anastomosis Present Ind","preferredDefinition":"A response used to indicate whether or not disease in a natural or surgically-induced connection between tubular structures in the body has returned after a period of remission.","longName":"6423196v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BC24CA-4EA1-3F67-E053-F662850ACC64","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423201","version":"1","preferredName":"Recurrent Disease Remnant Gastrointestinal Tract Present Ind","preferredDefinition":"A response used to indicate whether or not disease in the remnant gastrointestinal tract has returned after a period of remission.","longName":"6423200v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74BCF680-358C-45D5-E053-F662850A361B","latestVersionIndicator":"Yes","beginDate":"2018-08-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-08-31","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 08/31/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423267","version":"1","preferredName":"Recurrent Disease Identification Type","preferredDefinition":"A response used to determine the type of procedure used to identify the return of a disease after a period of remission.","longName":"6423244v1.0:6423251v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750CD75C-A4AB-616C-E053-F662850AB4C7","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-04","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/04/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423276","version":"1","preferredName":"Study Subject Registration Ind","preferredDefinition":"A response used to indicate whether or not an individual that is observed and/or treated in the course of a particular study has been officially enrolled.","longName":"6423274v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750D194C-2A31-1B90-E053-F662850A2216","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-04","modifiedBy":"CLOHNES","dateModified":"2022-10-18","changeNote":"Created for Step Confirmation Form, 09/04/2018 JG","administrativeNotes":"10/18/22 Added 2 AQT and an alt OID, CCTG for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423305","version":"1","preferredName":"Surgical Excision Performed Date","preferredDefinition":"A response used to indicate the particular day, month and year in which the surgical removal of a part or all of a structure or organ was completed.","longName":"2014214v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750D66F7-A0C6-0671-E053-F662850A7FE1","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-04","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/04/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6423307","version":"1","preferredName":"Surgical Procedure Complete Excision Performed Ind","preferredDefinition":"A response used to indicate whether or not the surgical removal of an entire structure or organ was completed.","longName":"6423304v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750D8377-296B-5C6C-E053-F662850A7AEB","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-04","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/04/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6424003","version":"1","preferredName":"Recurrent Disease Pleural Cavity And/Or Pleural Effusion Present Ind","preferredDefinition":"A response used to indicate whether or not disease has returned in the cavity lined by the lined by the pleura, located in the thorax and contains heart and lungs and/or the increased amounts of fluid within the pleural cavity after a period of remission.","longName":"6424002v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7523F328-5706-60A1-E053-F662850A51BD","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-05","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/05/2015 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6424133","version":"1","preferredName":"Gastroesophageal Junction Adenocarcinoma Siewert Classification Type","preferredDefinition":"A response used to determine the anatomical classification of adenocarcinomas of the esophagogastric junction.","longName":"6424126v1.0:6424128v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7533E727-D8FE-2CC1-E053-F662850AFD39","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425395","version":"1","preferredName":"Intervention or Procedure Lymph Leakage Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which the loss of lymph into the surrounding tissue or body cavity occurred during or as a result of an intervention or a procedure.","longName":"6425386v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538D96D-9CEF-345D-E053-F662850ADFC6","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425410","version":"1","preferredName":"Intervention or Procedure Vocal Cord Paralysis Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which paralysis of the muscles of one or both vocal cords occurred during or as a result of an intervention or a procedure.","longName":"6425401v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538D0F2-1ADD-3457-E053-F662850A5D55","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425414","version":"1","preferredName":"Intervention or Procedure Hemorrhage Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which the flow of blood from a ruptured blood vessel occurred during or as a result of an intervention or a procedure.","longName":"6425412v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538D96D-9D69-345D-E053-F662850ADFC6","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425418","version":"1","preferredName":"Intervention or Procedure Pneumothorax Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which an abnormal presence of air in the pleural cavity occurred during or as a result of an intervention or a procedure.","longName":"6425417v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7536F9FD-225A-7B4D-E053-F662850AF9C8","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425422","version":"1","preferredName":"Surgical Procedure Pleural Effusion Intervention Required Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which increased amounts of fluid within the pleural cavity occurred during or as a result of a procedure that required action or ministration whose purpose is to improve health or to alter the course of a disease is considered essential and mandatory in order to prevent permanent impairment or damage.","longName":"6425421v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538D0F2-1B15-3457-E053-F662850A5D55","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425426","version":"1","preferredName":"Intervention or Procedure Arrhythmia Occurrence Ind","preferredDefinition":"A response used indicate whether or not an incident in which any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart occurred during or as a result of an intervention or a procedure.","longName":"6425425v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7538D0F2-1B3D-3457-E053-F662850A5D55","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6425442","version":"1","preferredName":"Intervention or Procedure Renal Failure Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which an acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood occurred during or as a result of an intervention or a procedure.","longName":"6425440v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"753A1F66-64D5-5201-E053-F662850A9F00","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6427562","version":"1","preferredName":"Patient Current Malignant Neoplasm Prior Radiation Therapy Administered Ind-3","preferredDefinition":"A response used to determine whether or not a current malignant neoplasm(s) was previously treated by means of exposure of the target or the whole body to radiation.","longName":"6426276v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7549981E-15B8-2D58-E053-F662850A0CED","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6427688","version":"1","preferredName":"Patient Other Malignant Neoplasm Prior Radiation Therapy Administered Ind-3","preferredDefinition":"A response used to determine whether or not a malignant neoplasm(s) different than the one(s) previously specified was previously treated by means of exposure of the target or the whole body to radiation.","longName":"6427682v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"754B712E-0331-0DD2-E053-F662850A213D","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6427784","version":"1","preferredName":"Patient Current Malignant Neoplasm Prior Chemotherapy Administered Ind-3","preferredDefinition":"A response used to determine whether or not a current malignant neoplasm(s) was previously treated with synthetic or naturally-occurring chemicals.","longName":"6427759v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"754BA707-571F-30B2-E053-F662850AAC62","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428083","version":"1","preferredName":"Patient Current Malignant Neoplasm Prior Immunotherapy Administered Ind-3","preferredDefinition":"A response used to determine whether or not a current malignant neoplasm(s) was previously managed with a treatment to boost or restore the ability of the immune system to fight this cancer.","longName":"6428082v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"754C76E3-41D8-60FF-E053-F662850A9FCD","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428087","version":"1","preferredName":"Prior Surgical Procedure Esophageal Gastric Performed Ind-3","preferredDefinition":"A response used to determine whether or not a surgery related to the esophagus or stomach was previously performed.","longName":"6428086v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75495C24-2102-25E2-E053-F662850A7F5D","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428091","version":"1","preferredName":"Prior Radiation Therapy Total Dose Administered Value","preferredDefinition":"A response used to determine the full quantity of treatment of a disease by means of exposure of the target or the whole body to radiation that was previously given.","longName":"6428090v1.0:2834340v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"754D1136-5D11-653E-E053-F662850AF42B","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/07/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428130","version":"1","preferredName":"Intervention or Procedure Other Complication Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident in which any disease or disorder different than the ones previously specified occurred during or as a result of an intervention or a procedure.","longName":"6428129v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75843197-AF1E-7ABD-E053-F662850A55F5","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/10/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428137","version":"1","preferredName":"Surgical Procedure Perioperative Death Occurrence Ind","preferredDefinition":"A response used to indicate whether or not death occurred during of or as a result of surgery.","longName":"6428136v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7585DF21-9B4A-02DE-E053-F662850A7D09","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/10/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6428493","version":"1","preferredName":"Esophagectomy Surgical Approach Performed Type","preferredDefinition":"A response used to indicate which type of procedure was performed to surgically remove part or all of the esophagus.","longName":"6428411v1.0:6428414v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75895610-41F5-51BF-E053-F662850AC05D","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/10/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429256","version":"1","preferredName":"Surgical Procedure Complete Excision Not Performed Reason","preferredDefinition":"A response used to provide an explanation as to why the entire structure or organ was not surgically removed.","longName":"6423312v1.0:6423314v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"758A7B75-BFD3-5C9F-E053-F662850A7563","latestVersionIndicator":"Yes","beginDate":"2018-09-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/10/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6429988","version":"1","preferredName":"Metastatic Neoplasm Pathology Confirmation Date","preferredDefinition":"A response used to indicate the date on which metastatic disease was pathologically confirmed.","longName":"6429937v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"75C6F7BD-D243-4C6D-E053-F662850A00E6","latestVersionIndicator":"Yes","beginDate":"2018-09-13","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-13","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/13/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430422","version":"1","preferredName":"Surgical Procedure Malignant Neoplasm Surgical Margin Outcome","preferredDefinition":"A response used to indicate a positive or negative result of the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","longName":"3242130v1.0:6204963v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76125CDC-60D8-640B-E053-F662850AB796","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430429","version":"1","preferredName":"Stable Disease Response Observed Date","preferredDefinition":"A response used to indicate the date on which the pathologic and/or clinical result from treatment shows that there is a neither decreasing nor increasing extent or severity observed in the disease.","longName":"6430427v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7612632E-87A4-6414-E053-F662850AEE51","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430433","version":"1","preferredName":"Disease Progression Response Observed Date","preferredDefinition":"A response used to indicate the date on which the pathologic and/or clinical result from treatment shows that the disease is worsening.","longName":"6430432v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"761249B2-8D7E-6410-E053-F662850A34D5","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2018-11-12","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430438","version":"1","preferredName":"Clinical Response Observed Date","preferredDefinition":"A response used to indicate the date on which a clinical response of the disease to therapy was observed.","longName":"6430437v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76138860-472E-4D53-E053-F662850A77E9","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2018-11-12","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430453","version":"1","preferredName":"Intervention or Procedure Esophageal Anastomotic Leakage Occurrence Ind","preferredDefinition":"A response used to indicate whether or not leakage due to breakdown of an esophageal anastomosis occurred during or as a result of an intervention or a procedure.","longName":"6430451v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76140A1E-2919-67D1-E053-F662850A1759","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430457","version":"1","preferredName":"Intervention or Procedure Esophageal Anastomosis Stenosis Occurrence Ind","preferredDefinition":"A response used to indicate whether or not narrowing or stricture of a vessel an esophageal anastomosis occurred during or as a result of an intervention or a procedure.","longName":"6430456v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7613EDFC-C313-6B4F-E053-F662850AD91F","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430480","version":"1","preferredName":"Malignant Primary Neoplasm Esophageal or Gastroesophageal Junction Disease Response Status","preferredDefinition":"A response used to indicate the pathologic and/or clinical changes that result from treatment observed in a malignant tumor which originated in either the esophagus or gastroesophageal junction.","longName":"6430476v1.0:6430468v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7615B407-4BB8-2A59-E053-F662850A8D0F","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430481","version":"1","preferredName":"Malignant Neoplasm Regional Lymph Node Disease Response Status","preferredDefinition":"A response used to indicate the pathologic and/or clinical changes that result from treatment observed in a malignant tumor(s) located in a regional lymph node(s).","longName":"6430479v1.0:6430468v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7615CF6D-424C-26DA-E053-F662850AB48A","latestVersionIndicator":"Yes","beginDate":"2018-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6430674","version":"1","preferredName":"Intervention or Procedure Acute Respiratory Distress Syndrome Acute Lung Injury Occurrence Ind","preferredDefinition":"A response used to indicate whether or not an incident occurred in which there was a progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition or a finding of acute onset of bilateral pulmonary infiltrates by chest radiograph and a PaO2/FiO2 of less than or equal to 300, in the absence of heart failure, during or as a result of an intervention or a procedure.","longName":"6430673v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76170640-1D51-315B-E053-F662850A3EDA","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2174, 09/18/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438406","version":"1","preferredName":"Patient Study Site Confirmation Intervention or Procedure Payment Or Insurance Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a subject to participate in a clinical study that address site confirmation of payments or insurance, as outlined in the study protocol, for an activity that produces an effect or intended to alter the course of a disease in a patient or population.","longName":"SITE_CONF_INTPROC_PAY_INSR","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C784A9-775E-626E-E053-F662850ACECE","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-26","modifiedBy":"TAYLORT","dateModified":"2019-08-12","changeNote":"11/15/18 tt released. 9/26/18 tt/EA8171.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6438415","version":"1","preferredName":"Patient Intervention or Procedure Payment Or Insurance Confirmation Receive Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A response to questions which are necessary to allow a subject to participate in a clinical study that address the confirmation of receipt for payments or insurance, as outlined in the study protocol, for an activity that produces an effect or intended to alter the course of a disease in a patient or population.","longName":"INTPROC_PAY_INSR_CONF_RECV","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C72E8B-3D33-6330-E053-F662850A424C","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-26","modifiedBy":"TAYLORT","dateModified":"2019-07-26","changeNote":"11/15/18 tt released. 9/26/18 tt/EA8171.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6471129","version":"1","preferredName":"Diagnosis Biopsy Confirmation Ind","preferredDefinition":"A response used to indicate whether or not the diagnosis of a disease, condition, or injury was verified via a microscopic examination of tissue specimens or fluid removed from the living body.","longName":"6471125v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77B903DC-5195-6DF6-E053-F662850A432F","latestVersionIndicator":"Yes","beginDate":"2018-10-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-08","modifiedBy":"GARRIDOJ","dateModified":"2018-11-12","changeNote":"Created for EA8143, 10/08/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6471337","version":"1","preferredName":"Oligometastasis Present Ind","preferredDefinition":"A response used to indicate whether or not a type of metastasis in which cancer cells from the original (primary) tumor travel through the body and form a small number of new tumors (metastatic tumors) in one or two other parts of the body is present.","longName":"6471336v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"77B9D5D7-05FF-3C28-E053-F662850A0BF3","latestVersionIndicator":"Yes","beginDate":"2018-10-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-08","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8143, 10/08/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6488203","version":"1","preferredName":"Imaging Technique Chest X-Ray Performed Ind","preferredDefinition":"A response used to indicate whether or not an x-ray examination of the chest for use in screening, diagnosis, surgical procedures or therapy was completed.","longName":"6486825v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786DBEE8-2945-1A43-E053-F662850AA396","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6174, 10/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6488204","version":"1","preferredName":"Imaging Technique Chest X-Ray Performed Date","preferredDefinition":"A response used to indicated the date on which an x-ray examination of the chest for use in screening, diagnosis, surgical procedures or therapy was completed.","longName":"6486825v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786C3DC6-57E5-1A3F-E053-F662850A3B2F","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6174, 10/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6488209","version":"1","preferredName":"Head and Neck CT Scan Performed Ind","preferredDefinition":"A response used to indicate whether or not a method of examining an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis was completed.","longName":"6488208v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786DA1EB-773A-035A-E053-F662850A13A0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6174, 10/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6488210","version":"1","preferredName":"Head and Neck CT Scan Performed Date","preferredDefinition":"A response used to indicated the date on which a method of examining an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis was completed.","longName":"6488208v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786DA1EB-7768-035A-E053-F662850A13A0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-10-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6174, 10/17/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6548510","version":"1","preferredName":"Chromosomal Abnormality Stratification Factors Type","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on an irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","longName":"6547594v1.0:6548498v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A033AAD-C00C-4961-E053-F662850AEA66","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-11-06","modifiedBy":"GARRIDOJ","dateModified":"2018-11-12","changeNote":"Created for EA9161, 11/06/2018 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6602145","version":"1","preferredName":"Patient Bilateral Oophorectomy Occurrence Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The indicator to address the surgical removal of both ovaries, as outlined in the study protocol, to determine patient eligibility for clinical trial participation.","longName":"BIL_OOPH_OCUR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EA3E84B-BC3A-78D7-E053-F662850A8E6A","latestVersionIndicator":"Yes","beginDate":"2019-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-04","modifiedBy":"TAYLORT","dateModified":"2019-01-07","changeNote":"1/4/19 tmt created for EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6602150","version":"1","preferredName":"Bilateral Oophorectomy Occurrence Age Number","preferredDefinition":"The number that represents the age when surgical removal of both ovaries occurred.","longName":"BIL_OOPH_AGE_NUM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EA39091-B707-78D3-E053-F662850A95AB","latestVersionIndicator":"Yes","beginDate":"2019-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-04","modifiedBy":"TAYLORT","dateModified":"2019-01-07","changeNote":"1/4/19 tmt created for EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6602154","version":"1","preferredName":"Endometrial Ablation Occurrence Age Number","preferredDefinition":"The number that represents the age when endometrial ablation occurred.","longName":"ENDML_ABLN_AGE_NUM","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EA3E84B-BC63-78D7-E053-F662850A8E6A","latestVersionIndicator":"Yes","beginDate":"2019-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-04","modifiedBy":"TAYLORT","dateModified":"2019-01-07","changeNote":"1/4/19 tmt created for EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6602158","version":"1","preferredName":"Patient Endometrial Ablation Occurrence Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The indicator to address endometrial ablation therapy, as outlined in the study protocol, to determine patient eligibility for clinical trial participation.","longName":"ENDML_ABLN_OCUR_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EA3E84B-BC8A-78D7-E053-F662850A8E6A","latestVersionIndicator":"Yes","beginDate":"2019-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-04","modifiedBy":"TAYLORT","dateModified":"2019-01-07","changeNote":"1/4/19 tmt created for EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6602234","version":"1","preferredName":"Patient Breast Benign Biopsy Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The indicator to address benign biopsy results of the breast, as outlined in the study protocol, to determine patient eligibility for clinical trial participation.","longName":"BRST_BNGN_BX_DX_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EA4C097-0633-78E4-E053-F662850AE57B","latestVersionIndicator":"Yes","beginDate":"2019-01-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-04","modifiedBy":"TAYLORT","dateModified":"2019-01-07","changeNote":"1/4/19 tmt created for EA1151.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6609901","version":"1","preferredName":"Imaging Technique Research Activity Clinical Study Consent Ind-3","preferredDefinition":"A response used to determine whether permission was given to conduct a systemic investigation using technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered or a clinical trial site is not participating due to lack of credentialing.","longName":"6050262v1.0:6609886v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F728F3D-0F37-4FEC-E053-F662850ABC85","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-01-14","modifiedBy":"GARRIDOJ","dateModified":"2020-10-06","changeNote":"Created for EA8153 Add# 2 OPEN Checklist changes, 01/14/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6630276","version":"1","preferredName":"Non-Protocol Therapy Administered Ind-3","preferredDefinition":"A response used to determine whether treatment not specified in a protocol was given.","longName":"6630275v1.0:6630279v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80DC5012-12CC-2779-E053-F662850A10BF","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-02-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for Notice of NPT and New Primary Form, 02/01/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6630283","version":"1","preferredName":"New Primary Malignant Neoplasm Or MDS Diagnosed Ind","preferredDefinition":"A response used to determine whether or not a malignant tumor at the original site of growth or a clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines which did not previously exist was diagnosed.","longName":"6630282v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"80D9A240-404F-2C1B-E053-F662850A6978","latestVersionIndicator":"Yes","beginDate":"2019-02-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-02-01","modifiedBy":"KUMMEROA","dateModified":"2022-04-28","changeNote":"Created for Notice of NPT and New Primary Form, 02/01/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6660853","version":"1","preferredName":"Patient Clinical Trial Eligibility Criteria Current Fulfill Yes No Indicator","preferredDefinition":"The indicator as to whether the patient meets eligibility criteria at the present time.","longName":"PT_MEET_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F7F337-1C91-3611-E053-F662850A0507","latestVersionIndicator":"Yes","beginDate":"2019-02-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-28","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"2/28/19 EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6660859","version":"1","preferredName":"Patient Malignant Neoplasm Clinical Trial Eligibility Criteria Stage","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the extent of a cancer in the patient's body as outlined in the study protocol.","longName":"CA_STG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F9ED32-BF5D-39FB-E053-F662850AFF06","latestVersionIndicator":"Yes","beginDate":"2019-02-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-28","modifiedBy":"TAYLORT","dateModified":"2019-08-21","changeNote":"2/28/19 EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6660909","version":"1","preferredName":"Patient ECOG Performance Status Or Trial Screening Health Care Provider Ineligibility Decision Indicator","preferredDefinition":"The indicator to address the patient's ECOG performance status or ineligibility decided by persons licensed to supply health care.","longName":"ECOGPS_INELG_DECSN_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8309BCBF-F89B-5A8F-E053-F662850A3080","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-01","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/1/19 EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6660913","version":"1","preferredName":"Patient Questionnaire Language Preference Indicator","preferredDefinition":"The indicator to address the patient's preferred language for questionnaires.","longName":"QSTR_LANG_PREF_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8309BB48-484A-5AA9-E053-F662850A08D4","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-01","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/1/19 EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6660923","version":"1","preferredName":"Patient Healthcare Activity Facility Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The indicator to determine eligibility for clinical trial participation for questions related to the patient's healthcare at a facility as outlined in the study protocol.","longName":"HLCR_FACLY_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"830BEA55-E60C-5EEE-E053-F662850A9F33","latestVersionIndicator":"Yes","beginDate":"2019-03-01","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-01","modifiedBy":"FINCHAMB","dateModified":"2023-11-03","changeNote":"4/9/19 edit to question text; tmt. 3/1/19 EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6661327","version":"1","preferredName":"Number of Pack Years Smoked History Stratification Factors Category","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on the measurement of the amount of smoking exposure an individual has had over time.","longName":"6661316v1.0:6661321v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"835AF88B-BCB3-3076-E053-F662850A9972","latestVersionIndicator":"Yes","beginDate":"2019-03-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-03-05","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA3161, 03/05/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6676560","version":"1","preferredName":"Verbal Consent Obtained Indicator","preferredDefinition":"Response that indicates whether permission to do something was verbally obtained.","longName":"VRBL_CONS_OBTN_YN","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84744684-451D-7863-E053-F662850A9CE3","latestVersionIndicator":"Yes","beginDate":"2019-03-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-19","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/19/19 curated for EAQ7171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6676561","version":"1","preferredName":"Verbal Consent Obtained Date","preferredDefinition":"The date when permission to do something was verbally obtained.","longName":"VRBL_CONS_OBTN_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8473DF17-4B33-4091-E053-F662850AAFE6","latestVersionIndicator":"Yes","beginDate":"2019-03-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-19","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/19/19 curated for EAQ7171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6680065","version":"1","preferredName":"Malignant Neoplasm Diagnosis Type Text","preferredDefinition":"Text field to provide the type of cancer diagnosis.","longName":"CA_TYP_TX","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849D3DA8-3C38-2428-E053-F662850A2197","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"3/21/19 created for EAQ171CD; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6690802","version":"1","preferredName":"Pneumonitis Severity Stratification Factors Grade","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on the severity of inflammation affecting the lung parenchyma.","longName":"6690798v1.0:6690799v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"865699BE-432A-4C43-E053-F662850AB592","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-04-12","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAQ172, 04/12/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6703190","version":"1","preferredName":"Potential Study Subject For Clinical Trial Participation Ind","preferredDefinition":"A response used to determine whether or not a living individual who, due to the possession of one or more characteristics such e.g. as a particular medical condition specific to the study, is pre-qualified as a prospective study subject in a research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","longName":"6703189v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86D2E3AD-8D0C-62E8-E053-F662850A3DF9","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-04-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA173, 04/18/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741168","version":"1","preferredName":"Molecular Based Risk Factor Clinical Trial Stratification Status","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol founded on molecules that increases the chance of developing a disease.","longName":"6740654v1.0:6741165v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88391626-9BC8-31C1-E053-F662850A37E4","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA171, 05/06/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741169","version":"1","preferredName":"Prior Lenalidomide Maintenance Therapy Dose","preferredDefinition":"A response used to determine the quantity of lenalidomide previously given during the continuation of treatment for an extended period of time to prevent relapse.","longName":"6740696v1.0:6741166v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88392B4A-D9C9-2D5D-E053-F662850A4494","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA171, 05/06/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6741260","version":"1","preferredName":"Serum Or Urine M Protein Present Ind","preferredDefinition":"A response used to determine whether or not aprotein complex comprised of two heavy chains and two light chains (monoclonal immunoglobulin/m protein) is found in the clear liquid part of the blood that remains after blood cells and clotting proteins have been removed and/or in the fluid that is excreted by the kidneys.","longName":"6741254v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883A813F-760D-221B-E053-F662850A2D58","latestVersionIndicator":"Yes","beginDate":"2019-05-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-06","modifiedBy":"GARRIDOJ","dateModified":"2019-05-07","changeNote":"Created for EAA171, 05/06/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6754098","version":"1","preferredName":"Diagnosis Biopsy Confirmation Indicator","preferredDefinition":"A response used to indicate whether the diagnosis of a disease, condition, or injury was verified via a microscopic examination of tissue specimens or fluid removed from the living body.","longName":"6471125v1.0:6753953v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"88786EED-327F-5F53-E053-F662850A1C5E","latestVersionIndicator":"Yes","beginDate":"2019-05-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-09","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8143, 05/09/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6755123","version":"1","preferredName":"Malignant Neoplasm Histology Grade","preferredDefinition":"A response used to determine degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type.","longName":"6755122v1.0:6043357v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"888AAF50-20C1-7E70-E053-F662850A36BA","latestVersionIndicator":"Yes","beginDate":"2019-05-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for E2112, 05/10/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6765695","version":"1","preferredName":"Clinical Laboratory Evaluation Program Specimen Testing Approval Obtained Ind","preferredDefinition":"A response used to determine whether approval of a procedure(s) for critical evaluation of a preparation of tissue or bodily fluid taken for examination or diagnosis was obtained from a program of the New York State Department of Health that administers the activities of the Clinical Laboratory Reference System and provides the oversight of over 1,000 clinical laboratories and blood banks, including out-of-state facilities that accept clinical specimens collected in New York State called Clinical Laboratory Evaluation Program (CLEP).","longName":"6765658v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89904B12-6FBD-14EB-E053-F662850A5CE6","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-05-23","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA4151, 05/23/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6774192","version":"1","preferredName":"Non-Protocol Therapy Administered Type","preferredDefinition":"A response used to determine the type of non-protocol therapy given.","longName":"6630275v1.0:6774175v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A70ED95-1021-20C0-E053-F662850A6477","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-06-03","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA Glib, 06/03/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6774199","version":"1","preferredName":"Additional New Primary Tumor To Report Ind","preferredDefinition":"A response used to determine whether there is an additional finding indicating the development of a tumor in a patient with a history of a previously diagnosed tumor with a different histopathologic profile in another anatomic site as compared to the most recent one to report.","longName":"6774198v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A70BC02-99E5-3A58-E053-F662850AA0B9","latestVersionIndicator":"Yes","beginDate":"2019-06-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-06-03","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA Glib, 06/03/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6813935","version":"1","preferredName":"Person Interest Pregnancy Within One Year Occurrence Ind","preferredDefinition":"A response used to determine whether a person is interested in becoming pregnant within one year of an event.","longName":"6813934v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D2B7C5C-8F92-7937-E053-F662850A2CBE","latestVersionIndicator":"Yes","beginDate":"2019-07-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-07-08","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for E1Q11 OPEN Checklist, 07/08/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6818513","version":"1","preferredName":"Patient Two Primary Neoplasm Diagnosis Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response as to whether or not the patient has a diagnosis of two primary cancers that meet the eligibility requirements for clinical trial participation.","longName":"TWO_PRIM_ELIG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DBC65C2-84A9-2952-E053-F662850AA1A7","latestVersionIndicator":"Yes","beginDate":"2019-07-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-15","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"7-15-19 tt created for EAQ162.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6825620","version":"1","preferredName":"Laboratory Test Result Recipient Contact Person Name","preferredDefinition":"A response used to determine the person acting as a channel for communication between groups or on behalf of a group that would receive the outcome of a laboratory test.","longName":"6825598v1.0:2018284v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E73EA56-7C2B-6C52-E053-F662850A4079","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-07-24","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA171 OPEN Checklist, 07/24/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6825623","version":"1","preferredName":"Laboratory Test Result Recipient Contact Person Telephone Number","preferredDefinition":"A response used to determine the telephone number for a person acting as a channel for communication between groups or on behalf of a group that would receive the outcome of a laboratory test.","longName":"6825598v1.0:2015979v3.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E73FE37-FEE8-6A5F-E053-F662850A34B4","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-07-24","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA171 OPEN Checklist, 07/24/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6825632","version":"1","preferredName":"Laboratory Test Result Recipient Contact Person Fax Number","preferredDefinition":"A response used to determine the fax number for a person acting as a channel for communication between groups or on behalf of a group that would receive the outcome of a laboratory test.","longName":"6825598v1.0:2019271v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E742C02-2584-7BC5-E053-F662850AD957","latestVersionIndicator":"Yes","beginDate":"2019-07-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-07-24","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA171, OPEN Checklist, 07/24/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6848692","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Risk Assessment Category","preferredDefinition":"A response used to determine the prognostic index for mantle cell lymphoma based on: age, performance status, lactate dehydrogenase (LDH), and leukocyte count which differentiates patients into low-, intermediate-, and high-risk groups.","longName":"6848688v1.0:6848685v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FAFC61B-8ECF-52F5-E053-F662850A1BEF","latestVersionIndicator":"Yes","beginDate":"2019-08-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-08-09","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA4181,08/09/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6848700","version":"1","preferredName":"Participant Autologous Hematopoietic Stem Cell Transplantation Eligible Ind","preferredDefinition":"Response used to determine is a participant is eligible for a stem cell transfer or transplantation in which the patient is his own donor.","longName":"6848696v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FB05290-1CA0-62B7-E053-F662850ADF03","latestVersionIndicator":"Yes","beginDate":"2019-08-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-08-09","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA4412, 08/09/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942051","version":"1","preferredName":"Induction Therapy Administration Timepoint Category","preferredDefinition":"A response used to determine the timepoint of administration of the first choice of treatment for a particular type of cancer.","longName":"6942029v1.0:6942030v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D8E0FF-8C88-3D14-E053-F662850A33F9","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8185, 09/18/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942146","version":"1","preferredName":"Radiation Therapy Radiosensitizing Agent Administration Plan Type","preferredDefinition":"A response used to determine the planned drugs to be used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.","longName":"6942145v1.0:6942058v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92DA7512-DB9C-7946-E053-F662850A976E","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8185, 09/18/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942236","version":"1","preferredName":"Prior Randomization Chemotherapy Disease Response Status","preferredDefinition":"A response used to determine the status of the pathologic and/or clinical changes that result from treatment received prior to randomization.","longName":"6942231v1.0:6942225v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92E82348-DAAA-67B3-E053-F662850A9F28","latestVersionIndicator":"Yes","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"GARRIDOJ","dateModified":"2022-04-22","changeNote":"Created for EA8185, 09/19/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942245","version":"1","preferredName":"Lymph Node Size Category","preferredDefinition":"A response used to determine the size of a bean-shaped organ surrounded by a connective tissue capsule that is part of the lymphatic system and is found throughout the body.","longName":"6942238v1.0:6942242v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92E812D0-910F-6FA1-E053-F662850AF30E","latestVersionIndicator":"Yes","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8185, 09/19/2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942252","version":"1","preferredName":"Transurethral Resection of Bladder Tumor Extent Disease Response Status","preferredDefinition":"A response used to determine the extent of disease response resulting from a surgical procedure used to treat bladder tumors, during which a resectoscope is passed through the urethra and into the bladder.","longName":"6942250v1.0:6942225v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92DE4D06-F217-2660-E053-F662850A96B8","latestVersionIndicator":"Yes","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"KUMMEROA","dateModified":"2022-05-16","changeNote":"Created for EA8185, 09/19/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6942260","version":"1","preferredName":"Protocol Treatment Arm Clinical Complete Response Or Clinical Benefit Outcome Ind","preferredDefinition":"A response used to determine where a specific treatment plan within a clinical trial resulted in either the disappearance of all signs of cancer based on physical exam or in an effect of a therapeutic intervention that prolongs life, improves function, and/or improves the way a subject feels.","longName":"6942257v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92E81955-6A70-3CC1-E053-F662850A0C27","latestVersionIndicator":"Yes","beginDate":"2019-09-19","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-19","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeNote":"Created for EA8185, 09/19/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6944355","version":"1","preferredName":"Human Study Subject Database Identifier","preferredDefinition":"One or more characters used to identify the subject in a database.","longName":"DB_ID","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9362C308-0E27-193E-E053-F662850A3967","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-25","modifiedBy":"TAYLORT","dateModified":"2019-09-25","changeNote":"9-25-19 Created for EA; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6951325","version":"1","preferredName":"Intervention or Procedure Plan Type","preferredDefinition":"A response used to determine the planned activity to be used that produces an effect, or is intended to alter the course of a disease in a patient or population.","longName":"6951315v1.0:6161027v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93C7EEF8-17D3-43CF-E053-F662850A6C13","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-09-30","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5181, 09/30/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6953311","version":"1","preferredName":"HIV Status And Lymph Node Involvement Status Category","preferredDefinition":"A response used to determine the grouping of items based on the human immunodeficiency virus result and the finding indicating whether or not cancer has spread to regional or distant lymph node(s).","longName":"6953306v1.0:6953307v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93DAFED1-8F28-4E4C-E053-F662850AB952","latestVersionIndicator":"Yes","beginDate":"2019-10-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-10-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2182, 10/01/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6972656","version":"1","preferredName":"Clinical Trial Site 18F-Fluorothyminde Radiotracer Access To Manufacturing Ability Clinical Study Lead Organization Approval Received Ind","preferredDefinition":"A response used to determine whether or not a clinical trial sites access to or ability to manufacture a 18F-Fluorothymidine radiotracer has been approved by the clinical study lead organization.","longName":"6972527v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94542F86-4E30-74C4-E053-F662850A37FA","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-10-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6183, 10/07/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6976024","version":"1","preferredName":"Metastatic Disease Anatomic Location Count Category","preferredDefinition":"A response used to categorize what amount of locations within the body that contain metastatic disease.","longName":"2728609v1.0:6975978v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9492724C-BF61-132C-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-10-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-10-10","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","changeNote":"Created for EA2183, 10/10/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6979496","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Brain Present Indicator","preferredDefinition":"A response used to determine whether or not a malignant neoplasm that has spread to the brain from another anatomic site or system is present.","longName":"6979449v1.0:2018823v1.1","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94A8083D-5332-774D-E053-F662850A3F57","latestVersionIndicator":"Yes","beginDate":"2019-10-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-10-11","modifiedBy":"SOKKERL","dateModified":"2023-05-03","changeNote":"Created for EA5182, 10/11/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6986590","version":"1","preferredName":"Sensitizing EGFR Gene Mutation Laboratory Test Result Type","preferredDefinition":"A response used to determine the outcome of a laboratory test that identifies the change in the sequence of the EGFR gene that results in increased sensitivity to EGFR inhibitory agents.","longName":"6984727v1.0:6986559v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E4FC8A-4924-6C3B-E053-F662850A2198","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-10-14","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5182, 10/14/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7068226","version":"1","preferredName":"Unique Identifier Provided Indicator","preferredDefinition":"A response used to determine whether or not a set of characters used as a code that is unique in the context or the system for which it is created was provided.","longName":"7068174v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9845CBB0-976D-3C93-E053-F662850AEED9","latestVersionIndicator":"Yes","beginDate":"2019-11-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-11-26","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAY131 (MATCH), 11/26/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7070169","version":"1","preferredName":"Concomitant Agent Other Administered Specify","preferredDefinition":"A response used to capture information regarding a pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study that is not specified the list of provided.","longName":"7070167v1.0:5566342v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98E4577B-41C0-14A3-E053-F662850A2D14","latestVersionIndicator":"Yes","beginDate":"2019-12-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-12-04","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA1181, 12/04/2019 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7113845","version":"1","preferredName":"Registering Study Site Specified Institution Ind","preferredDefinition":"A response used to determine whether the a specific facility in which study/protocol activities are conducted is the site of registration.","longName":"7113819v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AA179AA-C2F3-37E1-E053-F662850A9EE7","latestVersionIndicator":"Yes","beginDate":"2019-12-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2019-12-26","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA9152, 12/26/2019 (JG)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7119398","version":"1","preferredName":"HIV Status Database Case Report Form Completed Ind","preferredDefinition":"A response used to determine if the electronic document designed to record result of testing to determine if an individual is infected with the human immunodeficiency virus has been completed within a database.","longName":"7119397v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7BC580-0AD6-56E5-E053-F662850A8CA7","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-01-06","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2182, 01/06/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7155636","version":"1","preferredName":"Referring Physician Specialty Type","preferredDefinition":"A response used to determine the area of specialized study within the broader practice of medicine and surgery of a physician that directs a patient to an additional source of medical expertise for assistance, examination, information, or treatment.s.","longName":"7155633v1.0:7155634v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D4EAA8D-08BB-0C5C-E053-F662850A6C99","latestVersionIndicator":"Yes","beginDate":"2020-01-29","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-01-29","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2185, 01/29/2020 (JG)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171841","version":"2","preferredName":"Patient Informed Consent Age Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of eligibility verification for the patient's age at the time of informed consent as outlined in the study protocol.","longName":"ELIG_IC_AGE_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43BAD-EE14-5664-E053-4EBD850AC7E1","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-09-09","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171842","version":"2","preferredName":"ECOG Performance Status Outcome Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"Verification that the patient meets the ECOG Performance Status eligibility criteria outlined in the study protocol.","longName":"ELIG_ECOGPS_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7C3834F-75A3-5EBB-E053-4EBD850A8376","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-05-07","changeNote":"6/11/20 New version/VD v2 and change to LN; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171843","version":"2","preferredName":"Patient Metastatic Breast Carcinoma Diagnosis Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"A verification status to determine patient eligibility for the study protocol requirements of metastatic breast cancer.","longName":"ELIG_MBC_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D4A25B-3831-566A-E053-4EBD850AA9EA","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"KUMMEROA","dateModified":"2021-08-20","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171844","version":"2","preferredName":"Patient Bone Disease Radiologic Finding Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility for radiologically confirmed abnormal conditions of the bone as outlined in the study protocol.","longName":"ELIG_RAD_BONEDZ_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7C3B53A-3FA4-5EC1-E053-4EBD850AF312","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"FINCHAMB","dateModified":"2022-10-25","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171854","version":"2","preferredName":"Patient No RECIST Version 1.1 Measurable Lesion Or Disease Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The status of patient eligibility verification for the requirements of no RESIST 1.1 measurable lesions or diseases as outlined in the study protocol.","longName":"ELIG_NO_RECIST_MLES_OR_DZ_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D47EF8-5DAD-7BE8-E053-4EBD850A2C26","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD;edit to LN tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171855","version":"2","preferredName":"Patient FDG-PET Imaging No Medical Contraindication Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for the requirements of no contraindications to FDG-PET imaging as outlined in the study protocol.","longName":"ELIG_NO_FDGPET_CONTR_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D4A25B-3869-566A-E053-4EBD850AA9EA","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-03-03","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171856","version":"2","preferredName":"Patient Fulfill Renal Function Guideline For Imaging Procedures Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification to address the renal function guidelines for imaging procedures as outlined in the study protocol.","longName":"ELIG_RF_IMAG_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D48079-D5F2-0389-E053-4EBD850A56E3","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171857","version":"2","preferredName":"Patient Life Expectancy Eligibility Determination Confirmation Status","preferredDefinition":"The verification of patient eligibility with regards to the requirements for life expectancy as outlined in the study protocol.","longName":"ELIG_LIFE_EXPCY","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D42BBC-5539-5666-E053-4EBD850A46C7","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-08-19","changeNote":"6/11/20 CDE versioned for updated VD, change to LN, def; tmt. 3/18/20 changed to Draft Mod and released for edit to question text due to issues with special characters. 3/18/20 tmt re-entered question text per issues with randonode programming. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171858","version":"2","preferredName":"Patient Prior Cytotoxic Chemotherapy Metastatic Breast Carcinoma Occurrence Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for the requirements of cytotoxic chemotherapy for metastatic breast cancer as outlined in the study protocol.","longName":"ELIG_PRR_CYCHEMO_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D42BBC-5566-5666-E053-4EBD850A46C7","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171859","version":"2","preferredName":"Patient Investigational New Drug And Investigational Device Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for the requirements of investigational agents and investigational devices as outlined in the study protocol.","longName":"ELIG_IND_IDE_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D42414-B447-566C-E053-4EBD850A073C","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"KUMMEROA","dateModified":"2021-08-20","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171863","version":"2","preferredName":"Patient No Additional Malignant Neoplasm Disease Progression Or Therapeutic Procedure Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for the requirements of no additional cancer that is progressing or the administration of therapeutic agents as outlined in the study protocol.","longName":"ELIG_NO_ADDL_CA_PD_TX_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D4F9CB-EC7E-4D18-E053-4EBD850AB0E2","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171873","version":"2","preferredName":"Patient Imaging Procedure Sponsor Approved PET and CT Scan Medical Device Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for the performance of imaging studies on sponsor approved scanners as outlined in the protocol.","longName":"ELIG_APRVD_SCANR_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43FC9-BDB5-5668-E053-4EBD850AD07E","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171874","version":"2","preferredName":"Patient Imaging Technique Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The verification of patient eligibility for the imaging procedure requirements as outlined in the study protocol.","longName":"ELIG_IMAG_STAT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7C3B53A-3FD3-5EC1-E053-4EBD850AF312","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171875","version":"2","preferredName":"Patient Not Pregnant Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for not being pregnant or being negative for a pregnancy test as outlined in the study protocol.","longName":"ELIG_NOT_PREG_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D45DC5-A3E7-7E2A-E053-4EBD850ABA09","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171876","version":"2","preferredName":"Patient Not Breast Feeding Confirmation Clinical Trial Eligibility Criteria Status","preferredDefinition":"The status of patient eligibility verification for not breast-feeding as outlined in the study protocol.","longName":"ELIG_NOT_BRFEED_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43FC9-BDE0-5668-E053-4EBD850AD07E","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7171877","version":"1","preferredName":"Patient Systemic Therapy Receive Clinical Trial Eligibility Criteria Type","preferredDefinition":"The kind of treatment the patient will receive as outlined in the in the eligibility criteria of the protocol.","longName":"ELIG_TX_TP","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9ECCC75D-EB2B-7876-E053-F662850AB4C7","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-17","modifiedBy":"SOKKERL","dateModified":"2021-08-19","changeNote":"2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7190142","version":"2","preferredName":"Patient Receive Hormone Therapy For Disease Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The status of patient eligibility verification to address the receipt of hormonal therapy for the disease as outlined in the study protocol.","longName":"HRT_ELIG_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D47958-C829-5EAC-E053-4EBD850AC8BB","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2021-03-03","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 3-5-20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7190190","version":"2","preferredName":"Patient Receive Chemotherapy Per NCCN Or Healthcare Facility Standard Treatment Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The status of patient eligibility verification to address the receipt of chemotherapy per National Comprehensive Cancer Network or institutional standards as outlined in the study protocol.","longName":"7190189v1.0:5676955v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D43FC9-BE0B-5668-E053-4EBD850AD07E","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"FINCHAMB","dateModified":"2022-10-04","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 3-5-20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7190198","version":"2","preferredName":"Patient Receive Therapeutic Procedure For Disease Guidelines Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The status of patient eligibility verification to address the receipt of therapy for disease according to the guidelines as outlined in the study protocol.","longName":"7190193v1.0:5676955v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7D47958-C855-5EAC-E053-4EBD850AC8BB","latestVersionIndicator":"Yes","beginDate":"2020-03-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-11","modifiedBy":"TAYLORT","dateModified":"2020-06-12","changeNote":"6/11/20 CDE versioned for updated VD; tmt. 3-5-20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7263249","version":"1","preferredName":"Study Protocol Cohort Assignment Category","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._A group of individuals, identified by a common characteristic._An allotting or an appointment to a particular person or use, or for a particular time or object._A grouping of items based on some commonality or by user defined characteristics.","longName":"7263209v1.0:7263204v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A447CF15-9FB4-41E0-E053-F662850A6D72","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"GARRIDOJ","dateModified":"2021-02-05","changeNote":"Created for EA5191, 04/27/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7263253","version":"1","preferredName":"Additional Clinical Trial Eligibility Criteria Fulfill Ind","preferredDefinition":"Added; extra; further._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._Satisfy the requirements or expectations of._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"7263252v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A446FB38-F047-559B-E053-F662850A6781","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5191, 04/27/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7263258","version":"1","preferredName":"Prior Immunotherapy Administered Duration","preferredDefinition":"A response used to determine the period of time during which therapy designed to induce changes in a patient's immune status in order to treat disease was previously given.","longName":"2188716v1.0:7263254v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A44A5D3F-F2BF-51AF-E053-F662850A6916","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5191, 04/27/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7263278","version":"1","preferredName":"Treatment Regimen Administration Plan Type","preferredDefinition":"A response used to determine the intended treatment plan to be given.","longName":"7263272v1.0:6161027v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A44AD946-E261-4381-E053-F662850A39F0","latestVersionIndicator":"Yes","beginDate":"2020-04-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-04-27","modifiedBy":"FINCHAMB","dateModified":"2023-11-07","changeNote":"Created for EA5191, 04/27/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7283851","version":"1","preferredName":"Biopsy Confirmed Malignant Neoplasm Diagnosis Performed Count","preferredDefinition":"A response used to determine the number of procedures involving the removal of tissue specimens or fluid from the living body performed that verified a diagnosis of cancer.","longName":"7283849v1.0:7283844v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A50F4E7A-6718-0BF8-E053-F662850ACA27","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-05-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8184, 05/07/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330046","version":"1","preferredName":"Patient Age And Natural Language Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for age and language to allow clinical trial participation.","longName":"AGE_LANG_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE174B-E197-0531-E053-4EBD850A96F6","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330047","version":"1","preferredName":"Patient Personal Medical History Malignant Neoplasm Initial Treatment Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation for a personal medical history of cancer, that was initially treated, as outlined in the protocol.","longName":"PMH_CA_INLTX_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD8B50-DD1B-3061-E053-4EBD850AB8AD","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"GDEEN","dateModified":"2022-08-01","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330048","version":"1","preferredName":"Patient Cardiovascular Disorder Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for cardiovascular disease to allow clinical trial participation.","longName":"CARIODZ_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BFEB11-7CA8-4A94-E053-4EBD850A1F0D","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330049","version":"1","preferredName":"Patient Systolic Blood Pressure Assessment Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for systolic blood pressure to allow clinical trial participation.","longName":"SBP_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD654B-76E7-305F-E053-4EBD850AC9D1","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330050","version":"1","preferredName":"Patient Home Blood Pressure Monitoring Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for home blood pressure monitoring to allow clinical trial participation.","longName":"HOME_BP_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD26DC-A4BD-3063-E053-4EBD850AEAF8","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2020-07-28","changeNote":"7-28-20 tmt released. EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330051","version":"1","preferredName":"Patient Personal Medical History End Stage Renal Failure Or Intervention or Procedure Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation for a personal medical history of end-stage renal failure, or interventions and procedures, as outlined in the protocol.","longName":"ESRD_INTVPR_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BDF7B8-84CD-0C48-E053-4EBD850A4CA2","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-03-24","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330052","version":"1","preferredName":"Patient Personal Medical History Intervention Procedure Disease or Disorder Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation that address a personal medical history of interventions or procedures, diseases or disorders, as outlined in the protocol.","longName":"INTVPR_DZDIS_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BDF7B8-850C-0C48-E053-4EBD850A4CA2","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-05-25","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330053","version":"1","preferredName":"Patient Negation Brain Intervention or Procedure Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation for not having brain interventions or procedures.","longName":"NO_BRAIN_INTVPR_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE068A-A71D-5E39-E053-4EBD850A0E3D","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-20","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330054","version":"1","preferredName":"Patient Treated Brain Metastases Diagnosis Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that a patient with treated brain metastases meets the protocol eligibility criteria for clinical trial participation.","longName":"TRTD_BRAIN_METS_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BEDAAB-A010-5EBE-E053-4EBD850A6840","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330055","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the protocol eligibility requirements for central nervous system diseases or disorders to allow clinical trial participation.","longName":"CNS_DZDIS_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD990F-BF63-305B-E053-4EBD850A5829","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330056","version":"1","preferredName":"Patient Personal Medical History Negation Uncontrolled Blood Pressure Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient does not have uncontrolled blood pressure as outlined in the protocol to allow clinical trial participation.","longName":"NO_UNCTROL_BP_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BFEB11-7CCF-4A94-E053-4EBD850A1F0D","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330057","version":"1","preferredName":"Patient Arm Circumference Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for arm circumference to allow clinical trial participation.","longName":"ARMCIRC_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE174B-E1CA-0531-E053-4EBD850A96F6","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330058","version":"1","preferredName":"Patient Not Pregnant Or Breast Feeding Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient is not pregnant or breast-feeding as outlined in the protocol to allow clinical trial participation.","longName":"NOT_PREG_BRF_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BED0EC-B1EC-4ACF-E053-4EBD850A392C","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-03-24","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330059","version":"1","preferredName":"Patient Contraception Eligibility Determination Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the protocol eligibility requirements for contraception to allow clinical trial participation.","longName":"CNTCPT_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD0F55-AF5E-3059-E053-4EBD850AAC3B","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-03-25","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330060","version":"1","preferredName":"Patient Internet Access Or Smart Device Availability Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for internet access or smart devices to allow clinical trial participation.","longName":"INRNT_SMRDEV_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BEDAAB-A04F-5EBE-E053-4EBD850A6840","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-05-07","changeNote":"7-21-20 tmt released.  EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330062","version":"1","preferredName":"Patient Chronic Hepatitis B Virus Infectious Disorder Receive Suppressive Antiviral Therapy Undetectable Viral Load Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for clinical trial participation that address chronic HBV infection, and undetectable viral load when taking suppressive therapy.","longName":"HBV_SUPVTX_UVL_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE153C-3DBB-5ED2-E053-4EBD850AA5DB","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330063","version":"1","preferredName":"Patient Organ Bone Marrow Function Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements for organ and marrow function to allow clinical trial participation.","longName":"ORGN_BMARO_FCTN_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BFEDDC-C4C2-4B12-E053-4EBD850AFC6A","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330064","version":"1","preferredName":"Patient Hepatitis C Infection Personal Medical History Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation for a personal medical history of hepatitis C virus infection as outlined in the protocol.","longName":"PMH_HCV_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BFEDDC-C50D-4B12-E053-4EBD850AFC6A","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330065","version":"1","preferredName":"Patient Personal Medical History Investigational Treatment Safety Or Efficacy Study Negation Interference Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the eligibility requirements to allow clinical trial participation for a personal medical history that will not interfere with the safety or efficacy assessments of the investigational treatment as outlined in the protocol.","longName":"PMH_INVTX_INTFR_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE068A-A763-5E39-E053-4EBD850A0E3D","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-11","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7330066","version":"1","preferredName":"Patient Pregnancy Test Date","preferredDefinition":"The date of any examination performed to assess if a female is pregnant.","longName":"PREG_TST_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BD6E87-355E-0C46-E053-4EBD850A5917","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-06-10","modifiedBy":"TAYLORT","dateModified":"2021-01-07","changeNote":"EAQ191/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7334430","version":"1","preferredName":"PET CT Scan Assessment Outcome","preferredDefinition":"A response used to determine the result of an imaging technique that utilizes positron emission tomography and computed tomography in a single machine.","longName":"7334383v1.0:7334427v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84AE552-11FA-4751-E053-4EBD850AD35B","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8191, 06/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335594","version":"1","preferredName":"PET Negative For Extrapelvic Metastasis Stratification Factors Outcome","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients that are PET negative for extra-pelvic metastases are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"7335583v1.0:7334427v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BABFF-C9E0-0BDB-E053-4EBD850AFB0C","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8191, 06/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7335602","version":"1","preferredName":"PET Positive For Extrapelvic Metastasis Stratification Factors Category","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients that are PET positive for extra-pelvic metastases are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"7335597v1.0:7335599v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A84BE682-9E38-35DE-E053-4EBD850AD02C","latestVersionIndicator":"Yes","beginDate":"2020-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-06-17","modifiedBy":"KENNISHM","dateModified":"2021-06-09","changeNote":"Created for EA8191, 06/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7348093","version":"1","preferredName":"FDG-PET/CT Biopsy Assessment Result","preferredDefinition":"A response used to determine the final result of an imaging procedure that combines FDG PET with a CT scan to overlay activity data onto detailed anatomic image and removal of tissue specimens or fluid from the living body for microscopic examination performed to establish a diagnosis.","longName":"7348091v1.0:7334427v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A98D10AB-8E7D-5AD6-E053-4EBD850A11EF","latestVersionIndicator":"Yes","beginDate":"2020-07-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-07-03","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6192, 07/03/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7348096","version":"1","preferredName":"FDG-PET/CT Assessment Result","preferredDefinition":"A response used to determine the final results of an imaging procedure that combines FDG PET with a CT scan to overlay activity data onto detailed anatomic images.","longName":"7348095v1.0:7334427v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A98D230B-F8DE-5AFD-E053-4EBD850A60B2","latestVersionIndicator":"Yes","beginDate":"2020-07-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-07-03","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6192, 07/03/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7411308","version":"1","preferredName":"Treatment Step Intervention or Procedure Complete Follow Study Protocol Indicator","preferredDefinition":"A response used to determine whether or not an intervention or procedure during a specific treatment step was completed per the formal plan of an experiment or research activity protocol.","longName":"7411307v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE47D129-CDBB-0C64-E053-4EBD850A4A0F","latestVersionIndicator":"Yes","beginDate":"2020-09-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA5181, 09/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7412149","version":"1","preferredName":"Human Immunodeficiency Virus Laboratory Procedure Status","preferredDefinition":"A response used to determine HIV status.","longName":"7412082v1.0:7412083v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE5AD7F4-956A-29AC-E053-4EBD850A7A44","latestVersionIndicator":"Yes","beginDate":"2020-09-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-02","modifiedBy":"COLLIED","dateModified":"2022-04-01","changeNote":"Created for EA2176, 09/02/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7412153","version":"1","preferredName":"Prior Chemoradiotherapy Curative Intent Indicator","preferredDefinition":"A response used to determine whether or not treatment that combines chemotherapy with radiation therapy was previously given with the purpose of curing the disease.","longName":"7412152v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE5B4A2A-5206-2CF5-E053-4EBD850A5097","latestVersionIndicator":"Yes","beginDate":"2020-09-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-02","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2176, 09/02/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7412552","version":"1","preferredName":"Melanoma American Joint Committee on Cancer Staging Stratification Factors Stage","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a melanoma clinical protocol based on their AJCC staging system.","longName":"7412156v1.0:7412529v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6E7BCE-252A-121B-E053-4EBD850AA651","latestVersionIndicator":"Yes","beginDate":"2020-09-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-03","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6194, 09/03/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7415377","version":"1","preferredName":"Laboratory Procedure Lactate Dehydrogenase Outcome","preferredDefinition":"A response used to determine the result of a procedure testing a family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis.","longName":"2188749v1.0:7415374v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0B8855-E7E6-1649-E053-4EBD850A772F","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-11","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA6191, 09/11/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7425522","version":"1","preferredName":"Clonality Identifier Outcome Electronic Case Report Form Complete Indicator","preferredDefinition":"A response used to determine whether or not clonality ID results were reported on an auditable electronic record of information that is reported to the sponsor (or sponsor's agent such as an EDC provider) was completed.","longName":"7425507v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF84B29E-4C3C-19AD-E053-4EBD850AE6CA","latestVersionIndicator":"Yes","beginDate":"2020-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA181, 09/17/2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7425523","version":"1","preferredName":"Minimal Residual Disease Outcome Electronic Case Report Form Complete Indicator","preferredDefinition":"A response used to determine whether or not MRD results were reported on an auditable electronic record of information that is reported to the sponsor (or sponsor's agent such as an EDC provider) was completed.","longName":"7425520v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF840B3F-0B7A-2D3B-E053-4EBD850AAE73","latestVersionIndicator":"Yes","beginDate":"2020-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA1181, 09/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7425528","version":"1","preferredName":"Israeli Institution Indicator","preferredDefinition":"A response used to determine whether or not the in an established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research is located in Israel.","longName":"7425527v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF8500F7-896B-5873-E053-4EBD850AB364","latestVersionIndicator":"Yes","beginDate":"2020-09-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA9181, 09/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7425989","version":"1","preferredName":"Local Laboratory BCR/ABL1 Fusion Gene Outcome Status","preferredDefinition":"A response used to determine the status of a fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene as reported by a local laboratory.","longName":"7425980v1.0:5808650v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF976A44-AB16-5971-E053-4EBD850A6493","latestVersionIndicator":"Yes","beginDate":"2020-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA9181, 09/18/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7426119","version":"1","preferredName":"Intended Intervention or Procedure Administration Type","preferredDefinition":"A response used to determine the intended intervention or procedure to be administered.","longName":"7426117v1.0:7426118v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF9AF5C4-F92F-7A2E-E053-4EBD850A43DF","latestVersionIndicator":"Yes","beginDate":"2020-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA9181, 09/18/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7426143","version":"1","preferredName":"Central Laboratory Results Received Indicator","preferredDefinition":"A response used to determine whether or not results from a laboratory delivering the data for a particular study had been received.","longName":"7426142v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF9B5726-DF8B-5591-E053-4EBD850A5A93","latestVersionIndicator":"Yes","beginDate":"2020-09-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-09-18","modifiedBy":"GARRIDOJ","dateModified":"2022-04-20","changeNote":"Created for EA9181, 09/18/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7463455","version":"1","preferredName":"Metastasis Liver Bone Brain Present Indicator","preferredDefinition":"A response used to determine whether or not cancer cells from the liver, bones or brain have spread to other parts of the body.","longName":"7463454v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B17FB18C-2484-3D3F-E053-4EBD850AADFA","latestVersionIndicator":"Yes","beginDate":"2020-10-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-10-12","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8143, 10/12/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7487182","version":"1","preferredName":"Required eCRF Database Completed Indicator","preferredDefinition":"Something that is a necessary condition; something that is obligatory._An auditable electronic record of information that is reported to the sponsor (or sponsor's agent such as an EDC provider) on each trial subject to enable data pertaining to a clinical investigation protocol to be systematically captured, reviewed, managed, stored, analyzed, and reported. The eCRF is a CRF in which related data items and their associated comments, notes, and signatures are linked programmatically. See also case report form, CRF, eSRF.[CSUICI; Revised from FDA Final Guidance on eSource]_An information set with a regular structure.  Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"7487181v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3150639-B1A5-6F00-E053-4EBD850ABA4E","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8183, 11/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7487187","version":"1","preferredName":"Laboratory Procedure Baseline Prostate Specific Antigen Measurement Outcome Status","preferredDefinition":"A response used to verify the status of the prostate specific antigen level present in a sample obtained at baseline.","longName":"7487186v1.0:7487359v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31564BC-509D-6EFE-E053-4EBD850A9C56","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8183, 11/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7487191","version":"1","preferredName":"Radiation Therapy Administration Intent Indicator","preferredDefinition":"A yes or no response used to determine the intention to treat a disease by means of exposure of the target or the whole body to radiation.","longName":"7487190v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B314EB3E-6606-6F07-E053-4EBD850A09C0","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"FINCHAMB","dateModified":"2023-02-15","changeNote":"Created for EA8183, 11/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7506968","version":"1","preferredName":"Prior Therapeutic Procedure Anti-PD1 Monoclonal Antibody Anti-PD-L1 Monoclonal Antibody Cure Intent Administration Indicator","preferredDefinition":"A response used to determine whether or not anti-PD-1 (monoclonal antibody directed against programmed cell death protein 1) therapy or anti-PD-L1 (a monoclonal antibody directed against programmed death-ligand 1) therapy was previously administered with the intent to cure.","longName":"7506967v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4500D81-6B1A-2315-E053-4EBD850AD30B","latestVersionIndicator":"Yes","beginDate":"2020-11-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-17","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA3191, 11/17/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7513553","version":"1","preferredName":"Prostate Specific Antigen Measurement Value Clinical Study Protocol Criterion Met Indicator","preferredDefinition":"A response used to determine whether or not the numerical quantity measured of the prostate specific antigen present in a sample satisfies the requirements of the criteria outlined in a clinical study protocol.","longName":"7513551v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B48D994E-A5C1-1E52-E053-4EBD850ABB0A","latestVersionIndicator":"Yes","beginDate":"2020-11-20","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-20","modifiedBy":"KENNISHM","dateModified":"2021-06-03","changeNote":"Created for EA8183, 11/20/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525181","version":"1","preferredName":"Laboratory Procedure Hepatitis B Virus Hepatitis C Virus Negative Finding Outcome Indicator","preferredDefinition":"A response used to determine whether or not the result of a laboratory tests results for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) were negative.","longName":"7525180v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA57BE-4F58-6F92-E053-4EBD850AF212","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-12-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8184, 12/07/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525188","version":"1","preferredName":"Central Laboratory Hepatitis B Virus Hepatitis C Virus Outcome Received Ind-3","preferredDefinition":"A response used to determine whether or not Hepatitis B Virus and Hepatitis C Virus results from a laboratory delivering the data for a particular study had been received.","longName":"7525184v1.0:3506034v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA57BE-4FB6-6F92-E053-4EBD850AF212","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-12-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8184, 12/07/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525189","version":"1","preferredName":"Central Laboratory Gleason Score for Prostate Cancer Ki67 Measurement Outcome Receive Indicator","preferredDefinition":"A response used to determine whether or not the Gleason Score and the Ki67 measurement results from a laboratory delivering the data for a particular study had been received.","longName":"7525187v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DAAF32-448F-2E0B-E053-4EBD850A658A","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-12-07","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8184, 12/07/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525490","version":"1","preferredName":"Programmed Cell Death 1 Ligand 1 Combined Positive Score Outcome","preferredDefinition":"A response used to determine the PD-L1 Combined Positive Score (CPS) result.","longName":"7525489v1.0:7525479v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E86ED2-E28D-6806-E053-4EBD850A2563","latestVersionIndicator":"Yes","beginDate":"2020-12-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-12-07","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeNote":"Created for EA3139, 12/07/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525605","version":"1","preferredName":"Patient Clinical Trial Participation Eligibility Criteria Confirmation Status","preferredDefinition":"Verification that the patient meets the eligibility requirements for participating in a clinical trial.","longName":"ELIG_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5DA57BE-5096-6F92-E053-4EBD850AF212","latestVersionIndicator":"Yes","beginDate":"2020-12-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-12-08","modifiedBy":"DWARZEL","dateModified":"2022-05-03","changeNote":"EAQ201; TL.","administrativeNotes":"2022-5-3 ak Added AQT for EAQ201.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525606","version":"1","preferredName":"Patient Clinical Trial Refusal to Participate Eligibility Criteria Confirmation Status","preferredDefinition":"Verification that the patient meets the eligibility requirements for declining to participate in a clinical trial.","longName":"REF_TRIAL_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E25D80-593F-2E07-E053-4EBD850A0F49","latestVersionIndicator":"Yes","beginDate":"2020-12-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-12-08","modifiedBy":"TAYLORT","dateModified":"2021-05-19","changeNote":"EAQ201; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525607","version":"1","preferredName":"Patient Questionnaire Complete Eligibility Determination Confirmation Status","preferredDefinition":"Verification that the patient meets the eligibility requirements for the completion of questionnaires.","longName":"QUES_COMPL_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5F86B93-C36D-6AB3-E053-4EBD850ADDDB","latestVersionIndicator":"Yes","beginDate":"2020-12-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-12-08","modifiedBy":"FINCHAMB","dateModified":"2023-03-20","changeNote":"9/1/21 TL corrected typo in PQT. EAQ201; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7525608","version":"1","preferredName":"Patient Zip Code Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"Verification that the patient's zip code meets the requirements for participating in a clinical trial.","longName":"ZIPCOD_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E264EB-E255-6F98-E053-4EBD850A9151","latestVersionIndicator":"Yes","beginDate":"2020-12-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-12-08","modifiedBy":"TAYLORT","dateModified":"2021-05-19","changeNote":"EAQ201; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7534770","version":"1","preferredName":"Health Insurance Portability and Accountability Act Authorization Obtain Indicator","preferredDefinition":"A response used to determine whether or not HIPAA authorization was obtained.","longName":"5429973v1.0:7534636v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6C0F33F-DD79-7FD5-E053-4EBD850A4484","latestVersionIndicator":"Yes","beginDate":"2020-12-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-12-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for OPEN Checklist, 12/18/2020, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7547065","version":"1","preferredName":"Multiple Myeloma RISS Stage","preferredDefinition":"A response used to determine the plasma cell myeloma stage defined according to the Revised International Staging System (RISS) criteria.","longName":"6711245v1.0:7547064v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8B592E4-8461-4EC2-E053-4EBD850ADFE9","latestVersionIndicator":"Yes","beginDate":"2021-01-12","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-01-12","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAA181, 12 JAN 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7554795","version":"1","preferredName":"Resection Surgical Margins Residual Tumor Status","preferredDefinition":"A response used to determine the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","longName":"7554794v1.0:7062948v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCC7FF-FDEC-2EDC-E053-4EBD850A0025","latestVersionIndicator":"Yes","beginDate":"2021-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-01-25","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2192, 25 JAN 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7554799","version":"1","preferredName":"Platinum-Based Chemotherapy Administered Ind.","preferredDefinition":"A response used to determine whether or not synthetic or naturally-occurring chemicals derived from or containing platinum were used for the treatment of a disease.","longName":"7554798v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCD32F-0BD6-2ED2-E053-4EBD850A7A5A","latestVersionIndicator":"Yes","beginDate":"2021-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-01-25","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2192, 25 JAN 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7554803","version":"1","preferredName":"Neoadjuvant Platinum-Based Chemotherapy Administered Ind.","preferredDefinition":"A response used to determine whether or not synthetic or naturally-occurring chemicals derived from or containing platinum were administered for treatment of a disease prior to the primary treatment for the purpose of making the primary treatment more effective.","longName":"7554802v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BCBBE2-404B-2ED8-E053-4EBD850A18E1","latestVersionIndicator":"Yes","beginDate":"2021-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-01-25","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA2192, 25 JAN 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7574449","version":"1","preferredName":"Clinical Trial Eligibility Criteria Central Reviewer Confirmed Ind-2","preferredDefinition":"A response used to determine whether or not characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol have been verified by a person who critically evaluates and reports on laboratory test results, protocols, or other data.","longName":"7574448v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA6EFC16-13BE-66F2-E053-4EBD850A588D","latestVersionIndicator":"Yes","beginDate":"2021-02-03","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-03","modifiedBy":"ZHWENDY","dateModified":"2023-08-21","changeNote":"Created for EA2192, 03 Feb 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576140","version":"1","preferredName":"Primary Neoplasm Anatomic Site","preferredDefinition":"A response used to identify the location of a primary tumor.","longName":"7576139v1.0:7576136v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAD86304-4EAF-7368-E053-4EBD850AA122","latestVersionIndicator":"Yes","beginDate":"2021-02-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-08","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8192, 08 Feb 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7576321","version":"1","preferredName":"Screening Assessment External Performing Laboratory Outcome Indicator","preferredDefinition":"A response used to determine an whether an analysis of a sample(s) collected for assessment was provided by an outside laboratory.","longName":"5780037v1.0:7576318v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BAFD9DAB-7A3E-1DBC-E053-4EBD850A0866","latestVersionIndicator":"Yes","beginDate":"2021-02-10","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-10","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EAY131, 10 Feb 2021","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7580739","version":"1","preferredName":"Bladder Flat Urothelial Carcinoma Gross Appearance Status","preferredDefinition":"A response used to determine the predominant macroscopic features of an in situ or invasive urothelial carcinoma that arises from the bladder wall and does not grow toward the hollow part of the bladder are present in a tumor observed by pathologic gross examination.","longName":"7580737v1.0:7580731v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9F7162-2B4A-08CA-E053-4EBD850A9CCA","latestVersionIndicator":"Yes","beginDate":"2021-02-18","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-02-18","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeNote":"Created for EA8192, 18 Feb 2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652691","version":"1","preferredName":"Patient Primary Neoplasm Diagnosis Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient's diagnosis for primary cancer meets the study eligibility criteria.","longName":"PNEO_DX_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1C0501D-DAAB-798E-E053-4EBD850AFE1E","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-07","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652692","version":"1","preferredName":"Patient Personal Medical History Malignant Neoplasm Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient's medical history of cancer meets the study eligibility criteria.","longName":"PMH_CA_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1C27CF8-2522-482F-E053-4EBD850ADF17","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-07","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652697","version":"1","preferredName":"Patient Personal Medical History Skin Basal Cell Carcinoma Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient's medical history of basal cell skin carcinoma meets the study eligibility criteria.","longName":"BCC_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1C08329-984E-7916-E053-4EBD850AF0FA","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-07","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652699","version":"1","preferredName":"Patient English Language Eligibility Determination Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the study eligibility criteria with regards to English language.","longName":"ENGL_LANG_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-1690-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-07","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652702","version":"1","preferredName":"Patient E-mail Address Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the study eligibility criteria with regards to an email address.","longName":"EMAIL_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1C1B35A-C60D-6242-E053-4EBD850A6CBF","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-07","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652758","version":"1","preferredName":"Patient Mobile Telephone Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the study eligibility criteria with regards to a mobile phone.","longName":"MOB_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1F98A0D-FC02-4133-E053-4EBD850A3E22","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-10","modifiedBy":"FINCHAMB","dateModified":"2023-06-08","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7652759","version":"1","preferredName":"Patient Self Report Data Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"A response to confirm that the patient meets the study eligibility criteria with regards to self-report data.","longName":"SR_DATA_ELIG","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1F9E050-CA8A-4115-E053-4EBD850ACBF0","latestVersionIndicator":"Yes","beginDate":"2021-05-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-05-10","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7691718","version":"1","preferredName":"Clinical Study Protocol Addendum Activation Ind-2","preferredDefinition":"An indication as to whether or not the appendage to the trial protocol containing supplemental information has been activated.","longName":"7691717v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4FAC092-AB57-3C51-E053-4EBD850A89EA","latestVersionIndicator":"Yes","beginDate":"2021-06-17","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-06-17","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA9171 OPEN Checklist, 06/17/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7702033","version":"1","preferredName":"Acute Lymphoblastic Leukemia Immunophenotype Type","preferredDefinition":"A response used to determine the characterization of a set of Acute Lymphoblastic Leukemia cells according to the antigens expressed.","longName":"7701923v1.0:7701915v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C55C4679-0919-5E30-E053-4EBD850A1406","latestVersionIndicator":"Yes","beginDate":"2021-06-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-06-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA9152, 06/22/2021, JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7705150","version":"1","preferredName":"Credential Radiologist Imaging Technique Review Occurrence Ind-2","preferredDefinition":"An indication on whether or not any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy was evaluated by a credentialed radiologist.","longName":"7704916v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5612AE4-DBAC-36C8-E053-4EBD850AE993","latestVersionIndicator":"Yes","beginDate":"2021-06-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-06-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA8134, 06/22/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7768145","version":"1","preferredName":"Patient Consent Imaging Technique Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A response that indicates whether the patient chooses to take part in an image study.","longName":"CNST_IMG_IND","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9FEB492-8B49-5A3F-E053-4EBD850A8BF9","latestVersionIndicator":"Yes","beginDate":"2021-08-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-08-20","modifiedBy":"KUMMEROA","dateModified":"2021-08-31","changeNote":"2021-8-20 ak Created for EA1183.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7768146","version":"1","preferredName":"Patient Consent Imaging Technique Clinical Trial Eligibility Criteria Date","preferredDefinition":"A response used to indicate the date on which the patient consented to an image study.","longName":"CNST_IMG_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9FD4DF3-6733-0738-E053-4EBD850AAAFF","latestVersionIndicator":"Yes","beginDate":"2021-08-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-08-20","modifiedBy":"KUMMEROA","dateModified":"2021-08-31","changeNote":"2021-8-20 ak Created for EA1183.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7768150","version":"1","preferredName":"Patient Negation Growth Factor Administered Clinical Trial Eligibility Criteria Confirmation Status","preferredDefinition":"The status of patient eligibility verification to address that the patient did not receive a growth factor as outlined in the study protocol.","longName":"NON_GF_ELIG_CONF","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9FF0421-771B-5894-E053-4EBD850A0F63","latestVersionIndicator":"Yes","beginDate":"2021-08-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-08-20","modifiedBy":"KUMMEROA","dateModified":"2021-08-31","changeNote":"2021-8-20 ak Created for EA1183.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781322","version":"1","preferredName":"Receive Bortezomib Therapeutic Procedure Stratification Factors Status","preferredDefinition":"A response that indicates whether or not the patient received bortezomib (a dipeptide boronic acid analogue with antineoplastic activity) was previously administered; this response will to be used as a selected pre-treatment factor by which patients are segregated to assure equal balance of these factor before randomization to the intervention arms of a clinical protocol.","longName":"7781318v1.0:7781319v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB7E0264-2D8F-67AF-E053-4EBD850A8502","latestVersionIndicator":"Yes","beginDate":"2021-09-08","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-09-08","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EAA181 - 09/08/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7781439","version":"1","preferredName":"Unique Identifier Provided Ind-3","preferredDefinition":"A response used to determine whether or not a set of characters used as a code that is unique in the context or the system for which it is created was provided.","longName":"7068174v1.0:7781437v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB909F47-7209-078D-E053-4EBD850A482D","latestVersionIndicator":"Yes","beginDate":"2021-09-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-09-09","modifiedBy":"GARRIDOJ","dateModified":"2022-03-16","changeNote":"Created for EAY131, 09/09/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7784789","version":"1","preferredName":"Patient Race Ethnicity Stratifcation Factor Category","preferredDefinition":"Race and ethnicity pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"RACE_ETHNY_STRAT_CAT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC311AB1-35F9-43F6-E053-4EBD850A0AE5","latestVersionIndicator":"Yes","beginDate":"2021-09-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-09-17","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EAQ202 OPEN Eligibility Checklist","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7788485","version":"1","preferredName":"Radiation Therapy Intended Or Received Stratification Factor Ind-2","preferredDefinition":"A response used to determine whether or not treatment of a disease by means of exposure of the target or the whole body to radiation is intended or was previous received; this response will to be used as a selected pre-treatment factor by which patients are segregated to assure equal balance of these factor before randomization to the intervention arms of a clinical protocol.","longName":"7788484v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB08454-1316-7653-E053-4EBD850A254F","latestVersionIndicator":"Yes","beginDate":"2021-09-23","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-09-23","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA6174, 09/23/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797685","version":"1","preferredName":"Surgical Procedure Decipher Prostate Cancer Test Score Obtained Date","preferredDefinition":"A response used to determine the date on which a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue of was done for an individual in which a proprietary genetic test that evaluates a prostate cancer tumor for its potential for metastasis was obtained.","longName":"7797681v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE15B07E-F713-19D0-E053-4EBD850ACFE8","latestVersionIndicator":"Yes","beginDate":"2021-10-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-11","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA8183, 10/11/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797686","version":"1","preferredName":"Surgical Procedure Decipher Prostate Cancer Test Score Not Obtained Date","preferredDefinition":"A response used to determine the date on which a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue of was done for an individual in which a proprietary genetic test that evaluates a prostate cancer tumor for its potential for metastasis was not obtained.","longName":"7797684v1.0:2018550v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE154821-B643-19DC-E053-4EBD850AFA98","latestVersionIndicator":"Yes","beginDate":"2021-10-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-11","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA8183, 10/11/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7799625","version":"1","preferredName":"Immune Checkpoint Inhibitor Therapeutic Procedure Disease Progression Pattern Stratification Factors Type","preferredDefinition":"A response used to identifiable the pattern disease progression in a therapeutic agent that inhibits any of the immune checkpoint inhibitory proteins.","longName":"7799621v1.0:7799622v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF3A2A8-62B9-7216-E053-4EBD850AECAB","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeNote":"Created for EA3202, 10.22.2021 (JG)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7982644","version":"1","preferredName":"Disease or Disorder Most Recent Imaging Procedure Confirmation Date","preferredDefinition":"The date of the most recent imaging procedure that confirms an abnormal condition of the body or mind.","longName":"DZ_IMAG_CONF_DT","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D39B5883-0B2C-77FA-E053-4EBD850AE8E4","latestVersionIndicator":"Yes","beginDate":"2021-12-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-12-20","modifiedBy":"TAYLORT","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; EA1183: tl.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8013603","version":"1","preferredName":"Enrollment Stratification Factor Status","preferredDefinition":"A response used to determine the enrollment status using selected pre-treatment factor by which patients are segregated to assure equal balance of these factor before randomization to the intervention arms of a clinical protocol.","longName":"8013585v1.0:8013600v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D66CE523-B17A-1EC0-E053-4EBD850A9C3C","latestVersionIndicator":"Yes","beginDate":"2022-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-01-25","modifiedBy":"GARRIDOJ","dateModified":"2022-02-23","changeNote":"TL released 2/23/22.; Created for EA2183, 01/25/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8013606","version":"1","preferredName":"Immunotherapy Choice Stratification Factor Type","preferredDefinition":"A response used to indicate the immunotherapy treatment of choice; this response will to be used as a selected pre-treatment factor by which patients are segregated to assure equal balance of these factor before randomization to the intervention arms of a clinical protocol.","longName":"8013592v1.0:8013597v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D66CE523-B1A2-1EC0-E053-4EBD850A9C3C","latestVersionIndicator":"Yes","beginDate":"2022-01-25","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-01-25","modifiedBy":"GARRIDOJ","dateModified":"2022-02-23","changeNote":"Created for EA2183, 01/25/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8013871","version":"1","preferredName":"Induction Therapy Received Type","preferredDefinition":"A response used to determine which first choice of treatment for a particular type of cancer was taken.","longName":"8013867v1.0:8013868v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D67D3894-9E61-2EAE-E053-4EBD850A7E13","latestVersionIndicator":"Yes","beginDate":"2022-01-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-01-26","modifiedBy":"GARRIDOJ","dateModified":"2022-02-23","changeNote":"Created for EA2183, 01/26/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8014354","version":"1","preferredName":"Induction Therapy Complete Ind-2","preferredDefinition":"A response used to determine whether or not the first choice of treatment for a particular type of cancer was completed.","longName":"8014353v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D67E2AFB-D077-6255-E053-4EBD850A24FF","latestVersionIndicator":"Yes","beginDate":"2022-01-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-01-26","modifiedBy":"GARRIDOJ","dateModified":"2022-02-28","changeNote":"Created for EA2183, 01/26/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8137605","version":"1","preferredName":"Transurethral Resection of Bladder Tumor Stage Stratification Factors Category","preferredDefinition":"A response used to determine the selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on tumor staging after a surgical procedure used to treat bladder tumors, during which a resectoscope is passed through the urethra and into the bladder has been performed.","longName":"8137576v1.0:8137601v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD6F6DD-1ECE-617A-E053-4EBD850A70E1","latestVersionIndicator":"Yes","beginDate":"2022-04-04","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-04-04","modifiedBy":"GARRIDOJ","dateModified":"2022-04-26","changeNote":"Created for EA8212, 04 Apr 2022 (JG)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8176851","version":"1","preferredName":"Induction Chemotherapy Complete Prior To Randomization Stratification Factors Ind","preferredDefinition":"A response used to determine selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on whether or not a first choice of a synthetic or naturally-occurring chemicals for the treatment for a particular type of cancer.was previously used.","longName":"8176847v1.0:3506068v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD94C6AE-7A3B-7923-E053-4EBD850AE991","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-04-26","modifiedBy":"GARRIDOJ","dateModified":"2022-04-26","changeNote":"Created for EA8185, 04/26/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8178086","version":"1","preferredName":"Lymph Node N Category Stratification Factors Stage","preferredDefinition":"A response used to determine selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol based on one criteria of the TNM staging system, N which refers to the extent of lymph node involvement.","longName":"8176869v1.0:7736593v1.0","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDB9809F-A955-53E6-E053-4EBD850A30C6","latestVersionIndicator":"Yes","beginDate":"2022-04-28","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2022-04-28","modifiedBy":"ZHWENDY","dateModified":"2022-08-11","changeNote":"Created for EA8185, 04/28/2022 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11227488","version":"1","preferredName":"Patient Comprehension And Consent Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A yes/no response indicating whether the patient comprehends and complies with the study procedure as outlined in the protocol.","longName":"11227487v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E87CA3D9-B02F-5FAF-E053-731AD00A27ED","latestVersionIndicator":"Yes","beginDate":"2022-09-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2022-09-12","modifiedBy":"FINCHAMB","dateModified":"2023-06-27","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11334662","version":"1","preferredName":"Core Binding Factor Acute Myeloid Leukemia Present Type","preferredDefinition":"A response used to indicate Acute myeloid leukemia characterized present and to verify the type of cytogenetic abnormalities result in disruption of the transcription factor CBF.","longName":"11332301v1.00:11332303v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9D2A3D7-986B-1A2B-E053-731AD00A3D5E","latestVersionIndicator":"Yes","beginDate":"2022-09-29","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-09-29","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11334663","version":"1","preferredName":"Disease or Disorder European LeukemiaNet Risk Classification Core Binding Factor Type","preferredDefinition":"A response to disease or disorder of guidelines developed by the European LeukemiaNet group to optimize the selection of acute myeloid leukemia therapy based on a subject's genetic profile is present and to verify the type of cytogenetic abnormalities result in disruption of the transcription factor CBF.","longName":"11334657v1.00:11332303v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9D2CCDE-AD8E-1F50-E053-731AD00A679F","latestVersionIndicator":"Yes","beginDate":"2022-09-29","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-09-29","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11482947","version":"1","preferredName":"Regional Lymph Node Short Axis Size Measurement","preferredDefinition":"An annotation to indicate the size or magnitude of the regional lymph node short axis.","longName":"11482946v1.00:7349334v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB8E3C79-E6E3-6AB3-E053-731AD00A7BDB","latestVersionIndicator":"Yes","beginDate":"2022-10-21","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2022-10-21","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12062671","version":"1","preferredName":"Prior Treatment Maintenance Regimen Month Duration","preferredDefinition":"The period of time in months in which prior treatment maintenance occurred.","longName":"2196231v1.00:3386250v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED99E00C-CAE5-485B-E053-731AD00A1AD8","latestVersionIndicator":"Yes","beginDate":"2022-11-16","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2022-11-16","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"11/16/22 Created for EA BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12564461","version":"1","preferredName":"Hormone Receptor Estrogen Progesterone Positive Or Negative Clinical Trial Eligibility Indicator","preferredDefinition":"The yes/no response as to whether the patient has either a positive or negative Estrogen and Progesterone hormone receptor status as outlined in the study protocol.","longName":"12564458v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F45D04D7-D31C-1421-E053-731AD00ABF37","latestVersionIndicator":"Yes","beginDate":"2023-02-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-10","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"2/10/23 Created for EA1211. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12926685","version":"1","preferredName":"Disease or Disorder HER2 Positive Breast Carcinoma Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"The yes/no indicator to determine whether the HER2-positive diagnosis meets eligibility criteria as outlined in the study.","longName":"6013127v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F575BFBB-CABD-392D-E053-731AD00AF815","latestVersionIndicator":"Yes","beginDate":"2023-02-24","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-24","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"2/24/23 Curated for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13243946","version":"1","preferredName":"Patient Imaging Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator that determines the verification of patient eligibility for the imaging procedure requirements as outlined in the study protocol.","longName":"5025934v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A7B28E-6C57-6D7B-E053-731AD00A580D","latestVersionIndicator":"Yes","beginDate":"2023-03-24","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-24","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"Created for EA to accommodate PV's, as previous CDE didn't fit nature of the question. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13289852","version":"1","preferredName":"Prostate Gland Biopsy Follow-up Date","preferredDefinition":"The calendar date of the follow-up prostate gland biopsy.","longName":"3148098v1.00:2434927v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8373169-B503-197B-E053-731AD00A8F24","latestVersionIndicator":"Yes","beginDate":"2023-03-31","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-31","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"3/3/1/23 Curated for EA. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13298200","version":"1","preferredName":"First Systemic Therapy Assessment Status","preferredDefinition":"A text description of the status of a patients initial systemic therapy.","longName":"13268798v1.00:13268795v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F871E379-9B11-2969-E053-731AD00AFC40","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-03","modifiedBy":"SOKKERL","dateModified":"2023-09-30","changeNote":null,"administrativeNotes":"4/3/23 created for EA. BF; 9/30/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13298781","version":"1","preferredName":"Oropharynx Carcinoma CDKN2A-p16 Positive Present Indicator","preferredDefinition":"The indicator of whether CDKN2A-p16 positive oropharynx cancer was present.","longName":"13298369v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F872BF88-E53C-54FB-E053-731AD00A589F","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-03","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"4/3/23 Curated for EA. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13433946","version":"1","preferredName":"Therapeutic Procedure Curative Surgery Or Radiation Therapy Performed Indicator","preferredDefinition":"The indicator of whether or not a therapeutic procedure of curative surgery or radiation therapy was performed.","longName":"13433944v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2CC237-A484-65E6-E053-731AD00A485E","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2023-11-03","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13434010","version":"1","preferredName":"Clinical Trial No Cost Systemic Therapy Enrollment Indicator","preferredDefinition":"The indicator of whether or not the patient was enrolled in a clinical trial that provided systemic therapy at no cost.","longName":"13434008v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2D0C06-FDAA-6F0B-E053-731AD00A4E7F","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2023-10-04","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13434015","version":"1","preferredName":"Clinical Trial Offer Financial Navigation Enrollment Indicator","preferredDefinition":"The indicator of whether or not the patient was enrolled in a clinical trial that offered financial navigation.","longName":"13434014v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2D5A1D-E75B-7BB7-E053-731AD00A77CA","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13434019","version":"1","preferredName":"Other Clinical Trial Offer Out of Pocket Payment Or Financial Navigation Assistance Enrollment Indicator","preferredDefinition":"The indicator of whether or not the patient was enrolled in other clinical trials that offered out of pocket payment or financial navigation assistance.","longName":"13434018v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2D7C4D-B0D5-012C-E053-731AD00ACCD0","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13434022","version":"1","preferredName":"Indolent Malignant Neoplasm Present Indicator","preferredDefinition":"The indicator of whether or not an indolent malignant neoplasm was present.","longName":"13434021v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2DAFA0-3630-0BE6-E053-731AD00A6177","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2023-08-29","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13434165","version":"1","preferredName":"Healthcare Facility Clinical Oncology Visit Indicator","preferredDefinition":"The indicator of whether or not there was a healthcare facility clinical oncology visit.","longName":"3787073v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA2DF09D-9924-14A8-E053-731AD00AF155","latestVersionIndicator":"Yes","beginDate":"2023-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-25","modifiedBy":"FINCHAMB","dateModified":"2023-11-03","changeNote":null,"administrativeNotes":"2023.4.26 Released per review. ak2023.4.25 Created per ticket request CADSR0002331. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13441118","version":"1","preferredName":"Patient International Metastatic Renal Cell Carcinoma Database Consortium Criteria Risk Factor Score","preferredDefinition":"The numeric response for the stratification factor to address the participants International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria risk score.","longName":"8072482v1.00:13439137v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA3EF2E9-B496-11A8-E053-731AD00A37FE","latestVersionIndicator":"Yes","beginDate":"2023-04-26","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-26","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"4/26/23 Curated for EA. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13546957","version":"1","preferredName":"Participant Employed Indicator","preferredDefinition":"The yes/no indicator as to whether or not the participant is employed.","longName":"13546956v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB4618CA-2240-2F08-E053-731AD00A5BA1","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-09","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"Curated for EA 5/9/23.","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13546960","version":"1","preferredName":"Participant Randomized Protocol Arm Assigned Indicator","preferredDefinition":"The yes/no indicator to identify whether the participant has been assigned a randomized protocol treatment arm.","longName":"13546959v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB46DAA1-9023-4D4B-E053-731AD00A68CA","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-09","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"Curated for EA 5/9/23. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13546965","version":"1","preferredName":"Participant Protocol Assigned Role Indicator","preferredDefinition":"The yes/no indicator to determine whether a participant has been give an assigned role in the protocol or study.","longName":"13546964v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB4723A2-F4AC-6306-E053-731AD00ADB75","latestVersionIndicator":"Yes","beginDate":"2023-05-09","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-09","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"Curated for EA 5/9/23. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13563513","version":"1","preferredName":"Metastatic Disease Timing Type","preferredDefinition":"Text term to describe the timing type of the metastatic disease in relation to diagnosis of primary.","longName":"4514692v1.00:13563510v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB5F3984-4ABB-19CF-E053-731AD00A933F","latestVersionIndicator":"Yes","beginDate":"2023-05-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-10","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"Created for ECOG-ACRIN Stratification Factor Questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13565272","version":"1","preferredName":"Person Speak English Language Indicator","preferredDefinition":"The yes/no response as to whether a person speaks the English Language.","longName":"13565271v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6C3E71-23DA-632E-E053-731AD00A28BA","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"5/11/23 Created for EA.BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13567052","version":"1","preferredName":"RAS Family Gene Mutation Status","preferredDefinition":"The text term that represents the status of the RAS gene mutation.","longName":"7374102v1.00:13567048v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6D1790-846B-11E0-E053-731AD00A89D1","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"5/11/23 Created for ECOG-ACRIN Stratification Factor Questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13567111","version":"1","preferredName":"Primary Tumor Laterality Type","preferredDefinition":"The text term to designate the side of the body on which the tumor is located.","longName":"2188720v1.00:13567109v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6F252E-716E-6BC7-E053-731AD00A8801","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-11","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"5/11/23 Created for ECOG-ACRIN Stratification Factor Questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13816897","version":"1","preferredName":"Participant Survey Language Preference Type","preferredDefinition":"Text term that represents a participants survey language preference.","longName":"13816894v1.00:2670708v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FDA263E2-DBED-5749-E053-731AD00AB4E6","latestVersionIndicator":"Yes","beginDate":"2023-06-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-06-08","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"6/8/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13958133","version":"1","preferredName":"Participant Outcomes and Economics Assessment Unit Eligible Indicator","preferredDefinition":"The yes/no indicator to determine if a participant is eligible to complete surveys according to the Participant Outcomes and Economics Assessment Unit (OEAU) specified criteria.","longName":"13958120v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE430F18-EFE2-1422-E053-731AD00A7786","latestVersionIndicator":"Yes","beginDate":"2023-06-16","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-06-16","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"6/16/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14114662","version":"1","preferredName":"Tumor Location Anatomic Site Name","preferredDefinition":"The anatomic position of a tumor within an organ or system or within the patient as a whole.","longName":"2010859v2.31:14114659v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"00F1EDB0-139C-71FC-E063-731AD00A438B","latestVersionIndicator":"Yes","beginDate":"2023-07-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-07-20","modifiedBy":"FINCHAMB","dateModified":"2023-10-19","changeNote":null,"administrativeNotes":"7/20/23 created for ECOG-ACRIN stratification questions. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14216928","version":"1","preferredName":"Laboratory Procedure Physical Examination Assessment Indicator","preferredDefinition":"The yes/no indicator related to laboratory procedure(s) or physical examinations that involve the assessment of patient prior to therapy.","longName":"3105151v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"018FCB66-925C-796A-E063-731AD00A2D78","latestVersionIndicator":"Yes","beginDate":"2023-07-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-07-28","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"7/28/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14273431","version":"1","preferredName":"Image Scan Disease Progression Date","preferredDefinition":"The date on which an imaging scan occurred showing the progression or advancement of disease.","longName":"14273430v1.00:2018550v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"021ADC05-21A2-021A-E063-731AD00AA1AB","latestVersionIndicator":"Yes","beginDate":"2023-08-04","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-04","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"8/4/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14410510","version":"1","preferredName":"Participant Health Care Provider Assessment Eligibility Criteria Indicator","preferredDefinition":"The response indicating whether or not the participant is a Health Care Provider.","longName":"14410504v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02FA2752-7D5A-584E-E063-731AD00A41D8","latestVersionIndicator":"Yes","beginDate":"2023-08-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-08-15","modifiedBy":"FINCHAMB","dateModified":"2023-11-13","changeNote":null,"administrativeNotes":"8/15/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14506270","version":"1","preferredName":"Survey Complete Date","preferredDefinition":"The particular day, month and year the survey was completed.","longName":"5456193v1.00:2532012v2.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05F90A31-AE27-384D-E063-731AD00AE678","latestVersionIndicator":"Yes","beginDate":"2023-09-22","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-09-22","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"9/22/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14527085","version":"1","preferredName":"Disease Progression Post Agent Administration Yes No Indicator","preferredDefinition":"The indication of whether or not a patient's disease progressed after administration of an agent/drug.","longName":"14527084v1.00:3506068v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06EBEE7E-797B-6DDD-E063-731AD00AA167","latestVersionIndicator":"Yes","beginDate":"2023-10-04","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-10-04","modifiedBy":"FINCHAMB","dateModified":"2023-10-11","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14572330","version":"1","preferredName":"Magnetic Resonance Imaging Postoperative Complete Indicator","preferredDefinition":"The yes/no indicator to determine whether an MRI was completed after surgery.","longName":"14570320v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0889B083-B633-27DA-E063-731AD00AE465","latestVersionIndicator":"Yes","beginDate":"2023-10-25","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-10-25","modifiedBy":"FINCHAMB","dateModified":"2023-12-13","changeNote":null,"administrativeNotes":"10/25/23 created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14572334","version":"1","preferredName":"Magnetic Resonance Imaging Preoperative Complete Indicator","preferredDefinition":"The yes/no indicator to determine whether an MRI was completed prior to surgery.","longName":"14572333v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"088B3608-3362-76A9-E063-731AD00AE9A8","latestVersionIndicator":"Yes","beginDate":"2023-10-25","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-10-25","modifiedBy":"FINCHAMB","dateModified":"2023-11-21","changeNote":null,"administrativeNotes":"10/25/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14572340","version":"1","preferredName":"Patient Best Practice Therapeutic Procedure Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator as to whether the patient meets the eligibility requirements for participation in a clinical trial regarding treatment(s) that adheres to standard of care practices.","longName":"6763183v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"088BBDF2-92A4-1A53-E063-731AD00A5E2C","latestVersionIndicator":"Yes","beginDate":"2023-10-25","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-10-25","modifiedBy":"FINCHAMB","dateModified":"2023-11-22","changeNote":null,"administrativeNotes":"10/25/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14572343","version":"1","preferredName":"Central Pathology Review Diagnosis Confirmed Indicator","preferredDefinition":"The yes/no indicator that asks whether the diagnosis was pathologically confirmed.","longName":"14572342v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"088C2D36-CA92-2F27-E063-731AD00A7C52","latestVersionIndicator":"Yes","beginDate":"2023-10-25","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-10-25","modifiedBy":"FINCHAMB","dateModified":"2023-10-31","changeNote":null,"administrativeNotes":"10/25/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14596984","version":"1","preferredName":"Patient Mobile Telephone Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator to confirm that the patient meets the study eligibility criteria with regards to a mobile phone.","longName":"7652754v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"097F1BF4-A637-4356-E063-731AD00AFCD5","latestVersionIndicator":"Yes","beginDate":"2023-11-06","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-06","modifiedBy":"FINCHAMB","dateModified":"2023-11-08","changeNote":null,"administrativeNotes":"11/6/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607703","version":"1","preferredName":"Primary Neoplasm Surveillance Requirement Indicator","preferredDefinition":"The yes/no indicator to determine whether the primary tumor requires medical imaging surveillance.","longName":"14607702v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5A9B2D-6D41-4E11-E063-731AD00AD462","latestVersionIndicator":"Yes","beginDate":"2023-11-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-17","modifiedBy":"FINCHAMB","dateModified":"2023-12-13","changeNote":null,"administrativeNotes":"11/17/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14607705","version":"1","preferredName":"Imaging Surveillance Requirement Indicator","preferredDefinition":"The yes/no indicator to determine whether medical imaging surveillance is required.","longName":"14607704v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A5AE599-A16C-6260-E063-731AD00ABD07","latestVersionIndicator":"Yes","beginDate":"2023-11-17","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-17","modifiedBy":"FINCHAMB","dateModified":"2023-12-22","changeNote":null,"administrativeNotes":"11/17/23 Created for ECOG-ACRIN. BF;","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14616473","version":"1","preferredName":"Patient Measurable Disease Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no/not applicable indicator regarding whether a person has a tumor that can be accurately measured in size.","longName":"5036393v1.00:3506036v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AAE146D-7538-74AF-E063-731AD00A0B39","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-21","modifiedBy":"FINCHAMB","dateModified":"2023-12-13","changeNote":null,"administrativeNotes":"11/21/23 Created for ECOG-ACRIN eligibility criteria, there are other CDE's similar but we cannot use Coded Values for Yes/No/NA. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14633274","version":"1","preferredName":"Patient Age Indicator","preferredDefinition":"The yes/no/unknown/not applicable indicator that asks questions pertaining to the participants age.","longName":"2185959v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B605E61-D2D7-609E-E063-731AD00A1C77","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-30","modifiedBy":"SOKKERL","dateModified":"2024-02-14","changeNote":null,"administrativeNotes":"11/30/23 Created for ECOG-ACRIN. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14640693","version":"1","preferredName":"Biospecimen Future Research Activity Collection Yes/No Indicator","preferredDefinition":"The yes/no/unknown/not applicable indicator as to whether the patient agrees biospecimen collection can be used for further research.","longName":"14056177v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B7630D7-3C4F-0B2B-E063-731AD00A4C8F","latestVersionIndicator":"Yes","beginDate":"2023-12-01","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-12-01","modifiedBy":"FINCHAMB","dateModified":"2023-12-13","changeNote":null,"administrativeNotes":"12/1/23 Created for ECOG-ACRIN. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14666571","version":"1","preferredName":"Metastasis At Diagnosis Assessment Status Malignant Neoplasm Stratification Type","preferredDefinition":"The response that answers a stratification question related to the metastasis status of a malignant neoplasm.","longName":"3437694v1.00:14666569v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D082F3E-EEFD-3EE3-E063-731AD00A62A0","latestVersionIndicator":"Yes","beginDate":"2023-12-21","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-12-21","modifiedBy":"FINCHAMB","dateModified":"2024-01-22","changeNote":null,"administrativeNotes":"12/21/23 Created for ECOG-ACRIN Stratification questions.  BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14672212","version":"1","preferredName":"Imaging Technique Biomarker Name","preferredDefinition":"The text term to identify the imaging technique used for the detection of the biomarker","longName":"14672203v1.00:14672209v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E10303A-E6ED-2D5D-E063-731AD00A63DE","latestVersionIndicator":"Yes","beginDate":"2024-01-03","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-22","changeNote":null,"administrativeNotes":"1/3/24 Created for ECOG-ACRIN. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14678144","version":"1","preferredName":"Bone Marrow Biopsy Finding Indicator","preferredDefinition":"An indictor relating to the findings of bone marrow biopsy.","longName":"14678143v1.00:3506035v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0EC12582-1A59-06A3-E063-731AD00A6433","latestVersionIndicator":"Yes","beginDate":"2024-01-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-01-12","modifiedBy":"SOKKERL","dateModified":"2024-01-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14745989","version":"1","preferredName":"FLT3 Gene Mutation Abnormality Type","preferredDefinition":"A response that answers questions related to the type of genetic abnormality at the chromosomal level of the FLT3 Gene.","longName":"14745983v1.00:14745985v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10E28DC3-0560-28C7-E063-731AD00A3474","latestVersionIndicator":"Yes","beginDate":"2024-02-08","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-08","modifiedBy":"FINCHAMB","dateModified":"2024-02-08","changeNote":null,"administrativeNotes":"2/8/24 Created for ECOG-ACRIN Open Eligibility questions. BF","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14752859","version":"1","preferredName":"Target Lesion Measurement","preferredDefinition":"The response to indicate the sum of diameter of the target lesions.","longName":"6600709v1.00:14751427v1.00","contextName":"ECOG-ACRIN","contextVersion":"1","dataElementConceptPublicId":"2182401","dataElementConceptVersion":"1","valueDomainPublicId":"2018284","valueDomainVersion":"1","origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10F7AD93-189C-1570-E063-731AD00A3C52","latestVersionIndicator":"Yes","beginDate":"2024-02-09","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-09","modifiedBy":"FINCHAMB","dateModified":"2024-02-09","changeNote":null,"administrativeNotes":"2/9/24 Created for ECOG-ACRIN OPEN checklist questions. BF","unresolvedIssues":null,"deletedIndicator":"No"}]}